chrom	pos	rsid	ref	alt	disease/trait
chr1	1309988	.	G	A	Systemic lupus erythematosus
chr1	1312114	.	T	A	Crohn's disease;Ulcerative colitis
chr1	1312114	.	T	C	Crohn's disease;Ulcerative colitis
chr1	1312114	.	T	G	Crohn's disease;Ulcerative colitis
chr1	2523811	.	G	C	Rheumatoid arthritis
chr1	2552522	.	G	A	Rheumatoid arthritis;Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)
chr1	2559766	.	C	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr1	2562891	.	G	A	Autoimmune thyroid disease
chr1	2567423	.	G	C	Ulcerative colitis
chr1	2567423	.	G	T	Ulcerative colitis
chr1	2569783	.	G	T	Multiple sclerosis;Rheumatoid arthritis
chr1	2569899	.	C	T	Ulcerative colitis
chr1	2570077	.	A	G	Ulcerative colitis
chr1	2571341	.	C	T	Ulcerative colitis
chr1	2579316	.	G	A	Allergic disease (asthma, hay fever or eczema)
chr1	2579316	.	G	C	Allergic disease (asthma, hay fever or eczema)
chr1	2581777	.	C	G	Asthma;Ulcerative colitis
chr1	2581777	.	C	T	Asthma;Ulcerative colitis
chr1	2582239	.	A	T	Asthma
chr1	2585342	.	G	A	Multiple sclerosis
chr1	2585342	.	G	C	Multiple sclerosis
chr1	2589088	.	T	C	Multiple sclerosis
chr1	2592284	.	C	T	Primary biliary cholangitis
chr1	2592372	.	G	A	Rheumatoid arthritis
chr1	2594226	.	T	C	Multiple sclerosis
chr1	2595307	.	A	G	Celiac disease;Primary sclerosing cholangitis
chr1	2596694	.	T	C	Rheumatoid arthritis;Rheumatoid arthritis (ACPA-positive)
chr1	2597658	.	T	C	Autoimmune thyroid diseases (Graves disease or Hashimoto's thyroiditis);Graves' disease
chr1	2603539	.	G	A	Celiac disease;Rheumatoid arthritis
chr1	2607961	.	T	C	Celiac disease
chr1	2608357	.	C	T	Celiac disease and Rheumatoid arthritis
chr1	2622185	.	T	C	Diffuse large B-cell lymphoma or rheumatoid arthritis;Rheumatoid arthritis
chr1	2624201	.	T	A	Primary biliary cholangitis
chr1	2863195	.	C	T	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)
chr1	3396350	.	T	G	Ulcerative colitis
chr1	3412820	.	C	T	Rheumatoid arthritis
chr1	3435611	.	G	A	Asthma
chr1	3687131	.	A	T	Joint damage in rheumatoid arthritis
chr1	4089023	.	A	T	Interstitial lung diseases in rheumatoid arthritis
chr1	4133491	.	G	A	Diisocyanate-induced asthma
chr1	4389144	.	A	G	Systemic juvenile idiopathic arthritis
chr1	4521563	.	A	G	Systemic lupus erythematosus
chr1	4521563	.	A	T	Systemic lupus erythematosus
chr1	6144101	.	G	A	Crohn's disease
chr1	6307159	.	T	G	Asthma exacerbations in inhaled corticosteroid treatment
chr1	6452487	.	T	C	Multiple sclerosis
chr1	6470129	.	G	A	Multiple sclerosis
chr1	7901146	.	C	G	Rheumatoid arthritis
chr1	7954990	.	C	T	Behcet's disease
chr1	7961913	.	G	C	Ulcerative colitis
chr1	8204052	.	C	A	Psoriasis
chr1	8208035	.	G	A	Psoriasis
chr1	8230022	.	T	C	Psoriasis or type 2 diabetes (trans-disease meta-analysis)
chr1	8424763	.	A	T	Vitiligo
chr1	8437247	.	T	C	Autoimmune thyroid disease
chr1	8441726	.	A	T	Asthma;Asthma (moderate or severe)
chr1	8443319	.	C	G	Asthma and major depressive disorder;Nonatopic asthma
chr1	8443319	.	C	T	Asthma and major depressive disorder;Nonatopic asthma
chr1	8630874	.	G	C	Nonatopic asthma and/or BMI
chr1	9348900	.	A	C	Response to tocilizumab in rheumatoid arthritis
chr1	9419783	.	G	A	Asthma exacerbations in inhaled corticosteroid treatment
chr1	9729092	.	C	T	Diisocyanate-induced asthma
chr1	9819291	.	A	G	Diisocyanate-induced asthma
chr1	10583772	.	C	G	Allergic disease (asthma, hay fever or eczema)
chr1	10583772	.	C	T	Allergic disease (asthma, hay fever or eczema)
chr1	12069994	.	C	G	Atopic asthma
chr1	12115601	.	G	A	Asthma;Atopic asthma
chr1	13845127	.	A	G	Osteoarthritis (self-reported)
chr1	14960672	.	C	T	Asthma-COPD overlap syndrome
chr1	17224106	.	G	A	Depression in multiple sclerosis
chr1	17328912	.	C	G	Rheumatoid arthritis
chr1	18775271	.	G	A	Knee osteoarthritis
chr1	19059278	.	C	T	Ulcerative colitis
chr1	19141681	.	T	C	Composite immunoglobulin trait (IgA/IgG)
chr1	19811221	.	T	C	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr1	19813543	.	G	A	Ulcerative colitis
chr1	19816373	.	C	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Ulcerative colitis
chr1	19874497	.	A	G	Ulcerative colitis
chr1	19901230	.	G	T	Ulcerative colitis
chr1	19968007	.	C	G	Immunoglobulin light chain (AL) amyloidosis
chr1	20111141	.	A	T	Crohn's disease
chr1	20693912	.	C	T	Type 1 diabetes (age at diagnosis)
chr1	22371954	.	A	G	Ulcerative colitis
chr1	22373858	.	A	G	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr1	22375738	.	T	C	Ulcerative colitis
chr1	24182945	.	A	C	Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect)
chr1	24182945	.	A	G	Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect)
chr1	24924428	.	G	GTT	Asthma
chr1	24924428	.	G	GTTT	Asthma
chr1	24937506	.	G	A	Asthma
chr1	24946709	.	T	A	Crohn's disease
chr1	24965206	.	C	T	Immunoglobulin N-glycan 10 levels;Immunoglobulin N-glycan 11 levels;Immunoglobulin N-glycan 23 levels;Immunoglobulin N-glycan 8 levels
chr1	24966593	.	T	G	Psoriasis;Psoriasis vulgaris
chr1	25025090	.	G	C	Autoimmune thyroid disease
chr1	26275079	.	A	G	Asthma
chr1	31699492	.	G	A	Adult onset asthma and/or BMI;Asthma (adult onset);Nonatopic asthma;Nonatopic asthma and/or BMI
chr1	31699894	.	G	A	Asthma
chr1	31699894	.	G	T	Asthma
chr1	32738415	.	G	A	Multiple sclerosis
chr1	32738415	.	G	C	Multiple sclerosis
chr1	33522178	.	T	C	Response to anti-TNF therapy in rheumatoid arthritis
chr1	33685660	.	T	C	Coronary artery aneurysm in Kawasaki disease
chr1	34692115	.	T	A	Narcolepsy
chr1	35015950	.	T	C	Serum uric acid levels in response to allopurinol in gout
chr1	35622060	.	C	T	Type 1 diabetes
chr1	37781423	.	A	T	Type 1 diabetes
chr1	37812907	.	C	T	Rheumatoid arthritis;Type 1 diabetes with low genetic risk score
chr1	38151199	.	C	A	Rheumatoid arthritis;Rheumatoid arthritis (ACPA-positive)
chr1	38158457	.	G	A	Rheumatoid arthritis
chr1	38168207	.	A	T	Rheumatoid arthritis
chr1	38384667	.	A	C	joint destruction in rheumatoid arthritis (rapid vs slow)
chr1	38384667	.	A	G	joint destruction in rheumatoid arthritis (rapid vs slow)
chr1	44093000	.	A	G	Systemic juvenile idiopathic arthritis
chr1	44492543	.	C	T	Crohn's disease
chr1	45331833	.	C	G	Composite immunoglobulin trait (IgA/IgM)
chr1	46464760	.	C	T	Serum uric acid levels in response to allopurinol in gout
chr1	53163913	.	G	C	Systemic lupus erythematosus
chr1	53163913	.	G	T	Systemic lupus erythematosus
chr1	54465723	.	G	T	Food allergy
chr1	54702100	.	T	A	Adult asthma
chr1	54836263	.	T	C	Finger osteoarthritis
chr1	54836263	.	T	G	Finger osteoarthritis
chr1	55039974	.	G	A	Osteoarthritis of the knee (with total joint replacement)
chr1	55039974	.	G	T	Osteoarthritis of the knee (with total joint replacement)
chr1	58292243	.	T	C	Kawasaki disease
chr1	60576203	.	T	C	Response to tocilizumab in rheumatoid arthritis
chr1	60576203	.	T	G	Response to tocilizumab in rheumatoid arthritis
chr1	61326191	.	G	A	Celiac disease
chr1	61326191	.	G	C	Celiac disease
chr1	62583922	.	C	T	Crohn's disease
chr1	62987118	.	T	A	Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis
chr1	62987118	.	T	C	Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis
chr1	63022557	.	G	A	Post-bronchodilator FEV1 x air pollution (CO) interaction in childhood asthma
chr1	63022557	.	G	T	Post-bronchodilator FEV1 x air pollution (CO) interaction in childhood asthma
chr1	63023669	.	A	G	Post-bronchodilator FEV1 x air pollution (CO) interaction in childhood asthma
chr1	63633409	.	A	G	Type 1 diabetes with low genetic risk score
chr1	63641613	.	C	T	Type 1 diabetes
chr1	63643011	.	G	A	Type 1 diabetes
chr1	63643011	.	G	T	Type 1 diabetes
chr1	63643100	.	T	C	Type 1 diabetes
chr1	63648218	.	T	C	Type 1 diabetes
chr1	64748329	.	T	A	Alanine aminotransferase level after methotrexate initiation in rheumatoid arthritis
chr1	64963636	.	G	A	Autoimmune thyroid disease;Multiple sclerosis
chr1	66288850	.	G	A	Multiple sclerosis
chr1	67095407	.	T	C	Psoriasis
chr1	67132294	.	T	A	Crohn's disease;Crohn's disease or Leprosy (opposite effect)
chr1	67132294	.	T	G	Crohn's disease;Crohn's disease or Leprosy (opposite effect)
chr1	67182913	.	G	A	Crohn's disease;Ulcerative colitis
chr1	67228519	.	A	T	Psoriasis;Ulcerative colitis
chr1	67234232	.	C	A	Acute anterior uveitis (with or without ankylosing spondylitis);Ulcerative colitis
chr1	67236843	.	T	G	Crohn's disease
chr1	67237759	.	G	A	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr1	67240275	.	G	A	Ankylosing spondylitis;Crohn's disease;Psoriasis;Ulcerative colitis;Ulcerative colitis vs rheumatoid arthritis (ordinary least squares (OLS))
chr1	67242007	.	G	A	Crohn's disease;Ulcerative colitis
chr1	67242472	.	G	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Ulcerative colitis
chr1	67247663	.	T	C	Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect);Psoriasis or type 2 diabetes (trans-disease meta-analysis)
chr1	67256884	.	C	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr1	67260421	.	T	C	Psoriasis;Psoriasis vulgaris
chr1	67322032	.	G	A	Rheumatoid arthritis;Systemic sclerosis
chr1	67324617	.	T	C	Primary biliary cholangitis
chr1	67324915	.	T	C	Primary biliary cholangitis
chr1	67333487	.	T	A	Systemic lupus erythematosus
chr1	67333487	.	T	C	Systemic lupus erythematosus
chr1	67336688	.	A	C	Crohn's disease or systemic sclerosis;Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)
chr1	67340749	.	A	G	Systemic lupus erythematosus
chr1	67348757	.	T	C	Systemic sclerosis
chr1	67354511	.	C	T	Primary biliary cholangitis
chr1	67356694	.	A	G	Primary biliary cholangitis
chr1	67359716	.	A	C	Systemic lupus erythematosus
chr1	67373890	.	T	C	Systemic lupus erythematosus
chr1	69322799	.	T	G	Psoriasis
chr1	70529879	.	G	A	Ulcerative colitis
chr1	71808790	.	C	A	Systemic lupus erythematosus
chr1	72474590	.	A	T	Asthma and major depressive disorder
chr1	73644966	.	G	A	Asthma
chr1	77984833	.	C	A	Psoriasis
chr1	78157942	.	C	T	Crohn's disease
chr1	78360228	.	C	T	Skin fluorescence in type 1 diabetes
chr1	78372988	.	G	C	Type 1 diabetes with low genetic risk score
chr1	78537573	.	A	C	Depression in multiple sclerosis (post-diagnosis)
chr1	78790420	.	C	T	Asthma
chr1	80513736	.	G	C	Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count);Response to TNF inhibitor in rheumatoid arthritis (change in tender 28-joint count)
chr1	84845509	.	C	T	Type 1 diabetes
chr1	85823399	.	C	G	Coronary artery aneurysm in Kawasaki disease
chr1	85823399	.	C	T	Coronary artery aneurysm in Kawasaki disease
chr1	88507196	.	A	G	Narcolepsy
chr1	88756513	.	C	T	Subjective response to placebo treatment in childhood asthma (change in cough/wheeze)
chr1	91714361	.	C	T	Osteoarthritis of the hip or knee (hospital diagnosed)
chr1	92088726	.	G	A	Crohn's disease
chr1	92200342	.	A	G	Systemic lupus erythematosus
chr1	92358141	.	G	A	Type 1 diabetes
chr1	92358141	.	G	C	Type 1 diabetes
chr1	92362948	.	A	C	Multiple sclerosis and C-reactive protein levels (pleiotropy)
chr1	92469854	.	T	G	Multiple sclerosis and type 2 diabetes (pleiotropy);Systemic lupus erythematosus
chr1	92474402	.	T	C	Multiple sclerosis
chr1	92485653	.	G	A	Multiple sclerosis
chr1	92509907	.	C	T	Multiple sclerosis
chr1	92571555	.	C	A	Allergic disease (asthma, hay fever or eczema);Asthma or allergic disease (pleiotropy)
chr1	92607671	.	C	A	Epstein Barr virus nuclear antigen 1 IgG levels or multiple sclerosis
chr1	92653853	.	G	A	Systemic lupus erythematosus
chr1	92682820	.	C	T	Multiple sclerosis
chr1	92687078	.	C	T	Multiple sclerosis
chr1	92838046	.	T	C	Multiple sclerosis
chr1	92838046	.	T	G	Multiple sclerosis
chr1	92961312	.	G	C	Multiple sclerosis
chr1	92961312	.	G	T	Multiple sclerosis
chr1	100745004	.	C	G	Asthma exacerbations
chr1	100941963	.	A	G	Multiple sclerosis
chr1	100947346	.	T	G	Multiple sclerosis
chr1	100993403	.	T	A	Sj√∂gren's syndrome
chr1	101000498	.	C	T	Ulcerative colitis
chr1	101139197	.	T	C	Multiple sclerosis and HDL levels (pleiotropy)
chr1	101157404	.	T	C	Multiple sclerosis and C-reactive protein levels (pleiotropy)
chr1	102495801	.	T	A	Type 1 diabetes with low genetic risk score
chr1	102682275	.	T	C	Systemic juvenile idiopathic arthritis
chr1	102938828	.	T	C	Osteoarthritis (hip)
chr1	102998654	.	T	A	Osteoarthritis (hip)
chr1	102998654	.	T	C	Osteoarthritis (hip)
chr1	103000497	.	T	C	Osteoarthritis;Osteoarthritis of the hip or knee
chr1	103000497	.	T	G	Osteoarthritis;Osteoarthritis of the hip or knee
chr1	103107371	.	A	C	Osteoarthritis (hip)
chr1	103107371	.	A	G	Osteoarthritis (hip)
chr1	104042877	.	G	A	Ocular sarcoidosis
chr1	104042877	.	G	C	Ocular sarcoidosis
chr1	104169089	.	A	G	Ocular sarcoidosis
chr1	104753930	.	A	T	Oral corticosteroid burst in asthma
chr1	105538802	.	C	A	Crohn's disease
chr1	107461563	.	G	A	Kawasaki disease
chr1	107461563	.	G	C	Kawasaki disease
chr1	107668383	.	T	C	Lung function (FEV1) in asthma (dust mite allergen exposure interaction)
chr1	107800465	.	G	T	Hashimoto thyroiditis versus Graves' disease
chr1	111149818	.	T	C	Systemic lupus erythematosus
chr1	112068273	.	G	A	Diisocyanate-induced asthma
chr1	113437955	.	T	C	Autoimmune thyroid disease
chr1	113623135	.	A	C	Crohn's disease
chr1	113761186	.	C	A	Antineutrophil cytoplasmic antibody-associated vasculitis;Celiac disease and Rheumatoid arthritis;Crohn's disease;Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular);Rheumatoid arthritis;Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive);Systemic lupus erythematosus;Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies);Type 1 diabetes;Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event);Ulcerative colitis vs rheumatoid arthritis (ordinary least squares (OLS))
chr1	113834946	.	A	G	Alopecia areata;Autoimmune thyroid disease;Autoimmune thyroid diseases (Graves disease or Hashimoto's thyroiditis);Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Crohn's disease;Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS));Crohn's disease vs ulcerative colitis (ordinary least squares (OLS));Graves' disease;Idiopathic inflammatory myopathy;Late-onset myasthenia gravis;Myasthenia gravis;Rheumatoid arthritis;Rheumatoid arthritis (ACPA-positive);Rheumatoid arthritis (rheumatoid factor and anti-cyclic citrullinated peptide seronegative);Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive);Systemic lupus erythematosus;Systemic lupus erythematosus or rheumatoid arthritis;Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies);Type 1 diabetes;Type 1 diabetes and autoimmune thyroid diseases;Vitiligo
chr1	113943285	.	T	C	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr1	116219072	.	T	C	Diisocyanate-induced asthma
chr1	116495665	.	T	A	Multiple sclerosis
chr1	116587089	.	A	G	Asthma (childhood onset)
chr1	116721168	.	T	A	Rheumatoid arthritis
chr1	116738073	.	TC	T	Rheumatoid arthritis (ACPA-positive)
chr1	116800821	.	C	G	Multiple sclerosis
chr1	116800821	.	C	T	Multiple sclerosis
chr1	116840544	.	G	A	Gout (normal type)
chr1	116840544	.	G	T	Gout (normal type)
chr1	116922709	.	G	A	T-Cell Immunoglobulin and Mucin domain 1 levels
chr1	119475304	.	A	C	Diisocyanate-induced asthma
chr1	119716347	.	T	A	Multiple sclerosis
chr1	119716347	.	T	C	Multiple sclerosis
chr1	119731286	.	T	C	Multiple sclerosis
chr1	119895261	.	A	G	Crohn's disease;Type 1 diabetes
chr1	119908567	.	T	C	Crohn's disease
chr1	119921542	.	C	A	Systemic lupus erythematosus
chr1	119921542	.	C	T	Systemic lupus erythematosus
chr1	119962909	.	G	A	Type 1 diabetes
chr1	119986309	.	G	A	Systemic lupus erythematosus
chr1	145707383	.	A	T	Gout
chr1	147733635	.	C	T	Methotrexate-induced interstitial lung disease in rheumatoid arthritis
chr1	150474986	.	C	A	Osteoarthritis (hip)
chr1	150722004	.	A	G	Multiple sclerosis
chr1	150836557	.	A	G	Asthma (childhood onset)
chr1	151788046	.	G	C	Asthma
chr1	151790858	.	C	G	Asthma (childhood onset);Atopic asthma
chr1	151790858	.	C	T	Asthma (childhood onset);Atopic asthma
chr1	151824266	.	C	G	Allergic disease (asthma, hay fever or eczema)
chr1	151829204	.	G	A	Asthma;Asthma (childhood onset);Atopic asthma;Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Crohn's disease;Ulcerative colitis
chr1	151829204	.	G	C	Asthma;Asthma (childhood onset);Atopic asthma;Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Crohn's disease;Ulcerative colitis
chr1	151829204	.	G	T	Asthma;Asthma (childhood onset);Atopic asthma;Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Crohn's disease;Ulcerative colitis
chr1	151829917	.	A	G	Asthma (childhood onset);Atopic asthma
chr1	151853237	.	G	T	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr1	152027641	.	G	A	Allergic disease (asthma, hay fever or eczema)
chr1	152057072	.	G	A	Allergic disease (asthma, hay fever and/or eczema) (age of onset);Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis);Asthma
chr1	152101640	.	A	C	Allergic disease (asthma, hay fever or eczema);Asthma
chr1	152206676	.	C	T	Allergic disease (asthma, hay fever and/or eczema) (age of onset);Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis);Allergic disease (asthma, hay fever or eczema);Asthma;Asthma (childhood onset);Asthma onset (childhood vs adult);Atopic asthma;Pediatric asthma
chr1	152219980	.	G	T	Asthma (childhood onset)
chr1	152305146	.	G	A	Asthma (childhood onset)
chr1	152305146	.	G	C	Asthma (childhood onset)
chr1	152305146	.	G	T	Asthma (childhood onset)
chr1	152307547	.	G	A	Asthma (childhood onset);Atopic asthma
chr1	152307547	.	G	C	Asthma (childhood onset);Atopic asthma
chr1	152307547	.	G	T	Asthma (childhood onset);Atopic asthma
chr1	152312600	.	CACTG	C	Asthma
chr1	152313385	.	G	A	Allergic disease (asthma, hay fever and/or eczema) (age of onset);Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis);Allergic disease (asthma, hay fever or eczema);Asthma;Asthma (age of onset);Asthma (childhood onset);Asthma (moderate or severe);Atopic asthma;Metal allergy
chr1	152313385	.	G	T	Allergic disease (asthma, hay fever and/or eczema) (age of onset);Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis);Allergic disease (asthma, hay fever or eczema);Asthma;Asthma (age of onset);Asthma (childhood onset);Asthma (moderate or severe);Atopic asthma;Metal allergy
chr1	152347096	.	T	C	Allergic disease (asthma, hay fever or eczema);Asthma or allergic disease (pleiotropy)
chr1	152357053	.	C	T	Systemic sclerosis
chr1	152459455	.	C	T	Asthma and eczema
chr1	152468434	.	C	G	Asthma (childhood onset);Atopic asthma
chr1	152468434	.	C	T	Asthma (childhood onset);Atopic asthma
chr1	152473145	.	T	C	Asthma
chr1	152487271	.	T	C	Asthma (childhood onset)
chr1	152520083	.	G	A	Asthma
chr1	152577542	.	T	G	Psoriasis
chr1	152578800	.	A	G	Psoriasis
chr1	152578800	.	A	T	Psoriasis
chr1	152617711	.	C	G	Psoriasis or type 2 diabetes (trans-disease meta-analysis);Psoriasis
chr1	152617711	.	C	T	Psoriasis or type 2 diabetes (trans-disease meta-analysis);Psoriasis
chr1	152618187	.	T	C	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr1	152619708	.	C	A	Psoriasis vulgaris
chr1	152619708	.	C	T	Psoriasis vulgaris
chr1	152620961	.	T	C	Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect)
chr1	152631366	.	C	A	Psoriasis
chr1	152631366	.	C	G	Psoriasis
chr1	152693204	.	G	A	COVID-19 or psoriasis (trans-disease meta-analysis)
chr1	152693204	.	G	C	COVID-19 or psoriasis (trans-disease meta-analysis)
chr1	152720036	.	G	A	Psoriasis
chr1	152720036	.	G	C	Psoriasis
chr1	152760900	.	C	A	Psoriasis
chr1	152760900	.	C	G	Psoriasis
chr1	152760900	.	C	T	Psoriasis
chr1	152798817	.	A	G	Atopic asthma
chr1	152798817	.	A	T	Atopic asthma
chr1	152799487	.	T	A	Asthma;Asthma (childhood onset);Atopic asthma
chr1	152921415	.	C	G	Asthma or allergic disease (pleiotropy);Atopic asthma
chr1	152949110	.	T	C	Asthma;Asthma (childhood onset)
chr1	153079185	.	C	T	Allergic disease (asthma, hay fever and/or eczema) (age of onset);Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis)
chr1	153132598	.	G	A	Asthma (childhood onset)
chr1	153160647	.	T	C	Adverse response to inhaled corticosteroid treatment x age interaction in asthma
chr1	153164031	.	A	G	Adverse response to inhaled corticosteroid treatment x age interaction in asthma
chr1	154406893	.	A	C	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)
chr1	154429203	.	G	A	Systemic lupus erythematosus
chr1	154437880	.	ATT	A	Asthma
chr1	154452980	.	G	C	Rheumatoid arthritis;Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)
chr1	154453788	.	C	G	Ankylosing spondylitis;Asthma;Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr1	154454494	.	A	T	Allergic disease (asthma, hay fever or eczema);Rheumatoid arthritis;Rheumatoid arthritis (ACPA-positive)
chr1	154460401	.	C	A	Acute anterior uveitis (with or without ankylosing spondylitis)
chr1	154465420	.	T	A	Type 1 diabetes
chr1	154983036	.	T	C	Multiple sclerosis
chr1	155061442	.	C	T	Systemic lupus erythematosus
chr1	155157915	.	G	C	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr1	155224224	.	C	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr1	155260340	.	C	T	Crohn's disease
chr1	156087626	.	T	C	Ischemic heart disease in rheumatoid arthritis
chr1	157119355	.	C	T	Multiple sclerosis
chr1	157699488	.	C	A	Graves' disease;Multiple sclerosis;Multiple sclerosis and LDL levels (pleiotropy);Rheumatoid arthritis;Rheumatoid arthritis (ACPA-positive)
chr1	157699488	.	C	G	Graves' disease;Multiple sclerosis;Multiple sclerosis and LDL levels (pleiotropy);Rheumatoid arthritis;Rheumatoid arthritis (ACPA-positive)
chr1	157700500	.	C	A	Primary biliary cholangitis
chr1	157723932	.	A	T	Graves' disease
chr1	158962765	.	C	T	Asthma
chr1	159035859	.	A	T	Celiac disease or Rheumatoid arthritis
chr1	159073406	.	C	A	Psoriasis
chr1	159073406	.	C	T	Psoriasis
chr1	159181530	.	C	CT	Asthma
chr1	159199673	.	C	G	Asthma
chr1	159199673	.	C	T	Asthma
chr1	159338281	.	T	G	Diisocyanate-induced asthma
chr1	159722747	.	T	A	Inflammatory biomarkers in Kawasaki disease
chr1	159830120	.	G	A	Crohn's disease
chr1	159848723	.	C	T	Multiple sclerosis (OCB status)
chr1	160176704	.	C	G	Gout
chr1	160186352	.	C	T	Composite immunoglobulin trait (IgA/IgG)
chr1	160344148	.	G	C	Low affinity immunoglobulin gamma Fc region receptor II-b levels
chr1	160401437	.	G	C	Low affinity immunoglobulin gamma Fc region receptor II-a levels
chr1	160474183	.	T	C	Rheumatoid arthritis
chr1	160744153	.	T	A	Low affinity immunoglobulin gamma Fc region receptor II-a levels
chr1	160876494	.	T	C	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr1	160881378	.	T	A	Low affinity immunoglobulin gamma Fc region receptor II-b levels
chr1	160887174	.	A	T	Crohn's disease;Ulcerative colitis
chr1	161211344	.	C	T	Low affinity immunoglobulin gamma Fc region receptor II-b levels
chr1	161263721	.	A	G	Low affinity immunoglobulin gamma Fc region receptor II-a levels
chr1	161298867	.	T	A	Low affinity immunoglobulin gamma Fc region receptor II-b levels
chr1	161304521	.	G	A	Low affinity immunoglobulin gamma Fc region receptor II-a levels;Low affinity immunoglobulin gamma Fc region receptor II-b levels
chr1	161332564	.	A	G	Low affinity immunoglobulin gamma Fc region receptor II-a levels
chr1	161419170	.	T	C	Low affinity immunoglobulin gamma Fc region receptor II-b levels
chr1	161428687	.	A	C	Low affinity immunoglobulin gamma Fc region receptor II-a levels;Low affinity immunoglobulin gamma Fc region receptor II-b levels
chr1	161435263	.	C	T	Rheumatoid arthritis
chr1	161437447	.	CTT	C	Low affinity immunoglobulin gamma Fc region receptor II-a levels
chr1	161482684	.	A	AG	Low affinity immunoglobulin gamma Fc region receptor II-b levels
chr1	161483076	.	G	T	Low affinity immunoglobulin gamma Fc region receptor II-a levels
chr1	161485731	.	T	A	Low affinity immunoglobulin gamma Fc region receptor II-a levels
chr1	161487626	.	A	G	Low affinity immunoglobulin gamma Fc region receptor II-a levels
chr1	161498819	.	A	C	Low affinity immunoglobulin gamma Fc region receptor II-a levels
chr1	161498819	.	A	T	Low affinity immunoglobulin gamma Fc region receptor II-a levels
chr1	161499264	.	G	T	Low affinity immunoglobulin gamma Fc region receptor II-a levels
chr1	161500252	.	T	G	Low affinity immunoglobulin gamma Fc region receptor II-a/b levels
chr1	161502368	.	A	T	Ulcerative colitis
chr1	161502999	.	C	A	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr1	161504083	.	A	C	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr1	161505960	.	G	A	Rheumatoid arthritis (ACPA-positive)
chr1	161506085	.	G	A	Low affinity immunoglobulin gamma Fc region receptor II-a levels
chr1	161506085	.	G	C	Low affinity immunoglobulin gamma Fc region receptor II-a levels
chr1	161506085	.	G	T	Low affinity immunoglobulin gamma Fc region receptor II-a levels
chr1	161506414	.	C	T	Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)
chr1	161509955	.	A	C	Ankylosing spondylitis;Crohn's disease;Kawasaki disease;Low affinity immunoglobulin gamma Fc region receptor II-a levels;Low affinity immunoglobulin gamma Fc region receptor II-b levels;Systemic lupus erythematosus;Ulcerative colitis
chr1	161531084	.	A	G	Low affinity immunoglobulin gamma Fc region receptor II-b levels
chr1	161531084	.	A	T	Low affinity immunoglobulin gamma Fc region receptor II-b levels
chr1	161532097	.	C	G	Low affinity immunoglobulin gamma Fc region receptor II-b levels
chr1	161532097	.	C	T	Low affinity immunoglobulin gamma Fc region receptor II-b levels
chr1	161532114	.	A	G	Low affinity immunoglobulin gamma Fc region receptor II-a levels
chr1	161538712	.	AT	A	Low affinity immunoglobulin gamma Fc region receptor II-a levels;Low affinity immunoglobulin gamma Fc region receptor II-b levels
chr1	161549621	.	C	T	Low affinity immunoglobulin gamma Fc region receptor II-b levels
chr1	161549650	.	C	T	Low affinity immunoglobulin gamma Fc region receptor II-a/b levels
chr1	161557228	.	G	A	Systemic sclerosis;Systemic sclerosis (anti-centromere-positive)
chr1	161557228	.	G	C	Systemic sclerosis;Systemic sclerosis (anti-centromere-positive)
chr1	161600039	.	G	C	Systemic lupus erythematosus
chr1	161656008	.	A	G	Systemic lupus erythematosus
chr1	161671594	.	G	A	Low affinity immunoglobulin gamma Fc region receptor II-a/b levels
chr1	161676087	.	G	C	Low affinity immunoglobulin gamma Fc region receptor II-b levels
chr1	161679841	.	T	C	Low affinity immunoglobulin gamma Fc region receptor II-a levels
chr1	161679841	.	T	G	Low affinity immunoglobulin gamma Fc region receptor II-a levels
chr1	161690906	.	G	A	Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis
chr1	161694564	.	A	T	Low affinity immunoglobulin gamma Fc region receptor II-b levels
chr1	161723409	.	C	T	Low affinity immunoglobulin gamma Fc region receptor II-a levels
chr1	161726591	.	C	G	Low affinity immunoglobulin gamma Fc region receptor II-a levels
chr1	161745485	.	T	C	Low affinity immunoglobulin gamma Fc region receptor II-b levels
chr1	161936103	.	T	C	Low affinity immunoglobulin gamma Fc region receptor II-b levels
chr1	162176183	.	T	A	Low affinity immunoglobulin gamma Fc region receptor II-b levels
chr1	162479619	.	G	A	Takayasu arteritis
chr1	163394421	.	C	T	Low affinity immunoglobulin gamma Fc region receptor II-b levels
chr1	163807061	.	C	T	Asthma
chr1	165138742	.	G	A	Response to methotrexate in juvenile idiopathic arthritis
chr1	165863039	.	C	A	Multiple sclerosis
chr1	165863039	.	C	G	Multiple sclerosis
chr1	166516654	.	C	G	Cardiovascular event in rheumatoid arthritis
chr1	166805760	.	T	C	Osteoarthritis of the knee (with total joint replacement)
chr1	167326601	.	T	G	Adult onset asthma and/or BMI
chr1	167428034	.	G	A	Atopic asthma
chr1	167439433	.	C	T	Rheumatoid arthritis
chr1	167442147	.	A	G	Celiac disease;Celiac disease or Rheumatoid arthritis
chr1	167449231	.	C	T	Asthma
chr1	167451062	.	G	A	Asthma;Asthma (adult onset)
chr1	167451188	.	T	G	Asthma (adult onset);Systemic sclerosis
chr1	167457187	.	G	C	Allergic disease (asthma, hay fever or eczema);Asthma;Asthma or allergic disease (pleiotropy);Autoimmune thyroid disease
chr1	167457187	.	G	T	Allergic disease (asthma, hay fever or eczema);Asthma;Asthma or allergic disease (pleiotropy);Autoimmune thyroid disease
chr1	167458010	.	C	A	Asthma;Asthma (adult onset);Asthma (moderate or severe);Atopic asthma
chr1	167461956	.	G	T	Asthma
chr1	168538225	.	C	A	Psoriasis
chr1	170842658	.	G	A	Systemic lupus erythematosus
chr1	172705636	.	G	A	Celiac disease
chr1	172705957	.	T	C	Psoriasis
chr1	172706385	.	T	A	Systemic lupus erythematosus
chr1	172706385	.	T	C	Systemic lupus erythematosus
chr1	172711891	.	T	C	Celiac disease;Systemic lupus erythematosus
chr1	172731728	.	G	A	Allergic disease (asthma, hay fever or eczema);Asthma;Asthma (childhood onset)
chr1	172746562	.	A	G	Allergic disease (asthma, hay fever and/or eczema) (age of onset);Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis);Asthma (childhood onset);Asthma onset (childhood vs adult);Type 1 diabetes;Vitiligo
chr1	172810693	.	T	A	Atopic asthma
chr1	172810693	.	T	C	Atopic asthma
chr1	172875212	.	T	G	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Crohn's disease
chr1	172877652	.	A	G	Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS))
chr1	172877652	.	A	T	Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS))
chr1	172884320	.	C	T	Crohn's disease
chr1	172887910	.	C	A	Crohn's disease vs ulcerative colitis (ordinary least squares (OLS))
chr1	172887910	.	C	T	Crohn's disease vs ulcerative colitis (ordinary least squares (OLS))
chr1	172893094	.	A	G	Crohn's disease
chr1	172894808	.	G	A	Celiac disease
chr1	172895512	.	T	A	Celiac disease
chr1	172929237	.	T	C	Crohn's disease
chr1	172967562	.	A	C	Alopecia areata
chr1	172967562	.	A	T	Alopecia areata
chr1	173162354	.	A	T	Asthma;Asthma (childhood onset);Asthma onset (childhood vs adult)
chr1	173162769	.	T	A	Narcolepsy
chr1	173164350	.	G	A	Alopecia areata
chr1	173197108	.	A	G	Rheumatoid arthritis;Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)
chr1	173209324	.	C	T	Systemic lupus erythematosus
chr1	173222336	.	G	A	Systemic lupus erythematosus
chr1	173222336	.	G	T	Systemic lupus erythematosus
chr1	173237158	.	G	A	Systemic lupus erythematosus
chr1	173247234	.	A	G	Systemic lupus erythematosus
chr1	173257056	.	T	G	Systemic lupus erythematosus;Systemic lupus erythematosus and Systemic sclerosis
chr1	173282717	.	A	G	Systemic lupus erythematosus
chr1	173315060	.	G	A	Multiple sclerosis
chr1	173315060	.	G	T	Multiple sclerosis
chr1	173330604	.	C	T	Rheumatoid arthritis (ACPA-positive)
chr1	173337507	.	G	A	Systemic lupus erythematosus
chr1	173338762	.	T	C	Systemic lupus erythematosus
chr1	173340574	.	A	T	Systemic lupus erythematosus
chr1	173363490	.	A	C	Systemic sclerosis
chr1	173378698	.	G	C	Systemic lupus erythematosus
chr1	173380586	.	A	C	Rheumatoid arthritis
chr1	173380586	.	A	G	Rheumatoid arthritis
chr1	174192402	.	C	T	Osteoarthritis
chr1	178943270	.	C	G	Systemic lupus erythematosus
chr1	180676305	.	C	T	Asthma (childhood onset)
chr1	182579884	.	A	G	Multiple sclerosis
chr1	182579884	.	A	T	Multiple sclerosis
chr1	182869236	.	C	T	Type 1 diabetes with low genetic risk score
chr1	183207295	.	A	G	Systemic lupus erythematosus
chr1	183330915	.	T	A	Systemic lupus erythematosus
chr1	183563302	.	G	A	Systemic lupus erythematosus
chr1	183563302	.	G	C	Systemic lupus erythematosus
chr1	183563302	.	G	T	Systemic lupus erythematosus
chr1	183563445	.	G	A	Celiac disease;Celiac disease and Rheumatoid arthritis;Systemic lupus erythematosus;Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)
chr1	183563445	.	G	C	Celiac disease;Celiac disease and Rheumatoid arthritis;Systemic lupus erythematosus;Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)
chr1	183563445	.	G	T	Celiac disease;Celiac disease and Rheumatoid arthritis;Systemic lupus erythematosus;Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)
chr1	183573188	.	C	T	Systemic lupus erythematosus
chr1	186755871	.	G	A	Knee osteoarthritis
chr1	187274037	.	T	C	Exacerbations requiring hospitalisation in asthma
chr1	187274037	.	T	G	Exacerbations requiring hospitalisation in asthma
chr1	187430386	.	T	A	Exacerbations requiring hospitalisation in asthma
chr1	189754493	.	A	G	Systemic lupus erythematosus
chr1	191590226	.	A	T	Crohn's disease
chr1	192445292	.	A	G	Systemic vasculitis
chr1	192572342	.	C	A	Celiac disease;Multiple sclerosis
chr1	192572342	.	C	T	Celiac disease;Multiple sclerosis
chr1	192575665	.	A	T	Systemic lupus erythematosus
chr1	194360431	.	C	G	Takayasu arteritis
chr1	194360431	.	C	T	Takayasu arteritis
chr1	195778940	.	T	C	Post-bronchodilator lung function in asthma (FVC)
chr1	196735867	.	G	A	Asthma x Hispanic interaction (2df)
chr1	196976659	.	T	G	Asthma
chr1	197051528	.	T	G	Erectile dysfunction in type 1 diabetes
chr1	197336969	.	C	A	Lupus nephritis in systemic lupus erythematosus
chr1	197336969	.	C	T	Lupus nephritis in systemic lupus erythematosus
chr1	197356778	.	T	A	Asthma
chr1	197662011	.	G	A	Crohn's disease;Ulcerative colitis
chr1	197732149	.	G	C	Crohn's disease
chr1	197732862	.	C	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr1	197735587	.	C	G	Primary biliary cholangitis
chr1	197758512	.	A	G	Crohn's disease
chr1	197758512	.	A	T	Crohn's disease
chr1	197811836	.	T	A	Primary biliary cholangitis
chr1	197812068	.	C	T	Primary biliary cholangitis
chr1	198625639	.	G	A	Systemic lupus erythematosus
chr1	198629259	.	G	GA	Type 1 diabetes
chr1	198629259	.	G	GAA	Type 1 diabetes
chr1	198629533	.	G	A	Crohn's disease
chr1	198632575	.	A	G	Asthma;Crohn's disease
chr1	198671359	.	C	T	Asthma;Asthma (adult onset)
chr1	198684045	.	A	G	Asthma
chr1	198687278	.	A	G	Ulcerative colitis
chr1	198688721	.	T	A	Asthma (adult onset)
chr1	198688721	.	T	C	Asthma (adult onset)
chr1	198697103	.	A	G	Asthma;Pediatric asthma
chr1	198701340	.	G	A	Systemic lupus erythematosus
chr1	198703170	.	T	C	Vitiligo
chr1	198703170	.	T	G	Vitiligo
chr1	198764438	.	T	C	Celiac disease and Rheumatoid arthritis
chr1	198861813	.	T	C	Multiple sclerosis
chr1	199274100	.	G	A	Rheumatoid arthritis
chr1	200132792	.	A	G	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Ulcerative colitis
chr1	200905600	.	A	G	Multiple sclerosis;Ulcerative colitis vs rheumatoid arthritis (ordinary least squares (OLS))
chr1	200906114	.	T	A	Acute anterior uveitis (with or without ankylosing spondylitis);Celiac disease
chr1	200906769	.	T	C	Celiac disease;Multiple sclerosis
chr1	200908434	.	C	A	Crohn's disease;Ulcerative colitis
chr1	200908722	.	T	A	Ankylosing spondylitis
chr1	200908722	.	T	G	Ankylosing spondylitis
chr1	200909599	.	G	A	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr1	200912264	.	C	T	Celiac disease
chr1	200912467	.	G	A	Multiple sclerosis
chr1	200923009	.	T	C	Celiac disease
chr1	200962619	.	A	AC	Ulcerative colitis
chr1	200966738	.	T	C	Crohn's disease;Ulcerative colitis
chr1	201049931	.	C	T	Primary biliary cholangitis
chr1	201169300	.	G	A	Asthma
chr1	201625537	.	T	C	Celiac disease
chr1	201720270	.	A	G	Interstitial lung diseases in rheumatoid arthritis
chr1	202500595	.	T	C	Celiac disease
chr1	203122146	.	G	C	Asthma
chr1	203124073	.	G	A	Asthma;Asthma (childhood onset)
chr1	203656523	.	G	A	Composite immunoglobulin trait (IgA x IgG/IgM)
chr1	204798177	.	G	A	Diisocyanate-induced asthma
chr1	204798177	.	G	C	Diisocyanate-induced asthma
chr1	205515245	.	C	T	Coronary artery disease in type 1 diabetes
chr1	205540170	.	C	T	Systemic lupus erythematosus
chr1	206449447	.	C	CT	Asthma
chr1	206451019	.	C	G	Asthma
chr1	206451019	.	C	T	Asthma
chr1	206470429	.	C	T	Systemic lupus erythematosus
chr1	206472931	.	G	C	Allergic disease (asthma, hay fever or eczema)
chr1	206481989	.	C	T	Psoriasis
chr1	206766559	.	G	A	Crohn's disease;Systemic lupus erythematosus;Type 1 diabetes;Ulcerative colitis
chr1	206770623	.	C	A	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Systemic lupus erythematosus;Type 1 diabetes;Ulcerative colitis;Ulcerative colitis vs rheumatoid arthritis (ordinary least squares (OLS))
chr1	206771966	.	A	G	Behcet's disease
chr1	206771966	.	A	T	Behcet's disease
chr1	206781696	.	G	A	Systemic lupus erythematosus
chr1	206781696	.	G	C	Systemic lupus erythematosus
chr1	206786182	.	G	A	Acute anterior uveitis (with or without ankylosing spondylitis)
chr1	206935771	.	C	G	Polymeric immunoglobulin receptor levels
chr1	207479647	.	A	G	Systemic sclerosis
chr1	207692807	.	T	G	Multiple sclerosis
chr1	208432248	.	A	G	Kawasaki disease
chr1	210024924	.	G	A	Alopecia areata
chr1	210621464	.	T	C	Ankylosing spondylitis
chr1	211565125	.	A	G	Diisocyanate-induced asthma
chr1	212470318	.	A	G	Type 1 diabetes (age at diagnosis)
chr1	212685406	.	T	C	Asthma
chr1	212688020	.	G	A	Asthma
chr1	212883085	.	G	A	Asthma (childhood onset)
chr1	213985913	.	T	C	Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect)
chr1	219467338	.	A	C	Osteoarthritis;Osteoarthritis (hip);Osteoarthritis (hospital diagnosed);Osteoarthritis of the hip (hospital diagnosed);Osteoarthritis of the hip or knee (hospital diagnosed)
chr1	219467338	.	A	G	Osteoarthritis;Osteoarthritis (hip);Osteoarthritis (hospital diagnosed);Osteoarthritis of the hip (hospital diagnosed);Osteoarthritis of the hip or knee (hospital diagnosed)
chr1	219470882	.	A	G	Osteoarthritis of the hip or knee (with total joint replacement)
chr1	219570796	.	C	A	Osteoarthritis;Osteoarthritis (hip)
chr1	219580167	.	T	C	Osteoarthritis of the hip or knee
chr1	221898846	.	G	A	Type 1 diabetes with low genetic risk score
chr1	226727033	.	G	A	Allergic disease (asthma, hay fever or eczema);Asthma
chr1	229142587	.	C	T	Crohn's disease (time to first abdominal surgery)
chr1	229229244	.	T	A	Food allergy (parent-of-origin effect)
chr1	232383404	.	A	C	Immunoglobulin A
chr1	234498457	.	C	G	Systemic lupus erythematosus
chr1	234498457	.	C	T	Systemic lupus erythematosus
chr1	234590266	.	A	T	Psoriasis
chr1	234597720	.	A	G	Adult asthma
chr1	235199645	.	T	A	Asthma
chr1	235937740	.	C	T	Ocular sarcoidosis
chr1	240436606	.	A	G	Carotid plaques in rheumatoid arthritis
chr1	240558252	.	C	G	Response to allopurinol in gout (change in serum uric acid levels)
chr1	242604649	.	C	T	Asthma exacerbations in inhaled corticosteroid treatment
chr1	242802070	.	G	A	Systemic lupus erythematosus
chr1	244347874	.	G	A	Asthma (childhood onset)
chr1	245175674	.	C	T	Ischemic heart disease in rheumatoid arthritis
chr1	245533270	.	G	A	Ocular sarcoidosis
chr1	245587630	.	T	G	Osteoarthritis
chr1	245763940	.	G	A	Renal underexcretion gout
chr1	246280780	.	C	T	Systemic lupus erythematosus
chr10	3820350	.	C	T	Crohn's disease
chr10	3875982	.	T	G	Multiple sclerosis
chr10	3941915	.	C	T	Oral corticosteroid burst in asthma
chr10	4198678	.	G	A	Asthma (bronchodilator response)
chr10	4706126	.	G	A	Lung function (FEV1/FVC) in asthma
chr10	6000052	.	G	A	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr10	6000052	.	G	C	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr10	6013641	.	C	A	Asthma
chr10	6013641	.	C	T	Asthma
chr10	6016360	.	A	G	Asthma
chr10	6027930	.	C	A	Epstein Barr virus nuclear antigen 1 IgG levels or multiple sclerosis
chr10	6028576	.	C	A	Diisocyanate-induced asthma
chr10	6030130	.	G	C	Asthma;Asthma (childhood onset);Nonatopic asthma
chr10	6032488	.	G	A	Allergic disease (asthma, hay fever or eczema)
chr10	6032488	.	G	C	Allergic disease (asthma, hay fever or eczema)
chr10	6032488	.	G	T	Allergic disease (asthma, hay fever or eczema)
chr10	6047878	.	T	G	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)
chr10	6050383	.	T	G	Multiple sclerosis
chr10	6051176	.	C	T	Asthma;Asthma (adult onset);Asthma (childhood onset);Atopic asthma;Pediatric asthma
chr10	6052734	.	C	T	Allergic disease (asthma, hay fever or eczema);Asthma or allergic disease (pleiotropy);Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Crohn's disease;Systemic lupus erythematosus;Type 1 diabetes
chr10	6053447	.	A	T	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)
chr10	6054236	.	G	T	Systemic lupus erythematosus
chr10	6055320	.	T	C	Type 1 diabetes
chr10	6059750	.	T	A	Alopecia areata;Multiple sclerosis;Rheumatoid arthritis;Type 1 diabetes
chr10	6069112	.	T	C	Atopic asthma
chr10	6074291	.	G	A	Type 1 diabetes
chr10	6080046	.	T	A	Rheumatoid arthritis
chr10	6080706	.	T	A	Multiple sclerosis
chr10	6082658	.	T	C	Asthma and hay fever
chr10	6166048	.	C	T	Ocular sarcoidosis
chr10	6187611	.	A	G	Alopecia areata
chr10	6187611	.	A	T	Alopecia areata
chr10	6348230	.	G	A	Celiac disease
chr10	6348488	.	G	A	Celiac disease;Celiac disease and Rheumatoid arthritis;Rheumatoid arthritis;Rheumatoid arthritis (ACPA-positive);Type 1 diabetes
chr10	6351298	.	C	G	Rheumatoid arthritis
chr10	6351298	.	C	T	Rheumatoid arthritis
chr10	6359663	.	C	A	Celiac disease
chr10	6359663	.	C	G	Celiac disease
chr10	6359663	.	C	T	Celiac disease
chr10	6430929	.	G	C	Type 1 diabetes
chr10	6430929	.	G	T	Type 1 diabetes
chr10	6475205	.	T	C	Rheumatoid arthritis
chr10	6530263	.	C	A	Body mass index in asthmatics
chr10	6584252	.	G	A	Asthma;Atopic asthma
chr10	6586262	.	G	A	Asthma
chr10	6589261	.	C	G	Asthma (childhood onset)
chr10	6589261	.	C	T	Asthma (childhood onset)
chr10	6747501	.	C	T	Response to anti-TNF therapy in rheumatoid arthritis
chr10	6791131	.	C	T	Kawasaki disease or immunoglobulin A vasculitis (pleiotropy)
chr10	7410781	.	A	C	Myasthenia gravis
chr10	7410781	.	A	G	Myasthenia gravis
chr10	7410781	.	A	T	Myasthenia gravis
chr10	8061096	.	A	T	Asthma (adult onset)
chr10	8062378	.	A	G	Asthma;Asthma (adult onset)
chr10	8073399	.	C	A	Asthma;Asthma (moderate or severe)
chr10	8073399	.	C	T	Asthma;Asthma (moderate or severe)
chr10	8365606	.	T	G	Exacerbations requiring hospitalisation in asthma
chr10	8380654	.	A	G	Multiple sclerosis
chr10	8418702	.	C	T	Asthma
chr10	8419000	.	C	T	Asthma
chr10	8437905	.	A	G	Systemic lupus erythematosus
chr10	8468994	.	T	A	Asthma;Asthma (adult onset)
chr10	8473385	.	C	T	Asthma;Asthma (adult onset);Nonatopic asthma
chr10	8484656	.	G	A	Asthma and attention deficit hyperactivity disorder
chr10	8484656	.	G	C	Asthma and attention deficit hyperactivity disorder
chr10	8517780	.	G	A	Asthma
chr10	8524027	.	T	A	Asthma;Nonatopic asthma
chr10	8524027	.	T	C	Asthma;Nonatopic asthma
chr10	8540354	.	T	A	Allergic disease (asthma, hay fever or eczema)
chr10	8549406	.	C	A	Asthma;Asthma (childhood onset)
chr10	8553876	.	G	A	Asthma or allergic disease (pleiotropy)
chr10	8553876	.	G	T	Asthma or allergic disease (pleiotropy)
chr10	8563590	.	G	T	Allergic disease (asthma, hay fever or eczema)
chr10	8564051	.	A	G	Asthma;Asthma (childhood onset)
chr10	8735677	.	G	A	Asthma;Asthma (adult onset)
chr10	8735677	.	G	T	Asthma;Asthma (adult onset)
chr10	8799706	.	T	C	Allergic disease (asthma, hay fever or eczema);Asthma;Asthma and attention deficit hyperactivity disorder;Atopic asthma
chr10	8806288	.	A	T	Nonatopic asthma
chr10	8808772	.	C	T	Asthma
chr10	8850422	.	C	T	Nonatopic asthma
chr10	8894199	.	C	T	Allergic disease (asthma, hay fever or eczema)
chr10	8898431	.	A	G	Asthma
chr10	8898431	.	A	T	Asthma
chr10	8930055	.	G	A	Asthma
chr10	8956766	.	C	A	Atopic asthma;Nonatopic asthma
chr10	8956766	.	C	T	Atopic asthma;Nonatopic asthma
chr10	8959364	.	C	A	Nonatopic asthma
chr10	8959364	.	C	G	Nonatopic asthma
chr10	8959364	.	C	T	Nonatopic asthma
chr10	8960206	.	A	T	Asthma (adult onset);Nonatopic asthma
chr10	8968661	.	A	G	Asthma
chr10	8986983	.	C	G	Asthma;Endometriosis or asthma (pleiotropy)
chr10	8986983	.	C	T	Asthma;Endometriosis or asthma (pleiotropy)
chr10	8990592	.	C	G	Allergic disease (asthma, hay fever or eczema);Asthma;Asthma (adult onset);Atopic asthma;Nonatopic asthma
chr10	8995529	.	G	T	Asthma (adult onset)
chr10	8996394	.	T	C	Nonatopic asthma
chr10	9001441	.	G	A	Asthma (moderate or severe)
chr10	9001441	.	G	C	Asthma (moderate or severe)
chr10	9001441	.	G	T	Asthma (moderate or severe)
chr10	9004682	.	A	G	Asthma;Asthma (adult onset);Atopic asthma;Nonatopic asthma
chr10	9007290	.	C	G	Allergic disease (asthma, hay fever or eczema);Asthma;Asthma (adult onset);Asthma (childhood onset);Atopic asthma;Nonatopic asthma;Rheumatoid arthritis
chr10	9007290	.	C	T	Allergic disease (asthma, hay fever or eczema);Asthma;Asthma (adult onset);Asthma (childhood onset);Atopic asthma;Nonatopic asthma;Rheumatoid arthritis
chr10	9010779	.	G	A	Allergy;Asthma
chr10	9010779	.	G	C	Allergy;Asthma
chr10	9011110	.	G	C	Asthma (adult onset)
chr10	9011169	.	C	T	Self-reported allergy
chr10	9012362	.	C	T	Allergic disease (asthma, hay fever or eczema)
chr10	9012377	.	A	C	Asthma;Asthma (adult onset);Asthma (childhood onset)
chr10	9012824	.	G	A	Asthma
chr10	9015459	.	G	T	Nonatopic asthma
chr10	9016708	.	G	A	Asthma;Asthma (childhood onset);Atopic asthma
chr10	9020893	.	T	G	Asthma;Pediatric asthma
chr10	9021039	.	A	AAC	Asthma
chr10	9021039	.	A	ACA	Asthma
chr10	9022398	.	T	C	Adult asthma;Allergic disease (asthma, hay fever or eczema)
chr10	9022753	.	T	C	Asthma;Asthma (childhood onset)
chr10	9028714	.	T	G	Asthma
chr10	9034193	.	T	C	Nonatopic asthma
chr10	9066555	.	G	A	Asthma (adult onset);Atopic asthma;Nonatopic asthma
chr10	9066555	.	G	C	Asthma (adult onset);Atopic asthma;Nonatopic asthma
chr10	9069863	.	C	T	Asthma
chr10	9078931	.	A	G	Asthma (childhood onset)
chr10	9107417	.	G	C	Asthma exacerbations in inhaled corticosteroid treatment
chr10	9108236	.	A	C	Asthma (adult onset)
chr10	9166241	.	G	C	Asthma;Asthma (adult onset);Atopic asthma
chr10	9213927	.	C	T	Asthma
chr10	9251327	.	T	A	Atopic asthma
chr10	9251327	.	T	C	Atopic asthma
chr10	10522460	.	A	G	Takayasu arteritis
chr10	11246455	.	C	A	Follicular lymphoma or rheumatoid arthritis
chr10	11246455	.	C	G	Follicular lymphoma or rheumatoid arthritis
chr10	12185307	.	C	T	Asthma with severe exacerbations
chr10	12446137	.	G	A	Systemic lupus erythematosus
chr10	12603942	.	C	A	Coronary artery aneurysm in Kawasaki disease
chr10	13690319	.	C	G	Knee osteoarthritis
chr10	14365826	.	C	A	Ocular sarcoidosis
chr10	14394837	.	G	A	Steroid induced osteonecrosis of the femoral head and systemic lupus erythematosus;Steroid induced osteonecrosis of the femoral head in systemic lupus erythematosus
chr10	15496384	.	C	T	Systemic lupus erythematosus
chr10	15612888	.	T	C	Diisocyanate-induced asthma
chr10	16956341	.	A	C	Kawasaki disease
chr10	16956341	.	A	G	Kawasaki disease
chr10	18724467	.	G	A	Immunoglobulin A vasculitis
chr10	18821570	.	T	A	Exacerbations requiring hospitalisation in asthma
chr10	18889952	.	A	G	Immunoglobulin A vasculitis
chr10	19168458	.	T	C	Coronary artery disease in type 1 diabetes
chr10	19534538	.	C	T	Gout vs. Hyperuricemia
chr10	19640584	.	T	C	Ankylosing spondylitis
chr10	20879174	.	C	G	Coronary artery aneurysm in Kawasaki disease
chr10	21051164	.	C	G	Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count)
chr10	21379270	.	C	T	Endometriosis or asthma (pleiotropy)
chr10	21560840	.	G	A	Endometriosis or asthma (pleiotropy)
chr10	21728616	.	A	G	Endometriosis or asthma (pleiotropy)
chr10	21809772	.	A	G	Endometriosis or asthma (pleiotropy)
chr10	21834839	.	A	G	Endometriosis or asthma (pleiotropy)
chr10	21834839	.	A	T	Endometriosis or asthma (pleiotropy)
chr10	21835334	.	C	A	Endometriosis or asthma (pleiotropy)
chr10	21835334	.	C	T	Endometriosis or asthma (pleiotropy)
chr10	21844864	.	T	A	Endometriosis or asthma (pleiotropy)
chr10	21999203	.	C	T	Endometriosis or asthma (pleiotropy)
chr10	22960180	.	C	T	Systemic lupus erythematosus
chr10	23104137	.	A	G	Diisocyanate-induced asthma
chr10	23104137	.	A	T	Diisocyanate-induced asthma
chr10	23376509	.	G	T	Crohn's disease and sarcoidosis (combined)
chr10	24300978	.	G	A	Osteoarthritis of the knee (hospital diagnosed)
chr10	24300978	.	G	C	Osteoarthritis of the knee (hospital diagnosed)
chr10	24951155	.	C	T	Diisocyanate-induced asthma
chr10	26890667	.	T	G	Ulcerative colitis
chr10	27452030	.	C	T	Asthma (childhood onset)
chr10	27728643	.	A	G	Diisocyanate-induced asthma
chr10	28301454	.	C	A	Diisocyanate-induced asthma
chr10	28301454	.	C	T	Diisocyanate-induced asthma
chr10	31061565	.	A	T	Rheumatoid arthritis
chr10	31106832	.	G	C	Multiple sclerosis
chr10	31106832	.	G	T	Multiple sclerosis
chr10	31122426	.	C	T	Rheumatoid arthritis;Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)
chr10	31126177	.	C	T	Multiple sclerosis;Rheumatoid arthritis
chr10	33378350	.	G	A	Crohn's disease (time to first abdominal surgery)
chr10	35265126	.	T	C	Ulcerative colitis
chr10	35771381	.	A	C	Antineutrophil cytoplasmic antibody-associated vasculitis
chr10	35771381	.	A	G	Antineutrophil cytoplasmic antibody-associated vasculitis
chr10	36165947	.	C	T	Exacerbations requiring hospitalisation in asthma
chr10	38470625	.	C	A	Adult asthma
chr10	42507600	.	A	T	Systemic juvenile idiopathic arthritis
chr10	43254252	.	G	A	Asthma
chr10	48725929	.	T	G	Systemic lupus erythematosus
chr10	48728291	.	C	A	Systemic lupus erythematosus
chr10	48766611	.	T	C	Systemic lupus erythematosus
chr10	48766611	.	T	G	Systemic lupus erythematosus
chr10	48795554	.	G	A	Ulcerative colitis x smoking status (never vs former smoking) interaction
chr10	48810120	.	T	A	Systemic lupus erythematosus
chr10	48861350	.	G	T	Systemic lupus erythematosus
chr10	48911009	.	A	G	Systemic lupus erythematosus
chr10	51197961	.	C	A	Interferon alpha levels in systemic lupus erythematosus
chr10	51733713	.	G	A	Asthma
chr10	51733713	.	G	T	Asthma
chr10	52394860	.	T	A	Behcet's disease
chr10	55089225	.	A	C	Response to tocilizumab in rheumatoid arthritis
chr10	58153390	.	C	G	Crohn's disease
chr10	58187470	.	A	C	Crohn's disease
chr10	59313854	.	A	G	Response to zileuton treatment in asthma (FEV1 change interaction)
chr10	59706080	.	A	G	Gout
chr10	59706080	.	A	T	Gout
chr10	59707424	.	G	A	Gout
chr10	59707424	.	G	T	Gout
chr10	59734279	.	C	T	Alopecia areata
chr10	60350910	.	A	C	Oral corticosteroid burst in asthma
chr10	60551981	.	C	G	Oral corticosteroid burst in asthma
chr10	60767276	.	A	G	Oral corticosteroid burst in asthma
chr10	61000984	.	C	T	Food allergy
chr10	61020369	.	G	A	Milk allergy
chr10	61036479	.	C	T	Response to TNF inhibitor in rheumatoid arthritis (erythrocyte sedimentation rate)
chr10	61425904	.	A	G	Diisocyanate-induced asthma
chr10	61758862	.	T	G	Cholangiocarcinoma in primary sclerosing cholangitis (time to event)
chr10	61820063	.	C	T	Ulcerative colitis
chr10	62020112	.	C	T	Autoimmune thyroid disease;Rheumatoid arthritis;Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive);Vitiligo
chr10	62040245	.	G	A	Rheumatoid arthritis;Rheumatoid arthritis (ACPA-positive)
chr10	62089323	.	T	A	Gout
chr10	62089323	.	T	G	Gout
chr10	62198353	.	T	G	Rheumatoid arthritis
chr10	62241941	.	C	T	Systemic lupus erythematosus
chr10	62277122	.	G	T	Rheumatoid arthritis
chr10	62594503	.	C	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr10	62610240	.	C	G	Psoriasis
chr10	62621908	.	A	G	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr10	62622599	.	A	C	Allergic disease (asthma, hay fever or eczema);Asthma
chr10	62631615	.	G	A	Allergic disease (asthma, hay fever or eczema);Asthma;Asthma (childhood onset);Narcolepsy
chr10	62631615	.	G	C	Allergic disease (asthma, hay fever or eczema);Asthma;Asthma (childhood onset);Narcolepsy
chr10	62637161	.	G	A	Asthma
chr10	62637161	.	G	C	Asthma
chr10	62637778	.	T	C	Multiple sclerosis
chr10	62642076	.	T	A	Systemic lupus erythematosus
chr10	62642076	.	T	G	Systemic lupus erythematosus
chr10	62655424	.	A	C	Crohn's disease
chr10	62655424	.	A	G	Crohn's disease
chr10	62663656	.	C	A	Multiple sclerosis
chr10	62665366	.	G	A	Systemic lupus erythematosus
chr10	62677713	.	C	T	Asthma
chr10	62678726	.	G	C	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Crohn's disease
chr10	62685804	.	A	G	Crohn's disease;Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS));Ulcerative colitis
chr10	62689789	.	G	T	Multiple sclerosis
chr10	62710915	.	C	T	Crohn's disease
chr10	62718076	.	G	A	Crohn's disease
chr10	62734542	.	C	A	Crohn's disease or Leprosy (opposite effect)
chr10	62734542	.	C	T	Crohn's disease or Leprosy (opposite effect)
chr10	62745326	.	C	T	Systemic lupus erythematosus
chr10	62756546	.	T	C	Alopecia areata
chr10	62765375	.	C	T	Psoriasis or type 2 diabetes (trans-disease meta-analysis)
chr10	62778519	.	C	T	Cutaneous psoriasis
chr10	62781559	.	T	C	Crohn's disease
chr10	62801746	.	A	G	Behcet's disease
chr10	63340256	.	C	A	Asthma;Asthma (childhood onset)
chr10	63340256	.	C	T	Asthma;Asthma (childhood onset)
chr10	63667025	.	G	A	Asthma;Asthma (childhood onset)
chr10	66328750	.	C	A	Asthma (toluene diisocyanate-induced)
chr10	66328750	.	C	G	Asthma (toluene diisocyanate-induced)
chr10	66328750	.	C	T	Asthma (toluene diisocyanate-induced)
chr10	66965005	.	G	T	Ulcerative colitis
chr10	67531962	.	G	A	Systemic lupus erythematosus
chr10	67531962	.	G	C	Systemic lupus erythematosus
chr10	69368950	.	G	A	Lung function (FEV1/FVC) in asthma
chr10	69783412	.	C	T	Ulcerative colitis
chr10	70121102	.	A	G	Rheumatoid arthritis
chr10	70618733	.	C	G	Type 1 diabetes
chr10	71298712	.	A	G	Coronary artery aneurysm in Kawasaki disease
chr10	71336036	.	G	A	Diisocyanate-induced asthma
chr10	71356185	.	G	C	Systemic lupus erythematosus
chr10	71376162	.	G	C	Vitiligo
chr10	71741309	.	C	T	Systemic lupus erythematosus
chr10	71831773	.	G	A	Asthma (childhood onset)
chr10	73894042	.	G	A	Multiple sclerosis
chr10	73909432	.	G	C	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Crohn's disease
chr10	75052692	.	G	T	Ulcerative colitis
chr10	75751688	.	T	C	Ocular sarcoidosis
chr10	76855700	.	C	A	Osteoarthritis of the hip or knee (with total joint replacement)
chr10	76855700	.	C	G	Osteoarthritis of the hip or knee (with total joint replacement)
chr10	76855700	.	C	T	Osteoarthritis of the hip or knee (with total joint replacement)
chr10	79201071	.	C	G	Response to methotrexate in juvenile idiopathic arthritis
chr10	79288854	.	C	A	Multiple sclerosis
chr10	79298270	.	A	C	Celiac disease
chr10	80166946	.	G	C	Sarcoidosis
chr10	80194525	.	G	A	Sarcoidosis
chr10	80462422	.	C	G	Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS))
chr10	80486993	.	A	T	Asthma
chr10	80491075	.	T	G	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Crohn's disease
chr10	80494291	.	A	T	Crohn's disease
chr10	81531934	.	C	T	Kidney disease (early and late stages) in type 1 diabetes
chr10	81666211	.	A	G	Endometriosis or asthma (pleiotropy)
chr10	83493925	.	C	A	Self-reported allergy
chr10	83556502	.	C	T	Osteoarthritis (self-reported)
chr10	85216527	.	G	A	Post-bronchodilator lung function in asthma (FEV1)
chr10	85911274	.	T	G	Renal overload gout
chr10	86305355	.	T	C	Asthma;Asthma (childhood onset)
chr10	87155350	.	A	G	Gout
chr10	87155350	.	A	T	Gout
chr10	87189288	.	A	T	Gout (combined type)
chr10	88065014	.	A	G	Psoriasis
chr10	88065014	.	A	T	Psoriasis
chr10	88067364	.	A	C	Multiple sclerosis
chr10	88263276	.	T	C	Type 1 diabetes
chr10	88275897	.	C	A	Type 1 diabetes
chr10	88428167	.	G	A	Type 1 diabetes
chr10	88428167	.	G	T	Type 1 diabetes
chr10	88732445	.	T	C	Psoriasis
chr10	88990206	.	A	G	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr10	88994730	.	T	A	Ankylosing spondylitis
chr10	92624757	.	T	TCTCT	Asthma;Asthma (childhood onset);Asthma onset (childhood vs adult)
chr10	92624757	.	T	TTC	Asthma;Asthma (childhood onset);Asthma onset (childhood vs adult)
chr10	92631682	.	CTT	C	Asthma
chr10	92672243	.	C	A	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr10	92706738	.	G	A	Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect)
chr10	92722160	.	G	T	Multiple sclerosis
chr10	95042841	.	A	C	Gout
chr10	95524324	.	C	T	Diabetic nephropathy in type 1 diabetes
chr10	96397528	.	A	G	Takayasu arteritis
chr10	97048848	.	C	T	Ulcerative colitis
chr10	98540425	.	C	T	Type 1 diabetes
chr10	99095945	.	C	T	Asthma (childhood onset)
chr10	99518968	.	C	T	Ankylosing spondylitis;Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr10	99523570	.	TCCC	TGCA	Crohn's disease
chr10	99523571	.	C	G	Crohn's disease
chr10	99523573	.	C	A	Autoimmune thyroid disease;Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Ulcerative colitis
chr10	99523573	.	C	G	Autoimmune thyroid disease;Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Ulcerative colitis
chr10	99524480	.	T	A	Crohn's disease;Ulcerative colitis
chr10	99524480	.	T	G	Crohn's disease;Ulcerative colitis
chr10	99528007	.	G	A	Crohn's disease
chr10	99530544	.	T	C	Ulcerative colitis;Ulcerative colitis vs rheumatoid arthritis (ordinary least squares (OLS))
chr10	99531836	.	T	C	Crohn's disease;Ulcerative colitis
chr10	99532633	.	C	T	Crohn's disease
chr10	99538694	.	T	C	Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS))
chr10	99538694	.	T	G	Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS))
chr10	100251454	.	A	T	Psoriasis or type 2 diabetes (trans-disease meta-analysis)
chr10	102518504	.	ACTGT	A	Allergy
chr10	103597080	.	A	G	Diisocyanate-induced asthma
chr10	103630585	.	A	G	Diisocyanate-induced asthma
chr10	103653282	.	A	G	Rheumatoid arthritis
chr10	107930478	.	T	C	Systemic juvenile idiopathic arthritis
chr10	110426390	.	C	G	Crohn's disease
chr10	110426390	.	C	T	Crohn's disease
chr10	112628513	.	A	G	Multiple sclerosis
chr10	112995025	.	T	C	Psoriasis or type 2 diabetes (trans-disease meta-analysis);Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect)
chr10	112998590	.	C	G	Type 1 diabetes
chr10	112998590	.	C	T	Type 1 diabetes
chr10	116055008	.	A	G	Joint damage in rheumatoid arthritis
chr10	116058040	.	G	A	Response to anti-TNF therapy in rheumatoid arthritis
chr10	117467831	.	G	A	Pulmonary function in asthmatics
chr10	117467831	.	G	T	Pulmonary function in asthmatics
chr10	117854099	.	T	C	Celiac disease
chr10	117887745	.	T	G	Asthma (sex interaction)
chr10	119246715	.	T	A	Coronary artery aneurysm in Kawasaki disease
chr10	120587210	.	C	T	Asthma exacerbations in inhaled corticosteroid treatment
chr10	120940685	.	G	A	Type 1 diabetes with low genetic risk score
chr10	121521144	.	T	C	Gout
chr10	122400322	.	C	T	Type 1 diabetes in high risk HLA genotype individuals (time to event)
chr10	123169436	.	T	A	Childhood asthma exacerbations in long-acting beta2-agonist treatment
chr10	123620992	.	G	A	Joint damage in rheumatoid arthritis
chr10	123757564	.	T	A	Ulcerative colitis
chr10	123757564	.	T	C	Ulcerative colitis
chr10	124845846	.	A	T	Asthma control x inhaled corticosteroid treatment interaction (2df)
chr10	126878395	.	G	T	Response to TNF inhibitor in rheumatoid arthritis (change in disease activity score);Response to TNF inhibitor in rheumatoid arthritis (change in tender 28-joint count)
chr10	128875540	.	G	T	Moderate or severe prolonged lymphopenia in dimethyl fumarate-treated relapsing-remitting multiple sclerosis
chr10	131361823	.	A	G	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr10	131373856	.	G	C	Crohn's disease
chr10	131373856	.	G	T	Crohn's disease
chr10	132245320	.	C	T	Ocular sarcoidosis
chr10	132544853	.	C	G	Primary sclerosing cholangitis
chr10	132544853	.	C	T	Primary sclerosing cholangitis
chr10	133019423	.	G	A	Diisocyanate-induced asthma
chr10	133537670	.	T	G	Gout
chr11	308290	.	T	C	Autoimmune thyroid disease
chr11	321138	.	C	T	Multiple sclerosis
chr11	566936	.	C	A	Systemic lupus erythematosus
chr11	589564	.	T	C	Systemic lupus erythematosus
chr11	601785	.	T	C	Systemic lupus erythematosus and Systemic sclerosis
chr11	609888	.	T	C	Rheumatoid arthritis
chr11	613208	.	T	C	Systemic lupus erythematosus
chr11	614318	.	T	C	Systemic lupus erythematosus
chr11	617228	.	G	A	Systemic lupus erythematosus
chr11	618172	.	A	G	Systemic sclerosis
chr11	625085	.	A	G	Systemic lupus erythematosus
chr11	633689	.	T	C	Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)
chr11	646986	.	TAA	T	Primary biliary cholangitis
chr11	993745	.	C	G	Adult asthma
chr11	993745	.	C	T	Adult asthma
chr11	1116487	.	G	A	Asthma
chr11	1129831	.	A	G	Asthma;Asthma (adult onset)
chr11	1142570	.	A	G	Asthma (moderate or severe)
chr11	1151933	.	T	C	Asthma;Asthma (adult onset)
chr11	2027258	.	A	G	Celiac disease
chr11	2055620	.	C	A	Type 1 diabetes
chr11	2055620	.	C	T	Type 1 diabetes
chr11	2141880	.	T	G	Type 1 diabetes
chr11	2143569	.	G	A	Type 1 diabetes
chr11	2143569	.	G	C	Type 1 diabetes
chr11	2148544	.	A	G	Type 1 diabetes
chr11	2148544	.	A	T	Type 1 diabetes
chr11	2148913	.	G	A	Type 1 diabetes
chr11	2217058	.	A	C	Type 1 diabetes in high risk HLA genotype individuals (time to event)
chr11	2327389	.	T	A	Systemic sclerosis
chr11	2760289	.	G	A	Gout
chr11	2837316	.	C	T	Type 1 diabetes
chr11	2881830	.	G	A	Type 1 diabetes
chr11	2895485	.	A	T	Gout
chr11	3238579	.	G	A	Multiple sclerosis
chr11	6285654	.	T	A	Ocular sarcoidosis
chr11	6354579	.	C	A	Diisocyanate-induced asthma
chr11	6354579	.	C	T	Diisocyanate-induced asthma
chr11	7379335	.	G	T	Diisocyanate-induced asthma
chr11	7603399	.	C	A	Exacerbations requiring hospitalisation in asthma
chr11	7948164	.	A	C	Response to anti-TNF therapy in rheumatoid arthritis
chr11	8058878	.	T	C	Coronary artery disease in type 1 diabetes
chr11	9731194	.	C	G	Rheumatoid arthritis
chr11	10343497	.	A	G	End-stage knee osteoarthritis
chr11	10634076	.	C	T	Asthma
chr11	10639293	.	G	T	Asthma;Asthma (childhood onset)
chr11	10642486	.	G	T	Asthma;Asthma (childhood onset)
chr11	11065928	.	G	A	Asthma exacerbations in inhaled corticosteroid treatment
chr11	11084115	.	C	A	Knee osteoarthritis
chr11	11087692	.	T	C	Response to zileuton treatment in asthma (FEV1 change interaction)
chr11	11383855	.	C	T	Kawasaki disease
chr11	11482681	.	G	A	Response to tocilizumab in rheumatoid arthritis
chr11	11572026	.	C	T	Diisocyanate-induced asthma
chr11	12069460	.	A	G	Diisocyanate-induced asthma
chr11	12458540	.	A	G	Diisocyanate-induced asthma
chr11	12772983	.	A	C	Osteoarthritis of the hand
chr11	13737245	.	T	A	Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count);Response to TNF inhibitor in rheumatoid arthritis (change in tender 28-joint count)
chr11	16916299	.	T	A	Microalbuminuria in type 1 diabetes
chr11	16916299	.	T	G	Microalbuminuria in type 1 diabetes
chr11	17406354	.	C	G	Gout
chr11	17454913	.	C	G	Gout
chr11	17620582	.	T	C	Diisocyanate-induced asthma
chr11	18340835	.	T	G	Systemic lupus erythematosus
chr11	19760645	.	C	T	Subjective response to placebo treatment in childhood asthma (change in cough/wheeze)
chr11	19958686	.	G	A	Coronary artery aneurysm in Kawasaki disease
chr11	19962783	.	A	G	Response to TNF inhibitor in rheumatoid arthritis (change in tender 28-joint count)
chr11	19966866	.	G	A	Post-bronchodilator FEV1 x air pollution (CO) interaction in childhood asthma
chr11	19972258	.	A	G	Post-bronchodilator FEV1 x air pollution (CO) interaction in childhood asthma
chr11	20232053	.	A	G	Response to inhaled glucocorticoid treatment in asthma (change in FEV1)
chr11	20677383	.	C	A	Crohn's disease
chr11	20677383	.	C	G	Crohn's disease
chr11	20677383	.	C	T	Crohn's disease
chr11	23684142	.	C	G	Lung function (FEV1/FVC) in asthma
chr11	24637287	.	T	C	Crohn's disease (indolent vs progressive)
chr11	26719715	.	C	T	Diisocyanate-induced asthma
chr11	27778323	.	CG	C	Fulminant type 1 diabetes
chr11	27829084	.	C	A	Crohn's disease
chr11	28808335	.	A	C	Osteoarthritis of the hip or knee
chr11	28853450	.	A	C	Osteoarthritis of the hip or knee
chr11	30752733	.	G	T	Osteoarthritis
chr11	33955292	.	A	G	Type 1 diabetes with low genetic risk score
chr11	34759389	.	T	C	Systemic lupus erythematosus
chr11	35066852	.	G	C	Systemic lupus erythematosus
chr11	35071523	.	A	T	Systemic lupus erythematosus
chr11	35073939	.	A	T	Systemic lupus erythematosus
chr11	35076646	.	T	A	Systemic lupus erythematosus
chr11	35097935	.	A	T	Systemic lupus erythematosus
chr11	35253282	.	A	T	Vitiligo
chr11	35528905	.	G	A	Ocular sarcoidosis
chr11	35865269	.	C	T	Asthma
chr11	36322143	.	C	T	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)
chr11	36470641	.	T	C	Idiopathic inflammatory myopathy
chr11	36480237	.	A	T	Rheumatoid arthritis
chr11	45225625	.	T	C	Asthma
chr11	46583732	.	G	C	Ocular sarcoidosis
chr11	46583732	.	G	T	Ocular sarcoidosis
chr11	46723375	.	G	A	Thumb osteoarthritis severity (hand Klsum)
chr11	46723375	.	G	T	Thumb osteoarthritis severity (hand Klsum)
chr11	47338861	.	T	C	Multiple sclerosis
chr11	47952821	.	A	T	Osteoarthritis of the hip or knee
chr11	48155843	.	C	T	Kawasaki disease
chr11	55368743	.	C	T	Systemic lupus erythematosus
chr11	59901430	.	A	G	Ocular sarcoidosis
chr11	60961822	.	G	T	Type 1 diabetes
chr11	60993140	.	C	A	Multiple sclerosis
chr11	60993140	.	C	G	Multiple sclerosis
chr11	61008737	.	C	G	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Crohn's disease;Ulcerative colitis
chr11	61008737	.	C	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Crohn's disease;Ulcerative colitis
chr11	61064810	.	T	C	Multiple sclerosis
chr11	61066152	.	A	C	Multiple sclerosis
chr11	61138978	.	A	G	Rheumatoid arthritis
chr11	61142109	.	C	A	Rheumatoid arthritis;Rheumatoid arthritis (ACPA-positive)
chr11	61142109	.	C	T	Rheumatoid arthritis;Rheumatoid arthritis (ACPA-positive)
chr11	61796827	.	G	C	Crohn's disease
chr11	61806212	.	T	C	Asthma
chr11	61808334	.	TC	T	Asthma
chr11	61822009	.	A	C	Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS))
chr11	61826344	.	C	A	Asthma
chr11	61828092	.	C	T	Rheumatoid arthritis;Type 1 diabetes;Vitiligo
chr11	61843278	.	G	T	Adult onset asthma or type 2 diabetes;Asthma (adult onset);Nonatopic asthma or type 2 diabetes
chr11	61862632	.	G	A	Asthma (adult onset)
chr11	61862632	.	G	C	Asthma (adult onset)
chr11	64053157	.	C	T	Psoriasis
chr11	64342950	.	A	G	Primary biliary cholangitis
chr11	64342950	.	A	T	Primary biliary cholangitis
chr11	64343196	.	G	C	Crohn's disease or Leprosy (opposite effect)
chr11	64347665	.	C	A	Primary biliary cholangitis
chr11	64387509	.	T	C	Gout
chr11	64506358	.	C	G	Gout
chr11	64542619	.	C	A	Systemic lupus erythematosus
chr11	64542619	.	C	G	Systemic lupus erythematosus
chr11	64566642	.	C	T	Gout;Gout vs asymptomatic hyperuricemia
chr11	64587323	.	G	A	Systemic lupus erythematosus
chr11	64587323	.	G	T	Systemic lupus erythematosus
chr11	64668434	.	C	A	Gout;Renal overload gout;Renal underexcretion gout
chr11	64697931	.	T	A	Gout
chr11	64697931	.	T	G	Gout
chr11	65725735	.	T	G	Asthma
chr11	65787031	.	G	A	Systemic lupus erythematosus
chr11	65788053	.	A	C	Systemic lupus erythematosus
chr11	65788053	.	A	T	Systemic lupus erythematosus
chr11	65791795	.	A	T	Allergic disease (asthma, hay fever and/or eczema) (age of onset);Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis);Asthma;Asthma (childhood onset);Atopic asthma
chr11	65825973	.	A	T	Psoriasis
chr11	66283241	.	G	C	Gout
chr11	66734153	.	T	C	Osteoarthritis (hip)
chr11	67104849	.	C	T	Osteoarthritis (with total hip replacement)
chr11	69092380	.	C	CGGCTAAGGGGAGAGAGCCCGGAAGCCACGCACACCGGCGCAAGGGGCGGATA	Rheumatoid arthritis
chr11	69648142	.	G	A	Immunoglobulin light chain (AL) amyloidosis;Immunoglobulin light chain (AL) amyloidosis (heart involvement);Immunoglobulin light chain (AL) amyloidosis (kidney involvement);Immunoglobulin light chain (AL) amyloidosis (serum Ig lambda profile);Immunoglobulin light chain (AL) amyloidosis (serum Ig light chain only lambda based profile);Immunoglobulin light chain (AL) amyloidosis (serum Ig light chain only lambda/kappa based profile)
chr11	69781755	.	G	A	Type 1 diabetes
chr11	69781755	.	G	C	Type 1 diabetes
chr11	72959855	.	T	G	Crohn's disease
chr11	73183228	.	C	A	Body mass index in asthmatics
chr11	73183228	.	C	T	Body mass index in asthmatics
chr11	74561129	.	T	C	Renal underexcretion gout
chr11	75123789	.	G	C	Asthma
chr11	76147651	.	G	A	Thumb osteoarthritis severity (hand Klsum)
chr11	76323657	.	A	C	Asthma (childhood onset);Atopic asthma
chr11	76323657	.	A	T	Asthma (childhood onset);Atopic asthma
chr11	76324763	.	C	T	Asthma (childhood onset);Atopic asthma;Nonatopic asthma
chr11	76346902	.	C	T	Asthma
chr11	76362164	.	A	T	Asthma (childhood onset)
chr11	76402977	.	T	A	Atopic asthma
chr11	76462904	.	A	G	Atopic asthma
chr11	76487517	.	G	A	Asthma (childhood onset)
chr11	76537586	.	C	T	Asthma;Asthma (age of onset);Asthma (childhood onset)
chr11	76556723	.	T	A	Atopic asthma
chr11	76559639	.	A	G	Asthma;Asthma (moderate or severe)
chr11	76561595	.	C	G	Atopic asthma
chr11	76561595	.	C	T	Atopic asthma
chr11	76574378	.	C	T	Asthma (childhood onset)
chr11	76582483	.	G	A	Allergic disease (asthma, hay fever or eczema);Asthma;Asthma (adult onset);Food allergy
chr11	76588387	.	G	A	Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis);Allergic disease (asthma, hay fever or eczema);Asthma;Asthma (adult onset);Asthma (childhood onset);Asthma-COPD overlap syndrome;Asthma onset (childhood vs adult);Atopic asthma;Nonatopic asthma
chr11	76590272	.	C	T	Asthma;Crohn's disease
chr11	76590331	.	C	T	Crohn's disease
chr11	76632384	.	A	T	Allergic disease (asthma, hay fever or eczema)
chr11	76655646	.	T	G	Asthma;Atopic asthma
chr11	76658028	.	T	C	Asthma (childhood onset)
chr11	76666775	.	G	A	Asthma (childhood onset)
chr11	76708897	.	A	C	Atopic asthma
chr11	76795528	.	T	A	Osteoarthritis;Osteoarthritis of the hip or knee
chr11	78403273	.	C	T	Type 1 diabetes with low genetic risk score
chr11	85160633	.	T	C	Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count)
chr11	88086259	.	T	C	Multiple sclerosis (age of onset)
chr11	88934972	.	A	G	Rheumatoid arthritis (ACPA-negative)
chr11	89011257	.	T	C	Exacerbations requiring hospitalisation in asthma
chr11	89277878	.	G	A	Vitiligo
chr11	89284793	.	G	A	Vitiligo
chr11	89805517	.	T	A	Steroid induced osteonecrosis of the femoral head and systemic lupus erythematosus
chr11	89805517	.	T	C	Steroid induced osteonecrosis of the femoral head and systemic lupus erythematosus
chr11	93787149	.	C	T	Asthma with severe exacerbations
chr11	95688666	.	T	A	Multiple sclerosis
chr11	95688666	.	T	C	Multiple sclerosis
chr11	95692306	.	A	G	Allergic disease (asthma, hay fever or eczema)
chr11	95692362	.	C	T	Allergic disease (asthma, hay fever or eczema)
chr11	96063743	.	A	G	Osteoarthritis of the hip or knee (with total joint replacement)
chr11	96698259	.	C	A	Immunoglobulin A vasculitis
chr11	96698259	.	C	G	Immunoglobulin A vasculitis
chr11	96698259	.	C	T	Immunoglobulin A vasculitis
chr11	98216871	.	C	T	Behcet's disease
chr11	98708388	.	T	A	Asthma exacerbations in inhaled corticosteroid treatment
chr11	98708388	.	T	C	Asthma exacerbations in inhaled corticosteroid treatment
chr11	98730321	.	T	C	Crohn's disease (indolent vs progressive)
chr11	100271031	.	T	C	Gout vs. Hyperuricemia
chr11	100839163	.	G	A	Asthma
chr11	101871526	.	T	G	Systemic sclerosis
chr11	101900702	.	T	A	Response to methotrexate in juvenile idiopathic arthritis
chr11	101900702	.	T	C	Response to methotrexate in juvenile idiopathic arthritis
chr11	102519612	.	G	A	Narcolepsy with cataplexy
chr11	102519612	.	G	T	Narcolepsy with cataplexy
chr11	102591595	.	G	A	Adverse response to antithyroid drugs in Graves disease
chr11	102630934	.	G	A	Response to TNF inhibitor in rheumatoid arthritis (change in patient global heath assessment score)
chr11	102757321	.	G	A	Multiple sclerosis
chr11	102879534	.	C	A	Peanut allergy
chr11	102879534	.	C	T	Peanut allergy
chr11	103016500	.	A	G	Diisocyanate-induced asthma
chr11	103145464	.	G	A	Diisocyanate-induced asthma
chr11	106323170	.	T	TAAA	Coronary artery disease in type 1 diabetes
chr11	107967350	.	G	T	Rheumatoid arthritis
chr11	108096623	.	A	G	Rheumatoid arthritis
chr11	109152533	.	T	G	Knee osteoarthritis
chr11	109962432	.	A	G	Psoriasis
chr11	110088912	.	G	A	Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect)
chr11	110091706	.	A	G	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Psoriasis or type 2 diabetes (trans-disease meta-analysis);Psoriasis;Psoriasis vulgaris
chr11	111326133	.	T	A	Celiac disease
chr11	111405360	.	C	G	Multiple sclerosis
chr11	111405360	.	C	T	Multiple sclerosis
chr11	111563202	.	C	T	Nonatopic asthma and/or waist-to-hip ratio adjusted for BMI
chr11	111566171	.	T	C	Allergic disease (asthma, hay fever or eczema);Asthma or allergic disease (pleiotropy)
chr11	111603392	.	G	T	Asthma
chr11	111709215	.	G	A	Primary sclerosing cholangitis
chr11	111754361	.	C	T	Asthma-COPD overlap syndrome
chr11	113978180	.	G	A	Multiple sclerosis
chr11	114071429	.	C	T	Diisocyanate-induced asthma
chr11	114194103	.	T	C	Paneth cell defects in Crohn's disease
chr11	114360533	.	T	C	Asthma
chr11	114365008	.	C	G	Asthma
chr11	114365008	.	C	T	Asthma
chr11	114526440	.	A	AC	Ulcerative colitis
chr11	114526440	.	A	ACCACTCTCTTCCTC	Ulcerative colitis
chr11	114526441	.	A	C	Ulcerative colitis
chr11	114559688	.	A	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Ulcerative colitis
chr11	115841215	.	A	G	Diisocyanate-induced asthma
chr11	116158033	.	T	G	Early-onset myasthenia gravis
chr11	116728676	.	C	T	Multiple sclerosis (severity)
chr11	118609980	.	G	A	Multiple sclerosis
chr11	118609980	.	G	C	Multiple sclerosis
chr11	118768644	.	G	C	Systemic sclerosis
chr11	118777915	.	C	A	Systemic sclerosis
chr11	118805063	.	C	G	Allergy
chr11	118856134	.	C	G	Celiac disease;Systemic sclerosis
chr11	118858682	.	A	T	Rheumatoid arthritis
chr11	118867589	.	G	T	Primary biliary cholangitis
chr11	118869395	.	AT	A	Primary biliary cholangitis
chr11	118869396	.	T	A	Primary biliary cholangitis
chr11	118873063	.	T	A	Primary biliary cholangitis
chr11	118876060	.	T	C	Allergic disease (asthma, hay fever and/or eczema) (age of onset);Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis)
chr11	118877104	.	A	T	Multiple sclerosis;Systemic lupus erythematosus
chr11	118883644	.	C	A	Crohn's disease;Multiple sclerosis
chr11	118885029	.	A	G	Multiple sclerosis
chr11	118932913	.	G	A	Post-bronchodilator lung function in asthma (FVC)
chr11	121373007	.	C	T	Response to tocilizumab in rheumatoid arthritis
chr11	123226678	.	C	T	Food allergy (maternal genetic effects)
chr11	123369465	.	T	A	Immunoglobulin light chain (AL) amyloidosis
chr11	123369465	.	T	C	Immunoglobulin light chain (AL) amyloidosis
chr11	123459759	.	G	A	Ulcerative colitis
chr11	123484683	.	A	G	Immunoglobulin M against phosphorylcholine (IgM anti-PC) levels
chr11	123777625	.	T	G	IgE levels in asthmatics (D.p. specific)
chr11	123834718	.	T	C	Serum uric acid levels in response to allopurinol in gout
chr11	123909685	.	T	G	Serum uric acid levels in response to allopurinol in gout
chr11	125227371	.	C	T	Serum uric acid levels in response to allopurinol in gout
chr11	127891771	.	G	A	Asthma (childhood onset)
chr11	128261371	.	G	A	Allergic disease (asthma, hay fever or eczema);Asthma
chr11	128268972	.	TC	T	Pediatric asthma
chr11	128277554	.	C	A	Psoriasis
chr11	128277554	.	C	G	Psoriasis
chr11	128277554	.	C	T	Psoriasis
chr11	128283912	.	T	C	Asthma
chr11	128286419	.	A	G	Rheumatoid arthritis
chr11	128288294	.	A	G	Allergic disease (asthma, hay fever or eczema)
chr11	128291247	.	C	G	Allergic disease (asthma, hay fever and/or eczema) (age of onset);Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis)
chr11	128298736	.	C	A	Asthma
chr11	128302941	.	G	GA	Asthma;Asthma (childhood onset)
chr11	128315955	.	G	C	Endometriosis or asthma (pleiotropy)
chr11	128316987	.	T	G	Endometriosis or asthma (pleiotropy);Self-reported allergy
chr11	128324555	.	G	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Psoriasis
chr11	128413550	.	G	T	Systemic lupus erythematosus
chr11	128437550	.	G	GA	Primary biliary cholangitis
chr11	128437550	.	G	GAA	Primary biliary cholangitis
chr11	128441164	.	G	A	Systemic lupus erythematosus
chr11	128441164	.	G	T	Systemic lupus erythematosus
chr11	128444529	.	A	G	Systemic lupus erythematosus
chr11	128449583	.	C	T	Systemic lupus erythematosus
chr11	128454974	.	C	G	Systemic lupus erythematosus
chr11	128454974	.	C	T	Systemic lupus erythematosus
chr11	128455658	.	T	C	Primary biliary cholangitis
chr11	128459064	.	C	T	Systemic lupus erythematosus
chr11	128476898	.	T	C	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr11	128481247	.	G	A	Multiple sclerosis
chr11	128481247	.	G	T	Multiple sclerosis
chr11	128511079	.	C	A	Celiac disease;Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Ulcerative colitis
chr11	128511079	.	C	T	Celiac disease;Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Ulcerative colitis
chr11	128511972	.	A	C	Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect)
chr11	128522042	.	C	T	Celiac disease
chr11	128533313	.	T	C	Psoriasis
chr11	128536543	.	A	G	Psoriasis;Psoriasis vulgaris
chr11	128536543	.	A	T	Psoriasis;Psoriasis vulgaris
chr11	128540369	.	T	A	Psoriasis or type 2 diabetes (trans-disease meta-analysis)
chr11	128540369	.	T	C	Psoriasis or type 2 diabetes (trans-disease meta-analysis)
chr11	128540941	.	C	G	Multiple sclerosis
chr11	128540941	.	C	T	Multiple sclerosis
chr11	128545234	.	T	C	Celiac disease
chr11	128551280	.	G	A	Multiple sclerosis
chr11	128618427	.	G	A	Rheumatoid arthritis
chr11	128622844	.	T	C	Rheumatoid arthritis
chr11	128627057	.	C	T	Rheumatoid arthritis;Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)
chr11	128629105	.	T	C	Chronic lymphocytic leukemia or systemic lupus erythematosus;Systemic lupus erythematosus
chr11	128632327	.	A	G	Multiple sclerosis
chr11	128632601	.	A	G	Rheumatoid arthritis (ACPA-positive)
chr11	128724266	.	C	T	Systemic lupus erythematosus
chr11	128734279	.	C	A	Type 1 diabetes
chr11	128734279	.	C	T	Type 1 diabetes
chr11	128734337	.	G	T	Type 1 diabetes
chr11	128762660	.	T	C	Vitiligo
chr11	129451923	.	T	A	Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis
chr11	129451923	.	T	G	Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis
chr11	129982285	.	C	A	Carotid intima media thickness in rheumatoid arthritis
chr11	129982285	.	C	T	Carotid intima media thickness in rheumatoid arthritis
chr11	131642123	.	G	T	Interstitial lung diseases in rheumatoid arthritis
chr11	131886801	.	C	G	Severe exacerbations in childhood asthma
chr11	131886801	.	C	T	Severe exacerbations in childhood asthma
chr11	132452811	.	T	A	Takayasu arteritis
chr11	132452811	.	T	C	Takayasu arteritis
chr11	132706651	.	C	T	Crohn's disease (indolent vs progressive)
chr12	31864	.	G	A	Ocular sarcoidosis
chr12	204673	.	G	A	Diisocyanate-induced asthma
chr12	1631005	.	C	G	Gout
chr12	2046979	.	T	G	Asthma exacerbations in inhaled corticosteroid treatment
chr12	3055757	.	C	T	Narcolepsy with cataplexy
chr12	3188865	.	G	A	Psoriasis
chr12	3293526	.	A	G	Endometriosis or asthma (pleiotropy)
chr12	4031710	.	T	C	Systemic lupus erythematosus
chr12	4031710	.	T	G	Systemic lupus erythematosus
chr12	4275678	.	T	G	Psoriasis or type 2 diabetes (trans-disease meta-analysis)
chr12	4988312	.	G	A	Serum uric acid levels in response to allopurinol in gout
chr12	4988312	.	G	C	Serum uric acid levels in response to allopurinol in gout
chr12	5770242	.	TG	T	Serum uric acid levels in response to allopurinol in gout
chr12	5993660	.	T	TAC	Response to tofacitinib treatment in psoriasis (herpes zoster);Response to tofacitinib treatment in psoriasis (herpes zoster)(time to event)
chr12	5993660	.	T	TACAC	Response to tofacitinib treatment in psoriasis (herpes zoster);Response to tofacitinib treatment in psoriasis (herpes zoster)(time to event)
chr12	6332456	.	C	A	Multiple sclerosis
chr12	6332456	.	C	G	Multiple sclerosis
chr12	6332456	.	C	T	Multiple sclerosis
chr12	6333477	.	C	G	Multiple sclerosis
chr12	6333477	.	C	T	Multiple sclerosis
chr12	6381959	.	G	A	Ankylosing spondylitis;Crohn's disease
chr12	6393576	.	G	A	Ankylosing spondylitis;Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr12	6394334	.	G	C	Multiple sclerosis
chr12	6402830	.	C	G	Celiac disease
chr12	6405797	.	C	A	Multiple sclerosis
chr12	6451407	.	G	A	Multiple sclerosis
chr12	8548569	.	G	T	Takayasu arteritis
chr12	9680928	.	C	A	Autoimmune thyroid disease
chr12	9683329	.	G	T	Autoimmune thyroid disease
chr12	9736046	.	T	A	Autoimmune thyroid disease
chr12	10420495	.	C	A	Composite immunoglobulin trait (IgA/IgG)
chr12	10420495	.	C	G	Composite immunoglobulin trait (IgA/IgG)
chr12	10420495	.	C	T	Composite immunoglobulin trait (IgA/IgG)
chr12	10434512	.	A	C	Composite immunoglobulin trait (IgA/IgG)
chr12	10434512	.	A	G	Composite immunoglobulin trait (IgA/IgG)
chr12	10444608	.	C	G	Psoriasis
chr12	11788645	.	A	C	Asthma
chr12	11845842	.	A	G	Multiple sclerosis
chr12	12015197	.	A	G	Multiple sclerosis
chr12	13659623	.	C	T	Egg allergy (parent-of-origin effect)
chr12	14901082	.	G	A	Finger osteoarthritis
chr12	14911429	.	C	G	Finger osteoarthritis severity (hand Klsum);Hand osteoarthritis severity (hand Klsum);Osteoarthritis of the hand
chr12	14911429	.	C	T	Finger osteoarthritis severity (hand Klsum);Hand osteoarthritis severity (hand Klsum);Osteoarthritis of the hand
chr12	16546316	.	T	C	Diisocyanate-induced asthma
chr12	20687905	.	T	C	Response to TNF-alpha inhibitors in rheumatoid arthritis
chr12	20707159	.	G	A	Response to TNF-alpha inhibitors in rheumatoid arthritis
chr12	21275437	.	T	C	Diisocyanate-induced asthma
chr12	21906683	.	C	G	Gout
chr12	23793212	.	C	T	Systemic sclerosis
chr12	23806655	.	G	A	Osteoarthritis of the hip or knee
chr12	24660347	.	G	A	Rheumatoid arthritis
chr12	24660347	.	G	C	Rheumatoid arthritis
chr12	25860350	.	C	T	Takayasu arteritis
chr12	25890592	.	A	G	Ankylosing spondylitis
chr12	25890592	.	A	T	Ankylosing spondylitis
chr12	26440995	.	T	A	Endometriosis or asthma (pleiotropy)
chr12	26440995	.	T	C	Endometriosis or asthma (pleiotropy)
chr12	27842114	.	G	T	Osteoarthritis of the hip (with total joint replacement)
chr12	27851953	.	T	C	Osteoarthritis of the hip (with total joint replacement)
chr12	27862037	.	G	T	Osteoarthritis (hip);Osteoarthritis of the hip or knee
chr12	27872263	.	A	C	Osteoarthritis (hip);Osteoarthritis of the hip (with total joint replacement);Osteoarthritis (with total hip replacement)
chr12	28042192	.	A	G	Asthma and hay fever
chr12	28207052	.	A	G	Finger osteoarthritis severity (hand Klsum);Hand osteoarthritis severity (hand Klsum)
chr12	28540211	.	A	C	Osteoarthritis of the hand
chr12	28540211	.	A	G	Osteoarthritis of the hand
chr12	28540211	.	A	T	Osteoarthritis of the hand
chr12	32044036	.	C	T	Ocular sarcoidosis in sarcoidosis
chr12	32050917	.	T	C	Ocular sarcoidosis
chr12	40362670	.	C	T	Crohn's disease
chr12	41319504	.	C	T	Diisocyanate-induced asthma
chr12	41572059	.	A	C	Multiple sclerosis
chr12	46025303	.	C	T	Multiple sclerosis
chr12	46206380	.	G	T	Gout
chr12	47803199	.	G	A	Allergic disease (asthma, hay fever or eczema)
chr12	47809158	.	C	A	Asthma
chr12	47809158	.	C	T	Asthma
chr12	47811575	.	C	A	Asthma;Asthma (adult onset)
chr12	47811575	.	C	T	Asthma;Asthma (adult onset)
chr12	47862166	.	A	C	Gout
chr12	48021974	.	G	A	Rheumatoid arthritis
chr12	49951888	.	T	A	Allergic disease (asthma, hay fever or eczema)
chr12	49960654	.	A	C	Asthma
chr12	52246493	.	C	G	Diisocyanate-induced asthma
chr12	52246493	.	C	T	Diisocyanate-induced asthma
chr12	52286982	.	G	A	Diisocyanate-induced asthma
chr12	52286982	.	G	C	Diisocyanate-induced asthma
chr12	54081158	.	C	T	Self-reported childhood asthma in adult smokers
chr12	54974507	.	C	T	Asthma;Asthma (childhood onset);Atopic asthma
chr12	56001170	.	A	G	Rheumatoid arthritis
chr12	56001170	.	A	T	Rheumatoid arthritis
chr12	56013288	.	G	C	Vitiligo
chr12	56013288	.	G	T	Vitiligo
chr12	56023144	.	A	G	Vitiligo
chr12	56124624	.	T	A	Systemic sclerosis
chr12	57000851	.	G	C	Asthma
chr12	57055423	.	C	T	Asthma
chr12	57104437	.	T	C	Asthma
chr12	57449928	.	G	A	Gout
chr12	57739473	.	G	T	Multiple sclerosis
chr12	57788279	.	A	T	Multiple sclerosis
chr12	58890047	.	C	T	Leucine-rich repeats and immunoglobulin-like domains protein 3 levels
chr12	58895568	.	C	T	Osteoarthritis (with total hip replacement)
chr12	58895817	.	A	G	Osteoarthritis (hip)
chr12	58932883	.	G	A	Leucine-rich repeats and immunoglobulin-like domains protein 3 levels
chr12	59775461	.	G	A	Kawasaki disease
chr12	61856639	.	T	G	Asthma and hay fever
chr12	62144367	.	G	A	Alopecia areata
chr12	62144367	.	G	T	Alopecia areata
chr12	62764382	.	C	T	Osteoarthritis of the knee (with total joint replacement)
chr12	62943756	.	G	A	Carotid intima media thickness in rheumatoid arthritis
chr12	63918830	.	G	T	Bone erosion in rheumatoid arthritis
chr12	65324519	.	T	G	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr12	65543332	.	A	G	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr12	65543332	.	A	T	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr12	65644210	.	C	A	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr12	65644210	.	C	T	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr12	68044153	.	A	C	Systemic lupus erythematosus
chr12	68067917	.	G	A	Systemic lupus erythematosus
chr12	68103628	.	A	G	Ulcerative colitis vs rheumatoid arthritis (ordinary least squares (OLS))
chr12	68106206	.	G	A	Crohn's disease;Ulcerative colitis
chr12	68106295	.	G	A	Ulcerative colitis
chr12	68110812	.	G	A	Ulcerative colitis
chr12	68114342	.	G	A	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Ulcerative colitis
chr12	68140560	.	A	G	Alopecia areata
chr12	68202881	.	T	C	Ulcerative colitis
chr12	69448863	.	T	C	Complete remission in asthma
chr12	72330254	.	T	A	Rheumatoid arthritis
chr12	72330254	.	T	C	Rheumatoid arthritis
chr12	76615280	.	A	G	Systemic lupus erythematosus
chr12	76895640	.	T	A	Adult asthma
chr12	79345104	.	T	C	Systemic lupus erythematosus
chr12	82684840	.	T	C	Adult asthma
chr12	82684840	.	T	G	Adult asthma
chr12	82914584	.	G	C	Coronary artery aneurysm in Kawasaki disease
chr12	93494763	.	A	T	Peanut allergy (maternal genetic effects)
chr12	93613513	.	G	A	Joint damage in rheumatoid arthritis
chr12	93613513	.	G	C	Joint damage in rheumatoid arthritis
chr12	93787552	.	G	C	Osteoarthritis of the hip or knee
chr12	93787552	.	G	T	Osteoarthritis of the hip or knee
chr12	94164661	.	GCACACACACACA	G	Asthma
chr12	94188560	.	G	A	Asthma
chr12	94211187	.	G	T	Asthma
chr12	94225997	.	C	G	Asthma-COPD overlap syndrome
chr12	97342818	.	A	G	joint destruction in rheumatoid arthritis (rapid vs slow)
chr12	97522694	.	A	G	Kawasaki disease
chr12	99392036	.	G	C	Peak cortisol response to low dose short synacthen test in corticosteroid treated asthma
chr12	100990180	.	T	G	Response to methotrexate in juvenile idiopathic arthritis
chr12	103499163	.	G	T	Autoimmune thyroid disease
chr12	106967165	.	G	A	Kawasaki disease
chr12	107662094	.	C	G	Post-bronchodilator lung function in asthma (FEV1);Post-bronchodilator lung function in asthma (FVC)
chr12	108236003	.	G	A	Knee osteoarthritis
chr12	108324152	.	C	A	Response to methotrexate in juvenile idiopathic arthritis
chr12	110688804	.	C	T	Composite immunoglobulin trait (IgA/IgG)
chr12	111270654	.	A	C	Type 1 diabetes
chr12	111277393	.	C	T	Composite immunoglobulin trait (IgA x IgG/IgM)
chr12	111395984	.	G	A	Rheumatoid arthritis;Vitiligo
chr12	111418869	.	C	T	Rheumatoid arthritis
chr12	111446804	.	T	A	Autoimmune thyroid disease;Celiac disease;Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Multiple sclerosis;Primary sclerosing cholangitis;Rheumatoid arthritis;Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive);Type 1 diabetes;Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)
chr12	111446804	.	T	C	Autoimmune thyroid disease;Celiac disease;Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Multiple sclerosis;Primary sclerosing cholangitis;Rheumatoid arthritis;Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive);Type 1 diabetes;Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)
chr12	111446804	.	T	G	Autoimmune thyroid disease;Celiac disease;Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Multiple sclerosis;Primary sclerosing cholangitis;Rheumatoid arthritis;Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive);Type 1 diabetes;Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)
chr12	111466567	.	T	A	Sj√∂gren's syndrome;Vitiligo
chr12	111469627	.	A	AC	Primary biliary cholangitis
chr12	111472415	.	A	G	Asthma (age of onset);Asthma (childhood onset);Systemic lupus erythematosus
chr12	111494996	.	C	A	Allergic disease (asthma, hay fever or eczema);Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)
chr12	111494996	.	C	T	Allergic disease (asthma, hay fever or eczema);Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)
chr12	111495741	.	C	A	Rheumatoid arthritis;Systemic lupus erythematosus
chr12	111495741	.	C	T	Rheumatoid arthritis;Systemic lupus erythematosus
chr12	111535554	.	A	G	Allergic disease (asthma, hay fever and/or eczema) (age of onset);Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis);Systemic lupus erythematosus
chr12	111569952	.	C	T	Allergic disease (asthma, hay fever or eczema);Alopecia areata;Asthma;Celiac disease;Celiac disease or Rheumatoid arthritis;Crohn's disease;Psoriasis or type 2 diabetes (trans-disease meta-analysis);Sarcoidosis;Systemic lupus erythematosus;Type 1 diabetes
chr12	111621753	.	C	T	Asthma;Asthma (childhood onset);Asthma onset (childhood vs adult);Psoriasis
chr12	111634620	.	A	G	Asthma;Primary biliary cholangitis
chr12	111920180	.	C	T	Ulcerative colitis x smoking status (never vs current smoking) interaction
chr12	112049014	.	A	G	Type 1 diabetes
chr12	112153882	.	G	A	Systemic lupus erythematosus
chr12	112153882	.	G	C	Systemic lupus erythematosus
chr12	112172910	.	G	A	Celiac disease and Rheumatoid arthritis
chr12	112172910	.	G	C	Celiac disease and Rheumatoid arthritis
chr12	112433568	.	A	G	Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)
chr12	112468611	.	A	G	Multiple sclerosis
chr12	112987349	.	C	A	Adult asthma
chr12	112987349	.	C	T	Adult asthma
chr12	114915295	.	A	G	Childhood asthma exacerbations in long-acting beta2-agonist treatment
chr12	115116280	.	A	AT	Agouti-related protein levels
chr12	116442573	.	T	C	Asthma with severe exacerbations
chr12	116458870	.	C	T	Systemic lupus erythematosus
chr12	116928726	.	C	T	Marginal zone lymphoma or rheumatoid arthritis
chr12	117321510	.	A	T	Baseline cortisol levels in response to low dose short synacthen test in corticosteroid treated asthma
chr12	117332939	.	A	C	Asymmetrical dimethylarginine levels in osteoarthritis
chr12	117991171	.	G	A	Systemic lupus erythematosus
chr12	118244946	.	C	G	Systemic lupus erythematosus
chr12	118865390	.	T	C	Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis
chr12	118913063	.	G	A	Systemic lupus erythematosus
chr12	119709120	.	G	A	Ulcerative colitis
chr12	120363020	.	A	G	Rheumatoid arthritis
chr12	120764861	.	A	G	Allergic disease (asthma, hay fever and/or eczema) (age of onset);Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis)
chr12	120766879	.	C	T	Systemic lupus erythematosus
chr12	120790826	.	C	CTT	Systemic lupus erythematosus
chr12	120920841	.	A	T	Asthma (childhood onset)
chr12	120927628	.	G	A	Asthma;Asthma (childhood onset);Asthma onset (childhood vs adult)
chr12	122133584	.	A	C	Gout
chr12	122133584	.	A	G	Gout
chr12	122133584	.	A	T	Gout
chr12	123108835	.	C	T	Asthma;Multiple sclerosis
chr12	123172178	.	G	T	Multiple sclerosis
chr12	123218875	.	A	AGCT	Osteoarthritis
chr12	123218875	.	A	AGTT	Osteoarthritis
chr12	123218875	.	A	AGTTGTT	Osteoarthritis
chr12	123248222	.	A	ATACT	Knee osteoarthritis
chr12	123258145	.	TG	T	Allergic disease (asthma, hay fever or eczema)
chr12	123286485	.	A	G	Allergy
chr12	123321672	.	C	T	Knee osteoarthritis
chr12	123890663	.	A	G	Osteoarthritis (hip)
chr12	123896099	.	T	A	Osteoarthritis of the hip or knee
chr12	124315096	.	C	A	Osteoarthritis (hip)
chr12	124315096	.	C	G	Osteoarthritis (hip)
chr12	124851404	.	C	A	Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis
chr12	125410562	.	G	A	Lung function (FEV1) in asthma
chr12	126249723	.	G	T	Diisocyanate-induced asthma
chr12	126523323	.	GTTTTACTTTTGTCTA	G	Diisocyanate-induced asthma
chr12	126807279	.	T	A	Gout (normal type)
chr12	128888528	.	A	C	Childhood onset systemic lupus erythematosus
chr12	128978158	.	C	T	Response to zileuton treatment in asthma (FEV1 change interaction)
chr12	129027065	.	G	T	Asthma
chr12	129632604	.	C	T	Diisocyanate-induced asthma
chr12	129982086	.	A	G	Diisocyanate-induced asthma
chr12	132463596	.	GCATCAC	G	Systemic lupus erythematosus
chr13	18792141	.	C	T	Serum uric acid levels in response to allopurinol in gout
chr13	19181923	.	T	C	Coronary artery aneurysm in Kawasaki disease
chr13	22056464	.	G	T	Asthma (childhood onset)
chr13	23188133	.	G	A	Asthma
chr13	24212777	.	T	G	Autoimmune thyroid disease
chr13	25593405	.	G	C	Oral corticosteroid burst in asthma
chr13	25593405	.	G	T	Oral corticosteroid burst in asthma
chr13	25702195	.	G	A	Oral corticosteroid burst in asthma
chr13	25702195	.	G	T	Oral corticosteroid burst in asthma
chr13	26841536	.	A	C	Asthma (toluene diisocyanate-induced)
chr13	26841536	.	A	G	Asthma (toluene diisocyanate-induced)
chr13	26841536	.	A	T	Asthma (toluene diisocyanate-induced)
chr13	26957130	.	T	C	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Ulcerative colitis
chr13	28029870	.	T	C	Autoimmune thyroid disease;Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)
chr13	28029870	.	T	G	Autoimmune thyroid disease;Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)
chr13	28048407	.	T	A	Psoriasis
chr13	28048407	.	T	C	Psoriasis
chr13	31593580	.	A	T	Glycated hemoglobin levels in type 1 diabetes
chr13	32718324	.	G	A	Asthma
chr13	33004095	.	A	G	Asthma exacerbations in inhaled corticosteroid treatment
chr13	33224125	.	A	C	Body mass index in asthmatics
chr13	34612315	.	T	A	Immunoglobulin light chain (AL) amyloidosis (serum IgG profile);Immunoglobulin light chain (AL) amyloidosis (serum Ig lambda profile)
chr13	35777629	.	A	C	Asthma (childhood onset)
chr13	39752145	.	A	G	Asthma
chr13	39776775	.	T	G	Multiple sclerosis;Psoriasis;Rheumatoid arthritis (ACPA-positive)
chr13	39781776	.	T	A	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular);Rheumatoid arthritis
chr13	39783540	.	A	T	Multiple sclerosis
chr13	39797285	.	G	C	Ocular sarcoidosis
chr13	39931373	.	C	T	Ulcerative colitis
chr13	40121855	.	G	A	Crohn's disease
chr13	40121855	.	G	C	Crohn's disease
chr13	40220445	.	A	C	Primary sclerosing cholangitis
chr13	40251245	.	A	G	Narcolepsy with cataplexy
chr13	40251245	.	A	T	Narcolepsy with cataplexy
chr13	40258875	.	T	A	Crohn's disease
chr13	40439840	.	T	C	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Ulcerative colitis
chr13	40599271	.	G	A	Allergic disease (asthma, hay fever or eczema)
chr13	41465152	.	C	G	Multiple sclerosis
chr13	42065933	.	T	A	Neuropeptide Y autoantibody levels in type 1 diabetes
chr13	42065933	.	T	C	Neuropeptide Y autoantibody levels in type 1 diabetes
chr13	42065933	.	T	G	Neuropeptide Y autoantibody levels in type 1 diabetes
chr13	42212544	.	A	G	Pulmonary function in asthmatics
chr13	42212544	.	A	T	Pulmonary function in asthmatics
chr13	42343795	.	C	T	Type 1 diabetes
chr13	42356523	.	T	C	Type 1 diabetes
chr13	42356523	.	T	G	Type 1 diabetes
chr13	42384997	.	A	T	Knee osteoarthritis
chr13	42473124	.	G	A	Autoimmune thyroid disease
chr13	42476318	.	T	C	Primary biliary cholangitis
chr13	42496070	.	T	A	Vitiligo
chr13	43642928	.	T	A	Response to tocilizumab in rheumatoid arthritis
chr13	43642928	.	T	C	Response to tocilizumab in rheumatoid arthritis
chr13	43910570	.	G	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Crohn's disease
chr13	43916045	.	C	A	Asthma
chr13	44480955	.	T	C	Antineutrophil cytoplasmic antibody-associated vasculitis
chr13	44901447	.	G	A	Diisocyanate-induced asthma
chr13	47269242	.	C	A	Asthma or chronic obstructive pulmonary disease
chr13	47376590	.	A	C	Sj√∂gren's syndrome
chr13	48045719	.	C	T	Thiopurine-induced early leukopenia in Crohn's disease
chr13	48676861	.	G	A	Response to inhaled corticosteroid treatment in asthma (change in FEV1)
chr13	50220092	.	G	A	Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect)
chr13	50220092	.	G	T	Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect)
chr13	50237084	.	T	C	Multiple sclerosis;Primary biliary cholangitis;Psoriasis or type 2 diabetes (trans-disease meta-analysis)
chr13	50243690	.	C	A	Multiple sclerosis
chr13	50268304	.	T	C	Multiple sclerosis
chr13	50547241	.	CA	C	Primary biliary cholangitis
chr13	51002034	.	G	A	Rheumatoid arthritis (ACPA-negative)
chr13	62645344	.	A	T	Crohn's disease (indolent vs progressive)
chr13	63064196	.	T	C	Asthma
chr13	63636265	.	A	G	Response to inhaled corticosteroid treatment in asthma (change in FEV1)
chr13	64317065	.	T	C	Rheumatoid arthritis
chr13	64356863	.	T	A	Rheumatoid arthritis
chr13	64362111	.	G	A	Rheumatoid arthritis
chr13	64362111	.	G	T	Rheumatoid arthritis
chr13	64366135	.	T	C	Rheumatoid arthritis
chr13	64371042	.	C	G	Rheumatoid arthritis
chr13	64372566	.	T	C	Rheumatoid arthritis
chr13	64376290	.	T	A	Rheumatoid arthritis
chr13	64376290	.	T	C	Rheumatoid arthritis
chr13	64504335	.	C	T	Takayasu arteritis
chr13	69314926	.	T	G	Endometriosis or asthma (pleiotropy)
chr13	70061278	.	A	T	Asthma (time to childhood onset) in early life tobacco smoke exposure
chr13	70071740	.	T	G	Asthma (time to childhood onset) x early life tobacco smoke interaction
chr13	73143663	.	C	CCTT	Exacerbations requiring hospitalisation in asthma
chr13	73143663	.	C	CCTTCTT	Exacerbations requiring hospitalisation in asthma
chr13	73421057	.	C	T	Asthma
chr13	73465798	.	C	G	Allergic disease (asthma, hay fever or eczema);Asthma;Pediatric asthma
chr13	73704828	.	A	G	Systemic lupus erythematosus
chr13	74298019	.	G	A	Interstitial lung diseases in rheumatoid arthritis
chr13	75752146	.	A	C	Type 1 diabetes
chr13	75752146	.	A	T	Type 1 diabetes
chr13	78976799	.	C	T	Ulcerative colitis
chr13	80488806	.	T	C	Response to inhaled corticosteroid treatment in asthma (change in FEV1)
chr13	81587764	.	C	A	Sj√∂gren's syndrome
chr13	81587764	.	C	T	Sj√∂gren's syndrome
chr13	82963398	.	A	C	Food allergy (maternal genetic effects)
chr13	87022817	.	G	A	Diisocyanate-induced asthma
chr13	92293631	.	T	A	Rheumatoid arthritis
chr13	92293631	.	T	C	Rheumatoid arthritis
chr13	92679633	.	G	A	Multiple sclerosis
chr13	99122393	.	G	A	Self-reported allergy
chr13	99255087	.	G	A	Crohn's disease;Ulcerative colitis
chr13	99341418	.	AG	A	Asthma
chr13	99343761	.	G	C	Asthma-COPD overlap syndrome
chr13	99388400	.	A	G	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr13	99418203	.	T	A	Asthma;Asthma (adult onset);Behcet's disease
chr13	99418203	.	T	G	Asthma;Asthma (adult onset);Behcet's disease
chr13	99429512	.	C	G	Type 1 diabetes
chr13	99868847	.	T	C	Rheumatoid arthritis (ACPA-negative)
chr13	101144683	.	A	G	Serum uric acid levels in response to allopurinol in gout
chr13	105419977	.	C	A	Oral corticosteroid burst in asthma
chr13	105419977	.	C	T	Oral corticosteroid burst in asthma
chr13	108839523	.	G	A	Steroid induced osteonecrosis of the femoral head and systemic lupus erythematosus
chr13	112366443	.	T	C	Diisocyanate-induced asthma
chr13	113040195	.	A	G	Osteoarthritis
chr13	113158648	.	G	C	Food allergy (parent-of-origin effect)
chr13	113919624	.	A	T	Response to tocilizumab in rheumatoid arthritis
chr14	20484972	.	T	G	Response to ustekinumab in psoriasis (improvement)
chr14	20581400	.	G	A	Food allergy (parent-of-origin effect);Milk allergy (parent-of-origin effect)
chr14	20642034	.	G	A	Lung function (FEV1) in asthma
chr14	20642034	.	G	C	Lung function (FEV1) in asthma
chr14	21746775	.	C	T	Type 1 diabetes with low genetic risk score
chr14	22383427	.	T	C	Type 1 diabetes
chr14	22390463	.	A	T	Type 1 diabetes with low genetic risk score
chr14	22533736	.	G	A	Narcolepsy;Narcolepsy with cataplexy
chr14	22570239	.	A	C	Crohn's disease (indolent vs progressive)
chr14	23370824	.	C	T	Type 1 diabetes
chr14	25024864	.	A	C	Ocular sarcoidosis
chr14	25024864	.	A	G	Ocular sarcoidosis
chr14	25486296	.	C	T	Finger osteoarthritis severity (hand Klsum)
chr14	25535506	.	T	C	Microalbuminuria in type 1 diabetes
chr14	26023027	.	G	A	Peanut allergy
chr14	26023027	.	G	C	Peanut allergy
chr14	26356241	.	C	A	Ocular sarcoidosis
chr14	28368384	.	G	A	Psoriasis
chr14	28663671	.	G	A	Ulcerative colitis
chr14	28744190	.	A	G	Takayasu arteritis
chr14	28780143	.	T	G	Multiple sclerosis--Brain Glutamate Levels
chr14	31349363	.	G	A	Adult asthma
chr14	32911892	.	T	A	Ankylosing spondylitis
chr14	32911892	.	T	C	Ankylosing spondylitis
chr14	33326385	.	G	A	Diisocyanate-induced asthma
chr14	33448832	.	C	G	Self-reported allergy
chr14	34720708	.	C	T	Takayasu arteritis
chr14	34894698	.	A	G	Colorectal carcinoma in primary sclerosing cholangitis
chr14	35169914	.	G	A	Response to zileuton treatment in asthma (FEV1 change interaction)
chr14	35177198	.	AT	A	Primary biliary cholangitis
chr14	35267067	.	C	T	Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count)
chr14	35292469	.	C	T	Allergic disease (asthma, hay fever or eczema)
chr14	35359535	.	T	G	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr14	35387142	.	G	A	Allergic disease (asthma, hay fever or eczema)
chr14	35412760	.	G	GA	Asthma
chr14	35412760	.	G	GAA	Asthma
chr14	35413729	.	A	T	Asthma
chr14	35415835	.	A	C	Asthma;Asthma (childhood onset)
chr14	37607943	.	C	G	Self-reported allergy
chr14	37607943	.	C	T	Self-reported allergy
chr14	37627796	.	T	TG	Allergic disease (asthma, hay fever or eczema)
chr14	37682050	.	A	G	Allergy
chr14	37977887	.	A	G	Coronary artery aneurysm in Kawasaki disease
chr14	37977887	.	A	T	Coronary artery aneurysm in Kawasaki disease
chr14	42913159	.	A	G	Methotrexate-induced interstitial lung disease in rheumatoid arthritis
chr14	45937713	.	C	T	Sj√∂gren's syndrome
chr14	47061638	.	A	C	Ocular sarcoidosis
chr14	47061638	.	A	T	Ocular sarcoidosis
chr14	47405354	.	A	G	Response to tocilizumab in rheumatoid arthritis
chr14	49843683	.	T	C	Type 1 diabetes
chr14	50159939	.	C	T	Immunoglobulin N-glycan 1 levels
chr14	50767442	.	A	G	Lupus nephritis in systemic lupus erythematosus
chr14	50797408	.	C	T	Diisocyanate-induced asthma
chr14	50850700	.	T	G	Asthma (time to childhood onset) x early life tobacco smoke interaction
chr14	51754057	.	A	C	Lung function (FVC) in asthma
chr14	51754057	.	A	G	Lung function (FVC) in asthma
chr14	51839373	.	A	C	Multiple sclerosis
chr14	53779635	.	A	C	Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis
chr14	53797133	.	C	A	Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis
chr14	56754421	.	G	A	Type 1 diabetes nephropathy
chr14	58092523	.	C	T	Lupus nephritis in systemic lupus erythematosus
chr14	61517225	.	A	G	Asthma
chr14	61613308	.	A	T	Severe exacerbations in childhood asthma
chr14	65450942	.	C	T	Immunoglobulin N-glycan 12 levels
chr14	65800106	.	G	T	Immunoglobulin N-glycan 7 levels
chr14	65803692	.	C	T	Immunoglobulin N-glycan 2 levels
chr14	68021957	.	G	A	Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count)
chr14	68021957	.	G	C	Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count)
chr14	68195642	.	C	T	Allergic disease (asthma, hay fever or eczema)
chr14	68264741	.	A	G	Systemic lupus erythematosus
chr14	68264741	.	A	T	Systemic lupus erythematosus
chr14	68265588	.	A	AAT	Asthma
chr14	68276590	.	A	G	Asthma
chr14	68276590	.	A	T	Asthma
chr14	68285926	.	C	T	Asthma or allergic disease (pleiotropy);Atopic asthma
chr14	68286570	.	T	G	Asthma (childhood onset)
chr14	68293424	.	C	G	Allergic disease (asthma, hay fever or eczema);Asthma;Asthma (childhood onset);Rheumatoid arthritis;Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)
chr14	68293810	.	A	G	Allergic disease (asthma, hay fever and/or eczema) (age of onset);Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis)
chr14	68332385	.	A	T	Asthma
chr14	68786647	.	A	C	Multiple sclerosis
chr14	68787474	.	C	A	Multiple sclerosis
chr14	68792785	.	T	C	Celiac disease
chr14	68793871	.	C	G	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular);Rheumatoid arthritis
chr14	68805252	.	C	A	Celiac disease
chr14	68805252	.	C	G	Celiac disease
chr14	68805252	.	C	T	Celiac disease
chr14	68811487	.	C	T	Celiac disease
chr14	69126022	.	G	A	Neuropeptide Y autoantibody levels in type 1 diabetes
chr14	71181355	.	T	C	Response to zileuton treatment in asthma (FEV1 change interaction)
chr14	72249807	.	A	G	Cutaneous psoriasis
chr14	72783972	.	G	T	Systemic lupus erythematosus
chr14	73273542	.	G	A	Macroalbuminuria in type 1 diabetes
chr14	74267460	.	C	T	Ocular sarcoidosis
chr14	74415130	.	G	A	Crohn's disease (time to progression)
chr14	75275048	.	C	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Crohn's disease
chr14	75495168	.	C	G	Multiple sclerosis
chr14	75547955	.	T	C	Multiple sclerosis
chr14	78072463	.	T	C	Crohn's disease
chr14	78319734	.	A	C	Coronary artery aneurysm in Kawasaki disease
chr14	84334260	.	T	A	Asthma
chr14	87916691	.	C	A	Systemic lupus erythematosus
chr14	87965984	.	C	A	Multiple sclerosis
chr14	88038597	.	C	G	Takayasu arteritis
chr14	90906615	.	T	C	Multiple sclerosis
chr14	92549049	.	A	G	Asthma
chr14	92549134	.	A	C	Asthma
chr14	92581110	.	A	G	Systemic juvenile idiopathic arthritis
chr14	92633522	.	A	C	Primary biliary cholangitis
chr14	92648442	.	G	A	Primary biliary cholangitis
chr14	92651884	.	C	T	Rheumatoid arthritis
chr14	92665735	.	G	A	Composite immunoglobulin trait (IgA/IgM)
chr14	92665735	.	G	C	Composite immunoglobulin trait (IgA/IgM)
chr14	93050120	.	T	C	Asthma-COPD overlap syndrome
chr14	93544435	.	G	A	Adult asthma
chr14	93544435	.	G	C	Adult asthma
chr14	93544435	.	G	T	Adult asthma
chr14	94000011	.	G	A	Coronary artery aneurysm in Kawasaki disease
chr14	94000011	.	G	T	Coronary artery aneurysm in Kawasaki disease
chr14	94378610	.	C	G	Antineutrophil cytoplasmic antibody-associated vasculitis;Osteoarthritis of the hip or knee (with total joint replacement)
chr14	94378610	.	C	T	Antineutrophil cytoplasmic antibody-associated vasculitis;Osteoarthritis of the hip or knee (with total joint replacement)
chr14	94397299	.	C	A	Antineutrophil cytoplasmic antibody-associated vasculitis
chr14	94479922	.	C	T	Lung function (FEV1/FVC) in asthma
chr14	95605411	.	G	A	Gout (age >=50)
chr14	95605411	.	G	C	Gout (age >=50)
chr14	96242445	.	A	T	Gout
chr14	96458513	.	G	A	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr14	97123059	.	A	G	Asthma exacerbations in inhaled corticosteroid treatment
chr14	97833777	.	G	A	Alopecia areata
chr14	97833777	.	G	C	Alopecia areata
chr14	98020208	.	G	C	IgE levels in asthmatics (D.f. specific)
chr14	98202441	.	AAG	A	Psoriasis
chr14	100692930	.	G	A	Oral corticosteroid burst in asthma
chr14	100839708	.	A	G	Type 1 diabetes
chr14	100840110	.	T	A	Type 1 diabetes
chr14	100840110	.	T	C	Type 1 diabetes
chr14	102724506	.	A	G	Asthma
chr14	102764421	.	G	A	Multiple sclerosis
chr14	102764421	.	G	T	Multiple sclerosis
chr14	102777609	.	C	A	Immunoglobulin measurement (zinc sulfate turbidity test)
chr14	102777733	.	C	A	Asthma (childhood onset)
chr14	102777733	.	C	T	Asthma (childhood onset)
chr14	102790624	.	A	C	Allergic disease (asthma, hay fever and/or eczema) (age of onset);Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis)
chr14	103098470	.	A	G	Primary biliary cholangitis
chr14	104513149	.	T	C	Rheumatoid arthritis
chr14	104938047	.	T	G	Systemic lupus erythematosus
chr14	104945922	.	G	T	Systemic lupus erythematosus
chr14	105490049	.	G	A	Composite immunoglobulin trait (IgA/IgG)
chr14	105591378	.	A	G	Polymeric immunoglobulin receptor levels
chr14	105598858	.	G	A	Composite immunoglobulin trait (IgA/IgG)
chr14	105632083	.	G	A	Immunoglobulin N-glycan 16 levels
chr14	105641600	.	G	A	Immunoglobulin G levels
chr14	105644577	.	G	A	Composite immunoglobulin trait (IgA/IgG)
chr14	105644577	.	G	T	Composite immunoglobulin trait (IgA/IgG)
chr14	105660219	.	A	C	Polymeric immunoglobulin receptor levels
chr14	105694755	.	TAAAG	T	Baseline cortisol levels in response to low dose short synacthen test in corticosteroid treated asthma
chr14	105706543	.	G	A	Immunoglobulin G index levels in multiple sclerosis
chr14	105707884	.	G	A	Composite immunoglobulin trait (IgA/IgG)
chr14	105709338	.	G	A	Composite immunoglobulin trait (IgA/IgM)
chr14	105733666	.	C	A	Composite immunoglobulin trait (IgG/IgM)
chr14	105855225	.	G	A	Systemic sclerosis
chr14	106040004	.	T	A	Polymeric immunoglobulin receptor levels
chr14	106040004	.	T	C	Polymeric immunoglobulin receptor levels
chr14	106696010	.	G	A	Kawasaki disease
chr14	106767970	.	C	T	Kawasaki disease
chr15	26476869	.	G	A	Diisocyanate-induced asthma
chr15	26558984	.	T	A	Response to methotrexate in juvenile idiopathic arthritis
chr15	26558984	.	T	C	Response to methotrexate in juvenile idiopathic arthritis
chr15	26558984	.	T	G	Response to methotrexate in juvenile idiopathic arthritis
chr15	26911390	.	CACACACAA	C	Crohn's disease
chr15	27596077	.	T	C	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr15	27902060	.	T	C	Asthma and eczema
chr15	28111713	.	C	T	Vitiligo
chr15	28120472	.	A	G	Diisocyanate-induced asthma
chr15	28130268	.	A	T	Osteoarthritis of the hip (with total joint replacement)
chr15	28290120	.	A	C	Vitiligo
chr15	29584445	.	G	A	Diisocyanate-induced asthma
chr15	31171175	.	G	A	Myasthenia gravis
chr15	31248192	.	C	T	Diisocyanate-induced asthma
chr15	31345463	.	T	C	Psoriasis
chr15	35639966	.	C	T	Crohn's disease (time to progression)
chr15	36057645	.	T	C	Response to tocilizumab in rheumatoid arthritis
chr15	38546063	.	T	A	Type 1 diabetes
chr15	38554821	.	C	T	Crohn's disease;Type 1 diabetes
chr15	38606989	.	T	C	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Crohn's disease
chr15	39674256	.	G	A	Asthma with severe exacerbations
chr15	41211532	.	C	A	Allergic disease (asthma, hay fever or eczema);Atopic asthma
chr15	41211532	.	C	G	Allergic disease (asthma, hay fever or eczema);Atopic asthma
chr15	41244154	.	C	A	Asthma (childhood onset)
chr15	41244154	.	C	G	Asthma (childhood onset)
chr15	41271752	.	A	G	Ulcerative colitis
chr15	41490523	.	G	A	Atopic asthma
chr15	41490523	.	G	T	Atopic asthma
chr15	45786109	.	G	T	Diisocyanate-induced asthma
chr15	46441258	.	C	A	Type 1 diabetes with low genetic risk score
chr15	46441258	.	C	T	Type 1 diabetes with low genetic risk score
chr15	47761032	.	C	A	Ulcerative colitis
chr15	48216203	.	C	T	Systemic lupus erythematosus
chr15	50438934	.	A	AT	Knee osteoarthritis
chr15	50438934	.	A	ATT	Knee osteoarthritis
chr15	50467231	.	G	A	Knee osteoarthritis
chr15	50492819	.	A	C	Ankylosing spondylitis
chr15	50492819	.	A	G	Ankylosing spondylitis
chr15	50495228	.	T	TTG	Osteoarthritis of the hip or knee (hospital diagnosed);Osteoarthritis of the knee (hospital diagnosed)
chr15	51677471	.	T	C	Asthma
chr15	52048569	.	A	G	Serum uric acid levels in response to allopurinol in gout
chr15	52242147	.	G	A	Systemic lupus erythematosus
chr15	52242147	.	G	C	Systemic lupus erythematosus
chr15	53449415	.	T	C	Coronary artery disease in type 1 diabetes
chr15	53872840	.	G	C	Asthma
chr15	57741661	.	A	G	Diisocyanate-induced asthma
chr15	57790169	.	T	A	Diisocyanate-induced asthma
chr15	57790169	.	T	G	Diisocyanate-induced asthma
chr15	57923529	.	C	A	Knee osteoarthritis
chr15	57954604	.	G	C	Osteoarthritis (hand, severe)
chr15	58042046	.	A	C	Osteoarthritis of the hand
chr15	58042046	.	A	G	Osteoarthritis of the hand
chr15	58042046	.	A	T	Osteoarthritis of the hand
chr15	58385696	.	A	T	Gout
chr15	58428495	.	G	C	Ocular sarcoidosis
chr15	59911174	.	A	C	Ocular sarcoidosis
chr15	60757370	.	A	C	Asthma;Asthma (adult onset)
chr15	60776148	.	G	A	Adult asthma;Allergic disease (asthma, hay fever or eczema);Asthma
chr15	60776505	.	G	A	Allergic disease (asthma, hay fever or eczema);Asthma;Asthma (moderate or severe)
chr15	60777002	.	T	C	Asthma;Asthma (childhood onset);Atopic asthma;Nonatopic asthma
chr15	60777222	.	A	C	Asthma
chr15	60777222	.	A	G	Asthma
chr15	60777789	.	C	T	Allergic disease (asthma, hay fever and/or eczema) (age of onset);Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis);Asthma;Asthma (age of onset);Asthma (childhood onset);Asthma onset (childhood vs adult);Asthma (time to onset)
chr15	60777984	.	G	A	Atopic asthma
chr15	60777984	.	G	T	Atopic asthma
chr15	60865204	.	G	A	Multiple sclerosis
chr15	60865204	.	G	C	Multiple sclerosis
chr15	60865204	.	G	T	Multiple sclerosis
chr15	62775234	.	C	CTG	Osteoarthritis (with total hip replacement)
chr15	64012645	.	T	C	Ulcerative colitis
chr15	67074150	.	C	A	Osteoarthritis (hip)
chr15	67074150	.	C	G	Osteoarthritis (hip)
chr15	67078051	.	A	G	Osteoarthritis (hip);Osteoarthritis of the hip or knee
chr15	67078168	.	C	A	Osteoarthritis (hip)
chr15	67078168	.	C	G	Osteoarthritis (hip)
chr15	67078906	.	C	T	Asthma;Asthma (adult onset);Asthma (childhood onset);Atopic asthma
chr15	67079082	.	T	G	Asthma
chr15	67088795	.	C	G	Nonatopic asthma
chr15	67088795	.	C	T	Nonatopic asthma
chr15	67093131	.	C	A	Asthma
chr15	67093131	.	C	G	Asthma
chr15	67121286	.	G	A	Asthma;Asthma (childhood onset)
chr15	67149412	.	C	A	Allergic disease (asthma, hay fever or eczema);Asthma;Asthma (adult onset);Asthma (childhood onset);Asthma (moderate or severe);Asthma onset (childhood vs adult);Nonatopic asthma;Pediatric asthma
chr15	67149412	.	C	T	Allergic disease (asthma, hay fever or eczema);Asthma;Asthma (adult onset);Asthma (childhood onset);Asthma (moderate or severe);Asthma onset (childhood vs adult);Nonatopic asthma;Pediatric asthma
chr15	67150258	.	C	T	Asthma;Atopic asthma;Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Crohn's disease;Endometriosis or asthma (pleiotropy);Ulcerative colitis
chr15	67152055	.	T	C	Ulcerative colitis x smoking status (never vs current smoking) interaction
chr15	67154447	.	G	A	Asthma;Endometriosis or asthma (pleiotropy)
chr15	67154447	.	G	T	Asthma;Endometriosis or asthma (pleiotropy)
chr15	67156025	.	G	A	Allergic disease (asthma, hay fever or eczema);Asthma
chr15	67157322	.	A	G	Asthma
chr15	67157967	.	A	G	Endometriosis or asthma (pleiotropy);Self-reported allergy
chr15	67163292	.	C	T	Allergic disease (asthma, hay fever and/or eczema) (age of onset);Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis);Allergic disease (asthma, hay fever or eczema);Asthma;Asthma (adult onset);Asthma (childhood onset);Asthma or allergic disease (pleiotropy);Endometriosis or asthma (pleiotropy)
chr15	67165360	.	A	G	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr15	67165502	.	G	A	Asthma (childhood onset)
chr15	67166301	.	T	C	Endometriosis or asthma (pleiotropy)
chr15	67166467	.	G	A	Endometriosis or asthma (pleiotropy)
chr15	67174805	.	G	T	Asthma (adult onset);Asthma (childhood onset);Atopic asthma
chr15	67175169	.	T	C	Nonatopic asthma
chr15	67175169	.	T	G	Nonatopic asthma
chr15	67175203	.	T	C	Endometriosis or asthma (pleiotropy)
chr15	67175947	.	A	G	Allergy;Asthma and hay fever;Endometriosis or asthma (pleiotropy)
chr15	67183097	.	C	T	Asthma (childhood onset)
chr15	67183150	.	C	G	Adult onset asthma and/or waist-to-hip ratio adjusted for BMI;Asthma;Asthma (adult onset);Atopic asthma;Nonatopic asthma;Nonatopic asthma and/or waist-to-hip ratio adjusted for BMI
chr15	67183150	.	C	T	Adult onset asthma and/or waist-to-hip ratio adjusted for BMI;Asthma;Asthma (adult onset);Atopic asthma;Nonatopic asthma;Nonatopic asthma and/or waist-to-hip ratio adjusted for BMI
chr15	67183426	.	C	CA	Asthma;Asthma (childhood onset)
chr15	69699078	.	G	A	Rheumatoid arthritis;Rheumatoid arthritis (ACPA-positive)
chr15	69703005	.	C	A	Rheumatoid arthritis
chr15	69718308	.	C	T	Rheumatoid arthritis;Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)
chr15	69751888	.	G	T	Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)
chr15	69755777	.	A	T	Rheumatoid arthritis
chr15	69862908	.	A	C	Joint damage in rheumatoid arthritis
chr15	70408417	.	A	G	Ocular sarcoidosis
chr15	70506220	.	C	T	Self-reported allergy
chr15	71314041	.	G	A	Asthma (moderate or severe)
chr15	71540729	.	CTT	C	Adverse response to inhaled corticosteroid treatment x age interaction in asthma
chr15	74257709	.	A	C	Diisocyanate-induced asthma
chr15	74317938	.	A	C	Immunoglobulin superfamily containing leucine-rich repeat protein 2 levels
chr15	74317938	.	A	G	Immunoglobulin superfamily containing leucine-rich repeat protein 2 levels
chr15	74317938	.	A	T	Immunoglobulin superfamily containing leucine-rich repeat protein 2 levels
chr15	74318848	.	T	C	Immunoglobulin superfamily containing leucine-rich repeat protein 2 levels
chr15	74325251	.	AT	A	Osteoarthritis of the hip or knee
chr15	74624584	.	C	T	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr15	74785026	.	C	T	Systemic lupus erythematosus;Systemic sclerosis
chr15	74798906	.	C	G	Systemic lupus erythematosus
chr15	74804102	.	T	A	Celiac disease
chr15	75866642	.	G	A	Gout
chr15	75866642	.	G	T	Gout
chr15	76057493	.	T	A	Post-bronchodilator lung function in asthma (FEV1/FVC)
chr15	76254592	.	G	T	Response to tocilizumab in rheumatoid arthritis
chr15	77537964	.	T	A	Systemic lupus erythematosus
chr15	77537964	.	T	C	Systemic lupus erythematosus
chr15	78356462	.	T	C	Immunoglobulin N-glycan 6 levels
chr15	78540881	.	A	T	Response to tocilizumab in rheumatoid arthritis
chr15	79527169	.	A	C	Osteoarthritis (self-reported)
chr15	79527169	.	A	G	Osteoarthritis (self-reported)
chr15	81115562	.	TG	T	Ocular sarcoidosis
chr15	83908598	.	A	C	Asthma
chr15	85535884	.	C	T	Psoriasis
chr15	85744493	.	G	C	Multiple sclerosis
chr15	85744493	.	G	T	Multiple sclerosis
chr15	85798401	.	G	C	Post-bronchodilator lung function in asthma (FEV1/FVC)
chr15	89777808	.	A	G	Coronary artery aneurysm in Kawasaki disease
chr15	90344352	.	A	C	Multiple sclerosis
chr15	90350436	.	C	T	Rheumatoid arthritis
chr15	90434101	.	G	A	Multiple sclerosis
chr15	90495651	.	C	CT	Rheumatoid arthritis
chr15	90844149	.	A	G	Diisocyanate-induced asthma
chr15	90844149	.	A	T	Diisocyanate-induced asthma
chr15	91198066	.	T	C	Gout (normal type)
chr15	91517544	.	G	T	Primary sclerosing cholangitis
chr15	91668544	.	G	A	Response to tocilizumab in rheumatoid arthritis
chr15	93288838	.	G	A	Type 1 diabetes
chr15	93288838	.	G	C	Type 1 diabetes
chr15	93598604	.	T	G	Type 1 diabetes nephropathy
chr15	93818088	.	G	C	Lung function (FEV1/FVC) in asthma
chr15	95542851	.	T	C	Ocular sarcoidosis
chr15	95598638	.	G	A	Response to TNF-alpha inhibitors in rheumatoid arthritis
chr15	96135957	.	C	T	Osteoarthritis (self-reported)
chr15	96933041	.	T	C	Crohn's disease (time to progression)
chr15	97064451	.	C	A	Systemic lupus erythematosus
chr15	97064451	.	C	T	Systemic lupus erythematosus
chr15	98221618	.	T	A	Diisocyanate-induced asthma
chr15	98221618	.	T	C	Diisocyanate-induced asthma
chr15	98631599	.	C	T	Knee osteoarthritis
chr15	98748177	.	A	G	Ocular sarcoidosis
chr16	1023552	.	A	G	Multiple sclerosis
chr16	1475709	.	G	C	Acute anterior uveitis in ankylosing spondylitis
chr16	1491460	.	C	T	Rheumatoid arthritis
chr16	3243407	.	T	A	Ankylosing spondylitis
chr16	3243407	.	T	C	Ankylosing spondylitis
chr16	3723109	.	C	T	Primary sclerosing cholangitis
chr16	4021721	.	C	T	Diisocyanate-induced asthma
chr16	4465333	.	C	G	Knee osteoarthritis
chr16	5030085	.	C	G	Kawasaki disease or immunoglobulin A vasculitis (pleiotropy)
chr16	5538688	.	T	C	Rheumatoid arthritis
chr16	5538688	.	T	G	Rheumatoid arthritis
chr16	5734291	.	G	A	Adverse response to inhaled corticosteroid treatment x age interaction in asthma
chr16	5734291	.	G	C	Adverse response to inhaled corticosteroid treatment x age interaction in asthma
chr16	5734291	.	G	T	Adverse response to inhaled corticosteroid treatment x age interaction in asthma
chr16	6078519	.	C	A	Gout
chr16	6078519	.	C	G	Gout
chr16	6078519	.	C	T	Gout
chr16	6086218	.	A	G	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)
chr16	7149459	.	C	G	joint destruction in rheumatoid arthritis (rapid vs slow)
chr16	7149459	.	C	T	joint destruction in rheumatoid arthritis (rapid vs slow)
chr16	7706047	.	G	A	Hydrolysed wheat protein allergy
chr16	7706047	.	G	C	Hydrolysed wheat protein allergy
chr16	7881283	.	C	T	Joint damage in rheumatoid arthritis
chr16	7883804	.	C	T	Joint damage in rheumatoid arthritis
chr16	8235826	.	A	G	Takayasu arteritis
chr16	8536243	.	T	C	Autoimmune thyroid disease
chr16	8638375	.	T	C	Systemic sclerosis (anti-topoisomerase-positive)
chr16	9864106	.	T	C	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr16	10265732	.	G	A	Subjective response to placebo treatment in childhood asthma (change in cough/wheeze)
chr16	10265732	.	G	C	Subjective response to placebo treatment in childhood asthma (change in cough/wheeze)
chr16	10265732	.	G	T	Subjective response to placebo treatment in childhood asthma (change in cough/wheeze)
chr16	10926598	.	T	G	Asthma (childhood onset)
chr16	10944503	.	C	T	Systemic lupus erythematosus
chr16	11020655	.	A	T	Multiple sclerosis
chr16	11031436	.	T	C	Asthma (childhood onset)
chr16	11080795	.	G	C	Systemic lupus erythematosus
chr16	11083944	.	A	G	Multiple sclerosis;Systemic lupus erythematosus
chr16	11086016	.	A	G	Type 1 diabetes
chr16	11095073	.	A	C	Primary biliary cholangitis
chr16	11095073	.	A	G	Primary biliary cholangitis
chr16	11095073	.	A	T	Primary biliary cholangitis
chr16	11095399	.	C	A	Primary biliary cholangitis
chr16	11096031	.	T	C	Systemic lupus erythematosus
chr16	11096177	.	T	TAA	Systemic lupus erythematosus
chr16	11100223	.	C	T	Alopecia areata
chr16	11100914	.	C	T	Multiple sclerosis;Type 1 diabetes
chr16	11105590	.	T	C	Multiple sclerosis
chr16	11121567	.	T	C	Asthma (adult onset);Asthma (childhood onset)
chr16	11121567	.	T	G	Asthma (adult onset);Asthma (childhood onset)
chr16	11129597	.	C	G	Allergic disease (asthma, hay fever or eczema)
chr16	11135732	.	T	C	Allergic disease (asthma, hay fever and/or eczema) (age of onset);Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis)
chr16	11135732	.	T	G	Allergic disease (asthma, hay fever and/or eczema) (age of onset);Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis)
chr16	11141273	.	T	G	Multiple sclerosis
chr16	11144926	.	G	A	Type 1 diabetes
chr16	11150801	.	G	C	Atopic asthma
chr16	11155472	.	G	A	Asthma (childhood onset);Multiple sclerosis
chr16	11159977	.	C	T	Atopic asthma
chr16	11183501	.	C	T	Allergic disease (asthma, hay fever or eczema);Allergy
chr16	11194949	.	G	A	Multiple sclerosis
chr16	11210463	.	C	T	Atopic asthma
chr16	11225500	.	C	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr16	11254001	.	T	G	Crohn's disease and psoriasis
chr16	11257354	.	A	G	Type 1 diabetes
chr16	11260234	.	A	G	Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect)
chr16	11319069	.	C	T	Multiple sclerosis
chr16	11342133	.	T	A	Multiple sclerosis
chr16	11381719	.	A	T	Multiple sclerosis and type 2 diabetes (pleiotropy)
chr16	11397150	.	C	G	Allergic disease (asthma, hay fever or eczema)
chr16	11655918	.	A	G	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr16	11740030	.	G	A	Rheumatoid arthritis
chr16	12908502	.	T	A	Sj√∂gren's syndrome
chr16	12908502	.	T	C	Sj√∂gren's syndrome
chr16	13813303	.	G	A	Asthma;Asthma (childhood onset)
chr16	13893862	.	T	C	Egg allergy
chr16	13893862	.	T	G	Egg allergy
chr16	15775609	.	C	T	Serum uric acid levels in response to allopurinol in gout
chr16	18006634	.	A	G	Crohn's disease (time to progression)
chr16	18006634	.	A	T	Crohn's disease (time to progression)
chr16	20331250	.	T	A	Type 1 diabetes
chr16	20331769	.	T	C	Type 1 diabetes
chr16	22969144	.	C	T	Type 1 diabetes (age at diagnosis)
chr16	23055939	.	T	G	Multiple sclerosis
chr16	23859885	.	A	AAG	Rheumatoid arthritis
chr16	23859885	.	A	AAGAGAG	Rheumatoid arthritis
chr16	23859885	.	A	AAGGG	Rheumatoid arthritis
chr16	23859885	.	A	AAGGGAGAG	Rheumatoid arthritis
chr16	24033920	.	C	G	Oral corticosteroid burst in asthma
chr16	24033920	.	C	T	Oral corticosteroid burst in asthma
chr16	24352448	.	A	C	Diisocyanate-induced asthma
chr16	24887651	.	C	A	Lupus nephritis in systemic lupus erythematosus
chr16	27234391	.	C	A	Asthma
chr16	27265406	.	G	A	Allergic disease (asthma, hay fever or eczema)
chr16	27348194	.	C	A	Asthma
chr16	27353989	.	G	A	Asthma (adult onset);Nonatopic asthma
chr16	27354132	.	C	A	Asthma
chr16	27354132	.	C	T	Asthma
chr16	27358181	.	A	T	Asthma;Asthma (adult onset)
chr16	27362659	.	C	T	Asthma (time to onset)
chr16	27369351	.	G	T	Asthma (childhood onset)
chr16	27370327	.	C	T	Asthma
chr16	27402245	.	C	G	Primary biliary cholangitis
chr16	27406423	.	G	A	Asthma
chr16	27406423	.	G	T	Asthma
chr16	27618340	.	G	A	Response to placebo treatment in childhood asthma (FVC change)
chr16	27618340	.	G	C	Response to placebo treatment in childhood asthma (FVC change)
chr16	27716458	.	A	G	Response to placebo treatment in childhood asthma (FVC change)
chr16	27743124	.	T	C	Response to placebo treatment in childhood asthma (FVC change)
chr16	28319469	.	C	A	Allergic disease (asthma, hay fever or eczema)
chr16	28494339	.	G	A	Type 1 diabetes
chr16	28494339	.	G	C	Type 1 diabetes
chr16	28495107	.	C	T	Allergic disease (asthma, hay fever or eczema)
chr16	28511823	.	T	A	Crohn's disease
chr16	28517460	.	G	C	Crohn's disease
chr16	28555683	.	A	G	Allergic disease (asthma, hay fever or eczema)
chr16	28584489	.	C	T	Allergic disease (asthma, hay fever or eczema)
chr16	28976948	.	C	G	Allergic disease (asthma, hay fever or eczema)
chr16	29809159	.	C	T	Multiple sclerosis
chr16	30145642	.	C	G	Multiple sclerosis
chr16	30160110	.	A	G	Ocular sarcoidosis
chr16	30171625	.	A	C	Multiple sclerosis
chr16	30471173	.	T	A	Ulcerative colitis
chr16	30471173	.	T	G	Ulcerative colitis
chr16	30474072	.	G	A	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr16	30802133	.	A	ATT	Systemic lupus erythematosus
chr16	30958165	.	G	A	Graves' disease
chr16	31174561	.	G	C	Autoimmune thyroid diseases (Graves disease or Hashimoto's thyroiditis);Graves' disease
chr16	31261032	.	G	A	Systemic lupus erythematosus
chr16	31265490	.	G	A	Systemic lupus erythematosus
chr16	31272002	.	C	G	Systemic lupus erythematosus
chr16	31272675	.	G	A	Systemic lupus erythematosus
chr16	31272675	.	G	T	Systemic lupus erythematosus
chr16	31287618	.	T	G	Systemic lupus erythematosus
chr16	31301932	.	C	T	Systemic lupus erythematosus
chr16	31315385	.	C	T	Systemic lupus erythematosus;Systemic lupus erythematosus and Systemic sclerosis
chr16	31357553	.	T	C	Systemic lupus erythematosus
chr16	50270338	.	C	T	Crohn's disease vs ulcerative colitis (ordinary least squares (OLS))
chr16	50301163	.	C	A	Autoimmune thyroid disease;Ulcerative colitis
chr16	50675812	.	G	A	Crohn's disease
chr16	50675812	.	G	C	Crohn's disease
chr16	50705671	.	C	G	Crohn's disease;Crohn's disease x smoking status (never vs current smoking) interaction
chr16	50712015	.	C	T	Asthma;Asthma (childhood onset);Crohn's disease
chr16	50722629	.	G	C	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr16	50722629	.	G	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr16	50722863	.	C	G	Crohn's disease
chr16	50722863	.	C	T	Crohn's disease
chr16	50722970	.	A	G	Crohn's disease;Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS));Crohn's disease vs ulcerative colitis (ordinary least squares (OLS))
chr16	50728860	.	T	C	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr16	50729867	.	G	GC	Crohn's disease
chr16	50756247	.	A	C	Asthma
chr16	50823782	.	A	T	Asthma (time to onset)
chr16	50888875	.	G	A	Crohn's disease
chr16	51887655	.	G	A	Type 1 diabetes with low genetic risk score
chr16	51887655	.	G	C	Type 1 diabetes with low genetic risk score
chr16	52471255	.	A	G	Response to tofacitinib treatment in rheumatoid arthritis (herpes zoster);Response to tofacitinib treatment in rheumatoid arthritis (herpes zoster)(time to event)
chr16	52471255	.	A	T	Response to tofacitinib treatment in rheumatoid arthritis (herpes zoster);Response to tofacitinib treatment in rheumatoid arthritis (herpes zoster)(time to event)
chr16	53766065	.	T	C	Osteoarthritis of the hip or knee
chr16	53766065	.	T	G	Osteoarthritis of the hip or knee
chr16	53766288	.	C	T	Osteoarthritis of the hip or knee
chr16	53787213	.	A	G	Psoriasis or type 2 diabetes (trans-disease meta-analysis)
chr16	53787213	.	A	T	Psoriasis or type 2 diabetes (trans-disease meta-analysis)
chr16	53788257	.	AT	A	Type 1 diabetes
chr16	53805223	.	T	A	Osteoarthritis
chr16	53805223	.	T	C	Osteoarthritis
chr16	53805223	.	T	G	Osteoarthritis
chr16	54026293	.	G	A	Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count)
chr16	54455881	.	C	A	Asthma (corticosteroid response)
chr16	57347441	.	G	C	Exacerbations requiring hospitalisation in asthma
chr16	57360950	.	C	G	Asthma
chr16	57360950	.	C	T	Asthma
chr16	58246174	.	G	A	Systemic lupus erythematosus
chr16	58293742	.	A	G	Systemic lupus erythematosus
chr16	61597297	.	T	G	Type 1 diabetes with low genetic risk score
chr16	62594871	.	T	C	Marginal zone lymphoma or rheumatoid arthritis
chr16	63726808	.	C	T	Takayasu arteritis
chr16	67346647	.	T	C	Agouti-related protein levels
chr16	67476655	.	C	T	Agouti-related protein levels
chr16	67540505	.	T	A	Agouti-related protein levels
chr16	67540505	.	T	C	Agouti-related protein levels
chr16	67709521	.	G	A	Agouti-related protein levels
chr16	67937477	.	C	T	Crohn's disease
chr16	68012420	.	T	TTC	Primary biliary cholangitis
chr16	68012421	.	AT	A	Primary biliary cholangitis
chr16	68394186	.	T	C	Agouti-related protein levels
chr16	68535537	.	T	A	Systemic lupus erythematosus
chr16	68552601	.	G	C	Ulcerative colitis
chr16	68557327	.	A	T	Ulcerative colitis
chr16	68640885	.	G	C	Ulcerative colitis
chr16	68791062	.	T	C	Crohn's disease x smoking status (never vs former smoking) interaction
chr16	69670439	.	T	A	Sj√∂gren's syndrome
chr16	69949939	.	C	T	Osteoarthritis of the hip or knee
chr16	71013581	.	G	A	Celiac disease
chr16	72975125	.	A	C	Kawasaki disease
chr16	72975125	.	A	T	Kawasaki disease
chr16	73547159	.	A	G	Multiple sclerosis (severity)
chr16	73991175	.	A	G	Type 1 diabetes with low genetic risk score
chr16	75133681	.	G	A	Crohn's disease (time to surgery)
chr16	75200974	.	C	A	Type 1 diabetes
chr16	75213347	.	T	C	Type 1 diabetes
chr16	76856229	.	T	C	Response to TNF-alpha inhibitors in rheumatoid arthritis
chr16	76856229	.	T	G	Response to TNF-alpha inhibitors in rheumatoid arthritis
chr16	78007968	.	G	A	Takayasu arteritis
chr16	78271396	.	A	G	Systemic juvenile idiopathic arthritis
chr16	78744762	.	C	G	Serum uric acid levels in response to allopurinol in gout
chr16	78744762	.	C	T	Serum uric acid levels in response to allopurinol in gout
chr16	79076699	.	C	T	Multiple sclerosis
chr16	79077400	.	T	C	Multiple sclerosis
chr16	79252606	.	G	C	Multiple sclerosis
chr16	79316307	.	T	C	Multiple sclerosis
chr16	79615497	.	A	G	Multiple sclerosis
chr16	79618644	.	C	T	Multiple sclerosis
chr16	79618823	.	C	T	Multiple sclerosis
chr16	80250127	.	G	C	Type 1 diabetes
chr16	81822338	.	A	C	Takayasu arteritis
chr16	81822338	.	A	G	Takayasu arteritis
chr16	81883307	.	A	G	Ulcerative colitis
chr16	82833851	.	C	A	Crohn's disease
chr16	82833851	.	C	G	Crohn's disease
chr16	82833851	.	C	T	Crohn's disease
chr16	83325171	.	A	G	IgE levels in asthmatics (D.f. specific)
chr16	83997047	.	T	A	Rheumatoid arthritis
chr16	83997047	.	T	C	Rheumatoid arthritis
chr16	83997047	.	T	G	Rheumatoid arthritis
chr16	84445975	.	T	A	Peanut allergy (parent-of-origin effect)
chr16	84445975	.	T	C	Peanut allergy (parent-of-origin effect)
chr16	84742465	.	C	A	Ocular sarcoidosis
chr16	85524373	.	A	C	Alopecia areata
chr16	85524373	.	A	G	Alopecia areata
chr16	85524373	.	A	T	Alopecia areata
chr16	85934034	.	A	G	Systemic lupus erythematosus
chr16	85938316	.	G	T	Systemic sclerosis
chr16	85958099	.	A	C	Systemic sclerosis;Systemic sclerosis (anti-centromere-positive)
chr16	85959043	.	C	T	Systemic lupus erythematosus
chr16	85960878	.	C	G	Multiple sclerosis;Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)
chr16	85960878	.	C	T	Multiple sclerosis;Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)
chr16	85976080	.	G	C	Crohn's disease
chr16	85976080	.	G	T	Crohn's disease
chr16	85977427	.	C	A	Multiple sclerosis;Rheumatoid arthritis
chr16	85977731	.	C	G	Systemic lupus erythematosus
chr16	85977731	.	C	T	Systemic lupus erythematosus
chr16	85981710	.	A	G	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Systemic lupus erythematosus
chr16	85984057	.	G	A	Multiple sclerosis
chr16	85985665	.	G	A	Primary biliary cholangitis;Systemic lupus erythematosus
chr16	85985910	.	G	A	Systemic lupus erythematosus
chr16	85985910	.	G	C	Systemic lupus erythematosus
chr16	85985910	.	G	T	Systemic lupus erythematosus
chr16	85987899	.	G	A	Multiple sclerosis
chr16	86587613	.	C	T	Systemic juvenile idiopathic arthritis
chr16	86793401	.	C	T	Diisocyanate-induced asthma
chr16	87117889	.	C	T	Possible neuropathic pain in post total joint replacement surgery for osteoarthritis
chr16	87541726	.	G	A	Systemic juvenile idiopathic arthritis
chr16	87637813	.	G	T	Osteoarthritis (self-reported)
chr16	88503726	.	G	A	Bone mineral accretion in asthma (oral corticosteroid dose interaction)
chr16	88976453	.	A	G	Vitiligo
chr16	88981246	.	T	A	Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)
chr16	88981246	.	T	C	Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)
chr16	89075315	.	G	A	Multiple sclerosis
chr16	89075315	.	G	C	Multiple sclerosis
chr16	89145003	.	A	G	Response to tofacitinib treatment in rheumatoid arthritis (herpes zoster);Response to tofacitinib treatment in rheumatoid arthritis (herpes zoster)(time to event)
chr16	89145003	.	A	T	Response to tofacitinib treatment in rheumatoid arthritis (herpes zoster);Response to tofacitinib treatment in rheumatoid arthritis (herpes zoster)(time to event)
chr16	89637957	.	G	A	Osteoarthritis
chr17	729948	.	G	C	joint destruction in rheumatoid arthritis (rapid vs slow)
chr17	2155055	.	A	AAT	Knee osteoarthritis
chr17	2155055	.	A	AT	Knee osteoarthritis
chr17	2155055	.	A	ATT	Knee osteoarthritis
chr17	2155055	.	A	ATTT	Knee osteoarthritis
chr17	2155055	.	A	ATTTT	Knee osteoarthritis
chr17	2155056	.	T	A	Knee osteoarthritis
chr17	2264396	.	A	C	Osteoarthritis
chr17	2788499	.	T	C	Interstitial lung diseases in rheumatoid arthritis
chr17	3884181	.	C	T	Systemic sclerosis (anti-topoisomerase-positive)
chr17	4618178	.	C	A	Allergic disease (asthma, hay fever or eczema);Asthma
chr17	4632019	.	G	A	Allergic disease (asthma, hay fever or eczema)
chr17	4875192	.	G	C	Multiple sclerosis
chr17	5522104	.	C	T	Crohn's disease (time to first abdominal surgery)
chr17	6346734	.	C	T	Diisocyanate-induced asthma
chr17	6379151	.	C	T	Diisocyanate-induced asthma
chr17	7331664	.	G	A	Systemic lupus erythematosus
chr17	7337072	.	C	A	Autoimmune thyroid disease;Systemic lupus erythematosus;Type 1 diabetes
chr17	7425502	.	A	C	Asthma
chr17	7558697	.	C	T	Composite immunoglobulin trait (IgA x IgG x IgM)
chr17	7730374	.	C	A	Type 1 diabetes
chr17	7730374	.	C	T	Type 1 diabetes
chr17	12290126	.	G	GC	Asthma
chr17	13655763	.	A	G	Asthma (childhood onset)
chr17	13768730	.	G	T	Osteoarthritis
chr17	13830489	.	C	G	Systemic lupus erythematosus
chr17	13830489	.	C	T	Systemic lupus erythematosus
chr17	14832175	.	A	C	Ankylosing spondylitis
chr17	14832175	.	A	T	Ankylosing spondylitis
chr17	15105113	.	A	G	Carotid plaques in rheumatoid arthritis
chr17	15105113	.	A	T	Carotid plaques in rheumatoid arthritis
chr17	16936587	.	A	C	Systemic lupus erythematosus
chr17	16936587	.	A	T	Systemic lupus erythematosus
chr17	20260795	.	A	G	Exacerbations requiring hospitalisation in asthma
chr17	22180454	.	A	G	Psoriasis
chr17	22190937	.	G	A	Cutaneous psoriasis
chr17	27595519	.	G	T	Systemic lupus erythematosus
chr17	27797882	.	G	A	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect);Psoriasis or type 2 diabetes (trans-disease meta-analysis);Psoriasis;Psoriasis vulgaris
chr17	27821141	.	G	A	Ankylosing spondylitis
chr17	34243528	.	G	A	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr17	34266646	.	A	G	Crohn's disease
chr17	34266955	.	G	A	Crohn's disease
chr17	34266955	.	G	C	Crohn's disease
chr17	34305359	.	G	A	Ulcerative colitis x smoking status (never vs current smoking) interaction
chr17	36486677	.	G	A	Multiple sclerosis
chr17	36486677	.	G	C	Multiple sclerosis
chr17	36925016	.	T	C	Fatigue in primary Sj√∂gren's syndrome
chr17	37374139	.	A	G	Celiac disease
chr17	39140376	.	G	T	Asthma (childhood onset)
chr17	39232314	.	C	T	Asthma (childhood onset)
chr17	39308437	.	G	C	Asthma (childhood onset)
chr17	39387196	.	T	A	Primary biliary cholangitis
chr17	39418339	.	G	C	Asthma
chr17	39423130	.	G	A	Asthma (childhood onset);Atopic asthma;Nonatopic asthma
chr17	39423130	.	G	C	Asthma (childhood onset);Atopic asthma;Nonatopic asthma
chr17	39453870	.	T	C	Systemic lupus erythematosus
chr17	39613752	.	C	G	Asthma and cardiovascular disease
chr17	39620391	.	A	T	Asthma (childhood onset)
chr17	39638098	.	T	C	Asthma
chr17	39654542	.	C	G	Asthma
chr17	39654542	.	C	T	Asthma
chr17	39665182	.	G	C	Asthma and cardiovascular disease
chr17	39671417	.	G	A	Asthma (childhood onset)
chr17	39673351	.	C	G	Asthma and cardiovascular disease
chr17	39674782	.	A	T	Asthma and cardiovascular disease
chr17	39683240	.	T	A	Asthma and cardiovascular disease
chr17	39702425	.	A	T	Asthma and cardiovascular disease
chr17	39729130	.	C	T	Systemic lupus erythematosus
chr17	39764941	.	T	C	Marginal zone lymphoma or systemic lupus erythematosus;Systemic lupus erythematosus
chr17	39793671	.	A	G	Asthma (childhood onset)
chr17	39819840	.	T	A	Asthma (childhood onset)
chr17	39822742	.	C	T	Asthma (childhood onset)
chr17	39829526	.	G	A	Asthma (childhood onset)
chr17	39850018	.	T	G	Atopic asthma;Nonatopic asthma
chr17	39850937	.	G	A	Systemic lupus erythematosus
chr17	39850937	.	G	T	Systemic lupus erythematosus
chr17	39884510	.	G	T	Asthma and cardiovascular disease;Crohn's disease;Rheumatoid arthritis;Rheumatoid arthritis (ACPA-positive);Type 1 diabetes;Ulcerative colitis
chr17	39896954	.	C	T	Type 1 diabetes
chr17	39900944	.	G	T	Asthma and cardiovascular disease;Asthma (childhood onset);Nonatopic asthma
chr17	39907128	.	C	G	Systemic sclerosis
chr17	39908216	.	T	A	Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)
chr17	39908718	.	G	A	Asthma;Asthma (childhood onset);Asthma onset (childhood vs adult)
chr17	39910014	.	G	C	Asthma;Asthma and cardiovascular disease
chr17	39911280	.	A	C	Asthma
chr17	39911790	.	T	A	Asthma;Asthma and cardiovascular disease;Asthma or allergic disease (pleiotropy)
chr17	39912261	.	T	A	Asthma;Pediatric asthma
chr17	39917590	.	G	A	Asthma
chr17	39917590	.	G	C	Asthma
chr17	39917590	.	G	T	Asthma
chr17	39917778	.	T	A	Asthma and cardiovascular disease;Self-reported allergy
chr17	39924659	.	G	C	Asthma and cardiovascular disease;Asthma with severe exacerbations
chr17	39925141	.	C	G	Asthma (childhood onset)
chr17	39932164	.	T	A	Asthma and cardiovascular disease
chr17	39933091	.	A	T	Asthma;Asthma and cardiovascular disease
chr17	39935407	.	G	T	Asthma and cardiovascular disease
chr17	39938921	.	G	A	Asthma
chr17	39942782	.	T	A	Asthma and cardiovascular disease
chr17	39948315	.	T	C	Asthma (childhood onset)
chr17	39952110	.	T	A	Asthma and cardiovascular disease
chr17	39952110	.	T	G	Asthma and cardiovascular disease
chr17	39954436	.	T	A	Asthma and cardiovascular disease
chr17	39958216	.	C	G	Asthma and cardiovascular disease
chr17	39966427	.	G	A	Asthma and cardiovascular disease;Asthma and hay fever
chr17	39966427	.	G	C	Asthma and cardiovascular disease;Asthma and hay fever
chr17	39966629	.	C	T	Asthma (childhood onset)
chr17	39984021	.	A	G	Asthma (childhood onset)
chr17	39992780	.	G	A	Allergic disease (asthma, hay fever or eczema)
chr17	39992780	.	G	C	Allergic disease (asthma, hay fever or eczema)
chr17	39994693	.	C	T	Atopic asthma
chr17	40012575	.	A	C	Asthma;Atopic asthma
chr17	40013006	.	G	T	Composite immunoglobulin trait (IgA x IgG)
chr17	40023022	.	G	C	Asthma and cardiovascular disease
chr17	40075600	.	T	G	Asthma (childhood onset)
chr17	40448294	.	C	T	Atopic asthma
chr17	40563356	.	C	T	Takayasu arteritis
chr17	40598548	.	G	C	Atopic asthma
chr17	40606948	.	C	A	Asthma (age of onset);Asthma (childhood onset)
chr17	40606948	.	C	T	Asthma (age of onset);Asthma (childhood onset)
chr17	40608272	.	T	A	Allergic disease (asthma, hay fever or eczema);Asthma;Asthma (childhood onset);Atopic asthma
chr17	40713238	.	A	T	Asthma
chr17	42147006	.	AAGAAAGAAAGAC	A	Autoimmune thyroid disease
chr17	42238611	.	G	T	Asthma (childhood onset)
chr17	42260917	.	C	CTT	Asthma
chr17	42260917	.	C	CTTT	Asthma
chr17	42262844	.	A	G	Allergic disease (asthma, hay fever or eczema)
chr17	42322333	.	C	G	Composite immunoglobulin trait (IgA/IgG)
chr17	42324649	.	C	G	Systemic lupus erythematosus
chr17	42329511	.	G	A	Multiple sclerosis
chr17	42329511	.	G	T	Multiple sclerosis
chr17	42364598	.	T	G	Atopic asthma
chr17	42375526	.	A	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Crohn's disease;Ulcerative colitis
chr17	42418754	.	A	G	Crohn's disease
chr17	42666566	.	C	A	Psoriasis or type 2 diabetes (trans-disease meta-analysis)
chr17	44898335	.	A	G	Endometriosis or asthma (pleiotropy)
chr17	44898335	.	A	T	Endometriosis or asthma (pleiotropy)
chr17	45221021	.	A	C	Asthma (childhood onset)
chr17	45221021	.	A	T	Asthma (childhood onset)
chr17	45259320	.	G	T	Asthma
chr17	45259769	.	G	C	Asthma;Atopic asthma
chr17	45314842	.	G	A	Joint damage in rheumatoid arthritis
chr17	45325639	.	T	C	Multiple sclerosis;Multiple sclerosis and LDL levels (pleiotropy)
chr17	45325639	.	T	G	Multiple sclerosis;Multiple sclerosis and LDL levels (pleiotropy)
chr17	45330304	.	G	A	Multiple sclerosis
chr17	45330304	.	G	C	Multiple sclerosis
chr17	45353330	.	A	G	Allergic disease (asthma, hay fever or eczema)
chr17	45378874	.	A	G	Allergic disease (asthma, hay fever or eczema);Asthma (childhood onset)
chr17	45379362	.	C	T	Systemic lupus erythematosus
chr17	45380520	.	G	A	Asthma;Asthma (childhood onset);Asthma onset (childhood vs adult)
chr17	45961419	.	A	G	Osteoarthritis (hip)
chr17	45980520	.	A	AC	Osteoarthritis
chr17	45996523	.	A	G	Type 1 diabetes
chr17	46291264	.	C	T	Asthma (childhood onset)
chr17	46788073	.	T	G	Celiac disease
chr17	46871734	.	G	C	Antineutrophil cytoplasmic antibody-associated vasculitis
chr17	46877618	.	T	C	Relapse in treatment-naive multiple sclerosis (time to event)
chr17	47530206	.	T	G	Multiple sclerosis or amyotrophic lateral sclerosis
chr17	47887076	.	T	C	Asthma with severe exacerbations
chr17	48885083	.	G	A	WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2 levels
chr17	49302219	.	G	C	Multiple sclerosis
chr17	49384071	.	G	A	Asthma;Pediatric asthma
chr17	49391824	.	G	C	Asthma (adult onset)
chr17	49391824	.	G	T	Asthma (adult onset)
chr17	49393125	.	A	G	Asthma-COPD overlap syndrome
chr17	49393125	.	A	T	Asthma-COPD overlap syndrome
chr17	49741459	.	C	T	Milk allergy
chr17	50780633	.	G	A	WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2 levels
chr17	50780633	.	G	C	WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2 levels
chr17	50804171	.	G	T	WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2 levels
chr17	50843312	.	C	T	WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2 levels
chr17	50857161	.	C	A	WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2 levels
chr17	50857161	.	C	T	WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2 levels
chr17	50884227	.	GC	G	WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2 levels
chr17	51593949	.	G	T	Post-bronchodilator FEV1 x air pollution (NO2) interaction in childhood asthma
chr17	53632737	.	A	G	Exacerbations requiring hospitalisation in asthma
chr17	56533930	.	C	T	Celiac disease
chr17	57321218	.	C	T	Decreased low contrast letter acuity in multiple sclerosis
chr17	57933599	.	G	A	Multiple sclerosis--Brain Glutamate Levels
chr17	59755030	.	T	A	Chronic lymphocytic leukemia or multiple sclerosis;Marginal zone lymphoma or multiple sclerosis
chr17	59755030	.	T	G	Chronic lymphocytic leukemia or multiple sclerosis;Marginal zone lymphoma or multiple sclerosis
chr17	61370008	.	T	A	Gout
chr17	61370008	.	T	C	Gout
chr17	61371584	.	A	G	Gout
chr17	61373080	.	T	A	Gout (combined type)
chr17	61373080	.	T	C	Gout (combined type)
chr17	64069832	.	G	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr17	65208429	.	G	A	Adverse response to antithyroid drugs in Graves disease
chr17	65867092	.	G	A	Endometriosis or asthma (pleiotropy)
chr17	66583327	.	G	A	Possible neuropathic pain in post total joint replacement surgery for osteoarthritis
chr17	66718990	.	A	C	Gout
chr17	66718990	.	A	T	Gout
chr17	66947338	.	G	T	Lung function (FEV1) in asthma
chr17	67873957	.	C	G	Psoriasis
chr17	68168777	.	C	G	Type 1 diabetes
chr17	68883786	.	C	T	T-Cell Immunoglobulin and Mucin domain 1 levels
chr17	69507360	.	G	T	Osteoarthritis (hip);Osteoarthritis of the hip (hospital diagnosed);Osteoarthritis of the hip or knee (hospital diagnosed)
chr17	69806211	.	A	C	Response to TNF-alpha inhibitors in rheumatoid arthritis
chr17	70263305	.	A	G	Thyrotoxic hypokalemic periodic paralysis and Graves disease;Thyrotoxic hypokalemic periodic paralysis in Graves disease
chr17	70276213	.	G	A	Thyrotoxic hypokalemic periodic paralysis and Graves disease
chr17	70295230	.	C	A	Thyrotoxic hypokalemic periodic paralysis and Graves disease
chr17	70295230	.	C	T	Thyrotoxic hypokalemic periodic paralysis and Graves disease
chr17	70303644	.	G	T	Thyrotoxic hypokalemic periodic paralysis and Graves disease
chr17	70310696	.	G	A	Thyrotoxic hypokalemic periodic paralysis and Graves disease;Thyrotoxic hypokalemic periodic paralysis in Graves disease
chr17	70310696	.	G	T	Thyrotoxic hypokalemic periodic paralysis and Graves disease;Thyrotoxic hypokalemic periodic paralysis in Graves disease
chr17	70330197	.	T	C	Thyrotoxic hypokalemic periodic paralysis and Graves disease;Thyrotoxic hypokalemic periodic paralysis in Graves disease
chr17	70380682	.	C	T	Thyrotoxic hypokalemic periodic paralysis and Graves disease;Thyrotoxic hypokalemic periodic paralysis in Graves disease
chr17	70384516	.	T	C	Thyrotoxic hypokalemic periodic paralysis and Graves disease
chr17	70437584	.	A	G	Thyrotoxic hypokalemic periodic paralysis and Graves disease
chr17	70496115	.	T	A	Thyrotoxic hypokalemic periodic paralysis and Graves disease
chr17	70496115	.	T	C	Thyrotoxic hypokalemic periodic paralysis and Graves disease
chr17	70718073	.	A	G	Renal overload gout
chr17	72016798	.	G	A	End-stage knee osteoarthritis;Knee osteoarthritis
chr17	73531941	.	A	G	Response to zileuton treatment in asthma (FEV1 change interaction)
chr17	75339695	.	C	T	Multiple sclerosis
chr17	75408456	.	C	G	Systemic lupus erythematosus
chr17	75829382	.	G	A	Adult onset asthma and/or BMI;Asthma;Asthma (adult onset);Nonatopic asthma;Nonatopic asthma and/or BMI
chr17	75894282	.	G	C	Psoriasis
chr17	77370538	.	G	A	Endometriosis or asthma (pleiotropy)
chr17	78232490	.	A	T	Rheumatoid arthritis
chr17	78356473	.	G	A	Asthma
chr17	78356473	.	G	C	Asthma
chr17	78377098	.	C	T	Systemic lupus erythematosus
chr17	78741036	.	A	G	Ulcerative colitis
chr17	78844832	.	A	G	Nonatopic asthma;Nonatopic asthma and/or BMI
chr17	78844832	.	A	T	Nonatopic asthma;Nonatopic asthma and/or BMI
chr17	78917207	.	C	A	Post-bronchodilator lung function in asthma (FEV1/FVC)
chr17	78917207	.	C	G	Post-bronchodilator lung function in asthma (FEV1/FVC)
chr17	79414777	.	T	C	Self-reported allergy
chr17	81071259	.	T	C	Serum uric acid levels in response to allopurinol in gout
chr17	82940212	.	T	C	Bone mineral accretion in asthma (oral corticosteroid dose interaction)
chr18	849177	.	A	C	Pulmonary function in asthmatics
chr18	849177	.	A	T	Pulmonary function in asthmatics
chr18	1811107	.	C	T	Chronic kidney disease (reduced eGFR or end stage renal disease) in type 1 diabetes
chr18	2946293	.	C	T	Body mass index in asthmatics
chr18	5857092	.	C	A	Immunoglobulin A
chr18	5857092	.	C	T	Immunoglobulin A
chr18	6522757	.	G	A	Bone mineral accretion in asthma (oral corticosteroid dose interaction)
chr18	8275859	.	T	C	Response to methotrexate in rheumatoid arthritis
chr18	10439156	.	T	A	Takayasu arteritis
chr18	12782449	.	A	G	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)
chr18	12782850	.	C	A	Autoimmune thyroid disease
chr18	12857003	.	G	T	Psoriasis
chr18	12857759	.	G	A	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Rheumatoid arthritis
chr18	12860802	.	G	A	Celiac disease and Rheumatoid arthritis
chr18	12885121	.	G	A	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)
chr18	14186392	.	G	A	Ocular sarcoidosis
chr18	14186392	.	G	C	Ocular sarcoidosis
chr18	15097278	.	A	T	Asthma exacerbations in inhaled corticosteroid treatment
chr18	15182382	.	G	A	Asthma exacerbations in inhaled corticosteroid treatment
chr18	21507398	.	T	C	Type 1 diabetes with low genetic risk score
chr18	23000571	.	A	G	Nonatopic asthma;Nonatopic asthma and/or waist-to-hip ratio adjusted for BMI
chr18	23007948	.	G	C	Late-onset myasthenia gravis
chr18	24913920	.	G	A	Takayasu arteritis
chr18	25506343	.	A	G	Systemic juvenile idiopathic arthritis
chr18	26018196	.	A	T	Autoimmune thyroid disease
chr18	26315873	.	G	A	Asthma-chronic obstructive  pulmonary disease overlap syndrome
chr18	26403713	.	C	T	Asthma-chronic obstructive  pulmonary disease overlap syndrome
chr18	26527900	.	G	T	Ocular sarcoidosis
chr18	27286085	.	G	A	Diisocyanate-induced asthma
chr18	28110320	.	C	G	Asthma-COPD overlap syndrome
chr18	28219995	.	A	G	Systemic lupus erythematosus
chr18	29955603	.	T	C	Gout vs. Hyperuricemia
chr18	31209762	.	T	C	Multiple sclerosis
chr18	33508114	.	G	A	Diisocyanate-induced asthma
chr18	33508114	.	G	T	Diisocyanate-induced asthma
chr18	33742030	.	C	T	Diisocyanate-induced asthma
chr18	33810904	.	G	A	Diisocyanate-induced asthma
chr18	39355576	.	A	C	Response to interferon beta in multiple sclerosis
chr18	40803519	.	T	A	Bone mineral accretion in asthma (oral corticosteroid dose interaction)
chr18	40803519	.	T	C	Bone mineral accretion in asthma (oral corticosteroid dose interaction)
chr18	42857686	.	C	T	Response to tocilizumab in rheumatoid arthritis
chr18	44733745	.	G	A	Coronary artery aneurysm in Kawasaki disease
chr18	45565696	.	G	A	Takayasu arteritis
chr18	45955188	.	C	T	Kawasaki disease
chr18	47496342	.	C	T	Asthma-chronic obstructive  pulmonary disease overlap syndrome
chr18	47872985	.	C	T	Coronary artery disease in type 1 diabetes
chr18	48053250	.	C	A	Systemic juvenile idiopathic arthritis
chr18	48053250	.	C	T	Systemic juvenile idiopathic arthritis
chr18	48386553	.	A	G	Asthma (childhood onset)
chr18	48515384	.	A	G	Rheumatoid arthritis
chr18	48868651	.	A	G	Crohn's disease;Ulcerative colitis
chr18	48924776	.	G	A	Asthma
chr18	49600629	.	A	C	Multiple sclerosis
chr18	49600629	.	A	G	Multiple sclerosis
chr18	49642209	.	T	C	Ocular sarcoidosis
chr18	49727534	.	C	T	Acute anterior uveitis in ankylosing spondylitis
chr18	50790789	.	G	T	Diisocyanate-induced asthma
chr18	50997791	.	G	A	Oligoclonal band status in multiple sclerosis
chr18	51055548	.	C	T	Asthma
chr18	51121270	.	G	A	Asthma;Asthma (childhood onset);Asthma onset (childhood vs adult)
chr18	51121270	.	G	T	Asthma;Asthma (childhood onset);Asthma onset (childhood vs adult)
chr18	51816394	.	A	G	Psoriasis
chr18	54273386	.	G	GT	Asthma
chr18	54273386	.	G	GTT	Asthma
chr18	54273386	.	G	GTTT	Asthma
chr18	54290038	.	G	A	Asthma;Asthma (childhood onset)
chr18	55422267	.	G	A	Lung function (FEV1/FVC) in asthma
chr18	55786872	.	G	A	Ocular sarcoidosis
chr18	57034213	.	T	A	Oral corticosteroid burst in asthma
chr18	57034213	.	T	G	Oral corticosteroid burst in asthma
chr18	57085083	.	T	C	Multiple sclerosis (age of onset)
chr18	57787145	.	G	A	Vitiligo
chr18	57960608	.	A	G	Antineutrophil cytoplasmic antibody-associated vasculitis
chr18	58353277	.	C	T	Diisocyanate-induced asthma
chr18	58389479	.	C	T	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr18	58518360	.	G	A	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr18	58546158	.	G	C	Multiple sclerosis;Multiple sclerosis and systolic blood pressure (pleiotropy)
chr18	58602505	.	A	G	Multiple sclerosis
chr18	58680812	.	A	G	Multiple sclerosis
chr18	58716960	.	T	A	Multiple sclerosis
chr18	58716960	.	T	G	Multiple sclerosis
chr18	59211042	.	C	T	Crohn's disease
chr18	60708701	.	A	G	Gout
chr18	62343215	.	A	T	Late-onset myasthenia gravis
chr18	62354271	.	T	A	Asthma
chr18	62361422	.	A	G	Vitiligo
chr18	62361422	.	A	T	Vitiligo
chr18	63263862	.	A	G	Multiple sclerosis
chr18	63263862	.	A	T	Multiple sclerosis
chr18	63775385	.	A	G	Allergic disease (asthma, hay fever and/or eczema) (age of onset);Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis);Asthma;Asthma (age of onset);Asthma (childhood onset);Asthma onset (childhood vs adult);Atopic asthma;Food allergy
chr18	68625280	.	T	TGGC	Ocular sarcoidosis
chr18	69405649	.	A	G	Type 1 diabetes
chr18	69405649	.	AT	A	Type 1 diabetes
chr18	69571112	.	C	T	Type 1 diabetes with low genetic risk score
chr18	69858790	.	T	G	Primary biliary cholangitis
chr18	69864406	.	T	A	Autoimmune thyroid disease;Type 1 diabetes
chr18	70340385	.	T	C	Milk allergy (parent-of-origin effect)
chr18	71175007	.	G	A	Systemic lupus erythematosus
chr18	71581359	.	T	C	Response to TNF-alpha inhibitors in rheumatoid arthritis
chr18	72107043	.	T	C	Multiple sclerosis (severity)
chr18	73510701	.	G	A	Systemic lupus erythematosus
chr18	73510701	.	G	C	Systemic lupus erythematosus
chr18	75471506	.	G	A	Serum uric acid levels in response to allopurinol in gout
chr18	75689695	.	C	A	Response to zileuton treatment in asthma (FEV1 change interaction)
chr18	75743798	.	A	G	Crohn's disease (indolent vs progressive)
chr18	75743798	.	A	T	Crohn's disease (indolent vs progressive)
chr18	75750899	.	T	G	Rheumatoid arthritis (ACPA-negative)
chr18	77661491	.	C	A	Diisocyanate-induced asthma
chr18	77661491	.	C	G	Diisocyanate-induced asthma
chr18	77739121	.	G	A	Diisocyanate-induced asthma
chr18	78649597	.	C	A	Rheumatoid arthritis
chr18	78938027	.	A	G	Diisocyanate-induced asthma
chr18	79400235	.	A	G	Rheumatoid arthritis
chr18	79460616	.	C	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Crohn's disease
chr18	79614321	.	C	A	Diisocyanate-induced asthma
chr18	79614321	.	C	T	Diisocyanate-induced asthma
chr18	79626912	.	G	A	Systemic lupus erythematosus
chr18	80192565	.	C	T	Osteoarthritis
chr19	838178	.	C	G	Antineutrophil cytoplasmic antibody-associated vasculitis
chr19	937136	.	C	G	Systemic lupus erythematosus
chr19	1079960	.	G	A	Composite immunoglobulin trait (IgA x IgG/IgM)
chr19	1112944	.	G	A	Systemic lupus erythematosus
chr19	1112944	.	G	C	Systemic lupus erythematosus
chr19	1112944	.	G	T	Systemic lupus erythematosus
chr19	1124032	.	G	A	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Crohn's disease
chr19	1124836	.	A	C	Crohn's disease
chr19	1124836	.	A	G	Crohn's disease
chr19	1152657	.	A	G	Asthma (childhood onset);Asthma onset (childhood vs adult)
chr19	1163935	.	C	A	Asthma
chr19	1186317	.	G	C	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr19	2177194	.	C	A	Osteoarthritis
chr19	2177194	.	C	G	Osteoarthritis
chr19	2177194	.	C	T	Osteoarthritis
chr19	3136093	.	C	T	Asthma;Atopic asthma
chr19	4355874	.	T	G	Asthma
chr19	4466469	.	G	A	Multiple sclerosis
chr19	4980853	.	T	A	Systemic lupus erythematosus
chr19	4980853	.	T	C	Systemic lupus erythematosus
chr19	6579018	.	G	GGC	Asthma
chr19	6579019	.	C	G	Asthma
chr19	6668961	.	C	G	Multiple sclerosis
chr19	6689054	.	T	A	Systemic lupus erythematosus
chr19	6689054	.	T	C	Systemic lupus erythematosus
chr19	7264538	.	T	C	Asthma (childhood onset)
chr19	7690056	.	A	G	Low affinity immunoglobulin epsilon Fc receptor levels
chr19	7699550	.	G	C	Low affinity immunoglobulin epsilon Fc receptor levels
chr19	9017666	.	G	T	Asthma
chr19	9030483	.	C	T	Asthma
chr19	9832588	.	T	C	Osteoarthritis of the hip or knee
chr19	10317045	.	T	A	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Rheumatoid arthritis;Type 1 diabetes
chr19	10317045	.	T	C	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Rheumatoid arthritis;Type 1 diabetes
chr19	10352442	.	G	C	Autoimmune thyroid disease;Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular);Multiple sclerosis;Psoriasis;Psoriasis or type 2 diabetes (trans-disease meta-analysis);Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect);Psoriasis vulgaris;Rheumatoid arthritis;Rheumatoid arthritis (ACPA-positive);Rheumatoid arthritis (rheumatoid factor and anti-cyclic citrullinated peptide seronegative);Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive);Sarcoidosis;Systemic lupus erythematosus;Type 1 diabetes
chr19	10354167	.	G	A	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Rheumatoid arthritis;Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)
chr19	10359243	.	G	A	Systemic lupus erythematosus
chr19	10359243	.	G	C	Systemic lupus erythematosus
chr19	10359299	.	A	C	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Crohn's disease;Psoriasis;Rheumatoid arthritis;Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive);Type 1 diabetes;Ulcerative colitis;Ulcerative colitis vs rheumatoid arthritis (ordinary least squares (OLS))
chr19	10359299	.	A	G	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Crohn's disease;Psoriasis;Rheumatoid arthritis;Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive);Type 1 diabetes;Ulcerative colitis;Ulcerative colitis vs rheumatoid arthritis (ordinary least squares (OLS))
chr19	10362257	.	A	C	Psoriasis
chr19	10402235	.	G	C	Crohn's disease
chr19	10463118	.	A	G	Psoriasis
chr19	10463118	.	A	T	Psoriasis
chr19	10489742	.	G	A	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr19	10640062	.	T	A	Osteoarthritis
chr19	10642292	.	A	T	Osteoarthritis
chr19	10661265	.	C	T	Rheumatoid arthritis;Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive);Systemic lupus erythematosus
chr19	10886206	.	G	A	Psoriasis
chr19	11063252	.	C	T	Multiple sclerosis
chr19	11571680	.	T	G	Multiple sclerosis (severity)
chr19	12702869	.	T	C	Diffuse large B-cell lymphoma or multiple sclerosis
chr19	12702869	.	T	G	Diffuse large B-cell lymphoma or multiple sclerosis
chr19	15566899	.	G	A	Response to tocilizumab in rheumatoid arthritis
chr19	15566899	.	G	C	Response to tocilizumab in rheumatoid arthritis
chr19	17056913	.	T	G	Nonatopic asthma;Nonatopic asthma and/or waist-to-hip ratio adjusted for BMI
chr19	17309480	.	G	C	Systemic lupus erythematosus
chr19	17323284	.	T	A	Rheumatoid arthritis
chr19	18125072	.	A	T	Primary biliary cholangitis
chr19	18193890	.	A	T	Multiple sclerosis
chr19	18283739	.	T	TAAAA	Autoimmune thyroid disease
chr19	18283739	.	T	TAAG	Autoimmune thyroid disease
chr19	18781918	.	C	A	Osteoarthritis biomarkers
chr19	18787521	.	C	T	Osteoarthritis (hip);Osteoarthritis (with total hip replacement)
chr19	19166593	.	C	A	Multiple sclerosis
chr19	23212515	.	A	G	Gout vs. Hyperuricemia
chr19	29530539	.	G	A	Crohn's disease
chr19	29530539	.	G	T	Crohn's disease
chr19	31157758	.	T	C	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr19	31667558	.	A	G	Narcolepsy with cataplexy
chr19	34165501	.	C	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr19	35897277	.	C	T	Type 1 diabetes
chr19	35897277	.	CAG	C	Type 1 diabetes
chr19	36013582	.	A	T	Type 1 diabetes with low genetic risk score
chr19	36633617	.	C	A	Type 1 diabetes with low genetic risk score
chr19	36862444	.	CT	C	Osteoarthritis (self-reported)
chr19	37034392	.	A	G	Type 1 diabetes with low genetic risk score
chr19	38484809	.	T	C	Diisocyanate-induced asthma
chr19	38523544	.	T	C	Peanut allergy (parent-of-origin effect)
chr19	40718299	.	G	A	Kawasaki disease
chr19	40775111	.	G	T	Kawasaki disease
chr19	41327879	.	G	A	Osteoarthritis;Osteoarthritis of the hip or knee;Osteoarthritis of the hip or knee (with total joint replacement)
chr19	42174477	.	C	CATAA	Type 1 diabetes with low genetic risk score
chr19	44640642	.	A	C	Multiple sclerosis
chr19	44642803	.	T	C	Multiple sclerosis;Multiple sclerosis and HDL levels (pleiotropy)
chr19	44908684	.	T	C	Adult onset asthma or type 2 diabetes
chr19	45782594	.	C	G	Lung function (FEV1) in asthma;Post-bronchodilator lung function in asthma (FEV1)
chr19	45816157	.	G	A	Asthma
chr19	45867123	.	G	C	Adult onset asthma and/or waist-to-hip ratio adjusted for BMI;Asthma;Asthma (adult onset);Nonatopic asthma;Nonatopic asthma and/or waist-to-hip ratio adjusted for BMI
chr19	45887197	.	C	G	Osteoarthritis of the hand
chr19	47158236	.	G	A	Multiple sclerosis;Multiple sclerosis and triglyceride levels (pleiotropy)
chr19	47158236	.	G	C	Multiple sclerosis;Multiple sclerosis and triglyceride levels (pleiotropy)
chr19	47871241	.	C	T	Type 1 diabetes with low genetic risk score
chr19	48019432	.	CT	C	Peak cortisol response to low dose short synacthen test in corticosteroid treated asthma
chr19	48626089	.	C	T	Psoriasis
chr19	48702851	.	C	G	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr19	48702915	.	C	T	Crohn's disease;Type 1 diabetes
chr19	48703160	.	A	G	Psoriasis
chr19	48703205	.	C	A	Behcet's disease;Primary sclerosing cholangitis
chr19	48703205	.	C	T	Behcet's disease;Primary sclerosing cholangitis
chr19	48703374	.	A	T	Psoriasis
chr19	48705608	.	G	A	Crohn's disease
chr19	48711017	.	G	A	Childhood asthma with severe exacerbations;Crohn's disease
chr19	48962236	.	G	C	Asthma
chr19	48962236	.	G	T	Asthma
chr19	49342638	.	C	G	Systemic lupus erythematosus
chr19	50895171	.	G	A	Diisocyanate-induced asthma
chr19	53178789	.	T	C	Asthma
chr19	54197981	.	G	A	Takayasu arteritis
chr19	54203380	.	T	A	Takayasu arteritis
chr19	54207310	.	G	A	Leukocyte immunoglobulin-like receptor subfamily B member 2 levels
chr19	54207310	.	G	C	Leukocyte immunoglobulin-like receptor subfamily B member 2 levels
chr19	54208113	.	A	G	Takayasu arteritis
chr19	54250239	.	C	A	Leukocyte immunoglobulin-like receptor subfamily B member 2 levels
chr19	54257485	.	A	G	Leukocyte immunoglobulin-like receptor subfamily B member 2 levels
chr19	54260474	.	G	A	Leukocyte immunoglobulin-like receptor subfamily B member 2 levels
chr19	54271122	.	T	C	Leukocyte immunoglobulin-like receptor subfamily B member 2 levels
chr19	54278734	.	T	C	Leukocyte immunoglobulin-like receptor subfamily B member 2 levels
chr19	54280275	.	C	A	Leukocyte immunoglobulin-like receptor subfamily B member 2 levels
chr19	54280275	.	C	T	Leukocyte immunoglobulin-like receptor subfamily B member 2 levels
chr19	54282520	.	G	A	Leukocyte immunoglobulin-like receptor subfamily B member 2 levels
chr19	54291446	.	C	G	Leukocyte immunoglobulin-like receptor subfamily B member 2 levels
chr19	54291446	.	C	T	Leukocyte immunoglobulin-like receptor subfamily B member 2 levels
chr19	54292240	.	G	A	Leukocyte immunoglobulin-like receptor subfamily B member 2 levels
chr19	54293995	.	T	C	Leukocyte immunoglobulin-like receptor subfamily B member 2 levels;Takayasu arteritis
chr19	54296519	.	C	T	Takayasu arteritis
chr19	54461539	.	A	T	Leukocyte immunoglobulin-like receptor subfamily B member 1 levels
chr19	54542896	.	T	C	Leukocyte immunoglobulin-like receptor subfamily B member 1 levels
chr19	54544858	.	T	C	Leukocyte immunoglobulin-like receptor subfamily B member 1 levels
chr19	54548687	.	C	T	Leukocyte immunoglobulin-like receptor subfamily B member 1 levels
chr19	54549174	.	G	A	Leukocyte immunoglobulin-like receptor subfamily B member 1 levels
chr19	54549174	.	G	C	Leukocyte immunoglobulin-like receptor subfamily B member 1 levels
chr19	54573515	.	A	G	Leukocyte immunoglobulin-like receptor subfamily B member 1 levels
chr19	54575519	.	G	A	Leukocyte immunoglobulin-like receptor subfamily B member 1 levels
chr19	54585932	.	G	A	Leukocyte immunoglobulin-like receptor subfamily B member 1 levels
chr19	54588509	.	G	A	Leukocyte immunoglobulin-like receptor subfamily B member 1 levels
chr19	54600931	.	C	T	Leukocyte immunoglobulin-like receptor subfamily B member 1 levels
chr19	54615303	.	C	T	Leukocyte immunoglobulin-like receptor subfamily B member 1 levels
chr19	54626781	.	C	T	Leukocyte immunoglobulin-like receptor subfamily B member 1 levels
chr19	54632388	.	T	A	Leukocyte immunoglobulin-like receptor subfamily B member 1 levels
chr19	54632690	.	A	G	Leukocyte immunoglobulin-like receptor subfamily B member 1 levels
chr19	54636880	.	C	G	Leukocyte immunoglobulin-like receptor subfamily B member 2 levels
chr19	54636880	.	C	T	Leukocyte immunoglobulin-like receptor subfamily B member 2 levels
chr19	54639836	.	C	G	Leukocyte immunoglobulin-like receptor subfamily B member 1 levels
chr19	54646481	.	G	A	Leukocyte immunoglobulin-like receptor subfamily B member 1 levels
chr19	54653455	.	CACTT	C	Leukocyte immunoglobulin-like receptor subfamily B member 1 levels
chr19	54657298	.	G	A	Leukocyte immunoglobulin-like receptor subfamily B member 1 levels
chr19	54713283	.	A	G	Killer cell immunoglobulin-like receptor 2DL4 levels
chr19	54713283	.	A	T	Killer cell immunoglobulin-like receptor 2DL4 levels
chr19	54804874	.	A	C	Killer cell immunoglobulin-like receptor 2DL4 levels
chr19	54804874	.	A	G	Killer cell immunoglobulin-like receptor 2DL4 levels
chr19	54834954	.	T	A	Killer cell immunoglobulin-like receptor 2DL4 levels
chr19	54862632	.	T	C	Killer cell immunoglobulin-like receptor 2DL4 levels
chr19	54866128	.	T	C	Killer cell immunoglobulin-like receptor 2DL4 levels
chr19	54867770	.	C	T	Killer cell immunoglobulin-like receptor 2DL4 levels
chr19	54868759	.	A	G	Ulcerative colitis
chr19	54871595	.	G	A	Ulcerative colitis
chr19	54878590	.	T	C	Killer cell immunoglobulin-like receptor 2DL4 levels
chr19	54881190	.	A	G	Killer cell immunoglobulin-like receptor 2DL4 levels
chr19	54908874	.	G	T	Killer cell immunoglobulin-like receptor 2DL4 levels
chr19	55067218	.	G	A	Leukocyte immunoglobulin-like receptor subfamily B member 1 levels
chr19	55228445	.	G	C	Systemic lupus erythematosus
chr19	55228445	.	G	T	Systemic lupus erythematosus
chr19	55368304	.	C	T	Osteoarthritis (hip);Osteoarthritis (with total hip replacement)
chr19	55802162	.	G	A	Multiple sclerosis (severity)
chr19	56620870	.	C	A	IgE levels in asthmatics
chr2	633063	.	G	A	Osteoarthritis of the hip or knee
chr2	633063	.	G	T	Osteoarthritis of the hip or knee
chr2	1403856	.	C	T	Autoimmune thyroid disease
chr2	1781887	.	C	A	Systemic sclerosis
chr2	2402716	.	C	T	Ulcerative colitis
chr2	3675436	.	G	A	Response to inhaled corticosteroid treatment in asthma (change in FEV1)
chr2	3697625	.	A	G	Chronic kidney disease (reduced eGFR or end stage renal disease) in type 1 diabetes
chr2	5523876	.	G	T	Crohn's disease
chr2	6303084	.	C	T	Immunoglobulin light chain (AL) amyloidosis (heart and kidney involvement)
chr2	6960080	.	T	C	Asthma-chronic obstructive  pulmonary disease overlap syndrome
chr2	7432948	.	G	A	Systemic lupus erythematosus
chr2	7913466	.	A	G	Multiple sclerosis
chr2	7971100	.	C	T	Response to anti-TNF therapy in rheumatoid arthritis
chr2	8299237	.	T	C	Allergic march (atopic dermatitis to asthma)
chr2	8301605	.	C	A	Asthma (age of onset);Asthma (childhood onset);Primary biliary cholangitis
chr2	9109909	.	C	A	Multiple sclerosis
chr2	9109909	.	C	G	Multiple sclerosis
chr2	9151105	.	T	C	Diisocyanate-induced asthma
chr2	10278047	.	C	A	Asthma exacerbations in inhaled corticosteroid treatment
chr2	10278047	.	C	T	Asthma exacerbations in inhaled corticosteroid treatment
chr2	11597965	.	T	A	Diisocyanate-induced asthma
chr2	11597965	.	T	C	Diisocyanate-induced asthma
chr2	12467767	.	T	C	Multiple sclerosis
chr2	12500615	.	G	A	Autoimmune thyroid diseases (Graves disease or Hashimoto's thyroiditis);Graves' disease;Multiple sclerosis;Type 1 diabetes
chr2	13542679	.	G	A	Diisocyanate-induced asthma
chr2	13586488	.	C	T	Diisocyanate-induced asthma
chr2	14517062	.	G	A	joint destruction in rheumatoid arthritis (rapid vs slow)
chr2	14562225	.	G	A	joint destruction in rheumatoid arthritis (rapid vs slow)
chr2	15780199	.	T	A	Asthma or chronic obstructive pulmonary disease
chr2	15780199	.	T	C	Asthma or chronic obstructive pulmonary disease
chr2	15918509	.	C	A	Ocular sarcoidosis
chr2	15918509	.	C	T	Ocular sarcoidosis
chr2	20198534	.	G	A	Joint damage in rheumatoid arthritis
chr2	20398749	.	A	C	Kidney disease (early stage) in type 1 diabetes
chr2	20488758	.	C	T	Systemic sclerosis
chr2	21296299	.	C	A	Depression in multiple sclerosis (pre-diagnosis)
chr2	21296299	.	C	G	Depression in multiple sclerosis (pre-diagnosis)
chr2	22328233	.	A	C	Systemic lupus erythematosus
chr2	22328233	.	A	G	Systemic lupus erythematosus
chr2	25228920	.	C	A	Crohn's disease x smoking status (never vs ever smoking) interaction
chr2	25228920	.	C	G	Crohn's disease x smoking status (never vs ever smoking) interaction
chr2	25228920	.	C	T	Crohn's disease x smoking status (never vs ever smoking) interaction
chr2	25278036	.	C	A	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr2	25291464	.	C	T	Primary biliary cholangitis
chr2	25382703	.	A	G	Crohn's disease
chr2	25693109	.	A	G	Decreased low contrast letter acuity in multiple sclerosis
chr2	25772946	.	C	T	Type 1 diabetes
chr2	25865493	.	C	T	Type 1 diabetes with low genetic risk score
chr2	25865493	.	CG	C	Type 1 diabetes with low genetic risk score
chr2	27412596	.	A	T	Crohn's disease
chr2	27419867	.	A	C	Takayasu arteritis
chr2	28391927	.	C	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Crohn's disease
chr2	28423934	.	G	A	Type 1 diabetes
chr2	30206869	.	C	A	Primary biliary cholangitis
chr2	30222160	.	T	G	Celiac disease and Rheumatoid arthritis;Celiac disease or Rheumatoid arthritis;Rheumatoid arthritis (ACPA-positive);Systemic lupus erythematosus
chr2	30249576	.	C	G	Multiple sclerosis
chr2	30249576	.	C	T	Multiple sclerosis
chr2	30268526	.	A	G	Asthma
chr2	33198734	.	C	T	Osteoarthritis of the hip or knee
chr2	33205536	.	G	C	Knee osteoarthritis
chr2	33205536	.	G	T	Knee osteoarthritis
chr2	33209269	.	A	G	Osteoarthritis
chr2	33210282	.	A	G	Knee osteoarthritis
chr2	33236308	.	A	G	Osteoarthritis of the hip or knee
chr2	33981969	.	G	A	Ocular sarcoidosis
chr2	34078378	.	A	G	Asthma
chr2	34078378	.	A	T	Asthma
chr2	34321239	.	C	T	Lung function (FEV1) in asthma
chr2	36448387	.	A	G	IgE levels in asthmatics
chr2	37504522	.	G	A	Response to TNF-alpha inhibitors in rheumatoid arthritis
chr2	37721427	.	C	T	Rheumatoid arthritis
chr2	37977506	.	A	G	Lung function (FEV1/FVC) in asthma
chr2	39888556	.	C	T	Asthma (childhood onset)
chr2	40127337	.	C	G	Asthma
chr2	40127337	.	C	T	Asthma
chr2	41789723	.	T	A	Asthma with severe exacerbations
chr2	41853484	.	T	A	Rheumatoid arthritis
chr2	41853484	.	T	G	Rheumatoid arthritis
chr2	41910220	.	T	G	Type 1 diabetes with low genetic risk score
chr2	41913324	.	A	T	Type 1 diabetes
chr2	43087705	.	C	T	Immunoglobulin A vasculitis
chr2	43098432	.	A	G	Multiple sclerosis
chr2	43098432	.	A	T	Multiple sclerosis
chr2	43131922	.	C	T	Multiple sclerosis
chr2	43484954	.	C	A	Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect)
chr2	43550825	.	C	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr2	43579779	.	C	T	Crohn's disease
chr2	43621525	.	T	C	Alopecia areata
chr2	45535468	.	T	A	Osteoarthritis (self-reported)
chr2	45772849	.	T	C	Diisocyanate-induced asthma
chr2	46184068	.	C	A	Response to zileuton treatment in asthma (FEV1 change interaction)
chr2	46184068	.	C	T	Response to zileuton treatment in asthma (FEV1 change interaction)
chr2	47617366	.	A	G	Vitiligo
chr2	47676957	.	C	T	Takayasu arteritis
chr2	47948199	.	G	A	Asthma
chr2	49728359	.	C	A	Systemic lupus erythematosus
chr2	49728359	.	C	G	Systemic lupus erythematosus
chr2	50909664	.	A	C	Response to zileuton treatment in asthma (FEV1 change interaction)
chr2	51509856	.	C	T	Response to tocilizumab in rheumatoid arthritis
chr2	52756635	.	T	G	Bronchodilator response in asthma
chr2	58626423	.	G	A	Post-bronchodilator FEV1 x air pollution (CO) interaction in childhood asthma
chr2	58809781	.	A	C	Myasthenia gravis
chr2	59212838	.	C	T	Osteoarthritis (with total hip replacement)
chr2	60197190	.	A	T	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr2	60324666	.	A	G	Nonatopic asthma or type 2 diabetes
chr2	60326008	.	C	A	Type 1 diabetes
chr2	60409281	.	A	G	Type 1 diabetes
chr2	60718420	.	G	A	Asthma
chr2	60759441	.	G	A	Systemic lupus erythematosus
chr2	60815015	.	A	G	Composite immunoglobulin trait (IgA/IgM)
chr2	60827845	.	C	G	Multiple sclerosis
chr2	60841032	.	C	T	Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS));Systemic lupus erythematosus
chr2	60854175	.	C	G	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr2	60990407	.	T	A	Crohn's disease and celiac disease
chr2	61594642	.	A	G	Systemic lupus erythematosus
chr2	62179864	.	CTTTTTTTTTTTT	C	Coronary artery disease in type 1 diabetes
chr2	62233985	.	G	C	Rheumatoid arthritis
chr2	62325186	.	A	C	Crohn's disease
chr2	62325186	.	A	T	Crohn's disease
chr2	62325541	.	A	G	Behcet's disease
chr2	62333197	.	A	C	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect)
chr2	62333197	.	A	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect)
chr2	62341310	.	G	A	Ankylosing spondylitis
chr2	62486398	.	C	T	Crohn's disease
chr2	62744832	.	A	C	Type 1 diabetes with low genetic risk score
chr2	62744832	.	ACACT	A	Type 1 diabetes with low genetic risk score
chr2	64122068	.	C	A	Kawasaki disease
chr2	64609133	.	C	A	Allergic disease (asthma, hay fever or eczema)
chr2	64609133	.	C	T	Allergic disease (asthma, hay fever or eczema)
chr2	65329190	.	C	A	Rheumatoid arthritis (ACPA-positive)
chr2	65381229	.	A	C	Systemic lupus erythematosus
chr2	65381229	.	A	G	Systemic lupus erythematosus
chr2	65381229	.	A	T	Systemic lupus erythematosus
chr2	65434709	.	T	C	Multiple sclerosis
chr2	65437216	.	C	T	Systemic lupus erythematosus
chr2	65440138	.	C	A	Crohn's disease
chr2	65459327	.	C	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr2	65474623	.	C	A	Psoriasis or type 2 diabetes (trans-disease meta-analysis)
chr2	65474623	.	C	T	Psoriasis or type 2 diabetes (trans-disease meta-analysis)
chr2	66827983	.	C	A	Milk allergy
chr2	68371823	.	T	A	Celiac disease
chr2	70459094	.	G	C	Osteoarthritis (self-reported)
chr2	70487661	.	T	C	Osteoarthritis (hip)
chr2	70490521	.	A	G	Osteoarthritis;Osteoarthritis (hip);Osteoarthritis (hospital diagnosed);Osteoarthritis (self-reported)
chr2	70493874	.	A	G	Osteoarthritis of the hip or knee
chr2	71812584	.	T	G	Asthma
chr2	71827707	.	C	T	Asthma
chr2	73973913	.	C	T	Systemic lupus erythematosus
chr2	73975451	.	T	C	Systemic lupus erythematosus
chr2	75246790	.	C	A	Diisocyanate-induced asthma
chr2	75246790	.	C	T	Diisocyanate-induced asthma
chr2	75489181	.	A	G	Gout
chr2	88794264	.	T	A	Multiple sclerosis
chr2	88794264	.	T	C	Multiple sclerosis
chr2	98693451	.	A	C	Ocular sarcoidosis
chr2	98773407	.	T	A	Idiopathic inflammatory myopathy
chr2	99844192	.	C	T	Type 1 diabetes nephropathy
chr2	100190052	.	T	A	Rheumatoid arthritis;Rheumatoid arthritis (ACPA-positive)
chr2	100196621	.	C	CT	Asthma
chr2	100196621	.	C	CTT	Asthma
chr2	100217755	.	T	G	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)
chr2	101671373	.	C	T	Asthma;Asthma (adult onset);Asthma (childhood onset);Atopic asthma
chr2	101809678	.	A	T	Asthma (time to onset)
chr2	101962555	.	G	A	Nonatopic asthma
chr2	101962555	.	G	T	Nonatopic asthma
chr2	102046427	.	T	G	Crohn's disease;Ulcerative colitis
chr2	102047167	.	T	C	Ankylosing spondylitis;Ulcerative colitis
chr2	102113414	.	C	G	Asthma (childhood onset)
chr2	102152913	.	G	T	Ankylosing spondylitis
chr2	102154822	.	T	C	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr2	102165764	.	A	G	Asthma (childhood onset)
chr2	102181785	.	T	C	Asthma;Asthma (childhood onset);Asthma onset (childhood vs adult)
chr2	102181785	.	T	G	Asthma;Asthma (childhood onset);Asthma onset (childhood vs adult)
chr2	102226205	.	A	G	Atopic asthma
chr2	102275879	.	G	A	Asthma;Asthma (adult onset);Asthma onset (childhood vs adult)
chr2	102297182	.	A	AAAAC	Asthma
chr2	102297182	.	A	AAAACAAAC	Asthma
chr2	102297182	.	A	AAAC	Asthma
chr2	102316052	.	G	A	Allergy
chr2	102319699	.	T	A	Allergic disease (asthma, hay fever or eczema);Asthma;Asthma (adult onset);Asthma (childhood onset);Asthma onset (childhood vs adult);Asthma or allergic disease (pleiotropy);Pediatric asthma
chr2	102319699	.	T	C	Allergic disease (asthma, hay fever or eczema);Asthma;Asthma (adult onset);Asthma (childhood onset);Asthma onset (childhood vs adult);Asthma or allergic disease (pleiotropy);Pediatric asthma
chr2	102332701	.	C	A	Asthma (adult onset);Asthma (moderate or severe);Nonatopic asthma
chr2	102337157	.	G	A	Asthma
chr2	102348282	.	C	G	Atopic asthma
chr2	102350446	.	C	T	Asthma;Asthma (childhood onset);Asthma onset (childhood vs adult)
chr2	102369762	.	G	T	Asthma
chr2	102386805	.	C	T	Asthma
chr2	102441432	.	A	G	Childhood asthma with severe exacerbations
chr2	102454108	.	T	A	Celiac disease
chr2	102470626	.	A	G	Asthma (childhood onset)
chr2	102475982	.	G	T	Asthma (adult onset);Nonatopic asthma
chr2	102476784	.	T	G	Celiac disease
chr2	102510080	.	A	G	Atopic asthma
chr2	102550572	.	A	G	Nonatopic asthma
chr2	102636570	.	A	G	Atopic asthma
chr2	102661403	.	G	C	Endometriosis or asthma (pleiotropy)
chr2	105176393	.	G	A	Asthma exacerbations in inhaled corticosteroid treatment
chr2	110841381	.	C	A	Composite immunoglobulin trait (IgG/IgM)
chr2	110841381	.	C	T	Composite immunoglobulin trait (IgG/IgM)
chr2	110940463	.	A	C	Alopecia areata
chr2	111050981	.	A	G	Alopecia areata
chr2	111117122	.	G	T	Adult onset asthma and/or BMI;Asthma (adult onset)
chr2	111119036	.	G	A	Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)
chr2	111119036	.	G	C	Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)
chr2	111119597	.	C	T	Systemic lupus erythematosus
chr2	111134218	.	T	C	Adult onset asthma and/or waist-to-hip ratio adjusted for BMI
chr2	111155479	.	T	C	Asthma
chr2	111175424	.	G	T	Asthma;Pediatric asthma;Primary sclerosing cholangitis
chr2	111231795	.	T	G	Primary sclerosing cholangitis
chr2	111252909	.	T	C	Vitiligo
chr2	111462782	.	T	A	Composite immunoglobulin trait (IgA x IgG/IgM)
chr2	111462782	.	T	C	Composite immunoglobulin trait (IgA x IgG/IgM)
chr2	111493181	.	G	A	Asthma
chr2	111511155	.	T	C	Asthma;Asthma (childhood onset)
chr2	111511550	.	A	T	Allergic disease (asthma, hay fever or eczema)
chr2	111520962	.	G	A	Atopic asthma
chr2	112065743	.	C	T	Acute anterior uveitis in ankylosing spondylitis
chr2	112144650	.	G	A	Systemic juvenile idiopathic arthritis
chr2	112144650	.	G	C	Systemic juvenile idiopathic arthritis
chr2	112144650	.	G	T	Systemic juvenile idiopathic arthritis
chr2	112819149	.	C	G	Behcet's disease
chr2	112832890	.	C	G	Allergic disease (asthma, hay fever or eczema)
chr2	112832890	.	C	T	Allergic disease (asthma, hay fever or eczema)
chr2	117481369	.	C	T	Type 1 diabetes with low genetic risk score
chr2	118638115	.	T	C	Multiple sclerosis
chr2	120863253	.	G	A	Diisocyanate-induced asthma
chr2	121261187	.	C	A	Behcet's disease
chr2	123529348	.	C	T	Coronary artery disease in type 1 diabetes
chr2	125137298	.	C	T	Asthma exacerbations in inhaled corticosteroid treatment
chr2	127000872	.	C	G	Systemic lupus erythematosus
chr2	127000872	.	C	T	Systemic lupus erythematosus
chr2	132989057	.	A	C	Multiple sclerosis (age of onset)
chr2	132989057	.	A	T	Multiple sclerosis (age of onset)
chr2	133472646	.	G	C	Multiple sclerosis
chr2	133472646	.	G	T	Multiple sclerosis
chr2	133602133	.	G	A	Gout (combined type)
chr2	133880928	.	A	C	Asthma (childhood onset)
chr2	133880928	.	A	G	Asthma (childhood onset)
chr2	134311223	.	T	A	Multiple sclerosis (severity)
chr2	134311223	.	T	C	Multiple sclerosis (severity)
chr2	134489652	.	T	C	Asthma x air pollution interaction (2df)
chr2	134585720	.	C	T	Type 1 diabetes with low genetic risk score
chr2	134688820	.	A	G	Type 1 diabetes with low genetic risk score
chr2	134722410	.	G	T	Type 1 diabetes
chr2	134845031	.	T	A	Type 1 diabetes
chr2	134875411	.	C	T	Diisocyanate-induced asthma
chr2	134947988	.	G	A	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr2	135080336	.	C	A	Type 1 diabetes with low genetic risk score
chr2	135149518	.	A	G	Type 1 diabetes
chr2	135197227	.	T	C	Type 1 diabetes with low genetic risk score
chr2	135301250	.	G	C	Type 1 diabetes with low genetic risk score
chr2	135403522	.	C	A	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr2	135403522	.	C	G	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr2	135403522	.	C	T	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr2	135516008	.	T	A	Type 1 diabetes with low genetic risk score
chr2	135516008	.	T	C	Type 1 diabetes with low genetic risk score
chr2	135571320	.	A	T	Type 1 diabetes
chr2	135623778	.	G	A	Type 1 diabetes with low genetic risk score
chr2	135671796	.	T	A	Type 1 diabetes
chr2	135671796	.	T	C	Type 1 diabetes
chr2	135671796	.	T	G	Type 1 diabetes
chr2	135818793	.	C	A	Osteoarthritis (self-reported)
chr2	135818793	.	C	G	Osteoarthritis (self-reported)
chr2	135859184	.	C	T	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr2	135964033	.	A	T	Systemic lupus erythematosus
chr2	136066296	.	AG	A	Type 1 diabetes with low genetic risk score
chr2	136066296	.	AGG	A	Type 1 diabetes with low genetic risk score
chr2	136218685	.	T	C	Multiple sclerosis
chr2	136218685	.	T	G	Multiple sclerosis
chr2	136221960	.	G	A	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr2	136740481	.	CT	C	Osteoarthritis (hospital diagnosed);Osteoarthritis of the hip or knee (hospital diagnosed)
chr2	137009624	.	G	A	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr2	137009624	.	G	GA	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr2	138460829	.	CAAA	C	Childhood asthma x sex interaction
chr2	140665410	.	G	A	Peak cortisol response to low dose short synacthen test in corticosteroid treated asthma
chr2	140665410	.	G	C	Peak cortisol response to low dose short synacthen test in corticosteroid treated asthma
chr2	140833839	.	G	A	Diisocyanate-induced asthma
chr2	140833839	.	G	C	Diisocyanate-induced asthma
chr2	140989680	.	A	G	Takayasu arteritis
chr2	140989680	.	A	T	Takayasu arteritis
chr2	141243326	.	T	A	Asthma (childhood onset)
chr2	141243326	.	T	C	Asthma (childhood onset)
chr2	141361833	.	A	G	Asthma and eczema
chr2	141543366	.	T	A	Type 1 diabetes
chr2	141543366	.	T	G	Type 1 diabetes
chr2	143602701	.	C	A	Ocular sarcoidosis
chr2	143840863	.	A	G	Diisocyanate-induced asthma
chr2	144232981	.	A	G	Multiple sclerosis
chr2	144724260	.	A	G	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr2	144734815	.	C	G	Crohn's disease
chr2	145067988	.	C	T	Endometriosis or asthma (pleiotropy)
chr2	145360501	.	G	A	Asthma (adult onset)
chr2	145382564	.	C	G	Nonatopic asthma
chr2	145382564	.	C	T	Nonatopic asthma
chr2	145387450	.	T	G	Asthma;Asthma (adult onset);Asthma onset (childhood vs adult)
chr2	145399111	.	G	A	Asthma (adult onset)
chr2	149798707	.	A	C	Asthma (sex interaction)
chr2	150787689	.	C	T	Multiple sclerosis
chr2	150917165	.	C	G	Systemic sclerosis
chr2	151206431	.	T	C	Crohn's disease (time to progression)
chr2	152400198	.	C	G	Asthma (childhood onset)
chr2	154368670	.	A	G	Coronary artery disease in type 1 diabetes
chr2	155400189	.	G	A	Systemic lupus erythematosus
chr2	155895409	.	T	C	Crohn's disease-related phenotypes
chr2	156450176	.	A	G	Possible neuropathic pain in post total joint replacement surgery for osteoarthritis
chr2	156742166	.	C	T	Ulcerative colitis
chr2	157012356	.	A	G	Diisocyanate-induced asthma
chr2	161647730	.	G	A	Type 1 diabetes (age at diagnosis)
chr2	162105535	.	T	C	Multiple sclerosis
chr2	162225885	.	C	A	Systemic lupus erythematosus
chr2	162225885	.	C	T	Systemic lupus erythematosus
chr2	162254026	.	A	G	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Psoriasis;Psoriasis or type 2 diabetes (trans-disease meta-analysis);Systemic lupus erythematosus;Type 1 diabetes;Ulcerative colitis;Vitiligo
chr2	162267541	.	C	T	Autoimmune thyroid disease;Immunoglobulin A;Psoriasis;Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect);Systemic lupus erythematosus;Type 1 diabetes
chr2	162268127	.	T	C	Autoimmune thyroid disease;Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Type 1 diabetes
chr2	162280432	.	A	G	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Type 1 diabetes
chr2	162368011	.	A	C	Type 1 diabetes
chr2	162368011	.	A	G	Type 1 diabetes
chr2	162404181	.	T	C	Psoriasis;Psoriasis vulgaris
chr2	162478172	.	T	C	Ocular sarcoidosis
chr2	163774442	.	T	C	Diisocyanate-induced asthma
chr2	163945275	.	T	G	Diisocyanate-induced asthma
chr2	164106976	.	T	C	Immunoglobulin A vasculitis
chr2	164694691	.	T	C	Psoriasis or type 2 diabetes (trans-disease meta-analysis)
chr2	164826436	.	T	C	joint destruction in rheumatoid arthritis (rapid vs slow)
chr2	168961203	.	G	A	Egg allergy
chr2	169154475	.	T	A	Gout
chr2	169154475	.	T	C	Gout
chr2	169261301	.	C	T	Relapse in multiple sclerosis
chr2	169416081	.	T	C	Ocular sarcoidosis
chr2	170499764	.	G	A	Coronary artery aneurysm in Kawasaki disease
chr2	172401022	.	C	A	Food allergy;Peanut allergy
chr2	172504191	.	T	C	Ocular sarcoidosis
chr2	173386140	.	G	A	Asthma
chr2	173688707	.	A	C	Endometriosis or asthma (pleiotropy)
chr2	174764492	.	G	A	Late-onset myasthenia gravis;Myasthenia gravis
chr2	174764492	.	G	T	Late-onset myasthenia gravis;Myasthenia gravis
chr2	176182444	.	C	A	Gout
chr2	176679823	.	G	C	Agouti-related protein levels
chr2	176906489	.	T	C	Sj√∂gren's syndrome
chr2	178431544	.	T	C	Multiple sclerosis (OCB status)
chr2	179127489	.	C	T	Response to tocilizumab in rheumatoid arthritis
chr2	180649002	.	G	A	Systemic lupus erythematosus
chr2	180721999	.	C	T	joint destruction in rheumatoid arthritis (rapid vs slow)
chr2	181131318	.	A	C	Celiac disease
chr2	181183725	.	T	A	Ankylosing spondylitis
chr2	182320437	.	T	C	joint destruction in rheumatoid arthritis (rapid vs slow)
chr2	185151747	.	T	C	Systemic lupus erythematosus
chr2	186711651	.	A	AT	Crohn's disease
chr2	188968308	.	A	G	Kawasaki disease
chr2	190656715	.	C	A	Multiple sclerosis
chr2	190656715	.	C	G	Multiple sclerosis
chr2	190656715	.	C	T	Multiple sclerosis
chr2	190673836	.	C	G	Primary biliary cholangitis;Rheumatoid arthritis
chr2	190673836	.	C	T	Primary biliary cholangitis;Rheumatoid arthritis
chr2	190679236	.	T	G	Primary biliary cholangitis
chr2	190700031	.	G	T	Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)
chr2	191009521	.	T	C	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)
chr2	191037458	.	A	T	Celiac disease;Celiac disease and Rheumatoid arthritis
chr2	191038032	.	G	A	Systemic lupus erythematosus;Systemic sclerosis
chr2	191047814	.	C	A	Systemic lupus erythematosus
chr2	191047814	.	C	T	Systemic lupus erythematosus
chr2	191048308	.	A	G	Celiac disease
chr2	191052591	.	T	G	Idiopathic inflammatory myopathy
chr2	191057148	.	C	G	Rheumatoid arthritis (ACPA-positive);Systemic sclerosis
chr2	191068528	.	G	A	Rheumatoid arthritis;Rheumatoid arthritis (ACPA-positive)
chr2	191068557	.	T	C	Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)
chr2	191071078	.	C	T	Primary biliary cholangitis;Sj√∂gren's syndrome
chr2	191073180	.	T	A	Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)
chr2	191075725	.	G	A	Systemic lupus erythematosus;Systemic lupus erythematosus and Systemic sclerosis
chr2	191075725	.	G	T	Systemic lupus erythematosus;Systemic lupus erythematosus and Systemic sclerosis
chr2	191079016	.	C	T	Primary biliary cholangitis;Rheumatoid arthritis;Rheumatoid arthritis (rheumatoid factor and anti-cyclic citrullinated peptide seronegative);Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive);Sj√∂gren's syndrome;Systemic lupus erythematosus;Ulcerative colitis vs rheumatoid arthritis (ordinary least squares (OLS))
chr2	191081596	.	C	T	Systemic lupus erythematosus
chr2	191084260	.	T	TA	Systemic lupus erythematosus
chr2	191084260	.	T	TAA	Systemic lupus erythematosus
chr2	191089272	.	A	C	Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS));Graves' disease;Systemic lupus erythematosus
chr2	191089272	.	A	T	Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS));Graves' disease;Systemic lupus erythematosus
chr2	191090463	.	TATA	T	Rheumatoid arthritis;Sj√∂gren's syndrome;Systemic lupus erythematosus
chr2	191090479	.	ATAC	A	Vitiligo
chr2	191094763	.	A	G	Rheumatoid arthritis;Rheumatoid arthritis (rheumatoid factor and anti-cyclic citrullinated peptide seronegative);Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)
chr2	191099907	.	T	G	Celiac disease or Rheumatoid arthritis;Primary biliary cholangitis;Rheumatoid arthritis;Sj√∂gren's syndrome;Systemic lupus erythematosus;Systemic sclerosis
chr2	191101726	.	G	C	Autoimmune thyroid disease;Systemic lupus erythematosus
chr2	191101726	.	G	T	Autoimmune thyroid disease;Systemic lupus erythematosus
chr2	191105153	.	G	C	Rheumatoid arthritis
chr2	191105394	.	C	G	Systemic lupus erythematosus;Type 1 diabetes
chr2	191108308	.	G	A	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular);Systemic sclerosis;Systemic sclerosis (anti-centromere-positive);Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)
chr2	191108837	.	A	G	Celiac disease
chr2	191807255	.	A	G	Knee osteoarthritis;Osteoarthritis of the hip or knee
chr2	191943742	.	T	C	Steroid induced osteonecrosis of the femoral head and systemic lupus erythematosus
chr2	195090010	.	A	G	Food allergy
chr2	195090010	.	A	T	Food allergy
chr2	197055445	.	C	G	Interferon alpha levels in systemic lupus erythematosus
chr2	198022936	.	G	T	Allergic disease (asthma, hay fever or eczema)
chr2	198025083	.	T	A	Systemic lupus erythematosus
chr2	198259003	.	G	A	Rheumatoid arthritis
chr2	198658398	.	C	A	Ulcerative colitis
chr2	198658398	.	C	T	Ulcerative colitis
chr2	198696033	.	A	G	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr2	198702963	.	C	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr2	198880294	.	C	A	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Ulcerative colitis
chr2	199425636	.	A	G	Ulcerative colitis
chr2	199807180	.	A	G	Diisocyanate-induced asthma
chr2	201247748	.	G	A	Multiple sclerosis
chr2	201247748	.	G	C	Multiple sclerosis
chr2	201289674	.	C	G	Rheumatoid arthritis
chr2	201289674	.	C	T	Rheumatoid arthritis
chr2	203522759	.	G	C	Osteoarthritis
chr2	203712200	.	C	CA	Asthma
chr2	203712200	.	C	CAA	Asthma
chr2	203745673	.	C	A	Celiac disease;Celiac disease and Rheumatoid arthritis;Rheumatoid arthritis;Rheumatoid arthritis (ACPA-positive)
chr2	203771467	.	A	T	Rheumatoid arthritis
chr2	203819074	.	G	C	Celiac disease
chr2	203829153	.	G	T	Rheumatoid arthritis
chr2	203843923	.	C	T	Celiac disease
chr2	203855416	.	G	A	Graves' disease
chr2	203857029	.	T	A	Alopecia areata;Graves' disease
chr2	203857029	.	T	C	Alopecia areata;Graves' disease
chr2	203858029	.	G	A	Type 1 diabetes
chr2	203858029	.	G	C	Type 1 diabetes
chr2	203858029	.	G	T	Type 1 diabetes
chr2	203864430	.	C	T	Graves' disease;Myasthenia gravis
chr2	203867991	.	A	G	Alopecia areata;Autoimmune thyroid disease
chr2	203867991	.	A	T	Alopecia areata;Autoimmune thyroid disease
chr2	203869764	.	C	T	Graves' disease
chr2	203874196	.	G	A	Celiac disease;Rheumatoid arthritis;Rheumatoid arthritis (ACPA-positive);Systemic lupus erythematosus;Type 1 diabetes
chr2	203875952	.	G	A	Vitiligo
chr2	203878211	.	G	A	Rheumatoid arthritis;Rheumatoid arthritis (ACPA-positive)
chr2	203878211	.	G	T	Rheumatoid arthritis;Rheumatoid arthritis (ACPA-positive)
chr2	203880280	.	T	C	Autoimmune thyroid diseases (Graves disease or Hashimoto's thyroiditis);Graves' disease;Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)
chr2	203937855	.	T	C	Celiac disease
chr2	204062982	.	T	C	Joint damage in rheumatoid arthritis
chr2	205285870	.	A	G	Knee osteoarthritis
chr2	205440538	.	A	G	Diisocyanate-induced asthma
chr2	205567988	.	T	A	Ocular sarcoidosis
chr2	205567988	.	T	C	Ocular sarcoidosis
chr2	206991641	.	C	G	Childhood asthma exacerbations in long-acting beta2-agonist treatment
chr2	208321398	.	A	G	Adult asthma
chr2	210630863	.	C	T	Body mass index in asthmatics
chr2	210976104	.	C	A	Response to zileuton treatment in asthma (FEV1 change interaction)
chr2	211721479	.	A	T	Asthma x Hispanic interaction (2df)
chr2	212304043	.	G	A	Type 1 diabetes nephropathy
chr2	212325005	.	A	C	Asthma (sex interaction)
chr2	212729246	.	G	T	Systemic lupus erythematosus
chr2	213154257	.	C	G	Multiple sclerosis
chr2	213161660	.	G	A	Ulcerative colitis
chr2	215430291	.	A	G	Endometriosis or asthma (pleiotropy)
chr2	216140757	.	A	AT	Ulcerative colitis x smoking status (never vs current smoking) interaction
chr2	216505032	.	A	G	Kidney disease (early stage) in type 1 diabetes
chr2	216505032	.	A	T	Kidney disease (early stage) in type 1 diabetes
chr2	216996799	.	T	C	Decreased low contrast letter acuity in multiple sclerosis
chr2	217759606	.	T	C	Type 1 diabetes with low genetic risk score
chr2	217812863	.	G	A	Asthma and hay fever
chr2	218145423	.	C	G	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Ulcerative colitis
chr2	219833404	.	A	C	Systemic lupus erythematosus and Systemic sclerosis
chr2	221342893	.	T	C	Diisocyanate-induced asthma
chr2	222005387	.	C	A	Diisocyanate-induced asthma
chr2	222005387	.	C	T	Diisocyanate-induced asthma
chr2	222057197	.	C	A	Diisocyanate-induced asthma
chr2	223293148	.	G	A	Coronary artery disease in type 1 diabetes
chr2	223799333	.	C	T	Asthma;Asthma (childhood onset)
chr2	226867246	.	T	C	Kawasaki disease
chr2	227256385	.	G	A	Diabetic nephropathy in type 1 diabetes;Kidney disease (end stage renal disease or albuminuria) in type 1 diabetes;Kidney disease (reduced eGFR and albuminuria or end stage renal disease) in type 1 diabetes;Macroalbuminuria in type 1 diabetes
chr2	227795396	.	C	G	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Crohn's disease;Ulcerative colitis
chr2	227795396	.	C	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Crohn's disease;Ulcerative colitis
chr2	227795646	.	C	T	Primary biliary cholangitis
chr2	227805760	.	C	A	Asthma (childhood onset);Ulcerative colitis
chr2	227805859	.	G	C	Asthma (childhood onset)
chr2	227840005	.	T	C	Asthma
chr2	227843146	.	C	T	Allergic disease (asthma, hay fever or eczema)
chr2	227857292	.	T	C	Allergic disease (asthma, hay fever or eczema)
chr2	228727588	.	T	C	Asthma
chr2	230232414	.	T	C	Crohn's disease
chr2	230232414	.	T	G	Crohn's disease
chr2	230242009	.	C	T	Multiple sclerosis
chr2	230250739	.	G	C	Crohn's disease;Multiple sclerosis
chr2	230250739	.	G	T	Crohn's disease;Multiple sclerosis
chr2	230252159	.	C	T	Crohn's disease
chr2	230283413	.	A	G	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr2	230313189	.	T	C	Sarcoidosis
chr2	232689486	.	C	T	Diisocyanate-induced asthma
chr2	233250193	.	C	A	Crohn's disease
chr2	233260144	.	G	C	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr2	233264857	.	G	C	Crohn's disease
chr2	233967393	.	A	G	Asthma (childhood onset)
chr2	233968199	.	G	A	Asthma
chr2	233968199	.	G	C	Asthma
chr2	233968199	.	G	T	Asthma
chr2	234770601	.	C	A	Asthma or allergic disease (pleiotropy)
chr2	234770601	.	C	G	Asthma or allergic disease (pleiotropy)
chr2	234770601	.	C	T	Asthma or allergic disease (pleiotropy)
chr2	235709582	.	G	A	Osteoarthritis of the knee (hospital diagnosed)
chr2	236897044	.	T	G	Bone mineral accretion in asthma (oral corticosteroid dose interaction)
chr2	237127724	.	C	T	Systemic lupus erythematosus
chr2	237162242	.	A	G	Asthma
chr2	237162242	.	A	T	Asthma
chr2	239519464	.	G	T	Diisocyanate-induced asthma
chr2	240630832	.	A	T	Crohn's disease
chr2	240639691	.	G	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Ulcerative colitis
chr2	240786220	.	G	A	Response to placebo treatment in childhood asthma (FVC change)
chr2	241338592	.	T	A	Type 1 diabetes
chr2	241468173	.	G	T	Vitiligo
chr2	241468331	.	A	G	Type 1 diabetes
chr2	241545286	.	C	T	Crohn's disease
chr2	241751355	.	T	C	Asthma (childhood onset);Atopic asthma
chr2	241776965	.	A	C	Asthma (childhood onset)
chr2	241797926	.	T	C	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Crohn's disease
chr2	241800856	.	C	T	Atopic asthma
chr2	241837710	.	G	A	Narcolepsy with cataplexy
chr20	914238	.	A	G	Food allergy;Peanut allergy
chr20	1225242	.	T	A	Multiple sclerosis
chr20	1225242	.	T	C	Multiple sclerosis
chr20	1629905	.	T	A	Type 1 diabetes
chr20	2537919	.	G	T	Systemic lupus erythematosus
chr20	3367760	.	A	G	Asthma
chr20	3476969	.	G	A	Diisocyanate-induced asthma
chr20	3846662	.	C	T	Asthma
chr20	4245273	.	G	A	Paneth cell defects in Crohn's disease
chr20	4377254	.	T	C	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr20	6113242	.	T	A	Crohn's disease
chr20	6113242	.	T	G	Crohn's disease
chr20	7377776	.	C	T	Systemic lupus erythematosus
chr20	7405311	.	T	C	Asthma (childhood onset)
chr20	9781800	.	G	A	Psoriasis
chr20	9781800	.	G	C	Psoriasis
chr20	10290719	.	A	G	Diisocyanate-induced asthma
chr20	14948299	.	A	G	Asthma (childhood onset);Asthma (time to childhood onset) x early life tobacco smoke interaction
chr20	14948299	.	A	T	Asthma (childhood onset);Asthma (time to childhood onset) x early life tobacco smoke interaction
chr20	15572166	.	C	A	Coronary artery aneurysm in Kawasaki disease
chr20	15572166	.	C	T	Coronary artery aneurysm in Kawasaki disease
chr20	15870432	.	A	G	Thyroid-associated orbitopathy in graves' disease
chr20	16284118	.	T	C	Asthma
chr20	16726753	.	A	T	Food allergy (maternal genetic effects)
chr20	17879062	.	A	G	Autoimmune thyroid disease
chr20	21239574	.	T	C	Peanut allergy
chr20	22709048	.	G	A	Psoriasis
chr20	22806984	.	T	C	Gout
chr20	24452435	.	A	C	Childhood asthma x sex interaction
chr20	25245309	.	A	G	Diisocyanate-induced asthma
chr20	30415672	.	TC	T	Ocular sarcoidosis
chr20	32261714	.	T	G	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Crohn's disease
chr20	32762102	.	T	G	Ulcerative colitis
chr20	32943738	.	C	T	Type 1 diabetes nephropathy
chr20	33130847	.	C	A	Ulcerative colitis
chr20	33130847	.	C	T	Ulcerative colitis
chr20	34077942	.	A	G	Vitiligo
chr20	35371344	.	G	GTT	Osteoarthritis of the hip or knee
chr20	35371344	.	G	GTTT	Osteoarthritis of the hip or knee
chr20	35713666	.	C	CA	End-stage knee osteoarthritis
chr20	35713666	.	C	CAA	End-stage knee osteoarthritis
chr20	35713666	.	C	CAAA	End-stage knee osteoarthritis
chr20	35713666	.	C	CAAAA	End-stage knee osteoarthritis
chr20	35713666	.	C	CAAAAA	End-stage knee osteoarthritis
chr20	35713666	.	C	CAAAAAA	End-stage knee osteoarthritis
chr20	35713666	.	C	CAAAAAAA	End-stage knee osteoarthritis
chr20	35713666	.	C	CAAAAAAAA	End-stage knee osteoarthritis
chr20	35713666	.	C	CAAAAAAAAA	End-stage knee osteoarthritis
chr20	35713666	.	C	CAAAAAAAAAA	End-stage knee osteoarthritis
chr20	35713666	.	C	CAAAAAAAAAAA	End-stage knee osteoarthritis
chr20	37225606	.	A	G	Kawasaki disease
chr20	37423443	.	C	T	Rheumatoid arthritis
chr20	40728825	.	G	A	Paneth cell defects in Crohn's disease
chr20	41309482	.	T	C	Multiple sclerosis
chr20	41317131	.	G	A	Multiple sclerosis
chr20	41339548	.	G	A	Multiple sclerosis
chr20	41864432	.	A	G	Bone mineral accretion in asthma (oral corticosteroid dose interaction)
chr20	42117790	.	GA	G	Lung function (FEV1) in asthma
chr20	42621891	.	A	AGGCTGAGTGATG	Exacerbations requiring hospitalisation in asthma
chr20	43305980	.	G	A	Coronary artery aneurysm in Kawasaki disease
chr20	44436388	.	A	C	Ulcerative colitis
chr20	44440356	.	G	A	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Ulcerative colitis
chr20	44440356	.	G	C	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Ulcerative colitis
chr20	44561731	.	C	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr20	45230458	.	C	A	Asthma
chr20	45967568	.	C	A	Celiac disease
chr20	45980011	.	G	A	Systemic sclerosis
chr20	46105671	.	C	A	Multiple sclerosis;Rheumatoid arthritis (ACPA-positive)
chr20	46107215	.	A	G	Multiple sclerosis
chr20	46111557	.	C	G	Crohn's disease;Multiple sclerosis
chr20	46119308	.	T	A	Multiple sclerosis;Rheumatoid arthritis;Rheumatoid arthritis (ACPA-positive);Systemic lupus erythematosus
chr20	46604118	.	T	A	Gout
chr20	46719767	.	C	A	Baseline cortisol levels in response to low dose short synacthen test in corticosteroid treated asthma
chr20	47053149	.	C	T	Asthma
chr20	47061144	.	G	A	Allergic disease (asthma, hay fever and/or eczema) (age of onset);Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis)
chr20	47466905	.	G	A	Osteoarthritis (hip)
chr20	47844694	.	C	T	Asthma x air pollution interaction (2df)
chr20	48763274	.	G	A	Narcolepsy with cataplexy
chr20	49805558	.	A	G	Multiple sclerosis
chr20	50506506	.	A	G	Vitiligo
chr20	51524602	.	T	C	Allergic disease (asthma, hay fever or eczema)
chr20	51524725	.	T	C	Self-reported allergy
chr20	51526084	.	G	A	Asthma
chr20	51925009	.	A	T	Joint damage in rheumatoid arthritis
chr20	52931763	.	A	T	Crohn's disease
chr20	52940622	.	G	A	Body mass index in non-asthmatics
chr20	53180814	.	A	G	Coronary artery aneurysm in Kawasaki disease
chr20	53180814	.	A	T	Coronary artery aneurysm in Kawasaki disease
chr20	53554702	.	A	T	Allergic disease (asthma, hay fever or eczema)
chr20	53555602	.	G	A	Atopic asthma
chr20	53555602	.	G	C	Atopic asthma
chr20	53555865	.	T	C	Asthma;Asthma (childhood onset)
chr20	53555865	.	T	G	Asthma;Asthma (childhood onset)
chr20	53568405	.	C	T	Asthma
chr20	53591817	.	G	A	Allergic disease (asthma, hay fever or eczema)
chr20	54798000	.	T	G	Celiac disease
chr20	57262207	.	C	A	Microalbuminuria in type 1 diabetes
chr20	57262207	.	C	T	Microalbuminuria in type 1 diabetes
chr20	57984096	.	A	G	Childhood asthma exacerbations in long-acting beta2-agonist treatment
chr20	57984096	.	A	T	Childhood asthma exacerbations in long-acting beta2-agonist treatment
chr20	58734941	.	A	G	Lung function (FVC) in asthma
chr20	59249254	.	A	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Crohn's disease;Ulcerative colitis
chr20	59602560	.	T	A	Response to tocilizumab in rheumatoid arthritis
chr20	59817947	.	G	T	Rheumatoid arthritis
chr20	60318758	.	T	C	Chronic kidney disease (severe chronic kidney disease vs normal kidney function) in type 1 diabetes
chr20	60320788	.	G	A	Type 1 diabetes nephropathy
chr20	60321657	.	A	G	Type 1 diabetes nephropathy
chr20	63690935	.	T	G	Allergic disease (asthma, hay fever or eczema);Asthma or allergic disease (pleiotropy)
chr20	63691346	.	A	T	Allergic disease (asthma, hay fever or eczema);Asthma
chr20	63696229	.	G	C	Ulcerative colitis
chr20	63717555	.	A	T	Crohn's disease;Ulcerative colitis
chr20	63718234	.	A	T	Crohn's disease
chr20	63748397	.	T	A	Asthma
chr20	63778360	.	C	G	Marginal zone lymphoma or multiple sclerosis;Multiple sclerosis
chr20	63778360	.	C	T	Marginal zone lymphoma or multiple sclerosis;Multiple sclerosis
chr20	64143830	.	A	C	Asthma
chr21	10540506	.	C	T	Celiac disease
chr21	15089947	.	A	G	Allergic rhinitis in non-asthmatics
chr21	15092828	.	A	G	Allergic rhinitis in non-asthmatics
chr21	15414477	.	C	G	Crohn's disease
chr21	17198794	.	C	T	Asthma exacerbations in inhaled corticosteroid treatment
chr21	19974842	.	A	G	Coronary artery disease in type 1 diabetes
chr21	20043380	.	T	C	Asthma
chr21	20724226	.	T	A	Type 1 diabetes
chr21	20885160	.	G	A	Osteoarthritis (self-reported)
chr21	21773630	.	T	C	Diisocyanate-induced asthma
chr21	21779123	.	C	G	Asthma;Asthma (childhood onset)
chr21	23556791	.	G	A	Coronary artery disease in type 1 diabetes
chr21	23962597	.	C	G	Asthma exacerbations in inhaled corticosteroid treatment
chr21	23962597	.	C	T	Asthma exacerbations in inhaled corticosteroid treatment
chr21	25397195	.	T	A	Rheumatoid arthritis
chr21	25397195	.	T	C	Rheumatoid arthritis
chr21	25768225	.	T	C	Gout (normal type)
chr21	28099170	.	G	T	Acute anterior uveitis in ankylosing spondylitis
chr21	33316948	.	A	T	Narcolepsy
chr21	33323876	.	G	T	Multiple sclerosis
chr21	33403138	.	T	G	Rheumatoid arthritis
chr21	33415005	.	A	G	Multiple sclerosis;Psoriasis
chr21	33424579	.	A	G	Crohn's disease
chr21	33464741	.	T	C	Psoriasis
chr21	33516314	.	T	A	Psoriasis
chr21	33516314	.	T	G	Psoriasis
chr21	33573415	.	T	A	Psoriasis
chr21	34555942	.	C	A	Rheumatoid arthritis
chr21	34642609	.	A	T	Psoriasis
chr21	34753521	.	C	T	Allergic rhinitis in non-asthmatics
chr21	35049034	.	T	C	Asthma (adult onset);Nonatopic asthma
chr21	35049034	.	T	G	Asthma (adult onset);Nonatopic asthma
chr21	35051694	.	C	T	Pediatric asthma
chr21	35080321	.	G	A	Allergic disease (asthma, hay fever or eczema);Asthma
chr21	35081540	.	A	G	Asthma
chr21	35092334	.	C	G	Asthma;Asthma (adult onset)
chr21	35095533	.	G	A	Allergic disease (asthma, hay fever or eczema)
chr21	35098568	.	C	T	Psoriasis
chr21	35107932	.	G	A	Endometriosis or asthma (pleiotropy)
chr21	35130261	.	A	G	Asthma;Atopic asthma
chr21	35320152	.	G	C	Endometriosis or asthma (pleiotropy)
chr21	35322878	.	T	C	Endometriosis or asthma (pleiotropy)
chr21	35340290	.	T	A	Asthma;Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular);Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)
chr21	35342682	.	TATGCAA	T	Asthma
chr21	35343463	.	C	G	Celiac disease and Rheumatoid arthritis;Rheumatoid arthritis;Rheumatoid arthritis (ACPA-positive)
chr21	35343463	.	C	T	Celiac disease and Rheumatoid arthritis;Rheumatoid arthritis;Rheumatoid arthritis (ACPA-positive)
chr21	35353673	.	A	G	Endometriosis or asthma (pleiotropy)
chr21	35365944	.	G	A	Rheumatoid arthritis
chr21	36635645	.	T	C	Asthma and hay fever
chr21	37763184	.	T	C	Response to placebo treatment in childhood asthma (FVC change)
chr21	38466902	.	C	T	Multiple sclerosis
chr21	38492803	.	A	G	Multiple sclerosis
chr21	38635298	.	T	C	Osteoarthritis of the hip or knee
chr21	38635298	.	T	G	Osteoarthritis of the hip or knee
chr21	38645522	.	G	T	Osteoarthritis (with total hip replacement)
chr21	38676371	.	G	A	Osteoarthritis (hip)
chr21	38687368	.	C	T	Osteoarthritis of the hip (with total joint replacement)
chr21	38919816	.	T	C	Crohn's disease
chr21	38937198	.	G	A	Finger osteoarthritis severity (hand Klsum)
chr21	39087168	.	G	A	Ulcerative colitis vs rheumatoid arthritis (ordinary least squares (OLS))
chr21	39093140	.	C	G	Takayasu arteritis
chr21	39093252	.	G	A	Ankylosing spondylitis;Takayasu arteritis
chr21	39097594	.	A	G	Ankylosing spondylitis
chr21	39213707	.	G	T	Osteoarthritis of the hip or knee (with total joint replacement)
chr21	39677417	.	GC	G	Asthma
chr21	39677418	.	C	T	Asthma
chr21	41139991	.	T	A	Rheumatoid arthritis
chr21	41244804	.	T	C	Systemic lupus erythematosus
chr21	41956642	.	C	A	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr21	42290799	.	C	G	Gout
chr21	42405248	.	C	T	Type 1 diabetes
chr21	42405613	.	G	T	Type 1 diabetes
chr21	42431719	.	T	A	Vitiligo
chr21	42434957	.	A	G	Celiac disease;Celiac disease and Rheumatoid arthritis;Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Primary sclerosing cholangitis;Rheumatoid arthritis;Rheumatoid arthritis (ACPA-positive);Type 1 diabetes
chr21	43426546	.	T	C	Allergic disease (asthma, hay fever or eczema)
chr21	44177774	.	C	T	Ulcerative colitis x smoking status (never vs current smoking) interaction
chr21	44195140	.	G	A	Crohn's disease;Ulcerative colitis
chr21	44195140	.	G	C	Crohn's disease;Ulcerative colitis
chr21	44195678	.	G	A	Crohn's disease
chr21	44195858	.	G	A	Ankylosing spondylitis;Crohn's disease;Ulcerative colitis
chr21	44195858	.	G	T	Ankylosing spondylitis;Crohn's disease;Ulcerative colitis
chr21	44196441	.	G	A	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr21	44201934	.	A	G	Type 1 diabetes
chr21	44204668	.	C	T	Type 1 diabetes
chr21	44209238	.	A	T	Celiac disease
chr21	44227538	.	T	C	Celiac disease
chr21	44230126	.	T	A	Rheumatoid arthritis
chr21	44230126	.	T	C	Rheumatoid arthritis
chr21	44230126	.	T	G	Rheumatoid arthritis
chr21	44233881	.	G	C	Rheumatoid arthritis;Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)
chr21	44236891	.	C	T	Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)
chr21	44283361	.	G	A	Rheumatoid arthritis
chr21	44294411	.	C	A	Type 1 diabetes
chr21	44294411	.	C	T	Type 1 diabetes
chr21	44998426	.	C	T	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr21	44998426	.	CG	C	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr21	45333789	.	C	T	Systemic lupus erythematosus
chr22	15473564	.	G	A	Celiac disease
chr22	16890657	.	CA	C	Ocular sarcoidosis
chr22	16899193	.	T	TGTTA	Ocular sarcoidosis
chr22	17685512	.	C	T	Baseline cortisol levels in response to low dose short synacthen test in corticosteroid treated asthma
chr22	17777938	.	T	C	Diisocyanate-induced asthma
chr22	18166589	.	T	C	Systemic lupus erythematosus
chr22	19750832	.	C	T	Rheumatoid arthritis
chr22	21562072	.	G	A	Rheumatoid arthritis
chr22	21562901	.	G	A	Systemic lupus erythematosus
chr22	21581863	.	C	A	Celiac disease
chr22	21630805	.	A	T	Idiopathic inflammatory myopathy;Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)
chr22	21642781	.	G	A	Rheumatoid arthritis
chr22	21851064	.	C	G	Multiple sclerosis
chr22	23333616	.	G	A	Asthma
chr22	23828809	.	T	G	Immunoglobulin N-glycan 11 levels
chr22	23837735	.	G	C	Immunoglobulin N-glycan 10 levels
chr22	24322440	.	G	A	Kawasaki disease
chr22	24914162	.	G	A	Primary sclerosing cholangitis
chr22	25592811	.	CCG	C	Coronary artery disease in type 1 diabetes
chr22	25592812	.	C	T	Coronary artery disease in type 1 diabetes
chr22	26747356	.	A	G	Peanut allergy (parent-of-origin effect)
chr22	27810924	.	A	C	Knee osteoarthritis
chr22	28334187	.	C	T	Multiple sclerosis
chr22	28882263	.	A	G	Composite immunoglobulin trait (IgA x IgG/IgM)
chr22	30097893	.	G	T	Crohn's disease;Ulcerative colitis
chr22	30156522	.	G	T	Type 1 diabetes
chr22	30185733	.	C	A	Type 1 diabetes
chr22	30285268	.	C	A	Rheumatoid arthritis
chr22	30285268	.	C	T	Rheumatoid arthritis
chr22	30785584	.	C	A	Takayasu arteritis
chr22	30785584	.	C	G	Takayasu arteritis
chr22	31226553	.	T	A	Multiple sclerosis
chr22	34413463	.	C	T	Acute anterior uveitis in ankylosing spondylitis
chr22	35972126	.	C	T	Lung function (FVC) in asthma
chr22	36862461	.	T	A	Allergic disease (asthma, hay fever or eczema);Crohn's disease
chr22	36862461	.	T	C	Allergic disease (asthma, hay fever or eczema);Crohn's disease
chr22	36862944	.	C	T	Asthma;Multiple sclerosis
chr22	36872513	.	A	G	Multiple sclerosis and triglyceride levels (pleiotropy)
chr22	37149465	.	T	A	Rheumatoid arthritis;Rheumatoid arthritis (ACPA-positive)
chr22	37149465	.	T	C	Rheumatoid arthritis;Rheumatoid arthritis (ACPA-positive)
chr22	37155567	.	A	G	Rheumatoid arthritis;Type 1 diabetes
chr22	37185445	.	C	G	Autoimmune thyroid disease;Graves' disease;Vitiligo
chr22	37283446	.	C	A	Response to methotrexate in juvenile idiopathic arthritis
chr22	37283446	.	C	T	Response to methotrexate in juvenile idiopathic arthritis
chr22	37799789	.	A	T	Osteoarthritis (with total hip replacement)
chr22	39003936	.	C	G	Asthma exacerbations in inhaled corticosteroid treatment
chr22	39003936	.	C	T	Asthma exacerbations in inhaled corticosteroid treatment
chr22	39008244	.	G	A	Asthma exacerbations in inhaled corticosteroid treatment
chr22	39263768	.	C	T	Crohn's disease;Ulcerative colitis
chr22	39266545	.	C	G	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr22	39339082	.	G	A	Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS))
chr22	39343182	.	C	G	Systemic lupus erythematosus
chr22	39344073	.	G	T	Primary biliary cholangitis
chr22	39351775	.	G	T	Primary biliary cholangitis;Rheumatoid arthritis;Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)
chr22	39442013	.	A	G	Immunoglobulin N-glycan 10 levels
chr22	39462191	.	A	G	Immunoglobulin N-glycan 23 levels
chr22	39679395	.	G	A	Response to methotrexate in juvenile idiopathic arthritis
chr22	39897459	.	C	A	Systemic lupus erythematosus
chr22	41035338	.	C	G	Crohn's disease
chr22	41035338	.	C	T	Crohn's disease
chr22	41157913	.	G	T	Osteoarthritis (hip)
chr22	41238083	.	A	ACGCGCGCC	Knee osteoarthritis;Osteoarthritis (hip);Osteoarthritis (with total hip replacement)
chr22	41361643	.	G	C	Vitiligo
chr22	41391946	.	G	A	Asthma (time to event)
chr22	41395532	.	T	A	Multiple sclerosis
chr22	41401543	.	C	A	Pediatric asthma
chr22	41408156	.	C	G	Atopic asthma
chr22	41459908	.	A	C	Asthma;Asthma (childhood onset)
chr22	41459908	.	A	T	Asthma;Asthma (childhood onset)
chr22	41522648	.	AG	A	Asthma
chr22	41630489	.	C	CG	Asthma
chr22	41630489	.	C	CT	Asthma
chr22	41630489	.	C	CTT	Asthma
chr22	41630489	.	C	CTTT	Asthma
chr22	42200247	.	C	A	Exacerbations requiring hospitalisation in asthma
chr22	43266235	.	G	A	Osteoarthritis
chr22	43928847	.	C	G	Gout
chr22	44107052	.	G	A	Systemic sclerosis (anti-centromere-positive)
chr22	44111992	.	G	T	Asthma x air pollution interaction (2df)
chr22	45350271	.	A	AAT	Rheumatoid arthritis
chr22	45350271	.	A	ATT	Rheumatoid arthritis
chr22	45424732	.	C	T	Post-bronchodilator lung function in asthma (FEV1)
chr22	45540440	.	A	G	Paneth cell defects in Crohn's disease
chr22	46903259	.	G	A	Asthma exacerbations in inhaled corticosteroid treatment
chr22	48083349	.	C	T	Takayasu arteritis
chr22	48331447	.	A	G	Ocular sarcoidosis;Ocular sarcoidosis in sarcoidosis
chr22	48331447	.	A	T	Ocular sarcoidosis;Ocular sarcoidosis in sarcoidosis
chr22	48779197	.	A	G	Egg allergy (parent-of-origin effect)
chr22	48931631	.	C	G	Response to placebo treatment in childhood asthma (FVC change)
chr22	50276187	.	G	A	Endometriosis or asthma (pleiotropy)
chr22	50532837	.	T	A	Chronic lymphocytic leukemia or multiple sclerosis;Diffuse large B-cell lymphoma or multiple sclerosis;Multiple sclerosis
chr3	1075549	.	A	G	Subjective response to placebo treatment in childhood asthma (change in cough/wheeze)
chr3	1590669	.	C	A	Systemic lupus erythematosus
chr3	1590669	.	C	G	Systemic lupus erythematosus
chr3	1590669	.	C	T	Systemic lupus erythematosus
chr3	1952960	.	C	A	Diisocyanate-induced asthma
chr3	3462176	.	C	T	Knee osteoarthritis
chr3	3573203	.	C	T	Asthma (childhood onset)
chr3	4974209	.	T	C	Autoimmune thyroid disease
chr3	4978778	.	C	A	Psoriasis vulgaris
chr3	4978778	.	C	G	Psoriasis vulgaris
chr3	5035903	.	C	T	Multiple sclerosis
chr3	5093886	.	T	C	Fulminant type 1 diabetes
chr3	6214310	.	T	C	Response to tocilizumab in rheumatoid arthritis
chr3	7865390	.	A	G	Systemic sclerosis
chr3	7865390	.	A	T	Systemic sclerosis
chr3	8604338	.	A	G	Gout vs. Hyperuricemia
chr3	8689796	.	C	T	Exacerbations requiring hospitalisation in asthma
chr3	8807896	.	T	A	Takayasu arteritis
chr3	10835926	.	C	T	Response to tocilizumab in rheumatoid arthritis
chr3	10844235	.	T	C	Pulmonary function in asthmatics
chr3	10844235	.	T	G	Pulmonary function in asthmatics
chr3	11601991	.	T	A	Osteoarthritis (with total hip replacement)
chr3	11601991	.	T	C	Osteoarthritis (with total hip replacement)
chr3	11869161	.	A	G	Microalbuminuria in type 1 diabetes
chr3	12657862	.	A	C	Asthma
chr3	13329174	.	A	T	Coronary artery disease in type 1 diabetes
chr3	13451731	.	A	G	Ulcerative colitis
chr3	13561699	.	A	T	Asthma
chr3	13806989	.	G	A	Ocular sarcoidosis
chr3	13806989	.	G	T	Ocular sarcoidosis
chr3	14673131	.	T	C	Sj√∂gren's syndrome
chr3	16919773	.	A	C	Primary biliary cholangitis
chr3	16954543	.	G	A	Psoriasis;Psoriasis vulgaris
chr3	16969982	.	C	T	Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect);Psoriasis or type 2 diabetes (trans-disease meta-analysis)
chr3	16996623	.	G	A	Psoriasis
chr3	18145113	.	A	G	Acute anterior uveitis in ankylosing spondylitis
chr3	18621496	.	C	T	Sj√∂gren's syndrome
chr3	18665366	.	G	A	Crohn's disease
chr3	18665366	.	G	C	Crohn's disease
chr3	18725912	.	C	A	Crohn's disease
chr3	18725912	.	C	G	Crohn's disease
chr3	18742931	.	A	G	Psoriasis
chr3	18763719	.	T	G	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr3	20588903	.	G	A	Osteoarthritis
chr3	20734902	.	C	G	Depression in multiple sclerosis (pre-diagnosis)
chr3	23084498	.	G	T	Diisocyanate-induced asthma
chr3	23470822	.	A	T	Vitiligo
chr3	23556495	.	C	A	Asthma
chr3	24240941	.	T	C	Asthma
chr3	25251475	.	T	C	Crohn's disease (time to first abdominal surgery)
chr3	25342096	.	C	A	Primary biliary cholangitis
chr3	25465539	.	A	G	Endometriosis or asthma (pleiotropy)
chr3	25539285	.	C	G	Gout
chr3	25539285	.	C	T	Gout
chr3	25596864	.	A	C	Carotid intima media thickness in rheumatoid arthritis
chr3	25596864	.	A	G	Carotid intima media thickness in rheumatoid arthritis
chr3	25596864	.	A	T	Carotid intima media thickness in rheumatoid arthritis
chr3	26678105	.	C	T	Ocular sarcoidosis
chr3	26804032	.	A	G	Asthma
chr3	27741524	.	C	T	Multiple sclerosis
chr3	27753416	.	C	A	Ankylosing spondylitis
chr3	27883014	.	G	A	Multiple sclerosis
chr3	27921000	.	A	G	Type 1 diabetes with low genetic risk score
chr3	28016414	.	A	G	Liver transplant-free survival in primary sclerosing cholangitis (time to event)
chr3	28029953	.	A	C	Epstein Barr virus nuclear antigen 1 IgG levels or multiple sclerosis;Multiple sclerosis
chr3	28030595	.	T	C	Multiple sclerosis;Systemic lupus erythematosus
chr3	28034494	.	T	C	Systemic lupus erythematosus
chr3	28034792	.	T	A	Systemic lupus erythematosus
chr3	28037080	.	G	T	Multiple sclerosis
chr3	28037594	.	C	G	Multiple sclerosis
chr3	28037594	.	C	T	Multiple sclerosis
chr3	28039951	.	A	G	Multiple sclerosis and HDL levels (pleiotropy)
chr3	29005953	.	A	G	Response to zileuton treatment in asthma (FEV1 change interaction)
chr3	30179572	.	T	A	Crohn's disease
chr3	31071900	.	G	A	Takayasu arteritis
chr3	32920559	.	A	T	Multiple sclerosis
chr3	32971991	.	T	A	Multiple sclerosis
chr3	32971991	.	T	C	Multiple sclerosis
chr3	32973977	.	G	C	Celiac disease
chr3	32973977	.	G	T	Celiac disease
chr3	33027599	.	G	C	Allergic disease (asthma, hay fever or eczema)
chr3	33042493	.	G	A	Allergic disease (asthma, hay fever or eczema);Asthma;Asthma (adult onset)
chr3	33123159	.	G	A	Atopic asthma
chr3	34359399	.	C	T	Exacerbations requiring hospitalisation in asthma
chr3	35598334	.	G	T	Asthma (childhood onset)
chr3	36197914	.	C	T	Asthma
chr3	36368109	.	T	G	Celiac disease
chr3	36524820	.	C	A	Kidney disease (end stage renal disease vs non-end stage renal disease) in type 1 diabetes
chr3	36638607	.	G	T	Erectile dysfunction in type 1 diabetes
chr3	36822669	.	A	G	Takayasu arteritis
chr3	38802156	.	T	C	Systemic lupus erythematosus
chr3	41827935	.	A	C	Immunoglobulin light chain (AL) amyloidosis
chr3	45828480	.	C	A	Multiple sclerosis
chr3	46193709	.	C	G	Celiac disease
chr3	46212159	.	C	T	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)
chr3	46232768	.	T	C	Celiac disease and Rheumatoid arthritis
chr3	46342713	.	G	A	Ulcerative colitis vs rheumatoid arthritis (ordinary least squares (OLS))
chr3	46363251	.	A	T	Rheumatoid arthritis
chr3	46387167	.	A	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr3	46415921	.	T	C	Type 1 diabetes;Ulcerative colitis
chr3	47005668	.	G	A	Multiple sclerosis
chr3	47722565	.	G	C	Renal underexcretion gout
chr3	48643620	.	C	G	Crohn's disease;Ulcerative colitis
chr3	49168885	.	G	T	Behcet's disease
chr3	49191068	.	C	T	Crohn's disease
chr3	49618715	.	T	C	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr3	49682296	.	G	T	Ulcerative colitis
chr3	49984616	.	G	A	Osteoarthritis
chr3	49984616	.	G	C	Osteoarthritis
chr3	52533952	.	A	G	Osteoarthritis of the knee (hospital diagnosed)
chr3	52786965	.	A	G	Osteoarthritis (hip)
chr3	53021295	.	G	C	Gout
chr3	53099133	.	C	A	Crohn's disease
chr3	53099133	.	C	T	Crohn's disease
chr3	54084687	.	T	C	Response to tofacitinib treatment in rheumatoid arthritis (herpes zoster);Response to tofacitinib treatment in rheumatoid arthritis (herpes zoster)(time to event)
chr3	54236514	.	A	T	Takayasu arteritis
chr3	55076280	.	T	G	Gout
chr3	56707557	.	A	T	Asthma
chr3	56880037	.	C	T	Multiple sclerosis and triglyceride levels (pleiotropy)
chr3	56932218	.	G	T	Rheumatoid arthritis
chr3	57041866	.	A	G	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr3	57129723	.	T	C	Asthma-COPD overlap syndrome
chr3	57259774	.	A	G	Type 1 diabetes
chr3	57269656	.	A	G	Type 1 diabetes with low genetic risk score
chr3	57295247	.	A	G	Type 1 diabetes with low genetic risk score
chr3	57373867	.	A	G	Type 1 diabetes
chr3	58197909	.	G	A	Autoimmune thyroid disease;Rheumatoid arthritis;Rheumatoid arthritis (ACPA-positive);Systemic sclerosis;Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)
chr3	58197909	.	G	C	Autoimmune thyroid disease;Rheumatoid arthritis;Rheumatoid arthritis (ACPA-positive);Systemic sclerosis;Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)
chr3	58317208	.	C	T	Rheumatoid arthritis;Rheumatoid arthritis (ACPA-positive)
chr3	58332737	.	A	C	Systemic lupus erythematosus
chr3	58380290	.	G	A	Systemic lupus erythematosus
chr3	58380290	.	G	C	Systemic lupus erythematosus
chr3	58414687	.	T	C	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)
chr3	58437771	.	A	C	Composite immunoglobulin trait (IgA x IgG/IgM)
chr3	58484624	.	C	T	Systemic lupus erythematosus
chr3	58526510	.	A	T	Systemic lupus erythematosus
chr3	58571114	.	T	C	Rheumatoid arthritis
chr3	58996349	.	C	T	Rheumatoid arthritis
chr3	61651395	.	A	G	Osteoarthritis (self-reported)
chr3	61651395	.	A	T	Osteoarthritis (self-reported)
chr3	64163491	.	A	G	Diisocyanate-induced asthma
chr3	64258442	.	T	C	Systemic juvenile idiopathic arthritis
chr3	64540891	.	A	G	Asthma
chr3	64722924	.	A	C	Type 1 diabetes with low genetic risk score
chr3	64722924	.	A	G	Type 1 diabetes with low genetic risk score
chr3	64722924	.	A	T	Type 1 diabetes with low genetic risk score
chr3	64734347	.	T	C	Type 1 diabetes
chr3	65559892	.	C	T	Asthma;Asthma (childhood onset)
chr3	65705300	.	C	CA	Ocular sarcoidosis
chr3	65706699	.	A	G	Ocular sarcoidosis in sarcoidosis
chr3	65774667	.	T	C	Crohn's disease-related phenotypes
chr3	65812468	.	T	A	Knee osteoarthritis
chr3	69203748	.	C	T	Celiac disease
chr3	70282556	.	T	G	Osteoarthritis (self-reported)
chr3	71104739	.	T	C	Primary sclerosing cholangitis
chr3	71126344	.	C	T	Crohn's disease
chr3	71205600	.	T	C	Asthma
chr3	71473942	.	C	T	Primary sclerosing cholangitis
chr3	71481195	.	C	G	Multiple sclerosis
chr3	71481195	.	C	T	Multiple sclerosis
chr3	71486187	.	T	A	Multiple sclerosis
chr3	71486187	.	T	G	Multiple sclerosis
chr3	71508794	.	C	A	Vitiligo
chr3	73225138	.	C	A	Serum uric acid levels in response to allopurinol in gout
chr3	73225138	.	C	T	Serum uric acid levels in response to allopurinol in gout
chr3	73227801	.	T	C	Serum uric acid levels in response to allopurinol in gout
chr3	78644690	.	T	C	Takayasu arteritis
chr3	78644690	.	T	G	Takayasu arteritis
chr3	80816613	.	G	C	Erectile dysfunction in type 1 diabetes
chr3	86448244	.	G	A	Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count)
chr3	86448244	.	G	T	Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count)
chr3	88945522	.	C	T	Post-bronchodilator FEV1 x air pollution (NO2) interaction in childhood asthma
chr3	89017438	.	A	G	Post-bronchodilator FEV1 x air pollution (NO2) interaction in childhood asthma
chr3	89027746	.	C	G	Post-bronchodilator FEV1 x air pollution (NO2) interaction in childhood asthma
chr3	89027746	.	C	T	Post-bronchodilator FEV1 x air pollution (NO2) interaction in childhood asthma
chr3	89842195	.	G	A	Systemic lupus erythematosus
chr3	89842195	.	G	T	Systemic lupus erythematosus
chr3	98635818	.	A	G	Narcolepsy with cataplexy
chr3	98635818	.	A	T	Narcolepsy with cataplexy
chr3	100627813	.	C	G	Exacerbations requiring hospitalisation in asthma
chr3	100627813	.	C	T	Exacerbations requiring hospitalisation in asthma
chr3	100656795	.	C	CAC	Multiple sclerosis
chr3	100656795	.	C	CCA	Multiple sclerosis
chr3	100757869	.	C	T	Asthma (childhood onset)
chr3	101078194	.	G	A	Joint damage in rheumatoid arthritis
chr3	101078194	.	G	C	Joint damage in rheumatoid arthritis
chr3	101078194	.	G	T	Joint damage in rheumatoid arthritis
chr3	101513249	.	C	G	Asthma
chr3	101898138	.	T	A	Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect);Psoriasis or type 2 diabetes (trans-disease meta-analysis)
chr3	101944711	.	A	G	Psoriasis;Psoriasis vulgaris
chr3	101944711	.	A	T	Psoriasis;Psoriasis vulgaris
chr3	102029794	.	A	G	Multiple sclerosis;Multiple sclerosis and C-reactive protein levels (pleiotropy)
chr3	102030178	.	C	T	Multiple sclerosis
chr3	102036894	.	C	A	Multiple sclerosis and triglyceride levels (pleiotropy)
chr3	102036894	.	C	T	Multiple sclerosis and triglyceride levels (pleiotropy)
chr3	103266621	.	T	G	Egg allergy (maternal genetic effects)
chr3	104256574	.	C	T	Coronary artery disease in type 1 diabetes
chr3	105867870	.	T	A	Multiple sclerosis
chr3	106216385	.	TA	T	Autoimmune thyroid disease
chr3	106543458	.	T	C	Coronary artery aneurysm in Kawasaki disease
chr3	107268624	.	T	G	Osteoarthritis of the knee (hospital diagnosed)
chr3	107340876	.	G	A	Asthma or allergic disease (pleiotropy)
chr3	107506831	.	G	A	Depression in multiple sclerosis
chr3	107844030	.	T	G	Diisocyanate-induced asthma
chr3	111762099	.	A	G	Crohn's disease-related phenotypes
chr3	111874722	.	C	T	Type 1 diabetes (age at diagnosis)
chr3	112036219	.	A	G	Endometriosis or asthma (pleiotropy)
chr3	112036219	.	A	T	Endometriosis or asthma (pleiotropy)
chr3	112350545	.	T	C	Crohn's disease vs ulcerative colitis
chr3	112550440	.	A	C	Asthma (childhood onset)
chr3	112550440	.	A	G	Asthma (childhood onset)
chr3	112789332	.	G	A	Crohn's disease (time to progression)
chr3	112852072	.	C	G	Rheumatoid arthritis;Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)
chr3	112852072	.	C	T	Rheumatoid arthritis;Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)
chr3	114218488	.	G	A	Asthma (childhood onset)
chr3	114257954	.	C	T	Type 1 diabetes with low genetic risk score
chr3	119542097	.	A	G	Systemic lupus erythematosus
chr3	119569567	.	A	T	Vitiligo
chr3	121783015	.	G	A	Multiple sclerosis
chr3	121824730	.	A	G	Multiple sclerosis;Multiple sclerosis and triglyceride levels (pleiotropy)
chr3	121933294	.	G	A	Allergic disease (asthma, hay fever or eczema)
chr3	121941817	.	A	G	Multiple sclerosis;Multiple sclerosis and HDL levels (pleiotropy)
chr3	122050675	.	T	A	Multiple sclerosis
chr3	122074340	.	C	T	Multiple sclerosis
chr3	122077921	.	G	A	Multiple sclerosis
chr3	122106350	.	G	A	Autoimmune thyroid disease
chr3	122153978	.	C	T	Systemic lupus erythematosus
chr3	124206424	.	A	G	Diffuse large B-cell lymphoma or systemic lupus erythematosus;Marginal zone lymphoma or systemic lupus erythematosus
chr3	124206424	.	A	T	Diffuse large B-cell lymphoma or systemic lupus erythematosus;Marginal zone lymphoma or systemic lupus erythematosus
chr3	126148404	.	C	G	Multiple sclerosis
chr3	128194003	.	C	CT	Asthma (childhood onset);Asthma onset (childhood vs adult)
chr3	128239849	.	T	C	Asthma (childhood onset)
chr3	128280587	.	T	C	Asthma
chr3	128294802	.	G	A	Asthma
chr3	128296335	.	C	G	Nonatopic asthma
chr3	128296335	.	C	T	Nonatopic asthma
chr3	129431542	.	C	G	Systemic sclerosis (anti-topoisomerase-positive)
chr3	131812484	.	T	C	Coronary artery aneurysm in Kawasaki disease
chr3	134992705	.	C	A	Asthma (childhood onset)
chr3	134992705	.	C	G	Asthma (childhood onset)
chr3	134992705	.	C	T	Asthma (childhood onset)
chr3	136683218	.	G	A	Rheumatoid arthritis
chr3	137722530	.	T	C	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr3	139324394	.	C	G	Kawasaki disease
chr3	139324394	.	C	T	Kawasaki disease
chr3	140276284	.	C	A	Asthma
chr3	140380851	.	C	T	Multiple sclerosis (OCB status)
chr3	140821876	.	A	G	Multiple sclerosis
chr3	141387221	.	T	A	Allergic disease (asthma, hay fever or eczema)
chr3	141388112	.	A	T	Asthma
chr3	141432148	.	G	A	Multiple sclerosis
chr3	141432148	.	G	T	Multiple sclerosis
chr3	141602994	.	A	ACT	Allergic disease (asthma, hay fever or eczema)
chr3	143446660	.	T	C	Rheumatoid arthritis
chr3	143474269	.	T	C	Lung function (FEV1) in asthma (dust mite allergen exposure interaction)
chr3	143491347	.	T	C	Lung function (FEV1) in asthma (dust mite allergen exposure interaction)
chr3	147211318	.	T	C	Adult asthma
chr3	148038899	.	G	T	Multiple sclerosis
chr3	151058813	.	G	A	Childhood asthma exacerbations in long-acting beta2-agonist treatment
chr3	151862085	.	A	T	Immunoglobulin A
chr3	151906841	.	G	A	Gout vs. Hyperuricemia
chr3	155327641	.	C	A	Response to inhaled corticosteroid treatment in asthma (change in FEV1)
chr3	155327641	.	C	G	Response to inhaled corticosteroid treatment in asthma (change in FEV1)
chr3	156592987	.	A	C	Asthma (adult onset)
chr3	156592987	.	A	T	Asthma (adult onset)
chr3	156638368	.	G	C	Asthma (childhood onset)
chr3	158729995	.	T	C	Diisocyanate-induced asthma
chr3	158878626	.	G	A	Paneth cell defects in Crohn's disease
chr3	159428036	.	A	G	Self-reported childhood asthma in adult smokers
chr3	159760101	.	C	T	Oral corticosteroid burst in asthma
chr3	159905770	.	C	T	Celiac disease
chr3	159911578	.	C	T	Celiac disease
chr3	159919889	.	C	A	Behcet's disease
chr3	159919889	.	C	G	Behcet's disease
chr3	159919889	.	C	T	Behcet's disease
chr3	159929885	.	A	G	Celiac disease
chr3	159945506	.	C	T	Primary biliary cholangitis
chr3	159947262	.	A	G	Behcet's disease;Celiac disease
chr3	159957140	.	T	C	Celiac disease
chr3	159959511	.	C	G	Primary biliary cholangitis
chr3	159973324	.	T	C	Multiple sclerosis
chr3	159976265	.	G	A	Systemic lupus erythematosus;Systemic sclerosis
chr3	159976265	.	G	C	Systemic lupus erythematosus;Systemic sclerosis
chr3	159981157	.	T	C	Multiple sclerosis
chr3	159992311	.	A	G	Primary biliary cholangitis
chr3	159994586	.	G	T	Multiple sclerosis
chr3	160001345	.	A	C	Sj√∂gren's syndrome
chr3	160001345	.	A	G	Sj√∂gren's syndrome
chr3	160623108	.	C	G	Primary biliary cholangitis
chr3	160712081	.	A	G	Response to methotrexate in rheumatoid arthritis
chr3	161059176	.	C	T	Kawasaki disease
chr3	169000309	.	T	A	Nonatopic asthma
chr3	169000309	.	T	G	Nonatopic asthma
chr3	169128913	.	C	T	Nonatopic asthma and/or waist-to-hip ratio adjusted for BMI
chr3	169409731	.	C	A	Asthma
chr3	169495902	.	A	G	Joint damage in rheumatoid arthritis
chr3	169495902	.	A	T	Joint damage in rheumatoid arthritis
chr3	169602270	.	C	G	Joint damage in rheumatoid arthritis
chr3	169602270	.	C	T	Joint damage in rheumatoid arthritis
chr3	169800667	.	T	G	Chronic lymphocytic leukemia or multiple sclerosis
chr3	169837302	.	A	T	Ocular sarcoidosis
chr3	171420998	.	C	G	Asthma exacerbations in inhaled corticosteroid treatment
chr3	171420998	.	C	T	Asthma exacerbations in inhaled corticosteroid treatment
chr3	174801440	.	C	A	Asthma with severe exacerbations
chr3	174801440	.	C	T	Asthma with severe exacerbations
chr3	175175985	.	C	T	Kawasaki disease
chr3	175243598	.	T	C	Systemic lupus erythematosus
chr3	175535845	.	G	A	Exacerbations requiring hospitalisation in asthma
chr3	176978234	.	A	G	Atopic asthma
chr3	177131952	.	C	A	Asthma;Asthma (adult onset);Atopic asthma
chr3	177131952	.	C	T	Asthma;Asthma (adult onset);Atopic asthma
chr3	177195111	.	C	T	Adult onset asthma and/or BMI
chr3	177377284	.	C	T	Systemic lupus erythematosus
chr3	178137844	.	G	A	Asthma (childhood onset)
chr3	179340761	.	C	G	Gout (normal type)
chr3	184372478	.	C	G	Diisocyanate-induced asthma
chr3	184372478	.	C	T	Diisocyanate-induced asthma
chr3	184894533	.	C	G	Takayasu arteritis
chr3	184894533	.	C	T	Takayasu arteritis
chr3	185806293	.	A	G	Psoriasis or type 2 diabetes (trans-disease meta-analysis)
chr3	186373264	.	T	C	Response to tocilizumab in rheumatoid arthritis
chr3	187333225	.	T	C	Osteoarthritis (hip)
chr3	187848180	.	T	A	Multiple sclerosis
chr3	187848180	.	T	G	Multiple sclerosis
chr3	187915480	.	G	A	Allergic disease (asthma, hay fever or eczema)
chr3	187963924	.	C	T	Asthma;Atopic asthma
chr3	188076045	.	T	C	Allergic disease (asthma, hay fever or eczema)
chr3	188269836	.	C	G	Multiple sclerosis
chr3	188269836	.	C	T	Multiple sclerosis
chr3	188327228	.	A	G	Asthma
chr3	188384316	.	G	T	Autoimmune thyroid disease
chr3	188394766	.	C	T	Celiac disease;Vitiligo
chr3	188415730	.	A	G	Asthma;Asthma (childhood onset);Atopic asthma;Endometriosis or asthma (pleiotropy);Nonatopic asthma
chr3	188593871	.	G	A	Osteoarthritis (hip)
chr3	188610688	.	A	T	Asthma
chr3	188682451	.	G	A	Asthma
chr3	188682451	.	G	C	Asthma
chr3	188683350	.	A	G	Asthma;Asthma (childhood onset);Atopic asthma
chr3	188683372	.	C	T	Crohn's disease
chr3	188684683	.	C	T	Asthma
chr3	188684798	.	C	T	Allergic disease (asthma, hay fever or eczema)
chr3	188724692	.	T	C	Allergic disease (asthma, hay fever or eczema);Asthma
chr3	188727995	.	A	C	Allergic disease (asthma, hay fever or eczema)
chr3	188752450	.	C	T	Systemic lupus erythematosus
chr3	189882371	.	A	G	Systemic lupus erythematosus
chr3	189897686	.	C	A	Psoriasis;Psoriasis vulgaris
chr3	189897686	.	C	G	Psoriasis;Psoriasis vulgaris
chr3	190017672	.	G	A	Osteoarthritis (hip)
chr3	191162345	.	T	C	Psoriasis
chr3	193161335	.	T	A	Serum uric acid levels in response to allopurinol in gout
chr3	193849727	.	C	T	joint destruction in rheumatoid arthritis (rapid vs slow)
chr3	195988997	.	T	A	Asthma
chr3	195988997	.	T	C	Asthma
chr3	195988997	.	T	G	Asthma
chr3	196616946	.	A	G	Allergic disease (asthma, hay fever or eczema);Asthma
chr3	196622133	.	C	T	Asthma
chr3	196632439	.	G	C	Asthma
chr3	196645675	.	C	A	Allergic disease (asthma, hay fever or eczema)
chr3	196645675	.	C	T	Allergic disease (asthma, hay fever or eczema)
chr3	196646711	.	C	T	Asthma or allergic disease (pleiotropy)
chr3	196650180	.	C	G	Atopic asthma
chr4	82429	.	G	T	Response to TNF inhibitor in rheumatoid arthritis (change in tender 28-joint count)
chr4	953186	.	G	C	Systemic sclerosis
chr4	960459	.	G	A	Systemic lupus erythematosus
chr4	1683484	.	T	G	Osteoarthritis
chr4	1715043	.	T	A	Osteoarthritis (hip)
chr4	1759200	.	C	A	Osteoarthritis of the hip or knee (with total joint replacement)
chr4	2699117	.	T	G	Systemic lupus erythematosus
chr4	2767542	.	C	A	Multiple sclerosis
chr4	2767542	.	C	T	Multiple sclerosis
chr4	3442776	.	G	T	Crohn's disease
chr4	4764538	.	G	A	Allergic disease (asthma, hay fever or eczema)
chr4	4773674	.	A	G	Allergic disease (asthma, hay fever or eczema)
chr4	5160662	.	C	T	Celiac disease
chr4	6017164	.	C	G	Response to zileuton treatment in asthma (FEV1 change interaction)
chr4	6017164	.	C	T	Response to zileuton treatment in asthma (FEV1 change interaction)
chr4	6169503	.	C	A	Coronary artery disease in type 1 diabetes
chr4	6175408	.	C	G	Response to zileuton treatment in asthma (FEV1 change interaction)
chr4	7183972	.	A	C	Crohn's disease (time to first abdominal surgery)
chr4	7183972	.	A	T	Crohn's disease (time to first abdominal surgery)
chr4	7256775	.	C	G	Systemic lupus erythematosus
chr4	7256775	.	C	T	Systemic lupus erythematosus
chr4	8556539	.	C	G	Systemic lupus erythematosus
chr4	8556539	.	C	T	Systemic lupus erythematosus
chr4	9636262	.	G	A	Gout
chr4	9920543	.	C	T	Gout vs asymptomatic hyperuricemia
chr4	9921380	.	G	A	Gout
chr4	9921380	.	G	T	Gout
chr4	9945032	.	C	A	Gout
chr4	9959396	.	A	AAG	Gout in chronic kidney disease
chr4	9993558	.	G	A	Gout;Gout (combined type);Renal underexcretion gout
chr4	9993632	.	A	T	Gout
chr4	10059523	.	C	T	Gout
chr4	10125860	.	C	G	Response to ustekinumab in psoriasis (improvement)
chr4	10565335	.	A	G	Systemic lupus erythematosus
chr4	10715315	.	G	A	Autoimmune thyroid disease;Primary sclerosing cholangitis
chr4	10724896	.	C	G	Rheumatoid arthritis;Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)
chr4	10725229	.	C	T	Vitiligo
chr4	10915291	.	T	C	Takayasu arteritis
chr4	11502867	.	G	A	Ankylosing spondylitis
chr4	11728827	.	A	C	Crohn's disease (indolent vs progressive)
chr4	12097711	.	A	G	Diisocyanate-induced asthma
chr4	12171045	.	C	T	Diisocyanate-induced asthma
chr4	13037816	.	A	G	Osteoarthritis;Osteoarthritis (hip);Osteoarthritis (with total hip replacement)
chr4	13097258	.	C	G	Rheumatoid arthritis
chr4	13097258	.	C	T	Rheumatoid arthritis
chr4	14885862	.	G	A	Asthma with severe exacerbations
chr4	15951847	.	C	T	Asthma exacerbations in inhaled corticosteroid treatment
chr4	16155043	.	T	A	Kidney disease (early stage) in type 1 diabetes
chr4	16155043	.	T	G	Kidney disease (early stage) in type 1 diabetes
chr4	19045994	.	C	T	Response to interferon beta in multiple sclerosis
chr4	21936817	.	A	G	Osteoarthritis of the knee (hospital diagnosed)
chr4	22089761	.	C	T	Rheumatoid arthritis
chr4	22794376	.	G	A	Peak cortisol response to low dose short synacthen test in corticosteroid treated asthma
chr4	23344561	.	G	A	Ankylosing spondylitis
chr4	23949395	.	C	G	Gout
chr4	24259293	.	C	G	Type 1 diabetes with low genetic risk score
chr4	25407216	.	G	A	Osteoarthritis
chr4	25407216	.	G	T	Osteoarthritis
chr4	26083889	.	G	A	Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive);Type 1 diabetes
chr4	26084947	.	A	G	Rheumatoid arthritis
chr4	26086506	.	G	A	Rheumatoid arthritis
chr4	26088753	.	A	G	Autoimmune thyroid disease
chr4	26089240	.	A	G	Rheumatoid arthritis
chr4	26089240	.	A	T	Rheumatoid arthritis
chr4	26097188	.	G	A	Rheumatoid arthritis
chr4	26097188	.	G	T	Rheumatoid arthritis
chr4	26102491	.	C	T	Rheumatoid arthritis;Rheumatoid arthritis (ACPA-positive)
chr4	26106575	.	G	C	Rheumatoid arthritis
chr4	26109971	.	G	A	Rheumatoid arthritis
chr4	26118379	.	T	C	Rheumatoid arthritis
chr4	26130739	.	T	A	Crohn's disease
chr4	26130739	.	T	C	Crohn's disease
chr4	26445765	.	G	A	Takayasu arteritis
chr4	27155691	.	A	G	Kawasaki disease
chr4	27161458	.	C	T	Neuropeptide Y autoantibody levels in type 1 diabetes
chr4	27165208	.	C	A	Neuropeptide Y autoantibody levels in type 1 diabetes
chr4	27165208	.	C	G	Neuropeptide Y autoantibody levels in type 1 diabetes
chr4	27165208	.	C	T	Neuropeptide Y autoantibody levels in type 1 diabetes
chr4	27165352	.	G	A	Neuropeptide Y autoantibody levels in type 1 diabetes
chr4	27165352	.	G	C	Neuropeptide Y autoantibody levels in type 1 diabetes
chr4	27170830	.	G	A	Neuropeptide Y autoantibody levels in type 1 diabetes
chr4	27187197	.	C	T	Neuropeptide Y autoantibody levels in type 1 diabetes
chr4	27213543	.	G	A	Neuropeptide Y autoantibody levels in type 1 diabetes
chr4	27213548	.	G	A	Neuropeptide Y autoantibody levels in type 1 diabetes
chr4	27213567	.	G	A	Neuropeptide Y autoantibody levels in type 1 diabetes
chr4	29898299	.	G	A	Ocular sarcoidosis
chr4	30702905	.	C	T	Diisocyanate-induced asthma
chr4	34923442	.	A	G	Body mass index in non-asthmatics
chr4	37062709	.	G	T	Multiple sclerosis--Brain Glutamate Levels
chr4	38719543	.	T	G	Multiple sclerosis
chr4	38721343	.	T	A	Asthma (childhood onset)
chr4	38743861	.	T	C	Allergic disease (asthma, hay fever or eczema)
chr4	38753856	.	A	C	Asthma (childhood onset)
chr4	38753856	.	A	T	Asthma (childhood onset)
chr4	38754349	.	A	G	Asthma;Nonatopic asthma
chr4	38766666	.	C	T	Atopic asthma
chr4	38787511	.	C	A	Allergic disease (asthma, hay fever or eczema);Asthma
chr4	38797027	.	C	A	Allergic disease (asthma, hay fever or eczema);Asthma;Asthma (age of onset);Asthma (childhood onset);Asthma onset (childhood vs adult);Composite immunoglobulin trait (IgG/IgM);Pediatric asthma
chr4	38800725	.	T	A	Asthma (childhood onset)
chr4	38809930	.	G	T	Self-reported allergy
chr4	38813881	.	A	C	Asthma (childhood onset)
chr4	38819070	.	G	A	Asthma (childhood onset)
chr4	38819070	.	G	C	Asthma (childhood onset)
chr4	38852748	.	C	T	Allergic disease (asthma, hay fever or eczema)
chr4	39086721	.	A	C	Asthma (childhood onset)
chr4	39388825	.	C	T	Asthma;Asthma (adult onset)
chr4	40301616	.	G	A	Graves' disease
chr4	42823845	.	G	A	Takayasu arteritis
chr4	42823845	.	G	T	Takayasu arteritis
chr4	42862679	.	G	A	Interferon alpha levels in systemic lupus erythematosus
chr4	46372280	.	C	T	Type 1 diabetes (age at diagnosis)
chr4	48026080	.	G	C	Gout;Renal underexcretion gout
chr4	48125245	.	A	G	Multiple sclerosis
chr4	49176118	.	T	C	Interstitial lung diseases in rheumatoid arthritis
chr4	52437952	.	G	A	Adult onset asthma and/or BMI;Asthma (adult onset)
chr4	52437952	.	G	C	Adult onset asthma and/or BMI;Asthma (adult onset)
chr4	53928308	.	C	T	Adult asthma;Asthma
chr4	54145602	.	T	C	Lupus nephritis in systemic lupus erythematosus
chr4	56691923	.	A	T	Systemic sclerosis
chr4	57514156	.	G	A	Ulcerative colitis
chr4	57598187	.	G	A	Diisocyanate-induced asthma
chr4	58347679	.	T	C	Asthma (childhood onset)
chr4	64304697	.	C	A	Kawasaki disease
chr4	65276878	.	G	A	Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis
chr4	65276878	.	G	C	Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis
chr4	65801177	.	C	T	Osteoarthritis
chr4	67198722	.	T	C	Multiple sclerosis (severity)
chr4	67198722	.	T	G	Multiple sclerosis (severity)
chr4	70493059	.	T	A	Diabetic nephropathy in type 1 diabetes
chr4	70493059	.	T	G	Diabetic nephropathy in type 1 diabetes
chr4	73990818	.	C	A	Ulcerative colitis
chr4	73990818	.	C	G	Ulcerative colitis
chr4	73990818	.	C	T	Ulcerative colitis
chr4	76744126	.	G	A	Systemic lupus erythematosus
chr4	77215780	.	G	C	Response to tocilizumab in rheumatoid arthritis
chr4	77587043	.	T	G	Rheumatoid arthritis
chr4	78592061	.	A	T	Rheumatoid arthritis
chr4	78607388	.	AC	A	Osteoarthritis (self-reported)
chr4	78638402	.	T	C	Osteoarthritis (self-reported)
chr4	78701519	.	C	T	Osteoarthritis (self-reported)
chr4	79049054	.	A	G	Systemic lupus erythematosus
chr4	79966815	.	A	G	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr4	79966815	.	A	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr4	80025321	.	T	A	Ankylosing spondylitis
chr4	80028675	.	C	G	Ankylosing spondylitis
chr4	80028675	.	C	T	Ankylosing spondylitis
chr4	80246155	.	C	T	Gout (combined type)
chr4	82872768	.	C	A	Adult asthma
chr4	85359485	.	A	G	Diisocyanate-induced asthma
chr4	85415875	.	C	G	Peanut allergy
chr4	85415875	.	C	T	Peanut allergy
chr4	85772164	.	G	A	Diisocyanate-induced asthma
chr4	86607925	.	A	G	Kidney disease (end stage renal disease vs non-end stage renal disease) in type 1 diabetes;Kidney disease (end stage renal disease vs normoalbuminuria) in type 1 diabetes
chr4	87670402	.	G	A	Gout;Gout vs asymptomatic hyperuricemia
chr4	87868966	.	G	A	Gout;Gout vs asymptomatic hyperuricemia
chr4	87973963	.	A	T	Gout
chr4	88112375	.	T	C	Gout vs asymptomatic hyperuricemia
chr4	88131171	.	G	C	Gout;Gout vs asymptomatic hyperuricemia;Gout vs. Hyperuricemia;Response to allopurinol in gout (change in serum uric acid levels);Serum uric acid levels in response to allopurinol in gout
chr4	88169725	.	T	G	Serum uric acid levels in response to allopurinol in gout
chr4	88170035	.	C	G	Serum uric acid levels in response to allopurinol in gout
chr4	88327909	.	T	C	Gout;Gout vs asymptomatic hyperuricemia
chr4	92954497	.	A	G	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr4	95103943	.	T	G	Hen's egg allergy
chr4	99318162	.	T	G	Gout;Gout vs asymptomatic hyperuricemia
chr4	99618739	.	T	G	Celiac disease
chr4	100505575	.	T	C	Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count)
chr4	100515044	.	A	G	Food allergy
chr4	101302229	.	C	A	Vitiligo
chr4	101794731	.	G	T	Systemic lupus erythematosus
chr4	101829919	.	G	T	Systemic lupus erythematosus
chr4	101859567	.	G	C	Systemic lupus erythematosus
chr4	101944147	.	G	A	Crohn's disease
chr4	102005766	.	G	A	Crohn's disease
chr4	102005766	.	G	T	Crohn's disease
chr4	102267552	.	C	A	Osteoarthritis
chr4	102267552	.	C	T	Osteoarthritis
chr4	102631552	.	C	A	Primary biliary cholangitis
chr4	102686096	.	C	T	Asthma and attention deficit hyperactivity disorder
chr4	105154341	.	T	G	Ulcerative colitis
chr4	105185196	.	C	A	Ulcerative colitis
chr4	105185196	.	C	G	Ulcerative colitis
chr4	105185196	.	C	T	Ulcerative colitis
chr4	105207797	.	C	T	Primary biliary cholangitis
chr4	105334432	.	T	C	Multiple sclerosis
chr4	105683278	.	C	A	Type 1 diabetes with low genetic risk score
chr4	105683278	.	C	T	Type 1 diabetes with low genetic risk score
chr4	105719474	.	C	T	Psoriasis
chr4	105897896	.	G	A	Asthma
chr4	105897896	.	G	T	Asthma
chr4	108801970	.	G	A	Systemic lupus erythematosus
chr4	113154532	.	A	T	Crohn's disease
chr4	115123255	.	C	A	Osteoarthritis of the knee (with total joint replacement)
chr4	115481897	.	G	A	Serum uric acid levels in response to allopurinol in gout
chr4	115655118	.	C	A	Systemic juvenile idiopathic arthritis
chr4	116341004	.	A	G	Crohn's disease (indolent vs progressive)
chr4	116929300	.	T	C	Ulcerative colitis
chr4	118194762	.	C	T	Lung function (FEV1/FVC) in asthma (dust mite allergen exposure interaction)
chr4	118942321	.	A	G	IgE levels in asthmatics
chr4	120663127	.	G	T	Osteoarthritis
chr4	121198294	.	C	T	Multiple sclerosis
chr4	121392885	.	A	C	Type 1 diabetes and autoimmune thyroid diseases
chr4	121392885	.	A	G	Type 1 diabetes and autoimmune thyroid diseases
chr4	121833304	.	G	T	Psoriasis
chr4	122084379	.	G	A	Asthma;Atopic asthma
chr4	122117140	.	C	A	Celiac disease and Rheumatoid arthritis
chr4	122117140	.	C	T	Celiac disease and Rheumatoid arthritis
chr4	122120316	.	G	C	Asthma
chr4	122134546	.	G	GAT	Asthma (moderate or severe)
chr4	122148495	.	TC	T	Asthma
chr4	122148496	.	CA	C	Asthma;Pediatric asthma
chr4	122194117	.	C	G	Asthma
chr4	122194117	.	C	T	Asthma
chr4	122194347	.	A	G	Celiac disease
chr4	122219899	.	T	C	Allergic disease (asthma, hay fever or eczema)
chr4	122219915	.	T	C	Allergic disease (asthma, hay fever and/or eczema) (age of onset);Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis);Asthma;Asthma (childhood onset);Atopic asthma
chr4	122240464	.	A	G	Crohn's disease;Ulcerative colitis
chr4	122297158	.	A	G	Rheumatoid arthritis
chr4	122322441	.	G	C	Type 1 diabetes
chr4	122340375	.	A	C	Celiac disease
chr4	122345366	.	A	G	Celiac disease
chr4	122345366	.	A	T	Celiac disease
chr4	122387310	.	G	A	Atopic asthma
chr4	122408207	.	G	A	Self-reported allergy;Type 1 diabetes;Ulcerative colitis
chr4	122430276	.	A	T	Crohn's disease
chr4	122432277	.	A	G	Asthma;Asthma (adult onset);Asthma (childhood onset);Asthma onset (childhood vs adult)
chr4	122438414	.	A	G	Asthma;Asthma (adult onset)
chr4	122451978	.	T	A	Asthma (childhood onset);Celiac disease
chr4	122451978	.	T	C	Asthma (childhood onset);Celiac disease
chr4	122465565	.	G	C	Allergic disease (asthma, hay fever or eczema)
chr4	122466445	.	G	A	Atopic asthma;Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)
chr4	122470309	.	A	G	Systemic lupus erythematosus
chr4	122473886	.	A	C	Alopecia areata
chr4	122473886	.	A	G	Alopecia areata
chr4	122478336	.	A	G	Rheumatoid arthritis
chr4	122481853	.	G	A	Allergic disease (asthma, hay fever and/or eczema) (age of onset);Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis)
chr4	122531076	.	C	G	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr4	122531076	.	C	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr4	122532955	.	A	ATAT	Allergic disease (asthma, hay fever or eczema)
chr4	122532956	.	C	A	Allergic disease (asthma, hay fever or eczema)
chr4	122578590	.	G	T	Primary sclerosing cholangitis
chr4	122588266	.	G	T	Celiac disease
chr4	122602720	.	G	T	Alopecia areata
chr4	122602871	.	G	A	Alopecia areata
chr4	122602871	.	G	C	Alopecia areata
chr4	122629959	.	A	G	Celiac disease;Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr4	122639784	.	C	G	Asthma (childhood onset);Atopic asthma
chr4	122667371	.	C	A	Primary biliary cholangitis
chr4	122680257	.	C	G	Asthma (time to event)
chr4	122680257	.	C	T	Asthma (time to event)
chr4	123742201	.	C	T	Diisocyanate-induced asthma
chr4	125651718	.	G	A	Exacerbations requiring hospitalisation in asthma
chr4	125651718	.	G	C	Exacerbations requiring hospitalisation in asthma
chr4	129344890	.	G	A	Exacerbations requiring hospitalisation in asthma
chr4	130869346	.	C	T	Multiple sclerosis (severity)
chr4	135866600	.	A	G	Oral corticosteroid burst in asthma
chr4	136301045	.	G	T	Joint damage in rheumatoid arthritis
chr4	137228466	.	T	C	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr4	137771096	.	G	A	Systemic lupus erythematosus
chr4	137771096	.	G	T	Systemic lupus erythematosus
chr4	144700176	.	G	A	Osteoarthritis (with total hip replacement)
chr4	148712886	.	A	G	Autoimmune thyroid disease
chr4	151293521	.	A	G	Asthma with severe exacerbations
chr4	152099409	.	C	G	Systemic lupus erythematosus
chr4	152099409	.	C	T	Systemic lupus erythematosus
chr4	153557590	.	A	G	Diisocyanate-induced asthma
chr4	154182301	.	C	T	Food allergy (maternal genetic effects)
chr4	154322452	.	T	C	Thyrotoxic hypokalemic periodic paralysis and Graves disease
chr4	155618869	.	G	T	Psoriasis
chr4	160738233	.	G	A	Narcolepsy with cataplexy
chr4	162090902	.	GATTCCTTGTCA	G	Osteoarthritis (self-reported)
chr4	164479668	.	C	T	Diisocyanate-induced asthma
chr4	165653115	.	A	G	Type 1 diabetes
chr4	165658495	.	G	A	Carotid plaques in rheumatoid arthritis
chr4	165909212	.	G	A	Multiple sclerosis
chr4	165916328	.	T	C	Type 1 diabetes (age at diagnosis)
chr4	168044582	.	G	T	Psoriasis
chr4	170967071	.	G	A	Lupus nephritis in systemic lupus erythematosus
chr4	172130730	.	G	A	Crohn's disease
chr4	173579655	.	A	G	Microalbuminuria in type 1 diabetes
chr4	173653255	.	C	G	Type 1 diabetes nephropathy
chr4	174204278	.	G	A	Diisocyanate-induced asthma
chr4	174721548	.	G	A	Urinary albumin excretion rate in type 1 diabetes
chr4	174721548	.	G	C	Urinary albumin excretion rate in type 1 diabetes
chr4	179363660	.	T	A	Ulcerative colitis
chr4	179363660	.	T	C	Ulcerative colitis
chr4	179746494	.	G	A	Multiple sclerosis
chr4	180182576	.	A	C	Diisocyanate-induced asthma
chr4	180182576	.	A	T	Diisocyanate-induced asthma
chr4	181478542	.	G	A	Multiple sclerosis
chr4	182622495	.	G	A	Diisocyanate-induced asthma
chr4	183356978	.	T	G	Gout
chr4	183688220	.	C	T	Systemic lupus erythematosus
chr4	184091248	.	C	T	Kawasaki disease
chr4	184646959	.	C	A	Kawasaki disease
chr4	184646959	.	C	T	Kawasaki disease
chr4	184710844	.	T	C	Systemic lupus erythematosus
chr4	184718015	.	G	C	Kawasaki disease
chr4	184718015	.	G	T	Kawasaki disease
chr4	185051943	.	A	C	Food allergy (parent-of-origin effect)
chr4	185399752	.	C	A	Systemic sclerosis
chr4	186082920	.	C	G	Autoimmune thyroid disease
chr4	186082920	.	C	T	Autoimmune thyroid disease
chr4	186897102	.	G	C	Gout
chr4	187920332	.	T	C	Diisocyanate-induced asthma
chr4	188972159	.	T	C	Crohn's disease
chr4	189228942	.	T	C	Systemic lupus erythematosus
chr5	95949	.	G	A	Asthma (childhood onset)
chr5	95949	.	G	C	Asthma (childhood onset)
chr5	583327	.	G	A	Ulcerative colitis
chr5	593968	.	T	C	Ulcerative colitis
chr5	1279675	.	C	T	Chronic lymphocytic leukemia or systemic lupus erythematosus
chr5	1282299	.	G	A	Systemic lupus erythematosus
chr5	1283640	.	C	A	Multiple sclerosis
chr5	1283640	.	C	T	Multiple sclerosis
chr5	1368882	.	A	G	Systemic lupus erythematosus
chr5	1729673	.	G	C	Response to TNF inhibitor in rheumatoid arthritis (change in tender 28-joint count)
chr5	3000871	.	A	G	Systemic lupus erythematosus
chr5	3525326	.	A	G	Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis
chr5	3670892	.	C	A	Rheumatoid factor seropositivity in rheumatoid arthritis
chr5	4985330	.	G	C	Systemic juvenile idiopathic arthritis
chr5	5074712	.	C	A	Asthma or allergic disease (pleiotropy)
chr5	6893947	.	G	A	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr5	9386473	.	C	T	Late-onset myasthenia gravis
chr5	10500534	.	A	C	Coronary artery disease in type 1 diabetes
chr5	10521556	.	G	A	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr5	10521556	.	G	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr5	11868176	.	C	T	Asthma with severe exacerbations
chr5	14610200	.	C	A	Allergic disease (asthma, hay fever or eczema);Asthma;Asthma (childhood onset);Asthma-COPD overlap syndrome;Asthma onset (childhood vs adult);Atopic asthma;Nonatopic asthma
chr5	14610200	.	C	G	Allergic disease (asthma, hay fever or eczema);Asthma;Asthma (childhood onset);Asthma-COPD overlap syndrome;Asthma onset (childhood vs adult);Atopic asthma;Nonatopic asthma
chr5	14700894	.	C	T	Allergic disease (asthma, hay fever or eczema)
chr5	15607339	.	C	T	Diisocyanate-induced asthma
chr5	15616567	.	A	G	Diisocyanate-induced asthma
chr5	15783391	.	A	G	Diisocyanate-induced asthma
chr5	15783487	.	A	G	Asthma (corticosteroid response)
chr5	19839394	.	A	T	Response to anti-TNF therapy in rheumatoid arthritis
chr5	21007781	.	T	A	Behcet's disease
chr5	21259029	.	G	T	Diisocyanate-induced asthma
chr5	21540699	.	G	A	Ocular sarcoidosis
chr5	21749239	.	T	A	Response to tocilizumab in rheumatoid arthritis
chr5	21749239	.	T	C	Response to tocilizumab in rheumatoid arthritis
chr5	22036799	.	T	A	Ocular sarcoidosis
chr5	22659297	.	T	C	Asthma exacerbations
chr5	26526530	.	C	G	Ocular sarcoidosis
chr5	26685401	.	A	G	Ocular sarcoidosis
chr5	28549074	.	T	A	Knee osteoarthritis
chr5	28549074	.	T	C	Knee osteoarthritis
chr5	30404961	.	G	A	Rheumatoid arthritis;Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)
chr5	30835972	.	G	A	Response to methotrexate in juvenile idiopathic arthritis
chr5	30835972	.	G	T	Response to methotrexate in juvenile idiopathic arthritis
chr5	30843680	.	A	G	Knee osteoarthritis
chr5	31696629	.	G	A	Self-reported childhood asthma in adult smokers
chr5	31696629	.	G	C	Self-reported childhood asthma in adult smokers
chr5	31696629	.	G	T	Self-reported childhood asthma in adult smokers
chr5	35482212	.	A	G	Paneth cell defects in Crohn's disease
chr5	35803475	.	C	T	Multiple sclerosis
chr5	35837132	.	G	A	Asthma;Autoimmune thyroid disease;Primary biliary cholangitis
chr5	35837132	.	G	T	Asthma;Autoimmune thyroid disease;Primary biliary cholangitis
chr5	35846713	.	G	T	Asthma;Atopic asthma
chr5	35850047	.	C	G	Primary biliary cholangitis
chr5	35850047	.	C	T	Primary biliary cholangitis
chr5	35852209	.	G	A	Primary biliary cholangitis
chr5	35862739	.	C	T	Allergic disease (asthma, hay fever or eczema);Asthma
chr5	35874473	.	C	T	Multiple sclerosis;Primary biliary cholangitis;Type 1 diabetes
chr5	35876172	.	A	G	Ulcerative colitis
chr5	35877403	.	G	A	Multiple sclerosis
chr5	35878993	.	C	T	Allergic disease (asthma, hay fever or eczema);Asthma or allergic disease (pleiotropy)
chr5	35879054	.	G	T	Multiple sclerosis
chr5	35881028	.	G	GT	Asthma;Primary biliary cholangitis
chr5	35881274	.	G	A	Asthma;Asthma (adult onset)
chr5	35881274	.	G	T	Asthma;Asthma (adult onset)
chr5	35881341	.	G	A	Ankylosing spondylitis;Primary biliary cholangitis
chr5	35883149	.	C	T	Type 1 diabetes
chr5	35885880	.	T	C	Systemic lupus erythematosus
chr5	35910427	.	C	T	Type 1 diabetes
chr5	35942940	.	A	C	Primary biliary cholangitis
chr5	37881312	.	G	C	Asthma
chr5	37881312	.	G	T	Asthma
chr5	38867630	.	C	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Crohn's disease;Ulcerative colitis
chr5	39406395	.	G	C	Systemic lupus erythematosus
chr5	40201698	.	C	A	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr5	40236916	.	T	C	Crohn's disease
chr5	40323665	.	G	T	Multiple sclerosis
chr5	40392626	.	T	C	Crohn's disease;Multiple sclerosis
chr5	40396323	.	G	A	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Multiple sclerosis
chr5	40401407	.	T	G	Crohn's disease
chr5	40410482	.	T	G	Crohn's disease;Ulcerative colitis
chr5	40410833	.	G	A	Ulcerative colitis
chr5	40431081	.	A	T	Crohn's disease
chr5	40492553	.	C	A	Allergic disease (asthma, hay fever or eczema)
chr5	40492553	.	C	G	Allergic disease (asthma, hay fever or eczema)
chr5	42375141	.	A	C	Systemic lupus erythematosus
chr5	42375141	.	A	T	Systemic lupus erythematosus
chr5	50140616	.	G	C	Lung function (FEV1/FVC) in asthma
chr5	50140616	.	G	T	Lung function (FEV1/FVC) in asthma
chr5	50964261	.	C	T	Joint damage in rheumatoid arthritis
chr5	53115498	.	G	A	Systemic juvenile idiopathic arthritis
chr5	54015672	.	C	A	Rheumatoid arthritis
chr5	56068744	.	G	C	Egg allergy (maternal genetic effects)
chr5	56264200	.	T	G	Celiac disease or Rheumatoid arthritis
chr5	57534776	.	G	T	Body mass index in childhood asthma
chr5	57837318	.	A	T	Type 1 diabetes (age at diagnosis)
chr5	57918990	.	A	C	Lupus nephritis in systemic lupus erythematosus
chr5	60073967	.	A	T	Asthma
chr5	68395641	.	A	C	Crohn's disease
chr5	68395641	.	A	G	Crohn's disease
chr5	68529306	.	A	C	Osteoarthritis (with total hip replacement)
chr5	68529306	.	A	T	Osteoarthritis (with total hip replacement)
chr5	72098560	.	C	T	Coronary artery disease in type 1 diabetes
chr5	72398072	.	C	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Crohn's disease;Ulcerative colitis
chr5	72400053	.	T	C	Asthma
chr5	72400091	.	C	A	Asthma (childhood onset)
chr5	72400091	.	C	G	Asthma (childhood onset)
chr5	72460843	.	C	A	Rheumatoid arthritis
chr5	72460843	.	C	G	Rheumatoid arthritis
chr5	72460843	.	C	T	Rheumatoid arthritis
chr5	73149674	.	T	C	Gout
chr5	73244023	.	C	A	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Crohn's disease
chr5	73255307	.	A	G	Crohn's disease
chr5	74384489	.	G	A	Systemic juvenile idiopathic arthritis
chr5	77247943	.	G	A	Autoimmune thyroid disease
chr5	77295276	.	C	G	Sj√∂gren's syndrome
chr5	78052816	.	A	C	Diisocyanate-induced asthma
chr5	78172000	.	G	A	Knee osteoarthritis
chr5	79733488	.	A	T	Diisocyanate-induced asthma
chr5	80384899	.	G	A	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr5	81269361	.	C	G	Response to placebo treatment in childhood asthma (FVC change)
chr5	81431680	.	G	A	Type 1 diabetes with low genetic risk score
chr5	82884487	.	A	G	Osteoarthritis biomarkers
chr5	83549670	.	G	A	Diisocyanate-induced asthma
chr5	83549670	.	G	T	Diisocyanate-induced asthma
chr5	83877774	.	C	T	Ankylosing spondylitis
chr5	83937200	.	G	A	Narcolepsy with cataplexy
chr5	84611411	.	G	A	Asthma and hay fever
chr5	94362147	.	C	T	Response to inhaled corticosteroid treatment in asthma (change in FEV1)
chr5	94870132	.	T	C	Multiple sclerosis
chr5	96783162	.	C	G	Behcet's disease
chr5	96783569	.	A	C	Psoriasis;Psoriasis vulgaris
chr5	96784466	.	G	C	Psoriasis or type 2 diabetes (trans-disease meta-analysis)
chr5	96785448	.	A	T	Acute anterior uveitis in ankylosing spondylitis;Acute anterior uveitis (with or without ankylosing spondylitis)
chr5	96788627	.	T	A	Ankylosing spondylitis
chr5	96790605	.	A	T	Acute anterior uveitis in ankylosing spondylitis;Ankylosing spondylitis
chr5	96793809	.	A	T	Ankylosing spondylitis
chr5	97021474	.	A	T	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)
chr5	97871838	.	T	A	Osteoarthritis (self-reported)
chr5	99135431	.	A	C	Asthma-COPD overlap syndrome
chr5	100841815	.	A	T	Systemic lupus erythematosus
chr5	100902370	.	A	AC	Primary biliary cholangitis
chr5	101171505	.	C	G	Crohn's disease (time to progression)
chr5	101770172	.	A	C	Ocular sarcoidosis
chr5	102611094	.	A	G	Crohn's disease
chr5	103268000	.	A	C	Rheumatoid arthritis;Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)
chr5	103612484	.	C	T	Crohn's disease
chr5	104354615	.	G	A	Multiple sclerosis
chr5	104659667	.	A	G	Asthma and attention deficit hyperactivity disorder
chr5	104686538	.	C	G	Asthma and major depressive disorder
chr5	105099675	.	T	C	Exacerbations requiring hospitalisation in asthma
chr5	105131414	.	C	A	Diisocyanate-induced asthma
chr5	105131414	.	C	T	Diisocyanate-induced asthma
chr5	107985181	.	G	T	Post-bronchodilator FEV1 x air pollution (NO2) interaction in childhood asthma
chr5	108498546	.	C	T	Ulcerative colitis
chr5	109108853	.	C	T	Asthma;Asthma (childhood onset)
chr5	110669048	.	C	G	Asthma (childhood onset)
chr5	110810746	.	C	A	Asthma;Atopic asthma
chr5	110810746	.	C	G	Asthma;Atopic asthma
chr5	110824180	.	T	C	Allergic disease (asthma, hay fever or eczema)
chr5	110825774	.	C	CAA	Asthma;Asthma (adult onset)
chr5	110825774	.	C	CAAA	Asthma;Asthma (adult onset)
chr5	110862415	.	C	T	Asthma
chr5	110923378	.	G	A	Asthma
chr5	110933992	.	C	T	Atopic asthma
chr5	111051427	.	G	C	Asthma;Asthma (childhood onset)
chr5	111052064	.	T	G	Atopic asthma
chr5	111066174	.	T	C	Allergic disease (asthma, hay fever or eczema);Asthma;Asthma (adult onset);Asthma (age of onset);Asthma and hay fever;Asthma (childhood onset);Asthma-COPD overlap syndrome;Asthma (moderate or severe);Asthma onset (childhood vs adult);Asthma or allergic disease (pleiotropy);Atopic asthma;Nonatopic asthma
chr5	111067157	.	C	A	Atopic asthma
chr5	111069301	.	A	C	Asthma;Asthma (moderate or severe);Pediatric asthma
chr5	111072304	.	C	T	Asthma;Asthma (adult onset);Asthma onset (childhood vs adult)
chr5	111082543	.	T	C	Asthma
chr5	111089365	.	G	A	Asthma
chr5	111096199	.	A	G	Atopic asthma
chr5	111096578	.	C	A	Asthma (childhood onset);Atopic asthma
chr5	111096578	.	C	G	Asthma (childhood onset);Atopic asthma
chr5	111128310	.	T	C	Childhood asthma with severe exacerbations
chr5	111128310	.	T	G	Childhood asthma with severe exacerbations
chr5	111133934	.	G	C	Asthma (childhood onset)
chr5	111136093	.	C	G	Asthma (adult onset);Atopic asthma;Nonatopic asthma
chr5	111230662	.	C	T	Autoimmune thyroid disease;Type 1 diabetes
chr5	111231900	.	C	T	Atopic asthma
chr5	111254701	.	C	T	Asthma
chr5	111285132	.	C	T	Asthma (childhood onset)
chr5	114305448	.	G	A	joint destruction in rheumatoid arthritis (rapid vs slow)
chr5	114305448	.	G	T	joint destruction in rheumatoid arthritis (rapid vs slow)
chr5	114463289	.	C	T	Coronary arterial lesions in patients with Kawasaki disease
chr5	116003035	.	G	A	Osteoarthritis of the hand
chr5	116261351	.	C	G	Asthma or chronic obstructive pulmonary disease
chr5	117157137	.	C	A	Diisocyanate-induced asthma
chr5	117157137	.	C	G	Diisocyanate-induced asthma
chr5	117713030	.	T	C	Peanut allergy (maternal genetic effects)
chr5	118673777	.	T	C	Diisocyanate-induced asthma
chr5	119348602	.	T	A	Allergic disease (asthma, hay fever or eczema)
chr5	122438887	.	G	T	Chronic kidney disease (end stage renal disease vs. normal eGFR) in type 1 diabetes
chr5	123279830	.	A	G	Self-reported allergy
chr5	123802198	.	T	A	Adult asthma
chr5	123802198	.	T	C	Adult asthma
chr5	125252465	.	C	A	Allergic rhinitis in non-asthmatics
chr5	125252465	.	C	G	Allergic rhinitis in non-asthmatics
chr5	125252697	.	C	T	Allergic rhinitis in non-asthmatics
chr5	126512664	.	C	G	Diisocyanate-induced asthma
chr5	128597766	.	T	C	Ocular sarcoidosis
chr5	128682720	.	T	C	Osteoarthritis of the hip or knee
chr5	129194101	.	T	C	Fatigue in primary Sj√∂gren's syndrome
chr5	129194101	.	T	G	Fatigue in primary Sj√∂gren's syndrome
chr5	129403217	.	A	C	Joint damage in rheumatoid arthritis
chr5	130768383	.	A	G	Crohn's disease
chr5	131277907	.	T	C	Crohn's disease
chr5	131429243	.	T	C	Diisocyanate-induced asthma
chr5	131619794	.	G	A	Asthma
chr5	132067045	.	C	T	Crohn's disease
chr5	132239645	.	G	A	Asthma and cardiovascular disease
chr5	132316836	.	A	C	Asthma and cardiovascular disease
chr5	132350453	.	G	A	Asthma and cardiovascular disease
chr5	132358384	.	T	C	Asthma and cardiovascular disease
chr5	132381358	.	G	A	Asthma and cardiovascular disease
chr5	132406536	.	G	C	Crohn's disease
chr5	132421409	.	A	G	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr5	132421409	.	A	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr5	132431071	.	T	TGTGATACCCCAA	Type 1 diabetes
chr5	132435113	.	C	T	Asthma and cardiovascular disease;Crohn's disease;Ulcerative colitis
chr5	132442760	.	A	G	Asthma (adult onset);Asthma and cardiovascular disease;Asthma (childhood onset);Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Crohn's disease;Ulcerative colitis
chr5	132448701	.	G	T	Asthma and cardiovascular disease;Crohn's disease
chr5	132449992	.	C	T	Asthma and cardiovascular disease
chr5	132450903	.	G	A	Asthma and cardiovascular disease
chr5	132451445	.	A	G	Asthma;Asthma (adult onset);Asthma and cardiovascular disease
chr5	132457594	.	C	T	Asthma and cardiovascular disease
chr5	132462795	.	C	T	Asthma and cardiovascular disease
chr5	132467845	.	T	C	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr5	132468655	.	C	A	Asthma and cardiovascular disease
chr5	132472976	.	A	T	Asthma or allergic disease (pleiotropy)
chr5	132473613	.	T	A	Nonatopic asthma
chr5	132493605	.	G	C	Asthma (sex interaction)
chr5	132530099	.	T	C	Asthma
chr5	132544224	.	A	G	Asthma
chr5	132549548	.	G	C	Nonatopic asthma
chr5	132552294	.	C	A	Asthma;Asthma (moderate or severe)
chr5	132565533	.	A	G	Asthma
chr5	132579521	.	G	A	Asthma and cardiovascular disease
chr5	132579587	.	A	G	Nonatopic asthma
chr5	132581248	.	A	C	Asthma;Asthma (childhood onset);Asthma onset (childhood vs adult)
chr5	132581248	.	A	T	Asthma;Asthma (childhood onset);Asthma onset (childhood vs adult)
chr5	132582752	.	T	G	Asthma and cardiovascular disease
chr5	132589495	.	T	C	Asthma
chr5	132616304	.	T	C	Asthma and cardiovascular disease
chr5	132616706	.	G	A	Asthma (childhood onset)
chr5	132617735	.	C	T	Asthma and cardiovascular disease
chr5	132620126	.	C	T	Asthma
chr5	132634182	.	T	C	Asthma and cardiovascular disease;Asthma (childhood onset)
chr5	132636210	.	C	T	Asthma and cardiovascular disease
chr5	132637485	.	A	G	Asthma
chr5	132637485	.	A	T	Asthma
chr5	132648366	.	A	G	Asthma and cardiovascular disease
chr5	132649143	.	C	G	Asthma (adult onset)
chr5	132649143	.	C	T	Asthma (adult onset)
chr5	132653444	.	A	G	Allergic disease (asthma, hay fever or eczema)
chr5	132656189	.	C	T	Asthma;Asthma (adult onset)
chr5	132660151	.	T	A	Allergy;Asthma;Asthma (childhood onset)
chr5	132660151	.	T	C	Allergy;Asthma;Asthma (childhood onset)
chr5	132660272	.	A	G	Asthma;Atopic asthma;Childhood asthma with severe exacerbations;Cutaneous psoriasis;Psoriasis;Self-reported allergy
chr5	132660753	.	A	G	Allergic disease (asthma, hay fever or eczema);Asthma;Asthma (childhood onset);Pediatric asthma;Psoriasis;Psoriasis or type 2 diabetes (trans-disease meta-analysis);Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect);Psoriasis vulgaris
chr5	132660808	.	A	C	Allergic disease (asthma, hay fever or eczema);Alopecia areata;Asthma
chr5	132663479	.	T	A	Atopic asthma
chr5	132669064	.	C	A	Asthma (childhood onset)
chr5	132669064	.	C	T	Asthma (childhood onset)
chr5	132672844	.	G	A	Asthma
chr5	132693166	.	T	A	Allergic disease (asthma, hay fever and/or eczema) (age of onset);Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis);Asthma (age of onset)
chr5	132693166	.	T	C	Allergic disease (asthma, hay fever and/or eczema) (age of onset);Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis);Asthma (age of onset)
chr5	132724891	.	C	A	Asthma or allergic disease (pleiotropy)
chr5	132734014	.	G	A	Asthma;Asthma (childhood onset);Nonatopic asthma
chr5	132734014	.	G	T	Asthma;Asthma (childhood onset);Nonatopic asthma
chr5	132770006	.	T	C	Asthma;Asthma (childhood onset)
chr5	133192580	.	T	C	Exacerbations requiring hospitalisation in asthma
chr5	133192580	.	T	G	Exacerbations requiring hospitalisation in asthma
chr5	133224458	.	C	A	Gout
chr5	133224458	.	C	G	Gout
chr5	133712084	.	T	C	Rheumatoid arthritis
chr5	134046765	.	T	A	Alopecia areata
chr5	134087804	.	T	A	Autoimmune thyroid disease
chr5	134087804	.	T	G	Autoimmune thyroid disease
chr5	134088199	.	T	A	Rheumatoid arthritis
chr5	134093501	.	G	T	Systemic lupus erythematosus
chr5	134103583	.	G	A	Asthma
chr5	135105767	.	A	G	Ulcerative colitis
chr5	135107916	.	G	A	Ulcerative colitis
chr5	142088291	.	C	T	Asthma
chr5	142088689	.	T	G	Asthma (adult onset)
chr5	142112854	.	C	T	Asthma;Asthma (childhood onset)
chr5	142119476	.	A	T	Multiple sclerosis
chr5	142127346	.	C	G	Primary biliary cholangitis
chr5	142130696	.	C	CAA	Asthma
chr5	142130696	.	C	CAAA	Asthma
chr5	142139376	.	A	AGGG	Asthma;Asthma (adult onset)
chr5	142143435	.	C	A	Multiple sclerosis
chr5	142143435	.	C	G	Multiple sclerosis
chr5	142150196	.	AAAAAT	A	Asthma
chr5	142158452	.	G	A	Asthma
chr5	142425523	.	G	T	Osteoarthritis of the hand
chr5	146767857	.	C	T	Takayasu arteritis
chr5	149311063	.	C	T	Ocular sarcoidosis
chr5	149646839	.	A	G	Asthma x air pollution interaction (2df)
chr5	150226431	.	C	T	Ulcerative colitis
chr5	150659110	.	T	C	Ulcerative colitis x smoking status (never vs current smoking) interaction
chr5	150732056	.	T	C	Cholangiocarcinoma in primary sclerosing cholangitis
chr5	151055333	.	G	T	Rheumatoid arthritis (ACPA-positive);Sj√∂gren's syndrome
chr5	151058916	.	C	G	Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)
chr5	151059427	.	C	G	Rheumatoid arthritis;Systemic sclerosis
chr5	151060536	.	G	A	Systemic sclerosis
chr5	151065654	.	T	C	Systemic lupus erythematosus
chr5	151070675	.	T	C	Myasthenia gravis
chr5	151076171	.	A	G	Systemic sclerosis
chr5	151078585	.	C	A	Psoriasis;Systemic lupus erythematosus
chr5	151081488	.	A	T	Systemic lupus erythematosus and Systemic sclerosis
chr5	152557157	.	G	T	Adult asthma
chr5	155011320	.	TA	T	Coronary artery disease in type 1 diabetes
chr5	155636254	.	A	G	Endometriosis or asthma (pleiotropy)
chr5	156073982	.	G	A	Multiple sclerosis (age of onset)
chr5	156326904	.	C	A	Egg allergy
chr5	156326904	.	C	G	Egg allergy
chr5	156502250	.	G	A	T-Cell Immunoglobulin and Mucin domain 1 levels
chr5	156618799	.	G	A	T-Cell Immunoglobulin and Mucin domain 1 levels
chr5	157045138	.	C	T	T-Cell Immunoglobulin and Mucin domain 1 levels
chr5	157185457	.	G	A	T-Cell Immunoglobulin and Mucin domain 1 levels
chr5	157185457	.	G	C	T-Cell Immunoglobulin and Mucin domain 1 levels
chr5	157209701	.	G	C	Asthma (adult onset)
chr5	157209701	.	G	T	Asthma (adult onset)
chr5	157264015	.	C	A	Asthma
chr5	157264015	.	C	G	Asthma
chr5	157299627	.	G	A	T-Cell Immunoglobulin and Mucin domain 1 levels
chr5	157299627	.	G	C	T-Cell Immunoglobulin and Mucin domain 1 levels
chr5	157325949	.	A	G	Asthma
chr5	157542675	.	C	G	Nonatopic asthma
chr5	157542675	.	C	T	Nonatopic asthma
chr5	158300905	.	G	C	Ocular sarcoidosis
chr5	158300905	.	G	T	Ocular sarcoidosis
chr5	158302049	.	T	A	Ocular sarcoidosis
chr5	159322080	.	G	A	Psoriasis
chr5	159337470	.	T	G	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr5	159356215	.	G	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr5	159387525	.	A	C	Crohn's disease;Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS))
chr5	159391737	.	A	C	Ankylosing spondylitis
chr5	159391737	.	A	T	Ankylosing spondylitis
chr5	159399784	.	C	A	Ankylosing spondylitis;Ulcerative colitis
chr5	159400761	.	C	A	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Crohn's disease;Crohn's disease or Leprosy (opposite effect);Takayasu arteritis;Ulcerative colitis
chr5	159400761	.	C	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Crohn's disease;Crohn's disease or Leprosy (opposite effect);Takayasu arteritis;Ulcerative colitis
chr5	159402519	.	A	G	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Psoriasis;Psoriasis or type 2 diabetes (trans-disease meta-analysis);Psoriasis vulgaris
chr5	159402519	.	A	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Psoriasis;Psoriasis or type 2 diabetes (trans-disease meta-analysis);Psoriasis vulgaris
chr5	159405269	.	C	A	Sarcoidosis
chr5	159405269	.	C	G	Sarcoidosis
chr5	159409099	.	T	A	Psoriasis
chr5	159409099	.	T	C	Psoriasis
chr5	159453388	.	C	T	Systemic lupus erythematosus
chr5	159456019	.	A	G	Systemic lupus erythematosus
chr5	159457527	.	A	G	Systemic lupus erythematosus
chr5	159459931	.	A	G	Systemic lupus erythematosus
chr5	159491886	.	G	A	Multiple sclerosis
chr5	160243619	.	C	T	Joint damage in rheumatoid arthritis
chr5	160443604	.	G	A	Systemic lupus erythematosus or rheumatoid arthritis
chr5	160452971	.	T	C	Systemic lupus erythematosus
chr5	160459613	.	A	G	Systemic lupus erythematosus
chr5	160460329	.	A	G	Sj√∂gren's syndrome;Systemic lupus erythematosus;Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)
chr5	160460329	.	A	T	Sj√∂gren's syndrome;Systemic lupus erythematosus;Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)
chr5	160482338	.	A	G	Allergic disease (asthma, hay fever or eczema)
chr5	160484499	.	C	A	Allergic disease (asthma, hay fever or eczema);Asthma
chr5	160487233	.	A	G	Asthma
chr5	160487233	.	A	T	Asthma
chr5	160491328	.	C	T	Asthma
chr5	163841095	.	G	A	Adverse response to inhaled corticosteroid treatment x age interaction in asthma
chr5	163841300	.	C	T	Adverse response to inhaled corticosteroid treatment x age interaction in asthma
chr5	163841780	.	T	TA	Adverse response to inhaled corticosteroid treatment x age interaction in asthma
chr5	163841780	.	T	TG	Adverse response to inhaled corticosteroid treatment x age interaction in asthma
chr5	164919530	.	G	T	Possible neuropathic pain in post total joint replacement surgery for osteoarthritis
chr5	167551225	.	G	A	Kidney disease (late stage) in type 1 diabetes
chr5	167634769	.	C	T	Exacerbations requiring hospitalisation in asthma
chr5	169708658	.	A	C	Coronary artery aneurysm in Kawasaki disease
chr5	169708658	.	A	G	Coronary artery aneurysm in Kawasaki disease
chr5	169708658	.	A	T	Coronary artery aneurysm in Kawasaki disease
chr5	170529575	.	C	A	Liver transplant-free survival in primary sclerosing cholangitis (time to event)
chr5	171444070	.	G	A	Osteoarthritis of the hip or knee
chr5	171482406	.	C	T	Osteoarthritis of the knee (with total joint replacement)
chr5	173374104	.	T	A	Immunoglobulin A vasculitis
chr5	173374104	.	T	C	Immunoglobulin A vasculitis
chr5	175184337	.	T	C	Response to anti-TNF therapy in rheumatoid arthritis
chr5	176740301	.	T	C	Osteoarthritis (self-reported)
chr5	177388879	.	G	C	Asthma
chr5	178186543	.	C	G	Rheumatoid arthritis
chr5	178186543	.	C	T	Rheumatoid arthritis
chr5	180433167	.	G	C	Joint damage in rheumatoid arthritis
chr5	180828963	.	A	G	Childhood asthma exacerbations in long-acting beta2-agonist treatment
chr6	382537	.	G	A	Rheumatoid arthritis;Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)
chr6	382559	.	G	A	Crohn's disease
chr6	382559	.	G	C	Crohn's disease
chr6	383546	.	C	T	Celiac disease
chr6	396321	.	C	T	Vitiligo
chr6	411554	.	C	A	Alopecia areata
chr6	426155	.	G	A	Rheumatoid arthritis
chr6	426155	.	G	T	Rheumatoid arthritis
chr6	520595	.	G	A	Multiple sclerosis
chr6	577820	.	A	G	Psoriasis
chr6	1759646	.	G	C	Late-onset myasthenia gravis
chr6	1759646	.	G	T	Late-onset myasthenia gravis
chr6	2957593	.	G	C	Crohn's disease
chr6	3420172	.	T	A	Crohn's disease
chr6	5479863	.	T	C	Endometriosis or asthma (pleiotropy)
chr6	5589406	.	A	C	Subjective response to placebo treatment in childhood asthma (change in cough/wheeze)
chr6	6276196	.	C	T	Asthma (childhood onset)
chr6	7099796	.	G	A	Multiple sclerosis
chr6	7099796	.	G	C	Multiple sclerosis
chr6	7118757	.	A	G	Chronic lymphocytic leukemia or multiple sclerosis;Gout;Multiple sclerosis
chr6	7118757	.	A	T	Chronic lymphocytic leukemia or multiple sclerosis;Gout;Multiple sclerosis
chr6	7236387	.	T	C	Steroid induced osteonecrosis of the femoral head and systemic lupus erythematosus
chr6	8311442	.	C	A	Type 1 diabetes with low genetic risk score
chr6	8311442	.	C	T	Type 1 diabetes with low genetic risk score
chr6	11938439	.	C	T	Takayasu arteritis
chr6	12159466	.	C	T	Asthma
chr6	14292589	.	C	T	Response to tofacitinib treatment in psoriasis (herpes zoster);Response to tofacitinib treatment in psoriasis (herpes zoster)(time to event)
chr6	14715651	.	T	A	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Systemic lupus erythematosus
chr6	14715651	.	T	C	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Systemic lupus erythematosus
chr6	14719265	.	G	A	Crohn's disease;Multiple sclerosis;Ulcerative colitis
chr6	15088920	.	T	C	Multiple sclerosis (severity)
chr6	15909294	.	C	T	Asthma exacerbations in inhaled corticosteroid treatment
chr6	16110152	.	T	C	Diisocyanate-induced asthma
chr6	16630667	.	T	G	Systemic lupus erythematosus
chr6	16636230	.	T	C	Systemic lupus erythematosus
chr6	16672529	.	C	T	Multiple sclerosis
chr6	16968557	.	C	A	Systemic lupus erythematosus
chr6	16968557	.	C	T	Systemic lupus erythematosus
chr6	16970739	.	C	A	Marginal zone lymphoma or systemic lupus erythematosus
chr6	17120009	.	A	C	Fulminant type 1 diabetes
chr6	17120009	.	A	T	Fulminant type 1 diabetes
chr6	19341070	.	G	A	Asthma
chr6	19677593	.	C	T	Pulmonary function in asthmatics
chr6	19780778	.	C	G	Ulcerative colitis
chr6	19780778	.	C	T	Ulcerative colitis
chr6	19823007	.	T	G	Lupus nephritis in systemic lupus erythematosus
chr6	19843536	.	C	A	Asthma (childhood onset)
chr6	20643496	.	G	A	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr6	20678199	.	G	C	Psoriasis vulgaris
chr6	20678199	.	G	T	Psoriasis vulgaris
chr6	20679478	.	A	G	Psoriasis or type 2 diabetes (trans-disease meta-analysis)
chr6	20679478	.	A	T	Psoriasis or type 2 diabetes (trans-disease meta-analysis)
chr6	20728282	.	C	T	Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect)
chr6	20728500	.	T	C	Crohn's disease;Ulcerative colitis
chr6	20812357	.	G	A	Crohn's disease
chr6	21430496	.	CTAG	CCAT	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Crohn's disease
chr6	21824163	.	C	T	Diisocyanate-induced asthma
chr6	21884209	.	G	A	Asthma
chr6	24523528	.	G	A	Crohn's disease (time to first abdominal surgery)
chr6	24523528	.	G	T	Crohn's disease (time to first abdominal surgery)
chr6	25365660	.	C	T	Type 1 diabetes
chr6	25371141	.	A	T	Type 1 diabetes with low genetic risk score
chr6	25510421	.	A	G	Gout
chr6	25513951	.	G	A	Systemic lupus erythematosus;Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr6	25701739	.	A	AT	Peak cortisol response to low dose short synacthen test in corticosteroid treated asthma
chr6	25701739	.	A	ATT	Peak cortisol response to low dose short synacthen test in corticosteroid treated asthma
chr6	25710343	.	G	A	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr6	25710343	.	G	C	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr6	25822433	.	C	T	Type 1 diabetes
chr6	25864590	.	C	T	Type 1 diabetes with low genetic risk score
chr6	25884291	.	G	A	Systemic lupus erythematosus
chr6	25928148	.	G	A	Systemic lupus erythematosus
chr6	25929860	.	G	A	Type 1 diabetes
chr6	26073147	.	C	A	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr6	26073147	.	C	G	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr6	26092913	.	G	A	Osteoarthritis (hip)
chr6	26098246	.	T	C	Osteoarthritis (hip)
chr6	26123274	.	T	C	Osteoarthritis;Osteoarthritis (hip)
chr6	26173024	.	ATT	A	Asthma
chr6	26199675	.	C	G	Type 1 diabetes
chr6	26199675	.	C	T	Type 1 diabetes
chr6	26264588	.	C	G	Osteoarthritis of the hip or knee
chr6	26266083	.	A	C	Type 1 diabetes with low genetic risk score
chr6	26316067	.	G	A	Type 1 diabetes
chr6	26408323	.	T	G	Type 1 diabetes with low genetic risk score
chr6	26463346	.	G	A	Type 1 diabetes
chr6	26463346	.	G	T	Type 1 diabetes
chr6	26581807	.	C	T	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr6	26732200	.	C	G	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr6	26935600	.	C	T	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr6	27104763	.	A	G	Type 1 diabetes with low genetic risk score
chr6	27174125	.	C	T	Type 1 diabetes
chr6	27218013	.	T	A	Gout
chr6	27281907	.	G	A	Type 1 diabetes with low genetic risk score
chr6	27303811	.	A	C	Asthma and major depressive disorder
chr6	27303811	.	A	G	Asthma and major depressive disorder
chr6	27303811	.	A	T	Asthma and major depressive disorder
chr6	27349237	.	AC	A	Type 1 diabetes
chr6	27457865	.	G	C	Type 1 diabetes with low genetic risk score
chr6	27523520	.	G	A	Type 1 diabetes
chr6	27559448	.	G	T	Type 1 diabetes with low genetic risk score
chr6	27559448	.	GT	G	Type 1 diabetes with low genetic risk score
chr6	27566749	.	A	G	Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)
chr6	27592808	.	A	C	Systemic lupus erythematosus
chr6	27624224	.	C	T	Type 1 diabetes
chr6	27700521	.	A	C	Type 1 diabetes with low genetic risk score
chr6	27731058	.	C	T	Type 1 diabetes
chr6	27803328	.	T	C	Type 1 diabetes with low genetic risk score
chr6	27883876	.	G	GT	Type 1 diabetes
chr6	27883876	.	G	T	Type 1 diabetes
chr6	27883876	.	GT	G	Type 1 diabetes
chr6	27883876	.	GTT	G	Type 1 diabetes
chr6	27883876	.	GTTT	G	Type 1 diabetes
chr6	27911422	.	C	A	Type 1 diabetes with low genetic risk score
chr6	28026638	.	A	T	Type 1 diabetes
chr6	28092461	.	T	C	Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)
chr6	28107123	.	C	T	Type 1 diabetes with low genetic risk score
chr6	28171932	.	A	T	Type 1 diabetes
chr6	28235278	.	T	G	Type 1 diabetes with low genetic risk score
chr6	28309894	.	T	A	Type 1 diabetes
chr6	28309894	.	T	G	Type 1 diabetes
chr6	28355925	.	G	A	Type 1 diabetes with low genetic risk score
chr6	28381921	.	A	G	Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)
chr6	28429899	.	AAC	A	Type 1 diabetes
chr6	28446593	.	T	C	Composite immunoglobulin trait (IgA/IgM)
chr6	28485841	.	T	G	Type 1 diabetes with low genetic risk score
chr6	28525919	.	G	A	Takayasu arteritis
chr6	28525919	.	G	C	Takayasu arteritis
chr6	28594470	.	TG	T	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr6	28699892	.	A	G	Type 1 diabetes
chr6	28705657	.	G	A	Type 1 diabetes with low genetic risk score
chr6	28728995	.	T	G	Asthma and major depressive disorder
chr6	28744470	.	A	G	Asthma
chr6	28828294	.	G	A	Type 1 diabetes
chr6	28828294	.	G	C	Type 1 diabetes
chr6	28835514	.	C	T	Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)
chr6	28938014	.	G	A	Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)
chr6	28939145	.	C	G	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr6	28966575	.	T	C	Asthma and major depressive disorder
chr6	28997735	.	G	A	Asthma
chr6	29051468	.	G	A	Type 1 diabetes with low genetic risk score
chr6	29051468	.	G	GT	Type 1 diabetes with low genetic risk score
chr6	29051468	.	G	T	Type 1 diabetes with low genetic risk score
chr6	29051468	.	GT	G	Type 1 diabetes with low genetic risk score
chr6	29058810	.	C	A	Type 1 diabetes (age at diagnosis)
chr6	29058810	.	C	T	Type 1 diabetes (age at diagnosis)
chr6	29089862	.	G	A	Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)
chr6	29097215	.	C	A	Takayasu arteritis
chr6	29100913	.	A	T	Type 1 diabetes
chr6	29100913	.	ATTCT	A	Type 1 diabetes
chr6	29215110	.	T	A	Type 1 diabetes
chr6	29238474	.	T	C	Type 1 diabetes with low genetic risk score
chr6	29257248	.	T	G	Asthma and major depressive disorder
chr6	29280787	.	C	CT	Takayasu arteritis
chr6	29290190	.	G	A	Systemic lupus erythematosus
chr6	29290190	.	G	T	Systemic lupus erythematosus
chr6	29388554	.	A	G	Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome);Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr6	29419226	.	G	T	Diisocyanate-induced asthma
chr6	29493953	.	G	C	Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)
chr6	29499942	.	G	A	Type 1 diabetes with low genetic risk score
chr6	29558785	.	G	A	Type 1 diabetes
chr6	29635735	.	A	G	Systemic lupus erythematosus
chr6	29639324	.	T	C	Type 1 diabetes with low genetic risk score
chr6	29683408	.	A	G	Type 1 diabetes
chr6	29737882	.	A	G	Multiple sclerosis
chr6	29737882	.	A	T	Multiple sclerosis
chr6	29755384	.	C	T	Crohn's disease
chr6	29785031	.	A	G	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr6	29791668	.	C	A	Takayasu arteritis
chr6	29791668	.	C	G	Takayasu arteritis
chr6	29791668	.	C	T	Takayasu arteritis
chr6	29792146	.	T	C	Takayasu arteritis
chr6	29792252	.	G	C	Takayasu arteritis
chr6	29795126	.	G	A	Systemic lupus erythematosus
chr6	29796695	.	C	T	Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)
chr6	29809899	.	T	C	Takayasu arteritis
chr6	29921473	.	C	T	Systemic lupus erythematosus
chr6	29925798	.	G	T	Allergic disease (asthma, hay fever or eczema)
chr6	29931850	.	C	T	Type 1 diabetes (age at diagnosis)
chr6	29941027	.	G	A	Asthma (childhood onset)
chr6	29942046	.	G	T	Systemic lupus erythematosus
chr6	29946109	.	T	G	Type 1 diabetes (age at diagnosis)
chr6	29949300	.	G	A	Type 1 diabetes
chr6	29952555	.	T	A	Multiple sclerosis
chr6	29952555	.	T	G	Multiple sclerosis
chr6	29953257	.	T	C	Takayasu arteritis
chr6	29958100	.	G	A	Takayasu arteritis
chr6	29961296	.	T	C	Atopic asthma
chr6	29961296	.	T	G	Atopic asthma
chr6	29966386	.	A	C	Ulcerative colitis
chr6	29967473	.	G	A	Graves' disease
chr6	29968855	.	C	T	Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; all treatment preparations)
chr6	29969558	.	GTTTA	G	Vitiligo
chr6	29971371	.	A	T	Systemic lupus erythematosus
chr6	29974306	.	C	A	Vitiligo
chr6	29974306	.	C	T	Vitiligo
chr6	29975879	.	G	T	Ankylosing spondylitis
chr6	29979963	.	T	C	Late-onset myasthenia gravis
chr6	29997052	.	A	T	Takayasu arteritis
chr6	30006148	.	C	T	Graves' disease
chr6	30010092	.	C	T	Asthma
chr6	30010575	.	G	A	Takayasu arteritis
chr6	30018547	.	T	A	Type 1 diabetes with low genetic risk score
chr6	30040969	.	A	C	Ulcerative colitis
chr6	30064745	.	A	C	Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome);Type 1 diabetes
chr6	30099791	.	C	G	Takayasu arteritis
chr6	30103553	.	C	T	Systemic lupus erythematosus;Takayasu arteritis
chr6	30107095	.	C	T	Asthma-COPD overlap syndrome
chr6	30110498	.	C	T	Type 1 diabetes and autoimmune thyroid diseases
chr6	30146101	.	G	A	Takayasu arteritis
chr6	30146101	.	G	C	Takayasu arteritis
chr6	30146101	.	G	T	Takayasu arteritis
chr6	30157766	.	C	T	Type 1 diabetes with low genetic risk score
chr6	30163346	.	T	G	Childhood onset ulcerative colitis
chr6	30184690	.	G	T	Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)
chr6	30198489	.	C	T	Takayasu arteritis
chr6	30201550	.	A	G	Asthma
chr6	30202510	.	A	G	Type 1 diabetes
chr6	30202733	.	T	C	Asthma (adult onset);Asthma (childhood onset)
chr6	30311297	.	C	G	Adult asthma
chr6	30317873	.	T	A	Systemic lupus erythematosus
chr6	30331468	.	T	A	Type 1 diabetes with low genetic risk score
chr6	30331468	.	T	G	Type 1 diabetes with low genetic risk score
chr6	30345252	.	C	A	Type 1 diabetes (age at diagnosis)
chr6	30345252	.	C	T	Type 1 diabetes (age at diagnosis)
chr6	30387407	.	A	G	Type 1 diabetes
chr6	30441472	.	T	C	Type 1 diabetes with low genetic risk score
chr6	30444126	.	C	A	Kawasaki disease
chr6	30464400	.	C	A	Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)
chr6	30464400	.	C	T	Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)
chr6	30487517	.	C	A	Asthma (age of onset)
chr6	30487517	.	C	G	Asthma (age of onset)
chr6	30569095	.	T	A	Type 1 diabetes
chr6	30569829	.	C	A	Graves' disease
chr6	30569829	.	C	G	Graves' disease
chr6	30576624	.	A	G	Type 1 diabetes with low genetic risk score
chr6	30685004	.	C	G	Type 1 diabetes
chr6	30685004	.	C	T	Type 1 diabetes
chr6	30733315	.	C	T	Type 1 diabetes with low genetic risk score
chr6	30746031	.	C	A	Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)
chr6	30801949	.	C	T	Type 1 diabetes
chr6	30814225	.	C	T	Type 1 diabetes and autoimmune thyroid diseases
chr6	30831622	.	T	A	Ulcerative colitis
chr6	30843488	.	G	C	Type 1 diabetes with low genetic risk score
chr6	30890477	.	T	C	Takayasu arteritis
chr6	30911859	.	C	T	Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)
chr6	30916259	.	A	T	Psoriasis
chr6	30919688	.	C	T	Microalbuminuria in type 1 diabetes
chr6	30931873	.	G	A	Systemic lupus erythematosus
chr6	30931873	.	G	T	Systemic lupus erythematosus
chr6	30936495	.	A	G	Asthma (time to event)
chr6	30936495	.	A	T	Asthma (time to event)
chr6	30954755	.	C	T	Type 1 diabetes (age at diagnosis)
chr6	30964532	.	C	T	Type 1 diabetes
chr6	30966087	.	T	C	Systemic lupus erythematosus
chr6	30973212	.	T	C	Systemic lupus erythematosus
chr6	30977848	.	A	T	Asthma (childhood onset)
chr6	30982273	.	G	A	Takayasu arteritis
chr6	31000992	.	C	G	Type 1 diabetes with low genetic risk score
chr6	31000992	.	C	T	Type 1 diabetes with low genetic risk score
chr6	31001408	.	A	C	Takayasu arteritis
chr6	31014432	.	A	G	Crohn's disease x smoking status (never vs current smoking) interaction
chr6	31014432	.	A	T	Crohn's disease x smoking status (never vs current smoking) interaction
chr6	31014767	.	G	A	Psoriasis vulgaris
chr6	31027112	.	A	G	Systemic lupus erythematosus
chr6	31034324	.	G	A	Thionamide-induced agranulocytosis in Graves' disease
chr6	31034839	.	C	T	Graves' disease
chr6	31056824	.	C	A	Thionamide-induced agranulocytosis in Graves' disease
chr6	31056824	.	C	T	Thionamide-induced agranulocytosis in Graves' disease
chr6	31067775	.	C	T	Ocular sarcoidosis
chr6	31090401	.	T	A	Behcet's disease;Graves' disease;Thyrotoxic hypokalemic periodic paralysis and Graves disease
chr6	31090401	.	T	C	Behcet's disease;Graves' disease;Thyrotoxic hypokalemic periodic paralysis and Graves disease
chr6	31090563	.	C	A	Myasthenia gravis
chr6	31110838	.	T	C	Type 1 diabetes (age at diagnosis)
chr6	31112239	.	C	A	Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)
chr6	31112239	.	C	G	Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)
chr6	31113288	.	T	C	Psoriasis
chr6	31117579	.	C	T	Type 1 diabetes with low genetic risk score
chr6	31120368	.	T	A	Adult asthma
chr6	31120368	.	T	G	Adult asthma
chr6	31121931	.	A	G	Takayasu arteritis
chr6	31124190	.	A	G	Thionamide-induced agranulocytosis in Graves' disease
chr6	31128024	.	G	A	Systemic lupus erythematosus
chr6	31128749	.	A	G	Psoriasis
chr6	31131800	.	G	A	Behcet's disease
chr6	31134496	.	T	A	Systemic lupus erythematosus
chr6	31134496	.	T	C	Systemic lupus erythematosus
chr6	31134496	.	T	G	Systemic lupus erythematosus
chr6	31134528	.	A	G	Takayasu arteritis
chr6	31135418	.	C	G	Type 1 diabetes
chr6	31138491	.	A	C	Systemic sclerosis
chr6	31138491	.	A	G	Systemic sclerosis
chr6	31142105	.	G	A	Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; all treatment preparations)
chr6	31142105	.	G	T	Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; all treatment preparations)
chr6	31142614	.	G	A	Psoriasis;Takayasu arteritis
chr6	31142614	.	G	C	Psoriasis;Takayasu arteritis
chr6	31143579	.	C	T	Ulcerative colitis
chr6	31144825	.	G	C	Takayasu arteritis
chr6	31145498	.	A	G	Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; IFNŒ≤-1a subcutaneous and intramuscular)
chr6	31148365	.	G	A	Takayasu arteritis
chr6	31151165	.	T	A	Takayasu arteritis
chr6	31151165	.	T	C	Takayasu arteritis
chr6	31151165	.	T	G	Takayasu arteritis
chr6	31173705	.	T	G	Type 1 diabetes (age at diagnosis)
chr6	31174468	.	C	A	Crohn's disease
chr6	31188008	.	G	C	Psoriasis
chr6	31202751	.	A	G	Lupus nephritis in systemic lupus erythematosus
chr6	31229085	.	G	A	Type 1 diabetes with low genetic risk score
chr6	31229486	.	G	A	Sarcoidosis
chr6	31229486	.	G	T	Sarcoidosis
chr6	31236917	.	C	G	Takayasu arteritis
chr6	31245448	.	A	G	Ulcerative colitis
chr6	31264212	.	G	A	Psoriasis
chr6	31267728	.	G	A	Psoriasis
chr6	31271729	.	C	G	Psoriasis vulgaris
chr6	31272944	.	C	T	Psoriasis
chr6	31274414	.	A	G	Takayasu arteritis
chr6	31274954	.	T	A	Psoriasis
chr6	31275040	.	A	T	Type 1 diabetes
chr6	31278044	.	A	G	Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)
chr6	31279629	.	C	G	Systemic lupus erythematosus
chr6	31280657	.	A	G	Type 1 diabetes (age at diagnosis)
chr6	31282829	.	A	C	Psoriasis
chr6	31285148	.	C	T	Psoriasis
chr6	31286101	.	C	T	Psoriasis
chr6	31287231	.	C	G	Psoriasis or type 2 diabetes (trans-disease meta-analysis)
chr6	31291060	.	G	A	Vitiligo
chr6	31291802	.	C	T	Psoriasis
chr6	31297046	.	G	A	Psoriasis
chr6	31298313	.	G	A	Psoriasis;Psoriasis vulgaris
chr6	31299841	.	A	G	Psoriasis
chr6	31301916	.	T	C	Crohn's disease
chr6	31306603	.	T	C	Crohn's disease
chr6	31306778	.	C	T	Cutaneous psoriasis;Psoriasis;Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect)
chr6	31312441	.	T	C	Takayasu arteritis
chr6	31331720	.	T	TTG	Systemic lupus erythematosus
chr6	31333042	.	T	C	Psoriasis vulgaris
chr6	31333859	.	G	T	Takayasu arteritis
chr6	31335547	.	A	G	Asthma;Asthma (childhood onset)
chr6	31344549	.	T	G	Psoriasis
chr6	31348918	.	C	A	Type 1 diabetes with low genetic risk score
chr6	31350367	.	T	C	Psoriasis
chr6	31353630	.	C	A	Atopic asthma
chr6	31353630	.	C	T	Atopic asthma
chr6	31353747	.	G	A	Asthma
chr6	31353747	.	G	C	Asthma
chr6	31353747	.	G	T	Asthma
chr6	31354129	.	A	G	Asthma (age of onset)
chr6	31354352	.	C	G	Ankylosing spondylitis
chr6	31354420	.	T	A	Asthma;Asthma (adult onset);Asthma (childhood onset)
chr6	31354420	.	T	C	Asthma;Asthma (adult onset);Asthma (childhood onset)
chr6	31354782	.	G	A	Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; all treatment preparations)
chr6	31355235	.	G	A	Allergic disease (asthma, hay fever and/or eczema) (age of onset);Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis);Allergic disease (asthma, hay fever or eczema)
chr6	31355944	.	G	C	Takayasu arteritis
chr6	31355944	.	G	T	Takayasu arteritis
chr6	31356722	.	C	A	Asthma
chr6	31356722	.	C	G	Asthma
chr6	31357111	.	G	A	Leukocyte immunoglobulin-like receptor subfamily B member 1 levels
chr6	31357111	.	G	T	Leukocyte immunoglobulin-like receptor subfamily B member 1 levels
chr6	31357178	.	C	T	Asthma
chr6	31358156	.	T	C	Ankylosing spondylitis
chr6	31358474	.	C	T	Composite immunoglobulin trait (IgA/IgM)
chr6	31358836	.	A	G	Myasthenia gravis
chr6	31360821	.	C	T	Acute anterior uveitis (with or without ankylosing spondylitis)
chr6	31360979	.	G	A	Atopic asthma
chr6	31360979	.	G	C	Atopic asthma
chr6	31361514	.	T	A	Atopic asthma
chr6	31361914	.	T	A	Sj√∂gren's syndrome
chr6	31363723	.	C	G	Psoriasis
chr6	31367559	.	G	A	Thionamide-induced agranulocytosis in Graves' disease
chr6	31367559	.	G	T	Thionamide-induced agranulocytosis in Graves' disease
chr6	31368323	.	C	A	Ankylosing spondylitis
chr6	31368473	.	A	G	Psoriasis
chr6	31368641	.	G	A	Behcet's disease
chr6	31372160	.	C	T	Psoriasis
chr6	31372381	.	A	G	Behcet's disease
chr6	31375050	.	G	T	Psoriasis
chr6	31377139	.	C	A	Acute anterior uveitis (with or without ankylosing spondylitis);Ankylosing spondylitis
chr6	31377139	.	C	T	Acute anterior uveitis (with or without ankylosing spondylitis);Ankylosing spondylitis
chr6	31377287	.	C	T	Psoriasis
chr6	31379045	.	T	C	Asthma (adult onset)
chr6	31380588	.	G	A	Primary sclerosing cholangitis
chr6	31382927	.	C	T	Graves' disease;Thyrotoxic hypokalemic periodic paralysis and Graves disease
chr6	31383277	.	G	T	Takayasu arteritis
chr6	31383313	.	G	A	Acute anterior uveitis (with or without ankylosing spondylitis)
chr6	31383435	.	G	A	Takayasu arteritis
chr6	31383887	.	G	A	Allergic disease (asthma, hay fever or eczema)
chr6	31384336	.	T	C	Self-reported allergy
chr6	31385552	.	G	A	Rheumatoid arthritis (ACPA-negative)
chr6	31385552	.	G	T	Rheumatoid arthritis (ACPA-negative)
chr6	31386015	.	T	G	Systemic lupus erythematosus
chr6	31386461	.	C	T	Takayasu arteritis
chr6	31387342	.	C	T	Psoriasis
chr6	31392512	.	A	G	Acute anterior uveitis in ankylosing spondylitis
chr6	31392866	.	AT	A	Systemic lupus erythematosus
chr6	31395249	.	G	A	Type 1 diabetes
chr6	31395249	.	G	T	Type 1 diabetes
chr6	31396930	.	G	A	Type 1 diabetes and autoimmune thyroid diseases
chr6	31398010	.	G	A	Ankylosing spondylitis
chr6	31406802	.	A	G	Systemic lupus erythematosus
chr6	31410197	.	C	T	Atopic asthma
chr6	31442080	.	A	G	Psoriasis
chr6	31442631	.	G	T	Asthma
chr6	31442744	.	A	G	Early-onset myasthenia gravis
chr6	31445184	.	T	C	Asthma;Asthma (childhood onset)
chr6	31447129	.	G	T	Systemic lupus erythematosus
chr6	31448075	.	C	T	Systemic lupus erythematosus
chr6	31449679	.	G	T	Type 1 diabetes (age at diagnosis)
chr6	31464003	.	T	G	Psoriasis
chr6	31464229	.	G	A	Systemic lupus erythematosus
chr6	31470613	.	A	G	Thionamide-induced agranulocytosis in Graves' disease
chr6	31477439	.	G	A	Psoriasis
chr6	31481085	.	C	A	Ulcerative colitis
chr6	31482137	.	T	C	Psoriasis
chr6	31483502	.	C	T	Psoriasis
chr6	31484146	.	T	A	Adult asthma
chr6	31484655	.	C	T	Atopic asthma
chr6	31491859	.	C	G	Psoriasis
chr6	31493831	.	C	T	Endometriosis or asthma (pleiotropy)
chr6	31493994	.	T	A	Endometriosis or asthma (pleiotropy)
chr6	31494468	.	C	T	Endometriosis or asthma (pleiotropy)
chr6	31495714	.	G	A	Endometriosis or asthma (pleiotropy)
chr6	31500769	.	A	G	Psoriasis
chr6	31504024	.	A	G	Asthma (childhood onset)
chr6	31504024	.	A	T	Asthma (childhood onset)
chr6	31504943	.	G	T	Asthma;Asthma and major depressive disorder;Asthma (childhood onset)
chr6	31507279	.	G	A	Atopic asthma
chr6	31508681	.	T	A	Type 1 diabetes with low genetic risk score
chr6	31511174	.	G	A	Kawasaki disease
chr6	31517324	.	A	C	Type 1 diabetes
chr6	31522869	.	C	T	Psoriasis
chr6	31548022	.	G	A	Late-onset myasthenia gravis
chr6	31548022	.	G	C	Late-onset myasthenia gravis
chr6	31550126	.	G	A	Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis)
chr6	31550126	.	G	C	Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis)
chr6	31552881	.	T	A	Asthma (childhood onset);Atopic asthma
chr6	31565601	.	G	A	Kawasaki disease
chr6	31570500	.	G	A	Asthma
chr6	31571990	.	C	T	Asthma
chr6	31572779	.	T	C	Atopic asthma
chr6	31573180	.	T	C	Asthma (childhood onset)
chr6	31574531	.	T	C	Asthma (childhood onset);Crohn's disease
chr6	31576865	.	A	G	Type 1 diabetes (age at diagnosis)
chr6	31587615	.	C	A	Systemic lupus erythematosus
chr6	31587615	.	C	T	Systemic lupus erythematosus
chr6	31594990	.	G	C	Atopic asthma
chr6	31600692	.	G	A	Type 1 diabetes and autoimmune thyroid diseases
chr6	31604887	.	G	A	Ulcerative colitis
chr6	31604887	.	G	T	Ulcerative colitis
chr6	31606748	.	C	T	Allergic disease (asthma, hay fever or eczema)
chr6	31607499	.	C	G	Crohn's disease
chr6	31607499	.	C	T	Crohn's disease
chr6	31613260	.	G	A	Systemic lupus erythematosus
chr6	31621958	.	C	T	Takayasu arteritis
chr6	31624031	.	A	G	Takayasu arteritis
chr6	31628361	.	A	G	Type 1 diabetes with low genetic risk score
chr6	31630712	.	A	G	Takayasu arteritis
chr6	31633043	.	A	G	Takayasu arteritis
chr6	31633074	.	G	T	Takayasu arteritis
chr6	31635993	.	A	G	Takayasu arteritis;Type 1 diabetes
chr6	31636814	.	C	T	Takayasu arteritis
chr6	31641495	.	T	C	Takayasu arteritis
chr6	31652743	.	T	G	Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)
chr6	31654829	.	C	A	Rheumatoid arthritis
chr6	31663557	.	A	G	Asthma (adult onset);Nonatopic asthma
chr6	31664357	.	C	A	Takayasu arteritis
chr6	31664357	.	C	T	Takayasu arteritis
chr6	31668965	.	A	G	Systemic lupus erythematosus
chr6	31672202	.	C	T	Takayasu arteritis
chr6	31681372	.	C	G	Takayasu arteritis
chr6	31681372	.	C	T	Takayasu arteritis
chr6	31687661	.	G	A	Takayasu arteritis
chr6	31707724	.	G	A	Takayasu arteritis
chr6	31741133	.	T	C	Takayasu arteritis
chr6	31743191	.	T	A	Takayasu arteritis
chr6	31753256	.	G	A	Systemic lupus erythematosus
chr6	31762974	.	G	A	Takayasu arteritis
chr6	31765873	.	G	A	Takayasu arteritis
chr6	31766173	.	CAG	C	Poor prognosis in Crohn's disease
chr6	31771343	.	G	T	Asthma (adult onset);Nonatopic asthma
chr6	31781365	.	G	A	Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)
chr6	31799896	.	T	A	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr6	31799896	.	T	TA	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr6	31826815	.	C	T	Systemic lupus erythematosus
chr6	31831299	.	T	G	Systemic lupus erythematosus
chr6	31835353	.	C	G	Thionamide-induced agranulocytosis in Graves' disease
chr6	31835353	.	C	T	Thionamide-induced agranulocytosis in Graves' disease
chr6	31840951	.	T	C	Systemic lupus erythematosus
chr6	31867385	.	G	A	Systemic lupus erythematosus
chr6	31867385	.	G	C	Systemic lupus erythematosus
chr6	31868665	.	A	G	Atopic asthma
chr6	31869289	.	C	T	Vitiligo
chr6	31879859	.	G	A	Atopic asthma
chr6	31879859	.	G	C	Atopic asthma
chr6	31879859	.	G	T	Atopic asthma
chr6	31880663	.	A	G	Takayasu arteritis
chr6	31880663	.	A	T	Takayasu arteritis
chr6	31902549	.	G	A	Systemic lupus erythematosus;Type 1 diabetes with low genetic risk score
chr6	31924864	.	T	C	Psoriasis
chr6	31949763	.	T	C	Ulcerative colitis
chr6	31951083	.	A	G	Systemic lupus erythematosus;Type 1 diabetes and autoimmune thyroid diseases;Type 1 diabetes
chr6	31965741	.	T	C	Anti-sp100 seropositivity in primary biliary cholangitis
chr6	31973120	.	A	G	Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)
chr6	32007481	.	C	A	Systemic lupus erythematosus
chr6	32007481	.	C	G	Systemic lupus erythematosus
chr6	32007481	.	C	T	Systemic lupus erythematosus
chr6	32026946	.	G	A	Systemic lupus erythematosus
chr6	32026946	.	G	C	Systemic lupus erythematosus
chr6	32037578	.	G	A	Systemic lupus erythematosus
chr6	32041524	.	A	G	Systemic lupus erythematosus
chr6	32049830	.	G	C	Systemic lupus erythematosus
chr6	32061428	.	G	A	Systemic lupus erythematosus;Type 1 diabetes
chr6	32061428	.	G	C	Systemic lupus erythematosus;Type 1 diabetes
chr6	32070773	.	C	T	Systemic lupus erythematosus
chr6	32082981	.	C	A	Systemic lupus erythematosus
chr6	32082981	.	C	T	Systemic lupus erythematosus
chr6	32092090	.	A	G	Systemic lupus erythematosus
chr6	32096949	.	T	C	Type 1 diabetes with low genetic risk score
chr6	32096949	.	T	G	Type 1 diabetes with low genetic risk score
chr6	32096949	.	TG	T	Type 1 diabetes with low genetic risk score
chr6	32111790	.	T	C	Ulcerative colitis
chr6	32111790	.	T	G	Ulcerative colitis
chr6	32115398	.	C	T	Takayasu arteritis
chr6	32128224	.	C	A	Sarcoidosis (Lofgren's syndrome);Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)
chr6	32128224	.	C	G	Sarcoidosis (Lofgren's syndrome);Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)
chr6	32143246	.	CA	C	Systemic lupus erythematosus
chr6	32166618	.	C	G	ICD10 L40: Psoriasis;Psoriasis
chr6	32179919	.	G	A	Takayasu arteritis
chr6	32179919	.	G	C	Takayasu arteritis
chr6	32180254	.	A	G	Takayasu arteritis
chr6	32180626	.	G	C	Psoriasis
chr6	32182039	.	T	C	Takayasu arteritis
chr6	32187804	.	A	G	Asthma
chr6	32193619	.	T	A	Sarcoidosis (non-Lofgren's syndrome without extrapulmonary manifestations)
chr6	32193619	.	T	G	Sarcoidosis (non-Lofgren's syndrome without extrapulmonary manifestations)
chr6	32212119	.	C	T	Mixed cryoglobulinemia vasculitis in chronic hepatitis C infection
chr6	32216568	.	T	C	Asthma
chr6	32220606	.	T	C	Systemic lupus erythematosus
chr6	32222629	.	A	G	Systemic sclerosis
chr6	32223680	.	G	A	Takayasu arteritis
chr6	32224440	.	C	T	Systemic lupus erythematosus
chr6	32231204	.	C	T	Type 1 diabetes with low genetic risk score
chr6	32233814	.	G	A	Atopic asthma
chr6	32234432	.	A	C	Type 1 diabetes
chr6	32234432	.	A	T	Type 1 diabetes
chr6	32237268	.	G	A	Ulcerative colitis
chr6	32237333	.	T	C	Crohn's disease
chr6	32238711	.	C	T	Type 1 diabetes (age at diagnosis)
chr6	32240547	.	C	A	Celiac disease
chr6	32240547	.	C	T	Celiac disease
chr6	32249455	.	A	G	Lupus nephritis in systemic lupus erythematosus
chr6	32249455	.	A	T	Lupus nephritis in systemic lupus erythematosus
chr6	32251212	.	G	A	Rheumatoid arthritis;Systemic sclerosis
chr6	32255481	.	T	C	Systemic lupus erythematosus
chr6	32279268	.	T	G	Ulcerative colitis
chr6	32286483	.	T	TTA	Systemic lupus erythematosus
chr6	32304379	.	A	T	Sj√∂gren's syndrome
chr6	32313239	.	A	G	Atopic asthma
chr6	32314291	.	G	A	Asthma (childhood onset)
chr6	32314291	.	G	C	Asthma (childhood onset)
chr6	32315077	.	A	G	Rheumatoid arthritis
chr6	32319552	.	C	T	Nonatopic asthma
chr6	32331681	.	T	C	Systemic lupus erythematosus
chr6	32333032	.	A	G	Kawasaki disease
chr6	32333032	.	A	T	Kawasaki disease
chr6	32334605	.	C	T	Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome);Type 1 diabetes with low genetic risk score
chr6	32337461	.	C	T	Asthma (childhood onset)
chr6	32337881	.	C	A	Type 1 diabetes (age at diagnosis)
chr6	32338202	.	G	T	Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis)
chr6	32343682	.	G	A	Atopic asthma
chr6	32353696	.	A	G	Systemic lupus erythematosus
chr6	32359144	.	T	C	Systemic lupus erythematosus
chr6	32368410	.	T	C	Multiple sclerosis
chr6	32368768	.	G	A	Celiac disease (PheCode 557.1)
chr6	32369853	.	G	A	Graves' disease
chr6	32369853	.	G	C	Graves' disease
chr6	32370918	.	A	G	Asthma
chr6	32377506	.	C	A	Vitiligo
chr6	32389462	.	T	A	Systemic lupus erythematosus
chr6	32390736	.	G	A	Asthma
chr6	32393356	.	A	G	Atopic asthma;Takayasu arteritis
chr6	32395438	.	T	C	Type 1 diabetes and autoimmune thyroid diseases
chr6	32396039	.	T	C	Sarcoidosis
chr6	32396067	.	C	T	Ulcerative colitis
chr6	32398119	.	A	G	Adult asthma;Asthma
chr6	32400000	.	A	T	Crohn's disease x smoking status (never vs current smoking) interaction
chr6	32400070	.	T	C	Crohn's disease x smoking status (never vs ever smoking) interaction
chr6	32400310	.	T	C	Multiple sclerosis (OCB status)
chr6	32400783	.	C	G	Systemic lupus erythematosus
chr6	32400783	.	C	T	Systemic lupus erythematosus
chr6	32405455	.	G	T	Crohn's disease
chr6	32405535	.	C	T	Knee osteoarthritis
chr6	32405601	.	A	T	Type 1 diabetes
chr6	32405921	.	G	A	Vitiligo
chr6	32405921	.	G	T	Vitiligo
chr6	32408196	.	C	A	Asthma;Rheumatoid arthritis
chr6	32408196	.	C	T	Asthma;Rheumatoid arthritis
chr6	32409276	.	C	T	Asthma (childhood onset)
chr6	32411536	.	A	ACACAC	Systemic lupus erythematosus
chr6	32411712	.	C	T	Asthma;Childhood asthma with severe exacerbations
chr6	32413132	.	A	C	Takayasu arteritis
chr6	32417115	.	G	A	Immunoglobulin A vasculitis
chr6	32421366	.	C	T	Thionamide-induced agranulocytosis in Graves' disease
chr6	32421478	.	C	A	Type 1 diabetes (age at diagnosis)
chr6	32421528	.	T	C	ACPA-positive rheumatoid arthritis (smoking interaction)
chr6	32427864	.	T	C	Type 1 diabetes (age at diagnosis)
chr6	32427949	.	A	G	Idiopathic inflammatory myopathy
chr6	32430086	.	G	T	Immunoglobulin A vasculitis
chr6	32433259	.	A	T	Immunoglobulin A vasculitis
chr6	32433440	.	C	T	Multiple sclerosis
chr6	32438565	.	A	C	Multiple sclerosis (OCB status)
chr6	32438696	.	A	G	Neutralising antibody response to interferon beta therapy in multiple sclerosis (antibody titre; IFNŒ≤-1a subcutaneous and intramuscular)
chr6	32438696	.	A	T	Neutralising antibody response to interferon beta therapy in multiple sclerosis (antibody titre; IFNŒ≤-1a subcutaneous and intramuscular)
chr6	32440267	.	A	C	Primary biliary cholangitis
chr6	32440720	.	A	G	Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome);Sj√∂gren's syndrome;Systemic lupus erythematosus
chr6	32440750	.	C	G	Type 1 diabetes
chr6	32440750	.	C	T	Type 1 diabetes
chr6	32441130	.	G	A	Adult asthma
chr6	32441753	.	G	A	Systemic sclerosis
chr6	32441931	.	C	T	Immunoglobulin A vasculitis
chr6	32442914	.	G	A	Primary biliary cholangitis
chr6	32443869	.	T	G	Immunoglobulin A vasculitis
chr6	32444069	.	C	A	Ulcerative colitis
chr6	32444069	.	C	G	Ulcerative colitis
chr6	32444069	.	C	T	Ulcerative colitis
chr6	32444658	.	G	A	Immunoglobulin A vasculitis
chr6	32444762	.	A	G	Immunoglobulin A vasculitis
chr6	32445274	.	A	G	Multiple sclerosis
chr6	32445317	.	A	G	Immunoglobulin A vasculitis
chr6	32445373	.	G	A	Immunoglobulin A vasculitis
chr6	32445682	.	G	A	Immunoglobulin A vasculitis
chr6	32445768	.	G	A	Multiple sclerosis
chr6	32445768	.	G	T	Multiple sclerosis
chr6	32446053	.	G	C	Immunoglobulin A vasculitis
chr6	32446496	.	T	A	ACPA-positive rheumatoid arthritis (smoking interaction);Asthma;Ulcerative colitis x smoking status (never vs ever smoking) interaction
chr6	32446496	.	T	C	ACPA-positive rheumatoid arthritis (smoking interaction);Asthma;Ulcerative colitis x smoking status (never vs ever smoking) interaction
chr6	32447303	.	G	A	ACPA-positive rheumatoid arthritis (smoking interaction)
chr6	32447434	.	G	A	Immunoglobulin A vasculitis
chr6	32448081	.	A	G	Immunoglobulin A vasculitis
chr6	32448198	.	G	A	Immunoglobulin A vasculitis
chr6	32448301	.	A	G	Immunoglobulin A vasculitis
chr6	32449301	.	T	A	Systemic lupus erythematosus
chr6	32449301	.	T	G	Systemic lupus erythematosus
chr6	32452182	.	A	G	Systemic lupus erythematosus
chr6	32452402	.	C	T	Immunoglobulin A vasculitis
chr6	32453727	.	T	C	Immunoglobulin A vasculitis
chr6	32455739	.	C	G	Asthma (adult onset);Nonatopic asthma
chr6	32456138	.	C	A	Systemic lupus erythematosus
chr6	32456138	.	C	G	Systemic lupus erythematosus
chr6	32456138	.	C	T	Systemic lupus erythematosus
chr6	32456254	.	C	T	Immunoglobulin A vasculitis
chr6	32456817	.	T	C	Asthma (adult onset);Atopic asthma;Nonatopic asthma
chr6	32457527	.	A	G	Immunoglobulin A vasculitis
chr6	32457985	.	A	T	Systemic juvenile idiopathic arthritis
chr6	32459604	.	G	T	Immunoglobulin A vasculitis
chr6	32460012	.	T	C	Immunoglobulin A vasculitis
chr6	32460995	.	A	G	Rheumatoid arthritis
chr6	32461526	.	G	A	Exacerbations requiring hospitalisation in asthma;Nonatopic asthma
chr6	32461526	.	G	C	Exacerbations requiring hospitalisation in asthma;Nonatopic asthma
chr6	32461866	.	T	C	Fulminant type 1 diabetes;Ulcerative colitis
chr6	32463370	.	A	G	Poor prognosis in Crohn's disease;Ulcerative colitis
chr6	32463370	.	A	T	Poor prognosis in Crohn's disease;Ulcerative colitis
chr6	32464723	.	G	A	Asthma
chr6	32465058	.	C	T	Ulcerative colitis
chr6	32465348	.	A	C	Immunoglobulin A vasculitis
chr6	32465390	.	G	T	Ulcerative colitis
chr6	32467772	.	G	A	Systemic lupus erythematosus
chr6	32469767	.	C	A	Systemic lupus erythematosus
chr6	32469977	.	G	A	Type 1 diabetes with low genetic risk score
chr6	32472544	.	CTG	C	Vitiligo (early onset)
chr6	32473192	.	G	A	Adult asthma
chr6	32474341	.	GC	G	Systemic lupus erythematosus
chr6	32475492	.	A	C	Immunoglobulin A vasculitis
chr6	32476421	.	G	C	Rheumatoid arthritis
chr6	32476421	.	G	T	Rheumatoid arthritis
chr6	32480822	.	C	A	Rheumatoid arthritis
chr6	32480822	.	C	G	Rheumatoid arthritis
chr6	32480822	.	C	T	Rheumatoid arthritis
chr6	32481634	.	T	C	Sarcoidosis (non-Lofgren's syndrome);Sarcoidosis (non-Lofgren's syndrome without extrapulmonary manifestations)
chr6	32482119	.	C	T	Systemic lupus erythematosus
chr6	32483985	.	A	C	Systemic lupus erythematosus
chr6	32483985	.	A	T	Systemic lupus erythematosus
chr6	32484011	.	G	C	Rheumatoid arthritis;Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)
chr6	32486076	.	T	C	Joint damage in rheumatoid arthritis
chr6	32486159	.	T	C	Rheumatoid arthritis
chr6	32486159	.	T	G	Rheumatoid arthritis
chr6	32490013	.	A	G	Asthma
chr6	32501644	.	A	C	Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies; IFNŒ≤-1a subcutaneous and intramuscular)
chr6	32501644	.	A	G	Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies; IFNŒ≤-1a subcutaneous and intramuscular)
chr6	32501644	.	A	T	Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies; IFNŒ≤-1a subcutaneous and intramuscular)
chr6	32514325	.	A	G	Asthma
chr6	32516743	.	C	A	Type 1 diabetes
chr6	32516743	.	C	G	Type 1 diabetes
chr6	32528217	.	T	A	Acute anterior uveitis (with or without ankylosing spondylitis)
chr6	32528394	.	C	A	Asthma
chr6	32528394	.	C	G	Asthma
chr6	32533367	.	C	T	Rheumatoid arthritis
chr6	32535377	.	A	G	Type 1 diabetes
chr6	32549268	.	G	C	Late-onset myasthenia gravis
chr6	32553130	.	T	C	Multiple sclerosis (OCB status)
chr6	32553130	.	T	G	Multiple sclerosis (OCB status)
chr6	32566804	.	T	A	Ulcerative colitis
chr6	32571334	.	T	A	Asthma
chr6	32573442	.	A	T	Asthma
chr6	32576344	.	T	C	Asthma
chr6	32578889	.	G	A	Asthma
chr6	32581754	.	T	C	Nonatopic asthma
chr6	32582349	.	C	G	Asthma (adult onset)
chr6	32586302	.	T	C	Asthma
chr6	32586627	.	C	G	Asthma (adult onset)
chr6	32586627	.	C	T	Asthma (adult onset)
chr6	32590413	.	G	C	Systemic lupus erythematosus
chr6	32590413	.	G	T	Systemic lupus erythematosus
chr6	32591987	.	T	C	Systemic lupus erythematosus
chr6	32593093	.	T	A	Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies; IFNŒ≤-1b subcutaneous)
chr6	32593593	.	C	T	Rheumatoid arthritis
chr6	32596935	.	C	G	Type 1 diabetes with low genetic risk score
chr6	32598319	.	C	G	Systemic lupus erythematosus
chr6	32600901	.	C	A	Adult asthma
chr6	32602623	.	T	C	Joint damage in rheumatoid arthritis
chr6	32602624	.	G	A	Neutralising antibody response to interferon beta therapy in multiple sclerosis (area under the curve for the first two years);Neutralising antibody response to interferon beta therapy in multiple sclerosis (maximum antibody levels);Neutralising antibody response to interferon beta therapy in multiple sclerosis (mean antibody levels)
chr6	32604425	.	C	T	Asthma (childhood onset)
chr6	32605694	.	A	G	Narcolepsy (onset before 2009 H1N1 influenza pandemic)
chr6	32605797	.	C	T	Systemic lupus erythematosus
chr6	32606214	.	T	A	Systemic lupus erythematosus
chr6	32606214	.	T	G	Systemic lupus erythematosus
chr6	32606283	.	A	C	Myasthenia gravis
chr6	32606394	.	G	A	Rheumatoid arthritis
chr6	32606394	.	G	C	Rheumatoid arthritis
chr6	32606581	.	G	A	Nonatopic asthma
chr6	32607091	.	C	T	Asthma
chr6	32607736	.	C	A	Crohn's disease
chr6	32607736	.	C	G	Crohn's disease
chr6	32607747	.	G	T	Asthma (adult onset)
chr6	32607854	.	A	G	Takayasu arteritis
chr6	32607958	.	A	G	Mixed cryoglobulinemia vasculitis in chronic hepatitis C infection
chr6	32608701	.	T	A	Systemic lupus erythematosus
chr6	32608701	.	T	C	Systemic lupus erythematosus
chr6	32609018	.	C	T	Narcolepsy (onset before 2009 H1N1 influenza pandemic)
chr6	32609603	.	A	G	Rheumatoid arthritis;Rheumatoid arthritis (ACPA-negative);Rheumatoid arthritis (ACPA-positive)
chr6	32610813	.	A	G	Atopic asthma
chr6	32611258	.	G	A	Ulcerative colitis
chr6	32613907	.	T	A	Systemic lupus erythematosus
chr6	32613907	.	T	G	Systemic lupus erythematosus
chr6	32613962	.	AAT	A	Asthma (moderate or severe)
chr6	32614112	.	C	T	Immunoglobulin A vasculitis
chr6	32614145	.	C	A	Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies)
chr6	32614145	.	C	T	Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies)
chr6	32614705	.	C	A	Composite immunoglobulin trait (IgA x IgG x IgM)
chr6	32614705	.	C	G	Composite immunoglobulin trait (IgA x IgG x IgM)
chr6	32614705	.	C	T	Composite immunoglobulin trait (IgA x IgG x IgM)
chr6	32614873	.	C	G	ACPA-positive rheumatoid arthritis (smoking interaction);Rheumatoid arthritis
chr6	32614963	.	C	T	Steroid induced osteonecrosis of the femoral head and systemic lupus erythematosus
chr6	32615580	.	A	T	ACPA-positive rheumatoid arthritis (smoking interaction)
chr6	32615624	.	C	A	Type 1 diabetes (age at diagnosis)
chr6	32615965	.	G	A	Rheumatoid arthritis (ACPA-negative)
chr6	32616103	.	A	G	Nonatopic asthma
chr6	32616804	.	C	T	Asthma (childhood onset)
chr6	32617103	.	A	G	Atopic asthma
chr6	32618190	.	A	G	Asthma
chr6	32618459	.	C	A	Asthma (childhood onset);Atopic asthma
chr6	32619017	.	T	G	Nonatopic asthma
chr6	32619077	.	G	A	Crohn's disease;Immunoglobulin A;Multiple sclerosis;Systemic lupus erythematosus;Ulcerative colitis;Ulcerative colitis or Crohn's disease
chr6	32619290	.	G	A	Late-onset myasthenia gravis
chr6	32619290	.	G	C	Late-onset myasthenia gravis
chr6	32619380	.	A	G	Asthma;Asthma (adult onset);Nonatopic asthma
chr6	32620208	.	A	G	Systemic lupus erythematosus
chr6	32620853	.	T	C	Adult asthma
chr6	32620936	.	T	A	Myasthenia gravis
chr6	32620936	.	T	C	Myasthenia gravis
chr6	32621440	.	A	T	Asthma (childhood onset);Atopic asthma
chr6	32622251	.	G	A	Takayasu arteritis
chr6	32622724	.	A	C	Sj√∂gren's syndrome
chr6	32622945	.	G	T	Immunoglobulin A vasculitis
chr6	32623148	.	G	A	Systemic sclerosis
chr6	32623176	.	T	C	Hydrolysed wheat protein allergy;Sj√∂gren's syndrome
chr6	32623281	.	A	C	Immunoglobulin A vasculitis
chr6	32623514	.	T	A	Vitiligo;Vitiligo (early onset);Vitiligo (late onset)
chr6	32623692	.	A	G	Immunoglobulin A vasculitis
chr6	32624423	.	T	C	Multiple sclerosis (OCB status);Oligoclonal band status in multiple sclerosis
chr6	32625016	.	C	T	Asthma (adult onset)
chr6	32625056	.	C	G	Neutralising antibody response to interferon beta therapy in multiple sclerosis (antibody titre; IFNŒ≤-1a subcutaneous)
chr6	32625421	.	G	A	Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies; IFNŒ≤-1a subcutaneous)
chr6	32625421	.	G	C	Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies; IFNŒ≤-1a subcutaneous)
chr6	32625742	.	G	A	Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; IFNŒ≤-1a subcutaneous and intramuscular)
chr6	32625900	.	A	G	Asthma
chr6	32626378	.	A	T	Rheumatoid arthritis
chr6	32626820	.	T	TAGA	Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; IFNŒ≤-1a subcutaneous)
chr6	32626821	.	A	AGAG	Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; IFNŒ≤-1a subcutaneous)
chr6	32626884	.	A	G	Systemic lupus erythematosus
chr6	32628945	.	A	AT	Neutralising antibody response to interferon beta therapy in multiple sclerosis (antibody titre; all treatment preparations);Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies; all treatment preparations)
chr6	32629245	.	G	A	ACPA-positive rheumatoid arthritis (smoking interaction)
chr6	32629287	.	G	A	Sj√∂gren's syndrome
chr6	32629564	.	G	A	Asthma
chr6	32630251	.	C	T	Allergic disease (asthma, hay fever or eczema)
chr6	32631710	.	G	C	Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; all treatment preparations)
chr6	32632222	.	G	A	Nonatopic asthma
chr6	32632280	.	A	G	Antineutrophil cytoplasmic antibody-associated vasculitis
chr6	32632598	.	T	C	Multiple sclerosis
chr6	32634619	.	C	T	Adult asthma
chr6	32634705	.	T	C	Adult onset asthma or type 2 diabetes;Asthma (adult onset)
chr6	32634706	.	G	A	Asthma (moderate or severe)
chr6	32634706	.	G	T	Asthma (moderate or severe)
chr6	32635230	.	A	G	Multiple sclerosis
chr6	32635710	.	T	C	Asthma
chr6	32636595	.	G	A	Asthma;Asthma (adult onset);Asthma (age of onset);Asthma (childhood onset);Asthma (time to onset);Type 1 diabetes
chr6	32637412	.	A	C	Asthma (adult onset);Autoimmune thyroid disease
chr6	32637412	.	A	G	Asthma (adult onset);Autoimmune thyroid disease
chr6	32637412	.	A	T	Asthma (adult onset);Autoimmune thyroid disease
chr6	32638107	.	C	T	Celiac disease;Immunoglobulin A;Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome);Systemic lupus erythematosus;Ulcerative colitis
chr6	32638467	.	C	G	Asthma
chr6	32638467	.	C	T	Asthma
chr6	32638702	.	G	A	Asthma
chr6	32639108	.	G	A	Asthma
chr6	32639108	.	G	C	Asthma
chr6	32639108	.	G	T	Asthma
chr6	32639135	.	A	G	Asthma
chr6	32639784	.	C	T	Ocular sarcoidosis
chr6	32641349	.	T	A	Childhood asthma with severe exacerbations
chr6	32641349	.	T	C	Childhood asthma with severe exacerbations
chr6	32641593	.	G	T	Asthma
chr6	32642480	.	T	C	Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; IFNŒ≤-1b subcutaneous);Neutralising antibody response to interferon beta therapy in multiple sclerosis (antibody titre; IFNŒ≤-1b subcutaneous)
chr6	32643864	.	A	G	Asthma (childhood onset)
chr6	32644524	.	T	A	Systemic lupus erythematosus
chr6	32644524	.	T	C	Systemic lupus erythematosus
chr6	32644620	.	A	G	Ulcerative colitis
chr6	32644653	.	T	A	Asthma
chr6	32644653	.	T	C	Asthma
chr6	32644878	.	A	G	Ocular sarcoidosis
chr6	32644878	.	A	T	Ocular sarcoidosis
chr6	32644956	.	G	A	Asthma
chr6	32645641	.	T	A	Systemic lupus erythematosus
chr6	32647569	.	C	G	Ocular sarcoidosis
chr6	32647733	.	C	T	Asthma
chr6	32647774	.	A	G	Atopic asthma;Pediatric asthma
chr6	32650032	.	A	G	Asthma
chr6	32652506	.	C	T	Adult asthma
chr6	32655373	.	T	C	Systemic lupus erythematosus
chr6	32657607	.	G	T	Systemic lupus erythematosus
chr6	32658092	.	T	C	Asthma
chr6	32658092	.	T	G	Asthma
chr6	32658238	.	C	A	Allergic disease (asthma, hay fever and/or eczema) (age of onset);Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis)
chr6	32658238	.	C	T	Allergic disease (asthma, hay fever and/or eczema) (age of onset);Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis)
chr6	32658353	.	G	A	Narcolepsy (age of onset)
chr6	32658490	.	G	T	Takayasu arteritis
chr6	32658495	.	C	A	Type 1 diabetes
chr6	32658534	.	T	C	Self-reported allergy
chr6	32658571	.	C	T	Allergic disease (asthma, hay fever or eczema);Asthma (adult onset);Asthma (childhood onset)
chr6	32658626	.	A	G	Allergic disease (asthma, hay fever or eczema);Allergy
chr6	32658661	.	A	T	Type 1 diabetes
chr6	32658698	.	G	A	Latent autoimmune diabetes vs. type 1 diabetes
chr6	32658824	.	A	G	Asthma and hay fever
chr6	32658837	.	A	G	Asthma or allergic disease (pleiotropy)
chr6	32658837	.	A	T	Asthma or allergic disease (pleiotropy)
chr6	32659200	.	T	A	Asthma
chr6	32659200	.	T	C	Asthma
chr6	32659207	.	A	C	Juvenile rheumatoid arthritis
chr6	32659473	.	C	A	Asthma-COPD overlap syndrome;Asthma (moderate or severe)
chr6	32659923	.	A	G	Asthma (adult onset);Nonatopic asthma
chr6	32659937	.	T	G	Ulcerative colitis
chr6	32660056	.	A	G	Adult asthma;Type 1 diabetes
chr6	32660651	.	C	A	Asthma and major depressive disorder
chr6	32660883	.	T	C	Sarcoidosis
chr6	32661939	.	T	C	Takayasu arteritis
chr6	32663120	.	T	C	Sarcoidosis
chr6	32664858	.	A	C	Systemic lupus erythematosus
chr6	32664858	.	A	G	Systemic lupus erythematosus
chr6	32665110	.	C	A	Asthma
chr6	32665110	.	C	T	Asthma
chr6	32665218	.	C	G	Atopic asthma
chr6	32665936	.	A	G	Narcolepsy (age of onset)
chr6	32666449	.	G	A	Ocular sarcoidosis
chr6	32666690	.	C	T	Autoimmune hepatitis in primary sclerosing cholangitis
chr6	32666988	.	T	C	Asthma (childhood onset)
chr6	32668172	.	G	A	Asthma
chr6	32668608	.	A	G	Asthma (age of onset)
chr6	32668608	.	A	T	Asthma (age of onset)
chr6	32668951	.	G	A	Crohn's disease
chr6	32670398	.	G	A	Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; all treatment preparations)
chr6	32679602	.	C	A	Exacerbations requiring hospitalisation in asthma
chr6	32679602	.	C	T	Exacerbations requiring hospitalisation in asthma
chr6	32681887	.	T	A	Asthma
chr6	32681887	.	T	C	Asthma
chr6	32682984	.	C	T	Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; IFNŒ≤-1b subcutaneous)
chr6	32683763	.	C	T	Narcolepsy (age of onset)
chr6	32684540	.	A	G	Asthma
chr6	32684540	.	A	T	Asthma
chr6	32684938	.	T	A	Type 1 diabetes
chr6	32686195	.	A	G	Primary biliary cholangitis
chr6	32687771	.	G	A	Immunoglobulin A vasculitis
chr6	32687953	.	A	G	Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; IFNŒ≤-1a subcutaneous and intramuscular)
chr6	32688139	.	C	G	Systemic lupus erythematosus
chr6	32689659	.	T	C	Systemic lupus erythematosus
chr6	32689801	.	T	C	Primary biliary cholangitis
chr6	32690139	.	T	C	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)
chr6	32690302	.	T	C	Asthma;Kawasaki disease
chr6	32690533	.	G	A	Crohn's disease
chr6	32690917	.	T	A	Systemic lupus erythematosus
chr6	32690917	.	T	C	Systemic lupus erythematosus
chr6	32691666	.	A	C	Crohn's disease
chr6	32691868	.	A	G	Primary sclerosing cholangitis
chr6	32692120	.	T	C	Immunoglobulin A vasculitis
chr6	32692964	.	G	A	Asthma (childhood onset)
chr6	32692964	.	G	T	Asthma (childhood onset)
chr6	32693798	.	C	T	Immunoglobulin A vasculitis
chr6	32694218	.	T	C	Asthma
chr6	32695144	.	C	A	Immunoglobulin A vasculitis
chr6	32695197	.	C	T	Asthma (adult onset)
chr6	32695381	.	G	A	Systemic lupus erythematosus
chr6	32695381	.	G	C	Systemic lupus erythematosus
chr6	32695854	.	T	C	Multiple sclerosis (OCB status)
chr6	32695987	.	G	A	Immunoglobulin A vasculitis
chr6	32696074	.	C	A	Graves' disease;Immunoglobulin G index levels in multiple sclerosis;Rheumatoid arthritis;Systemic sclerosis;Thyrotoxic hypokalemic periodic paralysis and Graves disease
chr6	32696074	.	C	T	Graves' disease;Immunoglobulin G index levels in multiple sclerosis;Rheumatoid arthritis;Systemic sclerosis;Thyrotoxic hypokalemic periodic paralysis and Graves disease
chr6	32696159	.	A	C	Immunoglobulin A vasculitis
chr6	32696222	.	G	C	Rheumatoid arthritis
chr6	32696261	.	A	G	Immunoglobulin A vasculitis
chr6	32696681	.	T	C	Lupus nephritis in systemic lupus erythematosus;Systemic lupus erythematosus
chr6	32696851	.	A	G	Immunoglobulin A vasculitis
chr6	32697103	.	T	G	Atopic asthma
chr6	32697348	.	C	T	Immunoglobulin A vasculitis
chr6	32697473	.	C	T	Immunoglobulin A vasculitis
chr6	32697643	.	T	G	Immunoglobulin A vasculitis
chr6	32697910	.	G	T	Immunoglobulin A vasculitis
chr6	32698749	.	C	T	Type 1 diabetes with low genetic risk score
chr6	32699290	.	T	C	Immunoglobulin A vasculitis
chr6	32699330	.	T	C	ACPA-positive rheumatoid arthritis (smoking interaction)
chr6	32699394	.	A	T	Anti-sp100 seropositivity in primary biliary cholangitis
chr6	32699886	.	G	C	Systemic lupus erythematosus
chr6	32700118	.	C	G	Type 1 diabetes (age at diagnosis)
chr6	32700133	.	G	A	Asthma;Type 1 diabetes
chr6	32700187	.	G	A	Systemic lupus erythematosus
chr6	32700187	.	G	C	Systemic lupus erythematosus
chr6	32701379	.	T	C	Systemic sclerosis
chr6	32702178	.	G	T	Rheumatoid arthritis
chr6	32702260	.	G	T	Immunoglobulin A vasculitis
chr6	32703056	.	G	A	Immunoglobulin A vasculitis
chr6	32703056	.	G	T	Immunoglobulin A vasculitis
chr6	32703201	.	A	C	Sero-negative rheumatoid arthritis
chr6	32703201	.	A	G	Sero-negative rheumatoid arthritis
chr6	32703326	.	T	C	Rheumatoid arthritis
chr6	32705797	.	A	T	ACPA-positive rheumatoid arthritis (smoking interaction)
chr6	32706448	.	T	C	Immunoglobulin A vasculitis
chr6	32706552	.	G	A	Adult onset asthma or type 2 diabetes
chr6	32706866	.	A	G	Immunoglobulin A vasculitis
chr6	32706948	.	A	G	Systemic lupus erythematosus
chr6	32707332	.	T	C	Alopecia areata
chr6	32707693	.	G	A	Rheumatoid arthritis
chr6	32707746	.	G	C	ACPA-positive rheumatoid arthritis (smoking interaction)
chr6	32707857	.	C	A	ACPA-positive rheumatoid arthritis (smoking interaction)
chr6	32707857	.	C	G	ACPA-positive rheumatoid arthritis (smoking interaction)
chr6	32710135	.	C	T	Multiple sclerosis (OCB status)
chr6	32710405	.	C	G	Immunoglobulin A vasculitis
chr6	32710405	.	C	T	Immunoglobulin A vasculitis
chr6	32710422	.	G	A	Nonatopic asthma;Nonatopic asthma and/or BMI
chr6	32711222	.	A	G	Alopecia areata;Immunoglobulin A vasculitis;Systemic lupus erythematosus
chr6	32711222	.	A	T	Alopecia areata;Immunoglobulin A vasculitis;Systemic lupus erythematosus
chr6	32711607	.	G	T	Immunoglobulin A vasculitis
chr6	32711685	.	A	G	Immunoglobulin A vasculitis
chr6	32712293	.	C	T	Immunoglobulin A vasculitis;Sarcoidosis (non-Lofgren's syndrome without extrapulmonary manifestations)
chr6	32712345	.	G	A	Systemic lupus erythematosus
chr6	32712345	.	G	C	Systemic lupus erythematosus
chr6	32713151	.	T	G	Crohn's disease;Rheumatoid arthritis
chr6	32713500	.	A	G	Immunoglobulin A vasculitis
chr6	32713706	.	T	C	ACPA-positive rheumatoid arthritis (smoking interaction);Vasculitis associated with antineutrophil cytoplasmic antibody reactive to myeloperoxidase
chr6	32713753	.	T	C	ACPA-positive rheumatoid arthritis (smoking interaction)
chr6	32713854	.	C	T	Peanut allergy
chr6	32714215	.	T	C	Immunoglobulin A vasculitis
chr6	32714242	.	A	C	ACPA-positive rheumatoid arthritis (smoking interaction)
chr6	32714358	.	C	T	Systemic lupus erythematosus
chr6	32714422	.	T	C	Type 1 diabetes (age at diagnosis)
chr6	32714617	.	T	G	Type 1 diabetes (age at diagnosis)
chr6	32714652	.	C	T	Systemic lupus erythematosus
chr6	32715035	.	C	A	Asthma;Asthma (childhood onset)
chr6	32717421	.	A	G	Atopic asthma
chr6	32720196	.	A	G	Asthma
chr6	32722109	.	A	G	Systemic lupus erythematosus
chr6	32725465	.	A	G	Adult asthma
chr6	32725465	.	A	T	Adult asthma
chr6	32731211	.	C	A	Immunoglobulin N-glycan 19 levels
chr6	32732306	.	A	C	Narcolepsy
chr6	32740587	.	T	TA	Systemic lupus erythematosus
chr6	32740587	.	T	TAAAATA	Systemic lupus erythematosus
chr6	32740587	.	T	TAAATA	Systemic lupus erythematosus
chr6	32740587	.	T	TAAATAAAATA	Systemic lupus erythematosus
chr6	32744080	.	T	C	Acute anterior uveitis (with or without ankylosing spondylitis)
chr6	32744232	.	A	C	Asthma (childhood onset)
chr6	32757416	.	A	G	Systemic lupus erythematosus
chr6	32759189	.	C	T	Takayasu arteritis
chr6	32759548	.	A	C	Systemic lupus erythematosus
chr6	32759548	.	A	G	Systemic lupus erythematosus
chr6	32759548	.	A	T	Systemic lupus erythematosus
chr6	32762309	.	G	A	Systemic lupus erythematosus
chr6	32775050	.	A	C	Nonatopic asthma
chr6	32777057	.	G	A	Asthma
chr6	32777057	.	G	C	Asthma
chr6	32777057	.	G	T	Asthma
chr6	32777750	.	G	T	Asthma (adult onset)
chr6	32781712	.	G	A	Systemic lupus erythematosus
chr6	32783639	.	G	A	Asthma
chr6	32783639	.	G	T	Asthma
chr6	32795737	.	A	C	Kawasaki disease
chr6	32795737	.	A	G	Kawasaki disease
chr6	32801612	.	T	A	Asthma
chr6	32801612	.	T	G	Asthma
chr6	32809144	.	T	C	Type 1 diabetes with low genetic risk score
chr6	32810138	.	CTTT	C	Systemic lupus erythematosus
chr6	32812947	.	G	A	Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)
chr6	32814828	.	C	G	Kawasaki disease
chr6	32814828	.	C	T	Kawasaki disease
chr6	32815628	.	C	T	Takayasu arteritis
chr6	32819398	.	G	C	ACPA-positive rheumatoid arthritis (smoking interaction)
chr6	32821623	.	A	G	Atopic asthma
chr6	32827255	.	G	A	ACPA-positive rheumatoid arthritis (smoking interaction)
chr6	32829996	.	T	C	Thionamide-induced agranulocytosis in Graves' disease
chr6	32830954	.	C	T	Type 1 diabetes and autoimmune thyroid diseases
chr6	32836522	.	C	G	Sarcoidosis (non-Lofgren's syndrome without extrapulmonary manifestations)
chr6	32836522	.	C	T	Sarcoidosis (non-Lofgren's syndrome without extrapulmonary manifestations)
chr6	32836637	.	A	G	Type 1 diabetes (age at diagnosis)
chr6	32836637	.	A	T	Type 1 diabetes (age at diagnosis)
chr6	32836793	.	G	A	Asthma (childhood onset);Atopic asthma;Type 1 diabetes
chr6	32837272	.	T	C	Composite immunoglobulin trait (IgA/IgG)
chr6	32838614	.	C	G	Type 1 diabetes (age at diagnosis)
chr6	32838614	.	C	T	Type 1 diabetes (age at diagnosis)
chr6	32838776	.	G	A	Ulcerative colitis (PheCode 555.2)
chr6	32850253	.	T	C	Systemic lupus erythematosus
chr6	32898318	.	A	G	Systemic lupus erythematosus
chr6	32898318	.	A	T	Systemic lupus erythematosus
chr6	32905142	.	C	T	Asthma (childhood onset)
chr6	32911694	.	A	G	Type 1 diabetes with low genetic risk score
chr6	32945469	.	C	T	Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)
chr6	32978829	.	CAG	C	Type 1 diabetes
chr6	32981027	.	C	T	Crohn's disease;Ulcerative colitis
chr6	32992717	.	G	A	Asthma (adult onset);Nonatopic asthma
chr6	32993584	.	G	A	Asthma
chr6	33015971	.	C	T	Nonatopic asthma
chr6	33020111	.	A	G	Type 1 diabetes with low genetic risk score
chr6	33037657	.	G	A	Ocular sarcoidosis
chr6	33037657	.	G	T	Ocular sarcoidosis
chr6	33058333	.	A	C	Systemic lupus erythematosus
chr6	33063835	.	C	T	Asthma;Asthma (childhood onset);Atopic asthma
chr6	33065933	.	T	C	Allergic disease (asthma, hay fever and/or eczema) (age of onset);Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis)
chr6	33066047	.	C	T	Asthma;Asthma (childhood onset)
chr6	33066800	.	C	A	Systemic lupus erythematosus
chr6	33066800	.	C	T	Systemic lupus erythematosus
chr6	33071848	.	T	A	Antineutrophil cytoplasmic antibody-associated vasculitis
chr6	33071848	.	T	C	Antineutrophil cytoplasmic antibody-associated vasculitis
chr6	33072321	.	C	T	Graves' disease
chr6	33073296	.	A	C	Graves' disease
chr6	33073296	.	A	T	Graves' disease
chr6	33075103	.	A	G	Asthma;Systemic sclerosis
chr6	33076238	.	G	T	Systemic lupus erythematosus
chr6	33078965	.	T	C	Osteoarthritis;Osteoarthritis of the hip or knee
chr6	33078975	.	G	A	Allergic disease (asthma, hay fever or eczema)
chr6	33078975	.	G	C	Allergic disease (asthma, hay fever or eczema)
chr6	33079254	.	T	C	Systemic lupus erythematosus
chr6	33080325	.	C	T	Asthma (childhood onset)
chr6	33080884	.	A	G	Aspirin exacerbated respiratory disease in asthmatics
chr6	33080911	.	G	GA	Antineutrophil cytoplasmic antibody-associated vasculitis
chr6	33080912	.	G	A	Antineutrophil cytoplasmic antibody-associated vasculitis
chr6	33081886	.	A	G	Primary biliary cholangitis
chr6	33087724	.	C	T	Knee osteoarthritis;Osteoarthritis of the hip or knee
chr6	33087761	.	C	T	Sj√∂gren's syndrome
chr6	33092341	.	G	A	Graves' disease;Thyrotoxic hypokalemic periodic paralysis and Graves disease
chr6	33102116	.	A	G	Antineutrophil cytoplasmic antibody-associated vasculitis
chr6	33103250	.	C	CTA	Neutralising antibody response to interferon beta therapy in multiple sclerosis (antibody titre; IFNŒ≤-1b subcutaneous);Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies; IFNŒ≤-1b subcutaneous)
chr6	33103250	.	C	CTATA	Neutralising antibody response to interferon beta therapy in multiple sclerosis (antibody titre; IFNŒ≤-1b subcutaneous);Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies; IFNŒ≤-1b subcutaneous)
chr6	33104395	.	T	G	Sj√∂gren's syndrome
chr6	33107889	.	C	T	Type 1 diabetes (age at diagnosis)
chr6	33128931	.	G	A	Asthma and attention deficit hyperactivity disorder;Asthma (childhood onset)
chr6	33130274	.	T	G	Atopic asthma
chr6	33130567	.	G	A	Asthma
chr6	33131761	.	G	T	Asthma;Asthma (childhood onset);Asthma onset (childhood vs adult)
chr6	33157195	.	A	G	Atopic asthma
chr6	33160210	.	C	A	Type 1 diabetes
chr6	33168798	.	C	T	Type 1 diabetes with low genetic risk score
chr6	33226700	.	G	A	Asthma
chr6	33301993	.	G	A	Type 1 diabetes with low genetic risk score
chr6	33341335	.	G	A	Systemic lupus erythematosus
chr6	33387741	.	C	T	Type 1 diabetes
chr6	33445230	.	G	A	Systemic lupus erythematosus
chr6	33464895	.	A	G	Type 1 diabetes with low genetic risk score
chr6	33472004	.	C	G	Asthma (childhood onset)
chr6	33472004	.	C	T	Asthma (childhood onset)
chr6	33489728	.	G	A	Type 1 diabetes
chr6	33512961	.	T	G	Crohn's disease or systemic sclerosis
chr6	33518955	.	G	A	Self-reported allergy
chr6	33518955	.	G	C	Self-reported allergy
chr6	33567689	.	T	C	Multiple sclerosis and systolic blood pressure (pleiotropy)
chr6	33647094	.	G	C	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr6	33685334	.	T	A	Multiple sclerosis and body mass index (pleiotropy)
chr6	33685334	.	T	C	Multiple sclerosis and body mass index (pleiotropy)
chr6	33729008	.	C	T	Multiple sclerosis and waist-to-hip-ratio (pleiotropy)
chr6	33888840	.	C	T	Celiac disease (PheCode 557.1)
chr6	33987724	.	A	C	Systemic lupus erythematosus
chr6	34260788	.	T	G	Systemic lupus erythematosus
chr6	34584135	.	C	G	Systemic lupus erythematosus
chr6	34848293	.	A	T	Systemic lupus erythematosus
chr6	34856859	.	A	T	Systemic lupus erythematosus
chr6	35147134	.	A	G	Systemic lupus erythematosus
chr6	35147134	.	A	T	Systemic lupus erythematosus
chr6	35254233	.	T	G	Asthma
chr6	35278542	.	A	T	Systemic lupus erythematosus
chr6	35568418	.	C	G	Autoimmune thyroid disease
chr6	36042054	.	AAG	AT	Rheumatoid arthritis
chr6	36042055	.	AG	A	Rheumatoid arthritis
chr6	36380912	.	T	A	Multiple sclerosis
chr6	36387877	.	A	T	Rheumatoid arthritis
chr6	36736516	.	T	G	Systemic lupus erythematosus
chr6	36747254	.	C	CG	Systemic lupus erythematosus
chr6	36747254	.	C	CGA	Systemic lupus erythematosus
chr6	36747254	.	C	CGT	Systemic lupus erythematosus
chr6	37487051	.	T	C	Diisocyanate-induced asthma
chr6	37538639	.	T	A	Systemic lupus erythematosus
chr6	41639846	.	G	C	Subjective response to placebo treatment in childhood asthma (change in cough/wheeze)
chr6	41829160	.	G	A	Cutaneous psoriasis
chr6	41829160	.	G	T	Cutaneous psoriasis
chr6	42039665	.	C	A	Crohn's disease
chr6	42039665	.	C	G	Crohn's disease
chr6	42039665	.	C	T	Crohn's disease
chr6	42909650	.	G	A	Ocular sarcoidosis
chr6	42909650	.	G	C	Ocular sarcoidosis
chr6	42909650	.	G	T	Ocular sarcoidosis
chr6	43028259	.	G	A	Ocular sarcoidosis
chr6	43678664	.	A	C	Joint damage in rheumatoid arthritis
chr6	43828231	.	G	T	Ulcerative colitis
chr6	44266184	.	C	G	Rheumatoid arthritis
chr6	44479267	.	A	G	Osteoarthritis of the hand
chr6	44479267	.	A	T	Osteoarthritis of the hand
chr6	44481960	.	G	A	Osteoarthritis
chr6	44801500	.	T	G	Asthma (childhood onset)
chr6	44809954	.	A	G	Osteoarthritis;Osteoarthritis (hip);Osteoarthritis of the hip or knee
chr6	45177665	.	C	G	Osteoarthritis of the hip or knee
chr6	45406446	.	A	G	Osteoarthritis (hip)
chr6	45715521	.	C	T	Gout (normal type)
chr6	45758093	.	A	AT	Coronary artery disease in type 1 diabetes
chr6	45758093	.	A	ATT	Coronary artery disease in type 1 diabetes
chr6	46032617	.	A	T	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr6	46677138	.	C	T	Hashimoto thyroiditis versus Graves' disease
chr6	48149081	.	A	G	Oral corticosteroid burst in asthma
chr6	48291355	.	T	C	Oral corticosteroid burst in asthma
chr6	51101004	.	C	T	Body mass index in non-asthmatics
chr6	55772142	.	A	G	Osteoarthritis (hip)
chr6	55773460	.	C	T	Osteoarthritis (with total hip replacement)
chr6	56562750	.	C	T	Oral corticosteroid burst in asthma
chr6	63486682	.	C	CTT	Asthma
chr6	63486682	.	C	CTTT	Asthma
chr6	64588658	.	G	A	Acute anterior uveitis (with or without ankylosing spondylitis)
chr6	64748694	.	C	T	Type 1 diabetes (age at diagnosis)
chr6	67602255	.	C	A	Ocular sarcoidosis
chr6	69672978	.	C	T	Response to zileuton treatment in asthma (FEV1 change interaction)
chr6	74616528	.	T	G	Systemic juvenile idiopathic arthritis
chr6	75236034	.	G	A	Diisocyanate-induced asthma
chr6	75236034	.	G	T	Diisocyanate-induced asthma
chr6	75454873	.	C	A	Osteoarthritis (hip);Osteoarthritis (with total hip replacement)
chr6	75531811	.	C	T	Osteoarthritis (hip)
chr6	84001929	.	G	A	Ocular sarcoidosis
chr6	84001929	.	G	T	Ocular sarcoidosis
chr6	89269986	.	A	C	Systemic lupus erythematosus
chr6	89517490	.	T	G	Knee osteoarthritis
chr6	89573771	.	T	C	Ocular sarcoidosis
chr6	89956054	.	A	G	Ankylosing spondylitis
chr6	90009445	.	T	C	Systemic lupus erythematosus
chr6	90099920	.	T	A	Celiac disease
chr6	90099920	.	T	C	Celiac disease
chr6	90119163	.	T	A	Asthma (childhood onset)
chr6	90119163	.	T	C	Asthma (childhood onset)
chr6	90155151	.	T	C	Type 1 diabetes
chr6	90170316	.	C	A	Celiac disease
chr6	90212021	.	C	G	Graves' disease
chr6	90216893	.	C	A	Celiac disease
chr6	90220794	.	T	A	Asthma
chr6	90220794	.	T	C	Asthma
chr6	90240909	.	C	T	Asthma (moderate or severe)
chr6	90247744	.	C	T	Type 1 diabetes;Vitiligo
chr6	90248512	.	C	G	Thyroid peroxidase autoantibody levels in type 1 diabetes;Type 1 diabetes
chr6	90248783	.	G	A	Allergic disease (asthma, hay fever or eczema)
chr6	90253895	.	A	AT	Asthma;Pediatric asthma
chr6	90253895	.	A	ATT	Asthma;Pediatric asthma
chr6	90263440	.	C	A	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Crohn's disease
chr6	90266890	.	G	A	Asthma;Asthma (childhood onset);Asthma onset (childhood vs adult)
chr6	90267049	.	G	A	Autoimmune thyroid diseases (Graves disease or Hashimoto's thyroiditis);Celiac disease;Celiac disease and Rheumatoid arthritis;Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Graves' disease;Multiple sclerosis;Rheumatoid arthritis;Type 1 diabetes;Vitiligo
chr6	90271600	.	T	A	Asthma
chr6	90271600	.	T	G	Asthma
chr6	90275479	.	A	T	Asthma;Asthma (adult onset);Asthma onset (childhood vs adult)
chr6	90276634	.	A	G	Asthma (adult onset)
chr6	90276840	.	A	G	Asthma;Nonatopic asthma
chr6	90276967	.	G	A	Asthma
chr6	90277793	.	C	G	Allergic disease (asthma, hay fever or eczema)
chr6	90279406	.	G	A	Graves' disease
chr6	90279406	.	G	C	Graves' disease
chr6	90280331	.	G	A	Autoimmune thyroid disease
chr6	90287050	.	A	G	Atopic asthma;Multiple sclerosis
chr6	90291613	.	CA	C	Asthma;Asthma (moderate or severe)
chr6	90291613	.	CAA	C	Asthma
chr6	90292775	.	A	G	Systemic lupus erythematosus
chr6	90296024	.	G	A	Asthma (childhood onset)
chr6	90296024	.	G	T	Asthma (childhood onset)
chr6	90296508	.	G	A	Asthma
chr6	90296508	.	G	C	Asthma
chr6	90301954	.	C	T	Asthma (adult onset);Asthma (childhood onset)
chr6	90305320	.	C	T	Systemic lupus erythematosus
chr6	90320722	.	T	C	Primary sclerosing cholangitis
chr6	90498823	.	T	A	Response to anti-TNF therapy in rheumatoid arthritis
chr6	90498823	.	T	C	Response to anti-TNF therapy in rheumatoid arthritis
chr6	90499109	.	A	G	Response to anti-TNF therapy in rheumatoid arthritis
chr6	91246945	.	T	C	Response to inhaled corticosteroid treatment in asthma (change in FEV1)
chr6	91486680	.	G	A	Late-onset myasthenia gravis
chr6	92324740	.	G	A	Childhood asthma exacerbations in long-acting beta2-agonist treatment
chr6	93373405	.	A	C	Diisocyanate-induced asthma
chr6	94847753	.	T	A	Coronary artery disease in type 1 diabetes
chr6	97571204	.	A	G	Multiple sclerosis (OCB status)
chr6	97910699	.	G	A	Response to inhaled glucocorticoid treatment in asthma (change in FEV1)
chr6	104775989	.	G	A	Multiple sclerosis
chr6	105164345	.	A	G	Multiple sclerosis
chr6	105813894	.	G	A	Multiple sclerosis
chr6	105813894	.	G	T	Multiple sclerosis
chr6	105987150	.	A	G	Crohn's disease
chr6	105987394	.	G	A	Crohn's disease;Ulcerative colitis
chr6	105987394	.	G	C	Crohn's disease;Ulcerative colitis
chr6	106026874	.	C	A	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr6	106026874	.	C	G	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr6	106026874	.	C	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr6	106074152	.	T	C	Ulcerative colitis
chr6	106082455	.	G	A	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr6	106090852	.	A	G	Systemic lupus erythematosus
chr6	106090852	.	A	T	Systemic lupus erythematosus
chr6	106115737	.	C	G	Primary biliary cholangitis
chr6	106115737	.	C	T	Primary biliary cholangitis
chr6	106121395	.	T	C	Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)
chr6	106165888	.	G	C	Asthma (childhood onset)
chr6	106214866	.	C	G	Atopic asthma
chr6	106286165	.	C	T	Systemic sclerosis
chr6	106564236	.	C	A	Steroid induced osteonecrosis of the femoral head and systemic lupus erythematosus
chr6	108049381	.	T	C	Psoriasis
chr6	108666024	.	T	TGTG	Poor prognosis in Crohn's disease
chr6	109007800	.	TTTTTTG	T	Asthma
chr6	111334327	.	G	A	Psoriasis
chr6	111352511	.	T	A	Psoriasis
chr6	111374888	.	T	C	Psoriasis
chr6	111526988	.	A	T	Crohn's disease;Ulcerative colitis
chr6	112340694	.	T	G	joint destruction in rheumatoid arthritis (rapid vs slow)
chr6	113158133	.	G	A	Asthma (childhood onset)
chr6	113158133	.	G	T	Asthma (childhood onset)
chr6	116369686	.	C	G	Systemic lupus erythematosus
chr6	116372957	.	C	G	Systemic lupus erythematosus
chr6	116372957	.	C	T	Systemic lupus erythematosus
chr6	117071395	.	T	A	Asthma
chr6	119953631	.	A	G	Systemic lupus erythematosus
chr6	123565086	.	C	T	Asthma exacerbations in inhaled corticosteroid treatment
chr6	124422361	.	A	G	Celiac disease
chr6	124422361	.	A	T	Celiac disease
chr6	126353208	.	A	G	Type 1 diabetes
chr6	126353208	.	A	T	Type 1 diabetes
chr6	126377573	.	A	G	Type 1 diabetes
chr6	126377573	.	A	T	Type 1 diabetes
chr6	126391101	.	G	A	Type 1 diabetes
chr6	126391101	.	G	C	Type 1 diabetes
chr6	126391101	.	G	T	Type 1 diabetes
chr6	126431738	.	C	G	Type 1 diabetes
chr6	126747838	.	T	C	Liver transplant-free survival in primary sclerosing cholangitis (time to event)
chr6	127134977	.	A	G	Crohn's disease
chr6	127136115	.	A	G	Crohn's disease
chr6	127756593	.	C	T	Type 1 diabetes with low genetic risk score
chr6	127822379	.	C	G	Asthma (childhood onset)
chr6	127835743	.	A	G	Celiac disease
chr6	127924620	.	G	T	Crohn's disease
chr6	127956006	.	A	G	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Crohn's disease
chr6	127957653	.	A	G	Celiac disease;Chronic lymphocytic leukemia or multiple sclerosis;Multiple sclerosis
chr6	127957653	.	A	T	Celiac disease;Chronic lymphocytic leukemia or multiple sclerosis;Multiple sclerosis
chr6	127958284	.	C	G	Asthma
chr6	127958284	.	C	T	Asthma
chr6	127958959	.	T	C	Multiple sclerosis
chr6	127966168	.	G	A	Asthma
chr6	127966168	.	G	T	Asthma
chr6	127970054	.	C	G	Asthma;Celiac disease
chr6	127970054	.	C	T	Asthma;Celiac disease
chr6	127970504	.	C	T	Asthma;Atopic asthma
chr6	127970926	.	T	A	Allergic disease (asthma, hay fever or eczema)
chr6	127972417	.	C	T	Asthma;Asthma (childhood onset);Celiac disease
chr6	127973564	.	T	A	Allergic disease (asthma, hay fever or eczema)
chr6	128989531	.	T	C	Asthma (childhood onset)
chr6	129897657	.	G	A	Multiple sclerosis
chr6	130348257	.	G	T	Multiple sclerosis
chr6	133178585	.	T	C	Asthma with severe exacerbations
chr6	135174088	.	C	G	Multiple sclerosis
chr6	135538559	.	G	C	Systemic lupus erythematosus
chr6	135679896	.	A	T	Systemic lupus erythematosus
chr6	136006932	.	C	T	Peak cortisol response to low dose short synacthen test in corticosteroid treated asthma
chr6	137116920	.	G	A	Multiple sclerosis
chr6	137117628	.	C	CT	Primary biliary cholangitis
chr6	137117628	.	C	CTT	Primary biliary cholangitis
chr6	137117628	.	C	CTTT	Primary biliary cholangitis
chr6	137131771	.	A	G	Multiple sclerosis
chr6	137193653	.	C	T	Behcet's disease
chr6	137638098	.	T	C	Primary biliary cholangitis;Sj√∂gren's syndrome
chr6	137638318	.	C	A	Multiple sclerosis
chr6	137638318	.	C	G	Multiple sclerosis
chr6	137638318	.	C	T	Multiple sclerosis
chr6	137641518	.	G	A	Multiple sclerosis
chr6	137641937	.	T	A	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr6	137646077	.	G	A	Multiple sclerosis
chr6	137651931	.	A	G	Celiac disease;Primary biliary cholangitis;Systemic lupus erythematosus
chr6	137652695	.	C	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr6	137678425	.	GA	G	Rheumatoid arthritis;Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)
chr6	137681038	.	C	A	Asthma;Asthma (childhood onset)
chr6	137681038	.	C	G	Asthma;Asthma (childhood onset)
chr6	137681038	.	C	T	Asthma;Asthma (childhood onset)
chr6	137681500	.	C	T	Rheumatoid arthritis
chr6	137682468	.	T	C	Type 1 diabetes
chr6	137682685	.	G	C	Celiac disease;Rheumatoid arthritis
chr6	137682685	.	G	T	Celiac disease;Rheumatoid arthritis
chr6	137684378	.	A	G	Asthma;Celiac disease;Celiac disease and Rheumatoid arthritis;Rheumatoid arthritis
chr6	137684378	.	A	T	Asthma;Celiac disease;Celiac disease and Rheumatoid arthritis;Rheumatoid arthritis
chr6	137685367	.	G	A	Rheumatoid arthritis;Rheumatoid arthritis (ACPA-positive);Systemic lupus erythematosus;Ulcerative colitis
chr6	137811379	.	T	G	Systemic lupus erythematosus and Systemic sclerosis
chr6	137850329	.	A	G	Allergic disease (asthma, hay fever or eczema)
chr6	137866361	.	C	T	Systemic lupus erythematosus or rheumatoid arthritis
chr6	137874556	.	T	C	Psoriasis
chr6	137874929	.	T	C	Rheumatoid arthritis;Systemic lupus erythematosus;Systemic sclerosis
chr6	137876687	.	C	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Psoriasis or type 2 diabetes (trans-disease meta-analysis);Psoriasis
chr6	137878280	.	G	T	Cutaneous psoriasis;Psoriasis;Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect);Psoriasis vulgaris
chr6	137913152	.	C	T	Primary sclerosing cholangitis
chr6	137916852	.	C	G	Systemic lupus erythematosus
chr6	137918297	.	C	T	Psoriasis vulgaris
chr6	137922602	.	C	G	Rheumatoid arthritis;Rheumatoid arthritis (ACPA-positive);Systemic lupus erythematosus;Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)
chr6	137923679	.	T	C	Multiple sclerosis
chr6	138197824	.	C	A	Psoriasis
chr6	139308387	.	C	T	Immunoglobulin N-glycan 10 levels
chr6	139580677	.	G	T	Multiple sclerosis
chr6	139590185	.	C	T	Multiple sclerosis
chr6	140802574	.	G	A	Diisocyanate-induced asthma
chr6	142901633	.	G	T	Asthma
chr6	143758717	.	A	G	Erectile dysfunction in type 1 diabetes
chr6	143977063	.	C	G	Adult onset asthma and/or BMI;Asthma (adult onset)
chr6	143977063	.	C	T	Adult onset asthma and/or BMI;Asthma (adult onset)
chr6	144034900	.	T	C	Peanut allergy (maternal genetic effects)
chr6	145083119	.	G	A	Response to mepolizumab in severe asthma
chr6	147671918	.	A	G	Asthma
chr6	147671918	.	A	T	Asthma
chr6	148193165	.	G	T	Autoimmune thyroid disease
chr6	149465353	.	CAAA	C	Asthma
chr6	149513438	.	T	A	Rheumatoid arthritis
chr6	149513438	.	T	C	Rheumatoid arthritis
chr6	149979828	.	T	C	Allergic disease (asthma, hay fever or eczema)
chr6	154156778	.	T	C	Asthma (childhood onset)
chr6	154306689	.	G	A	Asthma;Atopic asthma
chr6	154753371	.	T	G	Asthma
chr6	154813039	.	CAA	C	Asthma
chr6	154841029	.	T	C	Asthma
chr6	157098374	.	C	G	Allergic disease (asthma, hay fever or eczema)
chr6	157098374	.	C	T	Allergic disease (asthma, hay fever or eczema)
chr6	158203782	.	A	G	Systemic sclerosis
chr6	158913093	.	T	G	Celiac disease
chr6	158995412	.	A	C	Systemic lupus erythematosus
chr6	158995412	.	A	G	Systemic lupus erythematosus
chr6	159068759	.	G	A	Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS));Rheumatoid arthritis;Rheumatoid arthritis (ACPA-positive)
chr6	159069404	.	C	G	Crohn's disease;Crohn's disease and celiac disease
chr6	159077235	.	T	C	Celiac disease
chr6	159085568	.	C	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Psoriasis;Rheumatoid arthritis;Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)
chr6	159093828	.	G	T	Celiac disease
chr6	159094277	.	T	G	Psoriasis vulgaris
chr6	160130172	.	G	A	Gout
chr6	160130172	.	G	T	Gout
chr6	163217235	.	C	T	Ocular sarcoidosis
chr6	163922743	.	A	G	Diisocyanate-induced asthma;Fulminant type 1 diabetes
chr6	163922743	.	A	T	Diisocyanate-induced asthma;Fulminant type 1 diabetes
chr6	165152406	.	A	C	Asthma (sex interaction)
chr6	165152406	.	A	T	Asthma (sex interaction)
chr6	165633546	.	A	G	Autoimmune thyroid disease
chr6	166121254	.	A	C	Asthma
chr6	166506997	.	A	G	Exacerbations requiring hospitalisation in asthma
chr6	166969587	.	G	T	Graves' disease
chr6	166969779	.	G	T	Type 1 diabetes in high risk HLA genotype individuals (time to event)
chr6	166993145	.	G	A	Crohn's disease
chr6	167098098	.	T	G	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr6	167124266	.	A	G	Rheumatoid arthritis;Rheumatoid arthritis (ACPA-positive)
chr6	167126167	.	C	A	Rheumatoid arthritis
chr6	167135989	.	A	G	Response to zileuton treatment in asthma (FEV1 change interaction)
chr6	168034024	.	C	A	Kawasaki disease
chr6	168540944	.	G	A	Vitiligo
chr6	168540944	.	G	C	Vitiligo
chr6	169157918	.	C	A	Diisocyanate-induced asthma
chr6	170276994	.	G	A	Multiple sclerosis
chr6	170281387	.	G	T	Interferon alpha levels in systemic lupus erythematosus
chr7	2403667	.	T	A	Multiple sclerosis
chr7	2570131	.	C	T	Food allergy (parent-of-origin effect)
chr7	2693648	.	C	T	Response to placebo treatment in childhood asthma (FVC change)
chr7	2750246	.	A	G	Ulcerative colitis
chr7	3117642	.	G	C	Asthma
chr7	4134757	.	G	A	Crohn's disease (indolent vs progressive)
chr7	4134757	.	G	C	Crohn's disease (indolent vs progressive)
chr7	5397122	.	C	T	Ulcerative colitis
chr7	5868805	.	A	G	Interstitial lung diseases in rheumatoid arthritis
chr7	6005760	.	C	G	Ocular sarcoidosis
chr7	6005760	.	C	T	Ocular sarcoidosis
chr7	6276071	.	G	A	Asthma
chr7	7672101	.	C	G	Interstitial lung diseases in rheumatoid arthritis
chr7	8136157	.	T	A	Systemic lupus erythematosus
chr7	8136157	.	T	C	Systemic lupus erythematosus
chr7	9577350	.	T	C	Pulmonary function in asthmatics
chr7	10057028	.	T	G	Type 1 diabetes (age at diagnosis)
chr7	11137720	.	G	A	Self-reported childhood asthma in adult smokers
chr7	12182175	.	T	C	Crohn's disease
chr7	13615424	.	C	G	Renal underexcretion gout
chr7	13644138	.	T	C	Diisocyanate-induced asthma
chr7	14346007	.	T	C	Response to placebo treatment in childhood asthma (FVC change)
chr7	16666924	.	T	G	Ulcerative colitis
chr7	17157947	.	C	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr7	17403055	.	G	C	Ulcerative colitis
chr7	18224045	.	A	T	Osteoarthritis of the hip (hospital diagnosed)
chr7	18370370	.	A	C	Osteoarthritis (hip)
chr7	18396714	.	G	A	Osteoarthritis (hip)
chr7	18723029	.	C	A	Systemic juvenile idiopathic arthritis
chr7	18760790	.	G	A	Ulcerative colitis
chr7	18760790	.	G	T	Ulcerative colitis
chr7	19125257	.	A	G	Diisocyanate-induced asthma
chr7	19438358	.	A	T	Allergic rhinitis in non-asthmatics
chr7	20304503	.	G	A	Nonatopic asthma and/or waist-to-hip ratio adjusted for BMI
chr7	20336395	.	A	G	Allergic disease (asthma, hay fever or eczema);Nonatopic asthma
chr7	20336480	.	C	A	Nonatopic asthma and/or waist-to-hip ratio adjusted for BMI
chr7	20339178	.	G	A	Primary biliary cholangitis;Type 1 diabetes
chr7	20345190	.	G	A	Asthma (childhood onset)
chr7	20377088	.	T	C	Asthma;Endometriosis or asthma (pleiotropy)
chr7	20384300	.	G	GTCTGAACCAAGAT	Asthma;Asthma (childhood onset)
chr7	20386640	.	T	C	Asthma (childhood onset)
chr7	20416355	.	A	C	Asthma;Asthma (childhood onset);Atopic asthma
chr7	20416355	.	A	T	Asthma;Asthma (childhood onset);Atopic asthma
chr7	20496719	.	T	A	Asthma
chr7	20496719	.	T	G	Asthma
chr7	20504586	.	A	C	Asthma;Asthma (childhood onset);Asthma onset (childhood vs adult)
chr7	20504586	.	A	G	Asthma;Asthma (childhood onset);Asthma onset (childhood vs adult)
chr7	20521373	.	T	C	Allergic disease (asthma, hay fever or eczema);Asthma (childhood onset);Asthma or allergic disease (pleiotropy)
chr7	20521373	.	T	G	Allergic disease (asthma, hay fever or eczema);Asthma (childhood onset);Asthma or allergic disease (pleiotropy)
chr7	20530448	.	T	A	Asthma
chr7	20536128	.	C	T	Allergic disease (asthma, hay fever or eczema);Asthma;Asthma (childhood onset);Nonatopic asthma
chr7	20540024	.	T	C	Nonatopic asthma and/or BMI
chr7	20544936	.	G	A	Asthma
chr7	20545214	.	T	C	Asthma
chr7	20547220	.	A	C	Asthma;Atopic asthma
chr7	20547220	.	A	G	Asthma;Atopic asthma
chr7	20557306	.	A	G	Type 1 diabetes
chr7	21645609	.	A	G	Asthma exacerbations in inhaled corticosteroid treatment
chr7	21898622	.	C	T	Immunoglobulin light chain (AL) amyloidosis
chr7	22726602	.	A	G	Asthma;Systemic lupus erythematosus
chr7	22728408	.	A	C	Takayasu arteritis
chr7	22732641	.	G	C	Multiple sclerosis
chr7	22752699	.	A	T	Asthma
chr7	22769871	.	T	A	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)
chr7	22769871	.	T	C	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)
chr7	24200546	.	G	A	Asthma (childhood onset)
chr7	25121983	.	A	G	Systemic lupus erythematosus
chr7	25895542	.	C	T	Ocular sarcoidosis
chr7	26832962	.	C	A	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr7	27095695	.	C	A	Multiple sclerosis
chr7	27095695	.	C	G	Multiple sclerosis
chr7	27192143	.	C	T	Ulcerative colitis
chr7	28101332	.	G	T	Asthma;Asthma (childhood onset);Atopic asthma
chr7	28102567	.	G	T	Multiple sclerosis;Systemic lupus erythematosus;Type 1 diabetes
chr7	28123055	.	C	T	Systemic lupus erythematosus
chr7	28127772	.	A	G	Systemic lupus erythematosus
chr7	28127772	.	A	T	Systemic lupus erythematosus
chr7	28129126	.	GTCTT	G	Asthma
chr7	28132967	.	T	C	Asthma;Asthma (childhood onset)
chr7	28133113	.	C	T	Systemic lupus erythematosus
chr7	28133120	.	T	G	Multiple sclerosis
chr7	28135367	.	T	C	Rheumatoid arthritis
chr7	28146272	.	T	C	Systemic lupus erythematosus
chr7	28147725	.	A	C	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)
chr7	28147725	.	A	G	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)
chr7	28150502	.	C	A	Crohn's disease
chr7	28156794	.	G	A	Psoriasis or type 2 diabetes (trans-disease meta-analysis)
chr7	28189423	.	G	A	Type 1 diabetes
chr7	28232071	.	G	A	Diisocyanate-induced asthma
chr7	28435636	.	A	C	Diisocyanate-induced asthma
chr7	29092663	.	A	G	Vitiligo
chr7	29940855	.	C	A	Psoriasis
chr7	30474825	.	A	G	Knee osteoarthritis
chr7	31159653	.	G	A	Refractory celiac disease type II
chr7	31642839	.	C	G	Psoriasis
chr7	32177281	.	C	G	Gout
chr7	34003736	.	C	T	Asthma
chr7	34075100	.	C	T	Diisocyanate-induced asthma
chr7	36632719	.	A	G	Ocular sarcoidosis
chr7	37334906	.	G	A	Celiac disease;Primary biliary cholangitis
chr7	37342861	.	T	C	Celiac disease;Multiple sclerosis;Primary biliary cholangitis;Systemic sclerosis
chr7	37342861	.	T	G	Celiac disease;Multiple sclerosis;Primary biliary cholangitis;Systemic sclerosis
chr7	37346633	.	C	A	Psoriasis;Psoriasis vulgaris
chr7	37365375	.	C	A	Celiac disease
chr7	37365375	.	C	T	Celiac disease
chr7	37370336	.	T	TGAAAAGG	Autoimmune thyroid disease
chr7	37387686	.	C	T	Celiac disease and Rheumatoid arthritis
chr7	37387748	.	T	C	Rheumatoid arthritis
chr7	37391956	.	C	G	Primary biliary cholangitis
chr7	37397251	.	A	G	Celiac disease or Rheumatoid arthritis
chr7	37763129	.	C	G	Response to tofacitinib treatment in psoriasis (herpes zoster)(time to event)
chr7	37763129	.	C	T	Response to tofacitinib treatment in psoriasis (herpes zoster)(time to event)
chr7	38667217	.	C	A	Ankylosing spondylitis
chr7	38667217	.	C	T	Ankylosing spondylitis
chr7	39945012	.	G	A	Serum uric acid levels in response to allopurinol in gout
chr7	40657595	.	C	T	Asthma
chr7	42001387	.	A	G	Asthma
chr7	43176015	.	C	T	Osteoarthritis (self-reported)
chr7	43408191	.	T	C	Type 1 diabetes (age at diagnosis)
chr7	45859651	.	G	A	Poor prognosis in Crohn's disease
chr7	45864208	.	C	A	Rheumatoid arthritis
chr7	45864208	.	C	G	Rheumatoid arthritis
chr7	45864208	.	C	T	Rheumatoid arthritis
chr7	46130984	.	T	C	Childhood asthma x sex interaction
chr7	46439588	.	T	C	Endometriosis or asthma (pleiotropy)
chr7	46590756	.	A	C	Endometriosis or asthma (pleiotropy)
chr7	46590756	.	A	T	Endometriosis or asthma (pleiotropy)
chr7	46644856	.	C	T	Endometriosis or asthma (pleiotropy)
chr7	46681113	.	G	A	Diisocyanate-induced asthma
chr7	46912235	.	C	T	Acute anterior uveitis in ankylosing spondylitis
chr7	48863732	.	C	A	Type 1 diabetes with low genetic risk score
chr7	48863732	.	C	T	Type 1 diabetes with low genetic risk score
chr7	50136058	.	G	A	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Crohn's disease;Ulcerative colitis
chr7	50189102	.	C	G	Systemic lupus erythematosus
chr7	50189102	.	C	T	Systemic lupus erythematosus
chr7	50200284	.	A	T	Multiple sclerosis
chr7	50285971	.	C	T	Multiple sclerosis
chr7	50292600	.	A	T	Systemic lupus erythematosus
chr7	50398132	.	A	G	Type 1 diabetes
chr7	50597225	.	A	C	Systemic sclerosis
chr7	50597225	.	A	G	Systemic sclerosis
chr7	50598336	.	G	A	Response to zileuton treatment in asthma (FEV1 change interaction)
chr7	50598336	.	G	T	Response to zileuton treatment in asthma (FEV1 change interaction)
chr7	50947496	.	T	C	Type 1 diabetes
chr7	50955790	.	C	A	Type 1 diabetes
chr7	50959497	.	A	C	Type 1 diabetes
chr7	50961290	.	T	A	Type 1 diabetes
chr7	50961290	.	T	C	Type 1 diabetes
chr7	52041108	.	G	A	Lung function (FEV1/FVC) in asthma
chr7	54715680	.	T	A	Systemic lupus erythematosus
chr7	54715680	.	T	C	Systemic lupus erythematosus
chr7	54850224	.	G	T	Ocular sarcoidosis
chr7	63002917	.	TC	T	Exacerbations requiring hospitalisation in asthma
chr7	63002918	.	CA	C	Exacerbations requiring hospitalisation in asthma
chr7	71273743	.	G	A	Response to montelukast in asthma (change in FEV1)
chr7	74123572	.	T	C	Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)
chr7	74152347	.	G	A	Systemic lupus erythematosus
chr7	74196185	.	T	C	Steroid induced osteonecrosis of the femoral head and systemic lupus erythematosus
chr7	74196185	.	T	TGGAGGG	Steroid induced osteonecrosis of the femoral head and systemic lupus erythematosus
chr7	74214689	.	TAATATATATA	T	Systemic lupus erythematosus
chr7	74283211	.	T	C	Systemic lupus erythematosus
chr7	74495911	.	C	T	Systemic lupus erythematosus
chr7	74511782	.	A	G	Systemic lupus erythematosus
chr7	74526648	.	T	C	Systemic lupus erythematosus
chr7	74580705	.	G	C	Systemic lupus erythematosus
chr7	74606017	.	G	A	Systemic lupus erythematosus
chr7	74611831	.	AC	A	Rheumatoid arthritis
chr7	74625354	.	A	T	Systemic lupus erythematosus
chr7	74673141	.	T	G	Systemic lupus erythematosus
chr7	74781288	.	TC	T	Systemic lupus erythematosus
chr7	74781840	.	C	A	Systemic lupus erythematosus
chr7	75449782	.	G	A	Systemic lupus erythematosus
chr7	75556681	.	A	T	Systemic lupus erythematosus
chr7	75580635	.	G	A	Systemic lupus erythematosus
chr7	75628053	.	T	C	Systemic lupus erythematosus
chr7	75692143	.	C	G	Systemic lupus erythematosus
chr7	75692143	.	C	T	Systemic lupus erythematosus
chr7	75817656	.	C	A	Sarcoidosis
chr7	75993594	.	C	G	Sarcoidosis
chr7	76346269	.	C	G	Multiple sclerosis
chr7	77319034	.	G	T	Crohn's disease
chr7	77375843	.	T	TA	Asthma
chr7	77389225	.	C	G	Allergic disease (asthma, hay fever or eczema)
chr7	80032911	.	C	T	Diisocyanate-induced asthma
chr7	81720096	.	T	C	Gout
chr7	81732258	.	C	G	Gout (normal type)
chr7	81732258	.	C	T	Gout (normal type)
chr7	82059922	.	C	G	Exacerbations requiring hospitalisation in asthma
chr7	82059922	.	C	T	Exacerbations requiring hospitalisation in asthma
chr7	82210237	.	A	C	Crohn's disease (need for surgery)
chr7	82210237	.	A	T	Crohn's disease (need for surgery)
chr7	82228577	.	T	G	Ulcerative colitis
chr7	82453122	.	T	C	Diisocyanate-induced asthma
chr7	83528488	.	A	G	Asthma (childhood onset)
chr7	85834401	.	A	G	Kawasaki disease
chr7	86598195	.	T	C	Asthma
chr7	87231997	.	A	T	Food allergy
chr7	89141313	.	C	T	Systemic lupus erythematosus
chr7	92607515	.	A	G	Rheumatoid arthritis
chr7	92607515	.	A	T	Rheumatoid arthritis
chr7	92609830	.	A	G	Rheumatoid arthritis;Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)
chr7	93145706	.	T	C	Response to intravenous immunoglobulin treatment in Kawasaki disease
chr7	93145706	.	T	G	Response to intravenous immunoglobulin treatment in Kawasaki disease
chr7	95980891	.	G	A	Knee osteoarthritis
chr7	96089184	.	T	TA	Osteoarthritis of the hip or knee
chr7	96089184	.	T	TAA	Osteoarthritis of the hip or knee
chr7	96090521	.	T	TA	Osteoarthritis
chr7	96090521	.	T	TAA	Osteoarthritis
chr7	96090521	.	T	TAAA	Osteoarthritis
chr7	96090521	.	T	TTA	Osteoarthritis
chr7	96785743	.	C	T	Immunoglobulin A
chr7	98834984	.	G	A	Decreased low contrast letter acuity in multiple sclerosis
chr7	99162881	.	G	A	Ulcerative colitis
chr7	99162881	.	G	T	Ulcerative colitis
chr7	99478208	.	T	C	Diffuse cutaneous systemic sclerosis
chr7	100130923	.	C	T	Microalbuminuria in type 1 diabetes
chr7	100687290	.	C	A	Autoimmune thyroid disease
chr7	102132317	.	G	A	Osteoarthritis of the hip or knee (with total joint replacement)
chr7	103764368	.	G	A	Sj√∂gren's syndrome
chr7	103987589	.	C	T	Multiple sclerosis (age of onset)
chr7	104084676	.	A	G	Response to placebo treatment in childhood asthma (FVC change)
chr7	104366062	.	T	G	Asthma exacerbations in inhaled corticosteroid treatment
chr7	104821040	.	G	A	Gout
chr7	105500705	.	T	C	Systemic lupus erythematosus
chr7	106018005	.	G	A	Asthma (childhood onset);Childhood asthma with severe exacerbations
chr7	106036059	.	C	T	Asthma
chr7	106059997	.	T	C	Crohn's disease (indolent vs progressive)
chr7	106066016	.	C	A	Multiple sclerosis
chr7	106496127	.	T	A	Ocular sarcoidosis
chr7	106496127	.	T	C	Ocular sarcoidosis
chr7	107809588	.	T	A	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr7	107809588	.	T	G	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr7	107812658	.	G	A	Ulcerative colitis
chr7	107812658	.	G	T	Ulcerative colitis
chr7	107836468	.	T	A	Ulcerative colitis
chr7	107836468	.	T	G	Ulcerative colitis
chr7	107839074	.	C	A	Ulcerative colitis
chr7	107839870	.	T	A	Ulcerative colitis
chr7	107839870	.	T	G	Ulcerative colitis
chr7	107843992	.	G	A	Ulcerative colitis
chr7	107843992	.	G	T	Ulcerative colitis
chr7	107852344	.	A	G	Ulcerative colitis
chr7	109923507	.	T	C	Renal underexcretion gout
chr7	110352114	.	T	C	Multiple sclerosis
chr7	112519123	.	G	A	Osteoarthritis (hip)
chr7	112519123	.	G	T	Osteoarthritis (hip)
chr7	114384261	.	G	A	Osteoarthritis
chr7	114717488	.	A	G	Crohn's disease
chr7	117252792	.	T	C	Ulcerative colitis
chr7	117255109	.	G	A	Ulcerative colitis
chr7	117446559	.	C	G	Type 1 diabetes
chr7	117446559	.	C	T	Type 1 diabetes
chr7	117503548	.	C	G	Gout
chr7	117532167	.	G	A	Type 1 diabetes with low genetic risk score
chr7	117737591	.	G	T	Response to methotrexate in juvenile idiopathic arthritis
chr7	117818989	.	G	C	Response to methotrexate in juvenile idiopathic arthritis
chr7	119397460	.	G	T	Joint damage in rheumatoid arthritis
chr7	121326736	.	A	G	Ischemic heart disease in rheumatoid arthritis
chr7	124799545	.	T	A	Ankylosing spondylitis
chr7	124799545	.	T	C	Ankylosing spondylitis
chr7	127618330	.	C	A	Type 1 diabetes
chr7	127618330	.	C	T	Type 1 diabetes
chr7	128352800	.	T	C	Takayasu arteritis
chr7	128352800	.	T	G	Takayasu arteritis
chr7	128575797	.	T	C	Steroid induced osteonecrosis of the femoral head and systemic lupus erythematosus
chr7	128935743	.	TCTTAGCTATTGCTC	T	Rheumatoid arthritis;Systemic lupus erythematosus
chr7	128940626	.	G	A	Rheumatoid arthritis;Rheumatoid arthritis (ACPA-positive)
chr7	128945562	.	C	T	Systemic lupus erythematosus
chr7	128946981	.	C	T	Behcet's disease
chr7	128948946	.	T	C	Systemic lupus erythematosus
chr7	128954129	.	T	C	Diffuse cutaneous systemic sclerosis;Primary biliary cholangitis;Rheumatoid arthritis;Systemic lupus erythematosus;Systemic sclerosis;Systemic sclerosis (anti-centromere-positive);Systemic sclerosis (anti-topoisomerase-positive)
chr7	128956751	.	C	T	Systemic lupus erythematosus
chr7	128976528	.	C	T	Systemic lupus erythematosus
chr7	128977412	.	A	C	Primary biliary cholangitis;Systemic lupus erythematosus;Systemic lupus erythematosus or rheumatoid arthritis;Systemic sclerosis
chr7	128977412	.	A	G	Primary biliary cholangitis;Systemic lupus erythematosus;Systemic lupus erythematosus or rheumatoid arthritis;Systemic sclerosis
chr7	128984019	.	C	A	Diffuse cutaneous systemic sclerosis;Systemic sclerosis
chr7	128990259	.	T	A	Primary biliary cholangitis
chr7	129007888	.	C	T	Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)
chr7	129011468	.	C	T	Systemic sclerosis
chr7	129041008	.	C	T	Sj√∂gren's syndrome
chr7	129044262	.	G	C	Systemic sclerosis
chr7	129055929	.	C	A	Systemic lupus erythematosus;Systemic lupus erythematosus and Systemic sclerosis
chr7	129068068	.	G	C	Systemic sclerosis
chr7	129068743	.	T	A	Diffuse cutaneous systemic sclerosis;Systemic sclerosis;Systemic sclerosis (anti-topoisomerase-positive)
chr7	129077852	.	G	A	Systemic lupus erythematosus
chr7	129203569	.	C	T	Osteoarthritis (hip);Osteoarthritis (with total hip replacement)
chr7	129944187	.	G	T	Type 1 diabetes with low genetic risk score
chr7	131336340	.	G	A	Asthma (childhood onset)
chr7	131685280	.	T	C	Rheumatoid arthritis
chr7	133147459	.	A	G	Food allergy;Peanut allergy
chr7	136835151	.	T	C	Osteoarthritis (hospital diagnosed)
chr7	137458951	.	C	A	Osteoarthritis of the hip or knee
chr7	139641806	.	C	T	Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis
chr7	141614171	.	C	G	Psoriasis
chr7	142357119	.	C	T	Narcolepsy
chr7	146694428	.	A	G	Crohn's disease
chr7	148073993	.	G	A	Gout (age >=50)
chr7	148443990	.	A	C	Chronic kidney disease (severe chronic kidney disease vs normal kidney function) in type 1 diabetes
chr7	148443990	.	A	G	Chronic kidney disease (severe chronic kidney disease vs normal kidney function) in type 1 diabetes
chr7	148523356	.	A	G	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Crohn's disease;Ulcerative colitis
chr7	148560956	.	G	A	Crohn's disease
chr7	148560956	.	G	C	Crohn's disease
chr7	150676640	.	C	A	Multiple sclerosis
chr7	151184801	.	A	T	Renal underexcretion gout
chr7	151234719	.	G	A	Immunoglobulin N-glycan 2 levels
chr7	151239990	.	T	C	Immunoglobulin light chain (AL) amyloidosis
chr7	151708919	.	C	T	Gout
chr7	151717955	.	A	G	Gout
chr7	153020025	.	T	G	Paneth cell defects in Crohn's disease
chr7	153048725	.	T	C	Ulcerative colitis
chr7	154715590	.	A	G	Exacerbations requiring hospitalisation in asthma
chr7	154835628	.	A	G	Asthma
chr7	156017807	.	G	A	Diisocyanate-induced asthma
chr7	156017807	.	G	T	Diisocyanate-induced asthma
chr7	156553393	.	C	G	Knee osteoarthritis
chr8	723082	.	A	G	Joint damage in rheumatoid arthritis
chr8	822129	.	C	T	Takayasu arteritis
chr8	1242438	.	T	A	Osteoarthritis (self-reported)
chr8	1242438	.	T	G	Osteoarthritis (self-reported)
chr8	1935186	.	T	C	Multiple sclerosis
chr8	1935186	.	T	G	Multiple sclerosis
chr8	2191959	.	C	G	Ankylosing spondylitis
chr8	2191959	.	C	T	Ankylosing spondylitis
chr8	2693300	.	C	T	Adult asthma
chr8	3261257	.	G	A	Diisocyanate-induced asthma
chr8	3261257	.	G	C	Diisocyanate-induced asthma
chr8	3951280	.	T	C	Crohn's disease (time to progression)
chr8	3970616	.	C	G	Multiple sclerosis
chr8	3970616	.	C	T	Multiple sclerosis
chr8	4110597	.	C	A	Post-bronchodilator lung function in asthma (FEV1/FVC)
chr8	4168122	.	C	A	Response to methotrexate in juvenile idiopathic arthritis
chr8	4168122	.	C	G	Response to methotrexate in juvenile idiopathic arthritis
chr8	4546064	.	A	C	Osteoarthritis biomarkers
chr8	4554833	.	C	T	joint destruction in rheumatoid arthritis (rapid vs slow)
chr8	4983502	.	G	A	Coronary artery aneurysm in Kawasaki disease
chr8	5357195	.	T	A	Renal overload gout
chr8	6333897	.	G	C	Asthma;Asthma (childhood onset)
chr8	6345443	.	G	A	Diisocyanate-induced asthma
chr8	6668487	.	A	C	Asthma x air pollution interaction (2df)
chr8	8310952	.	G	C	Endometriosis or asthma (pleiotropy)
chr8	8317614	.	A	C	Endometriosis or asthma (pleiotropy)
chr8	8412181	.	A	T	Endometriosis or asthma (pleiotropy)
chr8	8412784	.	T	A	Endometriosis or asthma (pleiotropy)
chr8	8428606	.	T	A	Endometriosis or asthma (pleiotropy)
chr8	8442426	.	A	T	Endometriosis or asthma (pleiotropy)
chr8	8450534	.	A	G	Autoimmune thyroid disease
chr8	8666851	.	T	C	Osteoarthritis of the hip or knee
chr8	8666851	.	T	G	Osteoarthritis of the hip or knee
chr8	8786764	.	G	A	Endometriosis or asthma (pleiotropy)
chr8	8788215	.	G	A	Endometriosis or asthma (pleiotropy)
chr8	8788215	.	G	T	Endometriosis or asthma (pleiotropy)
chr8	8815291	.	C	A	Endometriosis or asthma (pleiotropy)
chr8	8817815	.	A	C	Endometriosis or asthma (pleiotropy)
chr8	8828344	.	A	C	Endometriosis or asthma (pleiotropy)
chr8	9222261	.	G	GT	Osteoarthritis (self-reported)
chr8	9227785	.	A	T	Osteoarthritis (hip)
chr8	9229768	.	A	C	Systemic lupus erythematosus
chr8	9229768	.	A	T	Systemic lupus erythematosus
chr8	9230169	.	G	C	Osteoarthritis
chr8	9230169	.	G	T	Osteoarthritis
chr8	9296109	.	C	G	Endometriosis or asthma (pleiotropy)
chr8	10033744	.	T	A	Systemic lupus erythematosus
chr8	10186480	.	C	A	Asthma-chronic obstructive  pulmonary disease overlap syndrome
chr8	10186480	.	C	T	Asthma-chronic obstructive  pulmonary disease overlap syndrome
chr8	10422718	.	G	C	Autoimmune thyroid disease
chr8	10422718	.	G	T	Autoimmune thyroid disease
chr8	10425916	.	G	C	Systemic lupus erythematosus
chr8	10855435	.	G	A	Endometriosis or asthma (pleiotropy)
chr8	10855435	.	G	T	Endometriosis or asthma (pleiotropy)
chr8	10869332	.	C	G	Systemic lupus erythematosus
chr8	10869332	.	C	T	Systemic lupus erythematosus
chr8	10873290	.	A	G	Endometriosis or asthma (pleiotropy)
chr8	10873556	.	T	A	Endometriosis or asthma (pleiotropy)
chr8	10954319	.	T	C	Endometriosis or asthma (pleiotropy)
chr8	10955964	.	C	G	Asthma and hay fever
chr8	10955964	.	C	T	Asthma and hay fever
chr8	10958061	.	C	G	Endometriosis or asthma (pleiotropy)
chr8	10961097	.	A	G	Endometriosis or asthma (pleiotropy)
chr8	11169932	.	G	A	Childhood onset systemic lupus erythematosus
chr8	11427710	.	A	C	Endometriosis or asthma (pleiotropy)
chr8	11458083	.	C	A	Multiple sclerosis
chr8	11480861	.	A	T	Rheumatoid arthritis;Systemic lupus erythematosus
chr8	11480957	.	C	A	Kawasaki disease
chr8	11480957	.	C	G	Kawasaki disease
chr8	11482456	.	G	T	Systemic lupus erythematosus
chr8	11482672	.	T	A	Systemic lupus erythematosus
chr8	11484361	.	G	A	Systemic lupus erythematosus
chr8	11484361	.	G	C	Systemic lupus erythematosus
chr8	11491452	.	G	C	Rheumatoid arthritis
chr8	11502048	.	T	A	Systemic sclerosis
chr8	11582510	.	G	A	Autoimmune thyroid disease
chr8	11605008	.	C	A	Endometriosis or asthma (pleiotropy)
chr8	11605506	.	C	T	Systemic lupus erythematosus
chr8	11605721	.	G	A	Endometriosis or asthma (pleiotropy)
chr8	11610254	.	G	A	Endometriosis or asthma (pleiotropy)
chr8	11779424	.	C	G	Ocular sarcoidosis
chr8	11779424	.	C	T	Ocular sarcoidosis
chr8	11877675	.	G	A	Type 1 diabetes
chr8	11877675	.	G	C	Type 1 diabetes
chr8	14575606	.	G	A	Joint damage in rheumatoid arthritis
chr8	14611016	.	C	A	Joint damage in rheumatoid arthritis
chr8	16931726	.	G	A	Allergic rhinitis in asthma
chr8	16931726	.	G	T	Allergic rhinitis in asthma
chr8	17534848	.	C	A	Response to zileuton treatment in asthma (FEV1 change interaction)
chr8	17534848	.	C	G	Response to zileuton treatment in asthma (FEV1 change interaction)
chr8	17534848	.	C	T	Response to zileuton treatment in asthma (FEV1 change interaction)
chr8	19065067	.	G	C	Urinary albumin excretion rate in type 1 diabetes
chr8	19190261	.	T	A	Gout
chr8	19190261	.	T	C	Gout
chr8	20451062	.	G	A	Type 1 diabetes with low genetic risk score
chr8	20451062	.	G	T	Type 1 diabetes with low genetic risk score
chr8	20501107	.	C	T	Rheumatoid arthritis
chr8	21125392	.	G	A	Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count)
chr8	21299082	.	T	C	Diisocyanate-induced asthma
chr8	21649156	.	T	G	Diisocyanate-induced asthma
chr8	23151624	.	A	C	Asthma
chr8	23281923	.	C	T	Systemic lupus erythematosus
chr8	24259209	.	G	C	Ankylosing spondylitis
chr8	24259209	.	G	T	Ankylosing spondylitis
chr8	24740807	.	C	T	Early-onset osteoarthritis
chr8	25664618	.	A	G	Subjective response to placebo treatment in childhood asthma (change in cough/wheeze)
chr8	28171501	.	C	T	Systemic lupus erythematosus
chr8	29858745	.	C	T	Diisocyanate-induced asthma
chr8	31568155	.	C	T	Asthma exacerbations in inhaled corticosteroid treatment
chr8	34187743	.	C	A	Asthma (childhood onset)
chr8	34187743	.	C	T	Asthma (childhood onset)
chr8	42176001	.	G	A	Systemic lupus erythematosus
chr8	48216682	.	G	T	Ulcerative colitis
chr8	51750918	.	A	T	Renal underexcretion gout
chr8	53206654	.	G	T	IgE levels in asthmatics (D.p. specific)
chr8	56068244	.	C	T	Systemic lupus erythematosus
chr8	56693303	.	A	AT	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr8	56693303	.	A	ATT	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr8	56693303	.	A	ATTT	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr8	56693303	.	AT	A	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr8	56793197	.	G	A	Asthma or allergic disease (pleiotropy)
chr8	58959618	.	A	G	Type 1 diabetes
chr8	60605840	.	C	G	Autoimmune thyroid disease
chr8	60652405	.	T	G	Systemic sclerosis
chr8	64769294	.	C	T	Food allergy (maternal genetic effects)
chr8	68678319	.	C	T	Osteoarthritis (with total hip replacement)
chr8	69560258	.	G	A	Crohn's disease
chr8	70397461	.	GA	G	Systemic lupus erythematosus
chr8	70529879	.	A	G	Multiple sclerosis
chr8	71188090	.	G	A	Paneth cell defects in Crohn's disease
chr8	71770458	.	C	T	Late-onset myasthenia gravis
chr8	72097031	.	A	G	Adult asthma
chr8	72126216	.	T	A	Gout
chr8	72451754	.	T	A	Multiple sclerosis (age of onset)
chr8	72451754	.	T	G	Multiple sclerosis (age of onset)
chr8	72930288	.	G	A	Coronary artery disease in type 1 diabetes
chr8	73095112	.	G	T	Crohn's disease
chr8	74461713	.	C	T	Response to tocilizumab in rheumatoid arthritis
chr8	75406931	.	C	T	Diisocyanate-induced asthma
chr8	76353999	.	C	T	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr8	77195989	.	C	T	Systemic lupus erythematosus
chr8	78643913	.	T	A	Systemic lupus erythematosus
chr8	80141887	.	G	A	Asthma exacerbations in inhaled corticosteroid treatment
chr8	80183160	.	C	G	Rheumatoid arthritis
chr8	80354702	.	T	TC	Asthma (moderate or severe)
chr8	80355920	.	T	A	Self-reported allergy
chr8	80380364	.	A	T	Allergic disease (asthma, hay fever or eczema);Allergy
chr8	80389777	.	T	TAA	Asthma;Asthma (adult onset)
chr8	80451970	.	G	A	Late-onset myasthenia gravis
chr8	83741379	.	C	T	Post-bronchodilator lung function in asthma (FVC)
chr8	87623714	.	G	A	Acute anterior uveitis in ankylosing spondylitis
chr8	89598206	.	G	A	Asthma
chr8	89598206	.	G	T	Asthma
chr8	89863690	.	T	A	Crohn's disease
chr8	92527474	.	A	T	Gout (PheCode 274.1)
chr8	93291573	.	A	G	Diisocyanate-induced asthma
chr8	94155019	.	A	G	Diisocyanate-induced asthma
chr8	95851818	.	C	T	Multiple sclerosis
chr8	96002361	.	T	A	Ocular sarcoidosis;Ocular sarcoidosis in sarcoidosis
chr8	96002361	.	T	C	Ocular sarcoidosis;Ocular sarcoidosis in sarcoidosis
chr8	100157595	.	A	AAT	Interstitial lung diseases in rheumatoid arthritis
chr8	100419573	.	C	T	Asthma
chr8	101451374	.	G	A	Rheumatoid arthritis
chr8	101451374	.	G	C	Rheumatoid arthritis
chr8	105325989	.	G	A	Takayasu arteritis
chr8	113280567	.	C	A	Asthma
chr8	113394871	.	G	A	Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count)
chr8	113873203	.	G	A	Bronchodilator response in asthma (inhaled corticosteroid treatment interaction)
chr8	114000368	.	C	G	Rheumatoid arthritis
chr8	114000368	.	C	T	Rheumatoid arthritis
chr8	115801679	.	G	A	Response to tocilizumab in rheumatoid arthritis
chr8	116297663	.	C	G	Asthma x Hispanic interaction (2df)
chr8	116297663	.	C	T	Asthma x Hispanic interaction (2df)
chr8	116321559	.	A	G	Asthma
chr8	116325159	.	A	G	Childhood asthma
chr8	116379918	.	C	T	Systemic juvenile idiopathic arthritis
chr8	116463052	.	T	C	Joint damage in rheumatoid arthritis
chr8	117013406	.	T	A	Asthma
chr8	117013406	.	T	G	Asthma
chr8	117191781	.	C	T	Psoriasis or type 2 diabetes (trans-disease meta-analysis)
chr8	117537137	.	T	C	Kawasaki disease
chr8	118379170	.	C	T	Multiple sclerosis
chr8	118461549	.	AT	A	Adverse response to inhaled corticosteroid treatment x age interaction in asthma
chr8	119070702	.	A	C	Type 1 diabetes
chr8	119070702	.	A	T	Type 1 diabetes
chr8	119895298	.	T	A	Post-bronchodilator lung function in asthma (FVC)
chr8	121263666	.	G	T	Lupus nephritis in systemic lupus erythematosus
chr8	121320840	.	T	C	Asthma
chr8	121918402	.	T	G	Lung function (FEV1) in asthma (dust mite allergen exposure interaction)
chr8	122693916	.	G	A	Type 1 diabetes nephropathy
chr8	124519112	.	C	T	Adult asthma
chr8	125334735	.	G	A	Behcet's disease
chr8	126080638	.	G	T	Crohn's disease
chr8	127087784	.	C	CA	Kidney disease (end stage renal disease vs macroalbuminuria) in type 1 diabetes
chr8	127087784	.	C	CAA	Kidney disease (end stage renal disease vs macroalbuminuria) in type 1 diabetes
chr8	127190780	.	T	TCG	Graves' disease
chr8	127190780	.	T	TCT	Graves' disease
chr8	127198421	.	T	G	Graves' disease
chr8	127816434	.	C	G	Asthma (childhood onset)
chr8	127816434	.	C	T	Asthma (childhood onset)
chr8	128064205	.	C	T	Multiple sclerosis
chr8	128144770	.	A	G	Autoimmune thyroid disease
chr8	128146699	.	A	C	Multiple sclerosis
chr8	128166844	.	A	C	Systemic lupus erythematosus
chr8	128178298	.	C	A	Systemic lupus erythematosus
chr8	128180025	.	T	C	Multiple sclerosis
chr8	128212448	.	C	T	Crohn's disease
chr8	128215706	.	A	G	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr8	128234169	.	T	C	Immunoglobulin A
chr8	128252174	.	A	G	Primary biliary cholangitis
chr8	128252343	.	A	C	Celiac disease
chr8	128252343	.	A	G	Celiac disease
chr8	128281872	.	T	C	Coronary artery aneurysm in Kawasaki disease
chr8	128303768	.	G	A	Celiac disease or Rheumatoid arthritis
chr8	128413347	.	A	G	Systemic lupus erythematosus
chr8	128415272	.	A	G	Systemic lupus erythematosus
chr8	128529854	.	T	C	Rheumatoid arthritis
chr8	128554935	.	T	C	Celiac disease and Rheumatoid arthritis;Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Crohn's disease
chr8	128557125	.	G	A	Autoimmune thyroid disease
chr8	128761289	.	G	A	Response to methotrexate in juvenile idiopathic arthritis
chr8	128775730	.	T	C	Response to methotrexate in juvenile idiopathic arthritis
chr8	129011095	.	T	C	Multiple sclerosis
chr8	129611859	.	G	A	Ulcerative colitis
chr8	129611859	.	G	C	Ulcerative colitis
chr8	129711482	.	A	G	Osteoarthritis (hip)
chr8	129718034	.	C	A	Osteoarthritis (with total hip replacement)
chr8	129756257	.	C	CA	Osteoarthritis (hip)
chr8	129756257	.	C	CAA	Osteoarthritis (hip)
chr8	129939865	.	G	A	Rheumatoid arthritis
chr8	130080167	.	T	C	Multiple sclerosis
chr8	130511037	.	G	A	Diisocyanate-induced asthma
chr8	130511037	.	G	T	Diisocyanate-induced asthma
chr8	131391985	.	C	T	Subjective response to placebo treatment in childhood asthma (change in cough/wheeze)
chr8	132149134	.	T	A	Asthma exacerbations in inhaled corticosteroid treatment
chr8	132149134	.	T	C	Asthma exacerbations in inhaled corticosteroid treatment
chr8	133041985	.	C	A	Multiple sclerosis
chr8	133041985	.	C	T	Multiple sclerosis
chr8	133200409	.	C	T	Autoimmune thyroid disease
chr8	133337863	.	C	T	Diisocyanate-induced asthma
chr8	133955165	.	T	G	Diisocyanate-induced asthma
chr8	133993052	.	G	A	Asymmetrical dimethylarginine levels in osteoarthritis
chr8	134456669	.	A	C	Oral corticosteroid burst in asthma
chr8	134838655	.	G	A	Bone mineral accretion in asthma (oral corticosteroid dose interaction)
chr8	134838655	.	G	C	Bone mineral accretion in asthma (oral corticosteroid dose interaction)
chr8	135099216	.	C	A	Oral corticosteroid burst in asthma
chr8	135099216	.	C	T	Oral corticosteroid burst in asthma
chr8	137292352	.	A	G	Ulcerative colitis
chr8	138872266	.	C	T	Asthma (bronchodilator response)
chr8	140606084	.	T	A	Type 1 diabetes
chr8	143903707	.	C	T	Knee osteoarthritis
chr8	144103704	.	G	A	Asthma
chr8	144103704	.	G	C	Asthma
chr9	1718534	.	C	A	Oral corticosteroid burst in asthma
chr9	1995749	.	C	G	Asthma (childhood onset)
chr9	3195775	.	G	A	Diisocyanate-induced asthma
chr9	3195775	.	G	C	Diisocyanate-induced asthma
chr9	3589117	.	A	G	Gout
chr9	4145873	.	A	G	Asthma
chr9	4145873	.	A	T	Asthma
chr9	4148717	.	G	C	Asthma
chr9	4290541	.	C	A	Osteoarthritis of the hip or knee;Osteoarthritis of the hip or knee (with total joint replacement)
chr9	4290541	.	C	T	Osteoarthritis of the hip or knee;Osteoarthritis of the hip or knee (with total joint replacement)
chr9	4290823	.	A	C	Type 1 diabetes
chr9	4290823	.	A	T	Type 1 diabetes
chr9	4291747	.	C	A	Type 1 diabetes
chr9	4291747	.	C	G	Type 1 diabetes
chr9	4291928	.	A	C	Osteoarthritis;Osteoarthritis of the hip or knee;Type 1 diabetes
chr9	4292083	.	G	A	Type 1 diabetes
chr9	4295583	.	A	G	Osteoarthritis of the hip or knee
chr9	4981600	.	AC	A	Crohn's disease;Ulcerative colitis
chr9	4981602	.	C	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Crohn's disease;Multiple sclerosis;Ulcerative colitis;Ulcerative colitis vs rheumatoid arthritis (ordinary least squares (OLS))
chr9	4984530	.	G	T	Systemic lupus erythematosus
chr9	5260079	.	C	G	Ulcerative colitis
chr9	5421234	.	G	A	Type 1 diabetes (age at diagnosis)
chr9	5438435	.	C	T	Autoimmune thyroid disease
chr9	5703334	.	C	G	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr9	5703334	.	C	T	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr9	5765648	.	G	A	Atopic asthma
chr9	5850375	.	A	G	Asthma
chr9	5888194	.	G	A	Asthma (childhood onset)
chr9	5888194	.	G	T	Asthma (childhood onset)
chr9	5893861	.	G	A	Multiple sclerosis
chr9	5893861	.	G	C	Multiple sclerosis
chr9	5893861	.	G	T	Multiple sclerosis
chr9	5950583	.	A	G	Asthma (adult onset)
chr9	6047765	.	C	T	Asthma;Asthma (adult onset);Asthma onset (childhood vs adult)
chr9	6049843	.	A	G	Asthma (adult onset);Atopic asthma
chr9	6051399	.	G	A	Allergic disease (asthma, hay fever or eczema);Asthma
chr9	6051399	.	G	C	Allergic disease (asthma, hay fever or eczema);Asthma
chr9	6051924	.	T	G	Asthma
chr9	6068077	.	A	T	Asthma and hay fever
chr9	6072597	.	T	A	Nonatopic asthma
chr9	6072597	.	T	C	Nonatopic asthma
chr9	6076102	.	G	A	Asthma
chr9	6076102	.	G	T	Asthma
chr9	6078614	.	C	T	Asthma (childhood onset)
chr9	6081804	.	G	C	Asthma;Asthma (childhood onset);Asthma onset (childhood vs adult)
chr9	6081804	.	G	T	Asthma;Asthma (childhood onset);Asthma onset (childhood vs adult)
chr9	6085078	.	T	G	Childhood asthma with severe exacerbations
chr9	6142157	.	A	C	Asthma (childhood onset);Atopic asthma
chr9	6142948	.	C	A	Asthma (time to onset)
chr9	6155226	.	G	T	Asthma and cardiovascular disease
chr9	6159758	.	C	T	Asthma
chr9	6161686	.	C	T	Asthma and cardiovascular disease
chr9	6163823	.	G	A	Asthma and cardiovascular disease
chr9	6163823	.	G	T	Asthma and cardiovascular disease
chr9	6169383	.	G	A	Asthma (childhood onset)
chr9	6172380	.	A	G	Self-reported allergy
chr9	6175522	.	G	A	Asthma (childhood onset);Atopic asthma
chr9	6175522	.	G	T	Asthma (childhood onset);Atopic asthma
chr9	6175855	.	A	T	Asthma and hay fever
chr9	6176871	.	C	G	Asthma
chr9	6177453	.	G	A	Asthma;Asthma or allergic disease (pleiotropy)
chr9	6187132	.	C	A	Allergic disease (asthma, hay fever or eczema);Asthma (adult onset);Asthma (childhood onset);Atopic asthma;Nonatopic asthma
chr9	6190076	.	A	C	Asthma;Childhood asthma with severe exacerbations
chr9	6193455	.	C	A	Asthma
chr9	6208030	.	G	T	Allergic disease (asthma, hay fever or eczema);Asthma;Asthma (moderate or severe)
chr9	6209697	.	A	T	Asthma;Asthma (adult onset);Asthma (childhood onset);Asthma onset (childhood vs adult);Nonatopic asthma;Pediatric asthma
chr9	6210099	.	T	A	Atopic asthma
chr9	6213387	.	G	A	Allergic disease (asthma, hay fever and/or eczema) (age of onset);Asthma (adult onset);Asthma (age of onset);Asthma (childhood onset);Asthma (time to onset)
chr9	6213387	.	G	C	Allergic disease (asthma, hay fever and/or eczema) (age of onset);Asthma (adult onset);Asthma (age of onset);Asthma (childhood onset);Asthma (time to onset)
chr9	6213468	.	C	A	Allergic disease (asthma, hay fever and/or eczema) (age of onset);Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis);Asthma;Asthma (age of onset);Asthma (childhood onset);Asthma onset (childhood vs adult)
chr9	6213468	.	C	G	Allergic disease (asthma, hay fever and/or eczema) (age of onset);Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis);Asthma;Asthma (age of onset);Asthma (childhood onset);Asthma onset (childhood vs adult)
chr9	6213468	.	C	T	Allergic disease (asthma, hay fever and/or eczema) (age of onset);Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis);Asthma;Asthma (age of onset);Asthma (childhood onset);Asthma onset (childhood vs adult)
chr9	6213820	.	A	C	Asthma
chr9	6213820	.	A	G	Asthma
chr9	6213829	.	A	G	Allergy
chr9	6213829	.	A	T	Allergy
chr9	6221246	.	T	C	Atopic asthma
chr9	6222149	.	T	C	Asthma (childhood onset)
chr9	6231239	.	A	G	Asthma (childhood onset)
chr9	6233082	.	A	G	Allergic disease (asthma, hay fever or eczema)
chr9	6233082	.	A	T	Allergic disease (asthma, hay fever or eczema)
chr9	6236407	.	T	G	Asthma (childhood onset)
chr9	6252690	.	T	G	Asthma;Atopic asthma
chr9	6255967	.	G	C	Asthma;Asthma (adult onset);Asthma (childhood onset);Nonatopic asthma;Asthma;Asthma strict;Asthma vs allergic disease;Childhood asthma vs allergic disease;ICD10 J45: Asthma
chr9	6305904	.	C	A	Atopic asthma
chr9	6308729	.	C	A	Childhood asthma with severe exacerbations
chr9	6308729	.	C	T	Childhood asthma with severe exacerbations
chr9	6362365	.	G	A	Asthma (adult onset);Nonatopic asthma
chr9	6380605	.	C	G	Asthma
chr9	6504189	.	A	C	Asthma
chr9	6504189	.	A	T	Asthma
chr9	6545605	.	C	A	Asthma
chr9	6555079	.	A	G	Asthma (childhood onset)
chr9	6583518	.	C	T	Atopic asthma
chr9	7045058	.	T	C	Systemic vasculitis
chr9	7071706	.	A	G	Systemic lupus erythematosus
chr9	7267614	.	A	T	Diisocyanate-induced asthma
chr9	8376477	.	C	T	Asthma (childhood onset)
chr9	8658954	.	T	C	Diisocyanate-induced asthma
chr9	8712601	.	C	G	Gout
chr9	9065941	.	C	G	Crohn's disease (time to progression)
chr9	11706771	.	T	C	Systemic juvenile idiopathic arthritis
chr9	12483941	.	A	C	Psoriasis
chr9	12521826	.	G	A	Asthma (childhood onset)
chr9	12857311	.	A	G	Osteoarthritis (self-reported)
chr9	14228472	.	G	A	Type 1 diabetes (age at diagnosis)
chr9	16414508	.	G	A	Diisocyanate-induced asthma
chr9	17938353	.	T	C	Multiple sclerosis
chr9	17938353	.	T	G	Multiple sclerosis
chr9	18890063	.	C	T	Diisocyanate-induced asthma
chr9	19579429	.	G	A	Body mass index in asthmatics
chr9	19579429	.	G	C	Body mass index in asthmatics
chr9	19994738	.	G	A	Asthma
chr9	20098713	.	A	G	Asthma (toluene diisocyanate-induced)
chr9	20324372	.	G	C	Type 1 diabetes;Type 1 diabetes with low genetic risk score
chr9	20497144	.	G	A	Response to montelukast in asthma (change in FEV1)
chr9	21255050	.	C	T	Response to mepolizumab in severe asthma
chr9	21589042	.	G	A	Autoimmune thyroid disease
chr9	21589042	.	G	C	Autoimmune thyroid disease
chr9	22067594	.	A	G	Asthma and cardiovascular disease
chr9	22072265	.	A	C	Endometriosis or asthma (pleiotropy)
chr9	22072265	.	A	G	Endometriosis or asthma (pleiotropy)
chr9	22081398	.	G	T	Endometriosis or asthma (pleiotropy)
chr9	22081851	.	C	T	Endometriosis or asthma (pleiotropy)
chr9	22084311	.	C	T	Endometriosis or asthma (pleiotropy)
chr9	22085599	.	T	C	Coronary artery disease in type 1 diabetes
chr9	22088095	.	A	G	Asthma and cardiovascular disease;Endometriosis or asthma (pleiotropy)
chr9	22088261	.	C	T	Asthma and cardiovascular disease;Endometriosis or asthma (pleiotropy)
chr9	22098575	.	A	G	Asthma and cardiovascular disease
chr9	22098575	.	A	T	Asthma and cardiovascular disease
chr9	22098620	.	A	G	Asthma and cardiovascular disease
chr9	22099569	.	C	A	Asthma and cardiovascular disease;Endometriosis or asthma (pleiotropy)
chr9	22099569	.	C	T	Asthma and cardiovascular disease;Endometriosis or asthma (pleiotropy)
chr9	22102166	.	C	T	Endometriosis or asthma (pleiotropy)
chr9	22103342	.	T	G	Asthma and cardiovascular disease;Endometriosis or asthma (pleiotropy)
chr9	22103814	.	A	G	Asthma and cardiovascular disease;Endometriosis or asthma (pleiotropy)
chr9	22105928	.	T	C	Asthma and cardiovascular disease
chr9	22110132	.	T	C	Asthma and cardiovascular disease;Endometriosis or asthma (pleiotropy)
chr9	22112242	.	A	C	Asthma and cardiovascular disease;Endometriosis or asthma (pleiotropy)
chr9	22112600	.	T	A	Asthma and cardiovascular disease;Endometriosis or asthma (pleiotropy)
chr9	22112600	.	T	C	Asthma and cardiovascular disease;Endometriosis or asthma (pleiotropy)
chr9	22114496	.	A	C	Asthma and cardiovascular disease
chr9	22114496	.	A	G	Asthma and cardiovascular disease
chr9	22114496	.	A	T	Asthma and cardiovascular disease
chr9	22115027	.	A	G	Asthma and cardiovascular disease
chr9	22115287	.	T	C	Asthma and cardiovascular disease
chr9	22115960	.	A	G	Asthma and cardiovascular disease;Endometriosis or asthma (pleiotropy)
chr9	22116047	.	A	G	Asthma and cardiovascular disease;Endometriosis or asthma (pleiotropy)
chr9	22116072	.	T	C	Asthma and cardiovascular disease;Endometriosis or asthma (pleiotropy)
chr9	22116072	.	T	G	Asthma and cardiovascular disease;Endometriosis or asthma (pleiotropy)
chr9	22119196	.	T	C	Endometriosis or asthma (pleiotropy)
chr9	22123767	.	A	C	Asthma and cardiovascular disease
chr9	22123767	.	A	T	Asthma and cardiovascular disease
chr9	22125348	.	A	C	Asthma and cardiovascular disease
chr9	22133285	.	G	A	Multiple sclerosis
chr9	22134069	.	G	A	Psoriasis or type 2 diabetes (trans-disease meta-analysis)
chr9	22134254	.	G	A	Type 1 diabetes
chr9	22589172	.	G	A	Crohn's disease (indolent vs progressive)
chr9	22862536	.	G	T	Childhood asthma
chr9	23166744	.	C	T	Fulminant type 1 diabetes
chr9	23585743	.	A	T	Asthma
chr9	23585841	.	T	C	Asthma;Asthma (childhood onset);Asthma onset (childhood vs adult)
chr9	23586656	.	T	A	Asthma
chr9	25691229	.	T	G	Subjective response to placebo treatment in childhood asthma (change in cough/wheeze)
chr9	26458552	.	G	A	Lung function (FEV1) in asthma (dust mite allergen exposure interaction)
chr9	27308290	.	A	C	Adult asthma;Asthma
chr9	27308290	.	A	G	Adult asthma;Asthma
chr9	27313559	.	G	A	Osteoarthritis (hospital diagnosed);Osteoarthritis of the hip or knee (hospital diagnosed)
chr9	27882655	.	C	T	Immunoglobulin A
chr9	29148451	.	G	A	Carotid plaques in rheumatoid arthritis
chr9	29632144	.	A	C	Lupus nephritis in systemic lupus erythematosus
chr9	29632144	.	A	G	Lupus nephritis in systemic lupus erythematosus
chr9	29632144	.	A	T	Lupus nephritis in systemic lupus erythematosus
chr9	30001317	.	C	T	Asthma
chr9	32523739	.	T	C	Psoriasis or type 2 diabetes (trans-disease meta-analysis);Psoriasis;Psoriasis vulgaris
chr9	34710263	.	G	C	Celiac disease;Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy);Rheumatoid arthritis;Rheumatoid arthritis (ACPA-positive)
chr9	34889447	.	G	C	Asthma or allergic disease (pleiotropy)
chr9	35700840	.	C	G	IgE levels in asthmatics
chr9	37002145	.	A	C	Composite immunoglobulin trait (IgA/IgM)
chr9	37034098	.	C	T	Coronary artery disease in type 1 diabetes
chr9	37037979	.	T	A	Response to tocilizumab in rheumatoid arthritis
chr9	37037979	.	T	G	Response to tocilizumab in rheumatoid arthritis
chr9	68225014	.	T	C	Ocular sarcoidosis
chr9	69340801	.	A	G	Coronary artery disease in type 1 diabetes
chr9	71266958	.	G	GC	Crohn's disease
chr9	71822481	.	C	T	Type 1 diabetes with low genetic risk score
chr9	72717879	.	C	A	Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect)
chr9	75888242	.	A	G	Ankylosing spondylitis
chr9	75984217	.	C	T	Takayasu arteritis
chr9	76291234	.	A	G	Multiple sclerosis (age of onset)
chr9	79424447	.	A	C	Asthma (childhood onset)
chr9	79424447	.	A	G	Asthma (childhood onset)
chr9	79424447	.	A	T	Asthma (childhood onset)
chr9	80238712	.	A	G	Osteoarthritis (self-reported)
chr9	81822500	.	C	G	Rheumatoid arthritis
chr9	81822500	.	C	T	Rheumatoid arthritis
chr9	82696232	.	C	T	Ulcerative colitis
chr9	84559192	.	A	T	Gout (normal type)
chr9	86348093	.	C	T	Diisocyanate-induced asthma
chr9	86912543	.	A	G	Asthma (childhood onset)
chr9	86912543	.	A	T	Asthma (childhood onset)
chr9	86916761	.	A	G	Systemic lupus erythematosus
chr9	88216417	.	T	C	Renal overload gout
chr9	88220811	.	T	A	Psoriasis
chr9	88220811	.	T	C	Psoriasis
chr9	88232441	.	C	A	Egg allergy (parent-of-origin effect)
chr9	88232441	.	C	T	Egg allergy (parent-of-origin effect)
chr9	88268715	.	A	G	Psoriasis
chr9	89591072	.	T	G	Asthma
chr9	90129733	.	G	A	Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis
chr9	95582584	.	C	G	Asthma
chr9	95582584	.	C	T	Asthma
chr9	97784318	.	C	T	Autoimmune thyroid disease
chr9	98001173	.	C	G	Primary biliary cholangitis
chr9	98685681	.	T	C	Response to TNF inhibitor in rheumatoid arthritis (change in tender 28-joint count)
chr9	98831543	.	T	C	joint destruction in rheumatoid arthritis (rapid vs slow)
chr9	98831543	.	T	G	joint destruction in rheumatoid arthritis (rapid vs slow)
chr9	98889824	.	A	G	Asthma-COPD overlap syndrome
chr9	99153605	.	C	G	Asthma
chr9	99153605	.	C	T	Asthma
chr9	99170569	.	G	GTAGA	Asthma
chr9	99227424	.	A	G	Asthma (childhood onset)
chr9	99575049	.	G	A	Systemic lupus erythematosus
chr9	99637981	.	C	T	Systemic lupus erythematosus
chr9	99998509	.	G	T	Ocular sarcoidosis
chr9	100091874	.	C	T	Ocular sarcoidosis
chr9	100222426	.	T	C	Ocular sarcoidosis
chr9	101664982	.	C	A	Coronary artery aneurysm in Kawasaki disease
chr9	101664982	.	C	T	Coronary artery aneurysm in Kawasaki disease
chr9	102283422	.	A	G	Asthma
chr9	104527104	.	C	T	Kawasaki disease
chr9	104793430	.	C	A	Gout
chr9	104793430	.	C	T	Gout
chr9	107608174	.	A	G	Takayasu arteritis
chr9	107654141	.	C	G	Osteoarthritis (with total hip replacement)
chr9	107654141	.	C	T	Osteoarthritis (with total hip replacement)
chr9	107981011	.	G	A	Egg allergy (maternal genetic effects)
chr9	109366718	.	G	A	Diisocyanate-induced asthma
chr9	109366718	.	G	C	Diisocyanate-induced asthma
chr9	109808616	.	A	G	Decreased low contrast letter acuity in multiple sclerosis
chr9	110329243	.	T	G	Post-bronchodilator FEV1 x air pollution (NO2) interaction in childhood asthma
chr9	110354903	.	C	A	Takayasu arteritis
chr9	111611994	.	G	C	Adult asthma
chr9	114011589	.	A	G	Coronary artery aneurysm in Kawasaki disease
chr9	114011589	.	A	T	Coronary artery aneurysm in Kawasaki disease
chr9	114143263	.	C	T	Osteoarthritis of the hip or knee
chr9	114146866	.	A	G	Knee osteoarthritis
chr9	114146866	.	A	T	Knee osteoarthritis
chr9	114148867	.	A	T	Osteoarthritis
chr9	114153934	.	C	A	End-stage knee osteoarthritis;Osteoarthritis of the hip or knee
chr9	114153934	.	C	G	End-stage knee osteoarthritis;Osteoarthritis of the hip or knee
chr9	114167047	.	T	C	Osteoarthritis (hospital diagnosed);Osteoarthritis of the hip (hospital diagnosed)
chr9	114743760	.	T	TCTC	Asthma
chr9	114746157	.	T	A	Asthma
chr9	114746157	.	T	C	Asthma
chr9	114790969	.	T	A	Crohn's disease;Ulcerative colitis
chr9	114813633	.	C	T	Crohn's disease
chr9	114818634	.	C	G	Crohn's disease
chr9	114829725	.	C	A	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr9	114842790	.	T	C	Ulcerative colitis
chr9	114930602	.	C	G	Composite immunoglobulin trait (IgA/IgG)
chr9	114930602	.	C	T	Composite immunoglobulin trait (IgA/IgG)
chr9	115078463	.	G	A	Osteoarthritis (hip);Osteoarthritis (with total hip replacement)
chr9	115078463	.	G	C	Osteoarthritis (hip);Osteoarthritis (with total hip replacement)
chr9	115080028	.	A	G	Osteoarthritis (hip)
chr9	115580747	.	G	A	Osteoarthritis (hip)
chr9	116504416	.	C	T	Osteoarthritis (hip)
chr9	116562650	.	G	A	Osteoarthritis (with total hip replacement)
chr9	117713024	.	A	G	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr9	117713024	.	A	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr9	117758822	.	C	T	Osteoarthritis (hip)
chr9	118363468	.	T	C	Osteoarthritis biomarkers
chr9	119222275	.	A	G	Multiple sclerosis
chr9	119426326	.	G	T	Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count)
chr9	120367694	.	T	C	Asthma
chr9	120888256	.	T	A	Allergic disease (asthma, hay fever or eczema)
chr9	120933004	.	C	A	Endometriosis or asthma (pleiotropy);Rheumatoid arthritis (ACPA-positive)
chr9	120933004	.	C	G	Endometriosis or asthma (pleiotropy);Rheumatoid arthritis (ACPA-positive)
chr9	120944104	.	T	A	Rheumatoid arthritis
chr9	123392075	.	C	T	Rheumatoid arthritis
chr9	124066235	.	G	A	Asthma exacerbations in inhaled corticosteroid treatment
chr9	126621621	.	G	T	Osteoarthritis (hip)
chr9	126624581	.	C	G	Osteoarthritis (hip)
chr9	128226337	.	C	G	Atopic asthma
chr9	128424504	.	C	T	Systemic lupus erythematosus
chr9	128721272	.	T	C	Asthma
chr9	129740522	.	G	A	Asthma
chr9	132221380	.	G	A	Systemic lupus erythematosus
chr9	132900647	.	C	T	Psoriasis
chr9	133060938	.	C	T	Type 1 diabetes
chr9	133209554	.	C	T	Immunoglobulin superfamily containing leucine-rich repeat protein 2 levels
chr9	133279427	.	T	A	Allergic disease (asthma, hay fever and/or eczema) (age of onset);Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis)
chr9	134614732	.	A	G	Crohn's disease (need for surgery)
chr9	134864107	.	G	A	Thyrotoxic hypokalemic periodic paralysis in Graves disease
chr9	134864107	.	G	C	Thyrotoxic hypokalemic periodic paralysis in Graves disease
chr9	136365140	.	C	G	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr9	136365140	.	C	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr9	136372044	.	C	A	Crohn's disease;Ulcerative colitis
chr9	136374886	.	C	G	Ankylosing spondylitis;Ulcerative colitis
chr9	136494980	.	C	T	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
chr9	136505189	.	G	A	Crohn's disease;Ulcerative colitis
chr9	136745506	.	A	C	Multiple sclerosis
chr9	137345136	.	C	T	Asthma (childhood onset)
chrX	3492628	.	A	G	Antineutrophil cytoplasmic antibody-associated vasculitis
chrX	5266661	.	C	T	Antineutrophil cytoplasmic antibody-associated vasculitis
chrX	12814981	.	C	A	Systemic lupus erythematosus
chrX	12821033	.	G	A	Systemic lupus erythematosus
chrX	12821671	.	C	G	Systemic lupus erythematosus
chrX	12900169	.	G	A	Systemic lupus erythematosus
chrX	12953405	.	C	T	Celiac disease
chrX	13005622	.	G	A	Asthma (childhood onset);Asthma
chrX	13596999	.	A	G	Multiple sclerosis
chrX	29719287	.	G	T	Vitiligo
chrX	30555616	.	G	C	Systemic lupus erythematosus
chrX	30559729	.	A	C	Systemic lupus erythematosus
chrX	30559729	.	A	T	Systemic lupus erythematosus
chrX	34874386	.	G	A	Multiple sclerosis
chrX	49283326	.	A	G	Asthma (childhood onset);Asthma
chrX	49283326	.	A	T	Asthma (childhood onset);Asthma
chrX	49628118	.	C	T	Vitiligo
chrX	54776087	.	T	A	Egg allergy
chrX	54776087	.	T	G	Egg allergy
chrX	56882269	.	T	A	Systemic lupus erythematosus
chrX	56882269	.	T	C	Systemic lupus erythematosus
chrX	77849367	.	A	G	Graves' disease
chrX	78148837	.	A	G	Graves' disease
chrX	78924458	.	C	T	Rheumatoid arthritis
chrX	78996282	.	AAAT	A	Graves' disease
chrX	79087812	.	C	T	Rheumatoid arthritis
chrX	79110630	.	T	A	Rheumatoid arthritis
chrX	79152362	.	A	AGTTACAGAATGCCT	Graves' disease
chrX	79238163	.	A	C	Graves' disease
chrX	79238163	.	A	T	Graves' disease
chrX	79241621	.	A	C	Graves' disease;Thyrotoxic hypokalemic periodic paralysis and Graves disease
chrX	89275066	.	T	G	Antineutrophil cytoplasmic antibody-associated vasculitis
chrX	90549128	.	A	G	Antineutrophil cytoplasmic antibody-associated vasculitis
chrX	91557719	.	A	G	Antineutrophil cytoplasmic antibody-associated vasculitis
chrX	113634280	.	G	A	Poor prognosis in Crohn's disease
chrX	120733621	.	A	G	Antineutrophil cytoplasmic antibody-associated vasculitis
chrX	142272785	.	C	T	Antineutrophil cytoplasmic antibody-associated vasculitis
chrX	145701165	.	A	G	Gout (age <50)
chrX	147961254	.	C	T	Antineutrophil cytoplasmic antibody-associated vasculitis
chrX	153924366	.	C	G	Systemic lupus erythematosus
chrX	153924366	.	C	T	Systemic lupus erythematosus
chrX	153982797	.	G	A	Celiac disease;Rheumatoid arthritis (ACPA-positive);Rheumatoid arthritis
chrX	154000721	.	T	A	Systemic lupus erythematosus
chrX	154000721	.	T	C	Systemic lupus erythematosus
chrX	154018741	.	A	G	Rheumatoid arthritis;Systemic lupus erythematosus
chrX	154036016	.	C	G	Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive);Rheumatoid arthritis
chrX	154059995	.	A	C	Systemic lupus erythematosus
chrX	154521643	.	A	G	Systemic lupus erythematosus
chrX	154717327	.	G	A	Type 1 diabetes
chrX	155005499	.	A	G	Antineutrophil cytoplasmic antibody-associated vasculitis
